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ABSTRACT 
 
Growing replacement tissues and organs in the laboratory will revolutionise healthcare; however, the 
maturation of cells into functional tissue constructs requires the controlled presentation of biochemical 
factors within a mechanically suitable scaffold. In nature, the presentation of such signals is provided 
through factors and structures existent within the nanoarchitecture of the extracellular matrix (ECM); 
therefore, in tissue engineering there is significant need to develop dynamic advanced artificial tissue 
constructs capable of mimicking the complexities of the native ECM. The requirement for bioactive, 
innervated constructs that contain biologically relevant signals delivered through tuneable mechanisms 
has yet to be achieved. 
One approach to address this key-challenge is offered through bioprinting, which allows for the 
controlled spatial distribution of bioinks containing cells, structures and signals within a single printed 
construct. However, currently bioprinting applications are severely limited by bioink function – with 
the majority of bioinks either lacking sufficient mechanical properties or biochemical signalling. 
Therefore, there is a key need to develop bioinks which adequately mimic the native ECM on a 
nanostructured, chemical level – particularly in establishing effective control over cell fate and tissue 
innervation. 
Tissue composition and extracellular signalling varies substantially between tissue-types, and 
therefore, advanced approaches that allow for ease of mechanical and biological tuneability through 
modular mechanisms would provide a practical avenue for bioink development. Self-assembling 
peptides (SAPs) are a unique class of biomaterials capable of spontaneously forming simple biomimetic 
structures which entangle to form highly hydrated, bioactive networks with favourable conditions for 
cell maturation. These biomaterials are easily tuned through modification of amino acid sequence, 
enabling tailored control over biochemical signalling between cells and scaffold. This provides the 
ability to artificially replicate natural signalling in a controlled manner – bringing about desired cell 
behaviour. Using these peptides, a variety of synergistic ECM-protein analogues have been developed, 
including Fmoc-FRGDF containing fibronectin’s attachment motif RGD, and Fmoc-DIKAV, 
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containing laminin’s attachment motif IKVAV. Fmoc-SAPs possess the ability to be further 
functionalised through macromolecule addition, allowing for the presentation of charged, 
developmentally or structurally-important macromolecules on the surface of peptide fibrils. These 
macromolecules can integrate with the peptide networks, facilitating additional signalling and allowing 
for mechanical tunability.  
Here, we take advantage of these properties to develop an advanced and dynamic bioink for 
bioprinting applications. Initially, material enhancement is investigated through development of multi-
sequence scaffolds. Specifically, Fmoc-FRGDF is combined with a synergistic cell attachment motif 
PHSRN, either through sequence engineering (Fmoc-FRGSFPHSRN) or through control over assembly 
properties (Fmoc-FRGDF/Fmoc-PHSRN coassembly). Here, the coassembled (Fmoc-FRGDF/Fmoc-
PHSRN) system forms a synergistic network which promotes the attachment, proliferation and 
migration of muscle cells in vitro. The potential of Fmoc-SAP multi-sequence scaffolds is further 
investigated through the development of an artificial tumour microenvironment for cancer-cell studies. 
Here, Fmoc-FRGDF is combined with Fmoc-DIKVAV and used as a spheroid (LLC, NOR-10, LLC + 
NOR-10) micro-environment. The coassembled Fmoc-FRGDF/Fmoc-DIKVAV microenvironment 
enhances cancer-cell growth and progression compared to 2D cultures, non-encapsulate spheroids, and 
spheroids encapsulated in agarose. Agarose was selected as a control owing to the similar physical 
properties yet lack of biofunctionalisation. Results from this study reinforce the potential of Fmoc-SAPs 
as advanced microenvironments, and further support the ease of biological functionalisation inherent 
with this material. 
Further scaffold functionalisation is investigated through macromolecule addition. Here, one of 
two macromolecules are coassembled into a Fmoc-FRGDF network. The first macromolecule is 
fucoidan, a seaweed-derived polysaccharide with known anti-inflammatory properties, while the second 
is versican, a developmentally important proteoglycan which plays a variety of roles in muscle 
development. Versican was selected owing to its charge similarity to fucoidan, yet vastly different 
biological function. Fucoidan addition was found to increase fibre bundling and alter hydrogel 
mechanical properties, while versican addition had no substantial effect on hydrogel mechanics when 
XXI 
 
compared to an Fmoc-FRGDF empty-vector control. Cell morphology was substantially altered by 
macromolecule addition, with fucoidan samples resulting in smaller, rounder cells with fewer 
multinucleated syncytia compared to an Fmoc-FRGDF control, while versican hydrogels showed an 
initial decrease in cell-size and multinucleation after 24h and a comparable cell-size and multinucleation 
following 72h. Here, it is possible that macromolecule addition perturbs cells attachment, and therefore, 
macromolecule selection is a key consideration. Interestingly, the regain of cell morphological 
characteristics in versican-containing hydrogels following 72h indicates the ability of cells to break-
down versican, while the maintenance of small, round cells in the fucoidan hydrogels shows an inability 
for cells to break down fucoidan.  
The ability of Fmoc-SAPs to form components in bioinks is investigated through assembly with 
gelatin methacryloyl (GelMA) macromolecules. Initially, GelMA nanostructure and mechanical 
properties are investigated in response to increased degree of methacrylation or increased control. Here, 
structure-function relationships are drawn, and 18% methacryloyl Gelma (LM-GelMA) is selected for 
further bioink development owing to favourable thermoresponsive viscoelastic properties and improved 
strain tolerance. LM-GelMA assembly with coassembled Fmoc-FRGDF/Fmoc-PHSRN is investigated 
as a potential avenue to develop biologically and mechanically tuneable hydrogels. The incorporation 
of Fmoc-SAPs allows for control over sequence selection, while control over mechanical properties is 
offered through GelMA inclusion. LM-GelMA/Fmoc-FRGDF/Fmoc-PHSRN (FPG-Hybrid) bioinks 
demonstrate enhanced printability and are shown to support primary myoblast differentiation. The 
potential of Fmoc-SAP/GelMA bioinks to act as a modular bioink toolkit is further investigated through 
Fmoc-FRGDF/Fmoc-PHSRN substitution with Fmoc-DIKVAV, to develop a neural-suitable bioink 
(DIKVAV-Hybrid). This DIKVAV-Hybrid bioink demonstrated unique mechanical morphological 
properties and is shown to support rat cortical neurosphere viability.  
Throughout this project, the networks have been vigorously characterised through various 
analytical techniques, including micro/nanoimaging (Transmission electron microscopy, Atomic force 
microscopy, Cryo-scanning electron microscopy), Small-angle X-ray scattering, Small-angle neutron 
scattering, rheology, and spectroscopy; while the overall effectiveness of these systems have been 
XXII 
 
analysed through in vitro muscle and neural cultures. Work detailed through this thesis aims to 
vigorously characterise Fmoc-SAP hydrogels and bioinks, providing the foundations for further 
biological studies and material optimisation.
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Chapter One: 
 
 
 
1.   
INTRODUCTION 
 
 
1.1 Problem Statement 
 
Natural and synthetic biomaterials have long been investigated in their potential to recapitulate the 
native extracellular matrix (ECM) accurately and subsequently promote healthy tissue development. 
The ability of these materials to provide artificial cellular microenvironments to transplanted cells 
provides significant promise for regenerative medicine and tissue engineering applications. However, 
material development remains a key challenge, with few materials adequately mimicking the 
complexities of the native cellular microenvironment. 
1.2 Background  
 
The ECM is a protein-rich microenvironment which supports cells and provides signals controlling 
cellular behaviour. These signals may be mechanical or biochemical, both of which are crucial for 
adequately differentiating cells down the desired lineage and toward healthy tissue development.1 
Furthermore, the natural architectures existent in the ECM play a key role in regulating nutrient/oxygen 
diffusion and cell fate.2-3 As such, biomaterials are required to demonstrate high biomimicry in regard 
to mechanical, biochemical, and morphological characteristics, all while being consistent (between 
batches), biodegradable, biocompatible (with non-cytotoxic degradation products), and in-
immunogenic.4-6  
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Hydrogels are biomaterials characteristic in their high hydration and similarity to the natural 
ECM. Self-assembling peptides (SAPs) are a unique class of hydrogels formed through the spontaneous 
immobilisation of surrounding fluid through the formation of larger structures from short peptide 
building blocks.7 These materials are highly advantageous for tissue engineering applications owing to 
their simple synthesis (through routine peptide synthesis practices), high mechanical tuneability, and 
ability to incorporate bioactive amino acid motifs.7 Furthermore, these materials are inherently 
biocompatible as they are formed from amino acids, making them readily degradable in vivo.7  
Fluorenylmethoxycarbonyl (Fmoc)-SAPs have grown substantial interest of late owing to their ability 
to take advantage of π-β assembly and subsequently facilitate self-organisation through π- π stacking 
between Fmoc-groups and antiparallel β-sheet formation between short peptide sequences.8 This allows 
for self-assembly of peptide sequences which are significantly shorter than other SAP types and 
therefore enables relatively simple control over mechanical properties and biological functionality.9 
Furthermore, the short nature of these peptides allow for ease of synthesis, ultimately resulting in a 
highly versatile, low-cost material.9  
Controlling extracellular architecture is another important consideration which can influence 
cell fate. The mechanisms of self-assembly in nature are similar to those experienced by SAPs; 
consequently, the resultant nano/microarchitectures of the fabricated artificial matrix are highly 
reminiscent of the native ECM.10 Control of scaffold micro/macrostructure is another critical 
consideration. Advances in additive manufacturing techniques have enabled the bioprinting of cell-
laden constructs capable of providing a spatiotemporal presentation of biological and physical cues to 
cells in a multicomponent structure.11 Despite this, material development for bioprinting applications 
remains a key challenge.  
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1.3 Project Significance 
 
Preclinical trials using cell replacement therapy has shown substantial promise for the treatment of 
many conditions.12-14 The range of applications for these therapies include cartilage repair,15 skeletal 
muscle regeneration,16 myocardial infarction,17 lung disease,18 burn treatment,19 and neuronal repair.20 
This technology is rich in potential for improving patient quality of life, with studies demonstrating that 
if therapeutic cells transplanted into the damaged tissue manage to survive, they integrate within the 
host tissue and provide symptomatic relief.  However, one of the major limitations has been the 
restricted availability of appropriately specified cells suitable for transplantation and unacceptably high 
rates of cell death following transplantation.  
Current tissue engineering approaches fail to adequately model the complexities of cell-ECM 
interactions required for effective cell proliferation and differentiation; furthermore, the lack of an 
advanced matrix which can easily be co-implanted to foster the transfer and integration of cells in an 
inflammatory environment severely limits the utility of this approach.21  
Inspired by this challenge, this thesis investigates the development of an advanced, biomimetic 
SAP-based scaffold, through tailored control of bioactivity, mechanical properties, and deposition 
technique. We seek to develop design protocols for increasing Fmoc-SAP bioactivity; while enhancing 
material suitability for emerging deposition technologies through the development of Fmoc-inspired 
bioink toolkits that can be used for multiple tissue types and demonstrate ease of mechanical and 
biological customisation. We show that bioactivity of Fmoc-hydrogels may be increased through the 
inclusion of multiple bioactive sequences and developmentally important biomacromolecules, resulting 
in a more comprehensive model of the ECM. Furthermore, we show enhanced structural properties 
enabled through the inclusion of structurally advantageous macromolecules, resulting in the 
development of hybrid, Fmoc-inspired bioinks which facilitate cell viability, attachment, migration, and 
proliferation. Moreover, the multi-component nature of these hybrid materials allows extensive tuning 
of bioactive properties through sequence selection and ease of mechanical customisation through 
macromolecule modification. 
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1.4  Project Aims 
 
Research Aim: To control the supramolecular assembly of peptides, proteins and polysaccharides to 
create a bioinspired, multicomponent, nanostructured biomaterial that can present multiple signals to 
mimic the structure/function relationship of living systems to advance in vitro cell culture technologies. 
Breaking this aim down further provides the following deliverables: 
Deliverable 1:  Engineer SAPs that form nanostructured scaffolds to present multiple bioactive 
sequences to mimic the ECM more effectively 
Deliverable 2: Use supramolecular interactions to incorporate structurally and developmentally 
important macromolecules to the matrix, improving its mechanical and chemical properties. 
Deliverable 3:  Develop SAP-inspired bioinks demonstrating enhanced printability and suitable long-
term shape fidelity. 
Deliverable 4:  Implement bioprinting technologies to fabricate complex three-dimensional (3D) 
constructs conducive to cellular survival, proliferation, and differentiation. 
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1.5  Thesis Outline 
 
This thesis focuses on the use of Fmoc-based SAPs as versatile tissue-engineering biomaterials, with a 
particular focus on improving scaffold bioactivity and mechanical tunability through the introduction 
of multiple cell-recognised motifs and biomacromolecules. Furthermore, this thesis aims to build on 
understandings of macromolecule interactions and subsequently develop bioink toolkits through the 
development of SAP-based hybrid hydrogels. 
The thesis begins with a literature review in Chapter 2 to highlight current research in 
biomaterial development, Fmoc-SAPs design, bioink development, and deposition techniques 
(including bioprinting). Chapter 3 provides a comprehensive account of the materials and methods 
used throughout the thesis. Chapter 4 details the development of multi-sequence bioactive scaffolds, 
and in particular the development of Fmoc-SAP hydrogels containing synergistic epitopes, RGD, and 
PHSRN. Chapter 5 investigates the use of a coassembled Fmoc-FRGDF/Fmoc-DIKVAV hydrogel as 
a 3D cancer model. Chapter 6 focuses on further functionalising SAP hydrogels through the 
introduction of structurally and developmentally essential macromolecules. Chapter 7 investigates 
gelatin modification through functionalisation with methacryloyl groups, analysing structure-function 
relationships in response to peptide concentration and degree of functionalisation (DoF); then, Chapter 
8 builds on these findings to develop novel SAP-based bioinks which demonstrate optimised 
printability. Chapter 9 investigates the ability of these bioinks to be used in neural tissue engineering 
applications, demonstrating the efficacy of this approach for use as a modular bioink toolkit. Finally, 
Chapter 10 acts as a concise review of the thesis, summarising the project before Chapter 11 discusses 
future direction. The Appendix provides supplementary information not detailed elsewhere.  
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Chapter Two: 
 
 
 
2.  
LITERATURE REVIEW: BIOPRINTING AND 
BIOFABRICATION WITH PEPTIDE AND 
PROTEIN BIOMATERIALS 
 
2.1  Preview 
 
We introduce cell-therapy based techniques and subsequently discuss biomaterial source with emphasis 
on peptide and protein-based biomaterials for 3D tissue engineering applications. Methods for 
controlling scaffold deposition are highlighted, including hydrogel casting, electrospinning, and 
bioprinting.  Biomaterials intended for bioprinting applications are discussed thereafter; following 
which we review frontier application-specific bioprinting approaches; highlighting printing technique 
and material design. Finally, we summarise essential findings and expected future direction. 
Publications Relevant to chapter: 
Boyd-Moss, M., Fox, K., Brandt, M., Nisbet, D., & Williams, R. (2017). Bioprinting and Biofabrication 
with Peptide and Protein Biomaterials. In Peptides and Peptide-based Biomaterials and their 
Biomedical Applications (pp. 95-129). Springer, Cham.11 
Abstract   The ability to fabricate biomimetic artificial tissue constructs through the controlled 
organisation of cells, structures and signals within a 3D scaffold offers significant promise to the fields 
of regenerative medicine, drug delivery and tissue engineering. Advances in additive manufacturing 
technologies have facilitated the printing of spatially defined cell-laden artificial tissue constructs 
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capable of providing a biomimetic spatiotemporal presentation of biological and physical cues to cells 
in a designed multicomponent structure. Despite significant progress in the field of bioprinting, a key 
challenge remains in developing and utilising materials that can adequately recapitulate the 
complexities of the native ECM on a nanostructured, chemical level during the printing process. This 
necessitates materials capable of establishing effective control over cell fate and innervation; with 
recent investments focusing on the development of candidate materials from protein and peptide-
derived biomaterials. The ability of these materials to form highly printable hydrogels which are 
reminiscent of the native ECM has seen significant use in a variety of regenerative applications, 
including organ bioprinting and non-organ bioprinting. Here, we discuss current and emerging 
technologies for tissue engineering applications, with a particular focus on bioprinting and the 
development of peptide-based bioinks. Furthermore, this work highlights application specific, peptide-
based bioprinting approaches and provides insight into current limitations and future perspectives of 
peptide-based bioprinting techniques. 
2.2  Introduction: 
 
Regenerative medicine and tissue engineering are rapidly advancing fields which aim to replace 
functional tissue which may have been lost to disease, trauma or congenital anomalies.22 A key 
challenge for researchers is the requirement to develop an advanced tissue engineered scaffold capable 
of adequately mimicking the complexities of the native ECM; providing the necessary behaviour cues 
to cells while promoting angiogenesis to enable the delivery of nutrients to developing tissue while 
facilitating waste removal.23-25 To achieve this, multidisciplinary techniques and insight from 
engineering, chemistry, material science, nanotechnology and biology are required to enable the tailored 
design of biomimetic scaffolds. These highly structured materials must reproduce aspects of the natural 
tissue environment; for instance, having the capacity to simultaneously provide both physical support 
and biologically relevant molecules to cells. Effective materials are required to mimic the native ECM, 
resulting in active promotion and regulation of regenerative cell behaviours, including survival, 
migration, proliferation, and differentiation down appropriate linages.26  
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The native ECM is a protein-rich, 3D microenvironment responsible for providing much of the 
structure and signalling of tissue while maintaining hydration and homeostatic balance.27 This non-
cellular constituent of tissue and comprises two main components; the fibrous network and the 
interstitial fluid. The relative proportion of fibrous ECM proteins to interstitial fluid differs between 
tissue types; as does the proportions of each different fibrous protein type, and is dependent on the 
functional and physical requirements of the tissue, with many tissue microenvironments having a very 
low proportion of solid material 28. 
The ECM fibrous network is formed from macromolecules secreted from epithelial and stromal 
cells and includes collagen, elastin, laminin, fibronectin, and proteoglycans (Figure 2-1); providing 
tissue with structural architecture, physical signalling and stress resistance.  Collagens are the most 
abundant fibrous protein in the ECM1. Secreted by fibroblasts; collagen gives the bulk physical structure 
and tensile resistance of the ECM, while providing physical signals through cryptic bioactive motifs 29. 
Furthermore, collagen forms binding partners with many of the ECM proteins, strengthening the 
ECM.30 The physical and bioactive signalling of collagen provides cues relating to cellular migration 
and adhesion; both of which are essential for viable 
tissue growth and development.  
Another major structural protein existent 
within the ECM is elastin, which provides tissue with 
recoil and elasticity. Multiple crosslinked tropoelastin 
subunits form mature elastin fibres; which are 
secreted by endothelial cells, chondroblasts and 
fibroblasts 31, 32. To avoid overstretch and maintain 
integrity, glycoproteins (predominantly fibrillins) 
coat elastin fibres, while collagen fibrils form binding 
partners with elastin and limit stretch under severe 
stress 30, 33. Laminins are another structural protein 
existent within the ECM; these proteins provide 
 
Figure 2-1 – Artistic depiction of native 
extracellular matrix showing fibrous 
proteins and proteoglycans.  
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signalling to cells while aiding in tensile stress resistance.34 Three laminin subunits (α, β and γ) form 
laminin, which when constructed, form a cross-like pattern; this structure allows the laminins to bind 
to other laminins and ECM proteins.35 Within laminin lies the cell signalling motif, IKVAV, which 
facilitates cell communication through integrin-mediated pathways; providing environmental cues to 
cells – particularly neural cells.36 Laminins are a major component in basement membranes, which 
allow cell anchorage.30, 33 Heparin sulphate proteoglycans (HSPGs) are proteoglycans found within the 
ECM with multiple heparan sulphate side chains. HSPGs can bind to various structural proteins through 
protein-protein interactions, heparin sulphate-protein (HS-protein) interactions or interactions with 
heparin sulphate chains. Furthermore, HSPGs also bind to growth factors, where they are later presented 
or ‘cleaved and released’ to receptors 30. Fibronectin is another essential glycoprotein secreted by 
fibroblasts. This fibrous macromolecule binds to numerous ECM proteins and integrins, and plays a 
key role in intercellular signalling thorough bioactive sequence presentation - including synergistic cell 
attachment sequences Arg-Gly-Asp (RGD) and Pro-His-Ser-Arg-Asn (PHSRN).30, 37 
The interstitial fluid component of the ECM primarily consists of glycosaminoglycans (GAGs), 
growth factors, water and electrolytes.38 One particular GAG, hyaluronic acid (HA), is a non-
proteoglycan polysaccharide, which acts to hydrate cells and proteins existent within the ECM 
microenvironment. HA provides tissues with resistance against compressive stresses through the 
absorption of water resulting in swelling.39 Proteoglycans are also involved with the uptake of water 
and binding of growth factors, all contributing to the interstitial fluid component of the ECM.40 The 
non-fibrous portion of the ECM acts as a buffer and a growth factor reservoir, while resisting 
compressive stresses applied to tissues and organs.  The combination of the interstitial fluid component 
with the fibrous protein network results in a complex stress resistant system ideal for healthy cell 
growth. 
The biological and mechanical characteristics of the native ECM differs significantly between 
tissue types, suggesting there is no ‘one size fits all’ solution, therefore, careful consideration of 
biological and mechanical properties is required when engineering biomaterials for tissue engineering 
applications. There are three key aspects which dictate the effectiveness of a tissue engineering 
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approach; these being: 1) Cell selection, 2) Material design, and 3) Deposition technique. Cell selection 
is an obvious yet essential consideration; not only must cell type be carefully considered, but so too cell 
seeding density, as cell-cell interactions are vital for successful control of cell behaviour.41-43 Material 
design must consider biological and physical signalling, including motif presentation, material stiffness, 
and material nano/microarchitecture.44-45 Moreover, the material source is an important consideration, 
with various materials available from natural, synthetic, and semi-synthetic sources – all of which have 
respective advantages and disadvantages.11 Deposition technique allows for control over biomaterial 
spatial deposition; here, a key focus is bioprinting technique, owing to the high spatial temporal control 
inherent with these systems. Ultimately, an advanced biomaterial must protect cells during the 
deposition technique (e.g. bioprinting), while providing suitable biological and mechanical signals to 
promote desired cell-fate within a cytocompatible environment. 
 
Figure 2-2 – Considerations for ideal biomaterial design.  
 
  
Cell 
Optimisation
Deposition 
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Properties
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2.3 Cell-Therapy-based Techniques  
 
Despite efforts of self-repair, the human body is limited in its potential to replace tissue lost to damage 
or disease. In most cases where cell function is disrupted, the innate ability of self-repair in mature 
tissue is insufficient.46 Regenerative medicine aims to remedy these shortcomings resulting in sufficient 
and desirable tissue repair; one promising avenue is offered through cell therapy. 
Cell therapy aims to repair, replace or enhance tissue which has been damaged or lost to disease 
or trauma.47 Here, isolated and well-characterised cells are transplanted into damaged sites, where cells 
ideally integrate with host tissue achieving improved tissue repair. However, for cell therapy to be 
successful, careful consideration must be placed into cell type and seeding density.43, 48  The success of 
cell therapy is dependent on effective integration of multiple fields, including biology, immunology, 
tissue-engineering, molecular biology, material science, and transplantational biology, and requires 
clinical expertise relating to the disease being treated.46 Therefore, a comprehensive tissue engineering 
approach not only focuses on cell isolation, characterisation, and transplantation; but also on artificial 
environment design, deposition, and engineering.  
2.3.1 Artificial Three-Dimensional Microenvironments as Native Extracellular Matrix 
Mimics  
 
Two-dimensional (2D) cell culture practices have been traditionally used for in vitro cell and drug 
research, however, the efficiency of such practices have been called into question as the environment is 
quite far removed from tissues native, in vivo state.49 Therefore, 3D culturing techniques have become 
increasingly popular as of late owing to a greater ability to mimic the native ECM.  Similarly, complex 
cell therapy approaches require more than just isolated cell transplantation; as such, the enhancement 
of biomaterials to better mimic the native ECM is a growing area of frontier research. These ECM 
mimics can be broadly placed into three classes: natural, synthetic, or semisynthetic. 
2.3.1.1 Natural 
 
The native ECM contains a variety of fibrous proteins and polysaccharides which provide both structure 
and biochemical support to tissue.27 Natural peptide/protein-based hydrogels are extensively used in 
tissue engineering and regenerative medicine due to their high bioactivity which provides suitable 
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chemical, physical, and biological signals essential for supporting cell responses including survival, 
adhesion, differentiation and proliferation.50 These materials also provide favourable degradation 
properties and are capable of producing hydrogels with high biocompatibility and biodegradability;50 
yet present a risk of pathogen transfer, immunogenic reaction and batch-to-batch variance.51 52 
In tissue engineering and regenerative medicine, the central aim of scaffold development is to 
recapitulate the ECM. As such, many studies use physical, chemical and enzymatic processes to remove 
cellular content from tissue and yield a decellularised extracellular matrix (dECM).53-54 Other common 
protein-based biomaterials including collagen, gelatin, fibrin, and fibroin/fibrinogen are discussed 
further below. 
Animal Sourced 
Decellularised ECM 
 
To address the shortcomings of conventional tissue and organ transplantations, current research focuses 
on developing scaffolds of greater biocompatibility, resulting in reduced immunological rejection. As 
such, the use of dECM materials in tissue engineering applications has gained significant momentum 
due to their inherent ability to mimic the complexities of the native ECM; providing signals and 
structure to developing tissue. Currently, there is no gold standard decellularisation process, rather a 
variety of processes exist which may be categorised as chemical, physical, or biological.55 Chemical 
decellularisation processes make use of chemical agents, including acids and bases, hypotonic and 
hypertonic solutions, detergents, alcohols, and other solvents; physical processes take advantage of 
temperature, force and pressure, and non-thermal irreversible electroporation; whilst biological 
processes may employ enzymatic agents or non-enzymatic agents, including chelating agents, toxins, 
serum and serine protease inhibitors.56 The effectiveness of decellularisation is dependent on tissue 
source, density, organisation, composition, and finally, the desired final use of the tissue or organ.55-56 
An alternative approach focuses on the development of highly hydrated networks using 
lyophilised dECM tissue which is ground into a powder before subsequent dissolve in solution. These 
hydrated networks - or hydrogels - have become increasingly popular in soft tissue engineering 
applications due to their innate ability to maintain cell hydration and homeostatic balance. The ability 
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of hydrogels to absorb incredibly large amounts of water arises from hydrophilic functional groups 
attached to the polymeric backbone, while their resistance to dissolution arises from crosslinks between 
network chains.57 Hydrogels developed from dECM do not retain the 3D ultrastructure of the native 
tissue, but still maintain in vitro and in vivo biologic activity, and thus, still retain much of the functional 
complexities of their tissue origin.58-59 
The use of dECM tissue provides significant promise to tissue engineering applications; either 
as whole decellularised tissue constructs or as hydrogels. The use of whole decellularised constructs 
which retain the ultrastructure of tissues may be highly beneficial when considering full organ 
replacement; while dECM hydrogels may be of greater benefit when gels need to conform to specific 
shapes or fill voids. Despite the potential promise of this class of material, there are still significant 
issues relating to batch-batch variability and dECM composition.   
Collagen and Gelatin-based Biomaterials 
 
Similar to dECM-based hydrogels, collagen and gelatin-based hydrogels have been extensively 
investigated in tissue engineering applications due to their inherent biocompatibility, adhesive qualities, 
high porosity, high tensile strength and biodegradability; however their lack of rigidity, batch-to-batch 
variability and immunogenicity concerns limit their applicability in tissue engineering applications.60-61  
There are at least 19 different types of collagens existent in the native ECM; however, collagen type I 
is most extensively used in tissue engineering applications owing to its abundance and 
biocompatibility.4, 62 Collagen has a unique structure in which three individual polypeptide chains twist 
to form a 3-stranded rope-like structure.63 Partial hydrolysis of collagen breaks down this structure into 
single-stranded, gelatin molecules.50 Despite being denatured, gelatin can retain relevant moieties, 
including important cell attachment motifs such as Arg-Gly-Asp (RGD) sequences.64 Crosslinking of 
collagen and gelatin hydrogels is enabled through the use of glutaraldehyde, genipin, or water-soluble 
carbodiimides; or non-covalently through the entanglement of fibres.4, 50  Collagen is enzymatically 
degraded through collagenase and serine protease, allowing for local degradation controlled by cells 
present in the ECM.4  
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Gelatin may be further chemically modified through the addition of methacryloyl 
(methacrylamide and methacrylate groups) side groups, resulting in biofunctional materials of high 
mechanical tuneability which is reminiscent of a collagen-rich native ECM. 65 The resulting material, 
gelatin methacryloyl (GelMA), facilitates covalent crosslinking – typically through (photo)radical-
initiating systems and enzymatic crosslinking.65 In contrast to enzymatic crosslinking, photo-
crosslinking offers high spatial and temporal control over the crosslinking process.66  GelMA has 
demonstrated incredible promise for regenerative engineering applications, including bone,67 
cartilage,68 muscle,69 and vascular tissue engineering.70  
Hyaluronic Acid 
 
Hyaluronic acid (HA) (also known as hyaluronan) is an anionic,  non-sulphated linear GAG composed 
of repeating disaccharide units of D-glucuronic acid and N-acetylglucosamine 61. The abundant negative 
charges allow HA to absorb a substantial quantity of water, enabling expansion up to 1000 times its 
solid volume and consequently, the formation of a loose hydrated network with limited stability 71. This 
viscoelastic ECM protein is readily modified to permit the tuning of physical and biological properties, 
including solubility, degradation rate, viscosity and amphiphilicity.72 HA modification is performed 
through photopolymerization, enzyme-catalysed crosslinking, and Michael addition to form hydrogel 
structures.61 HA naturally interacts with several cell surface receptors (hyaladherins) which are involved 
in regulation of growth factor signalling and metabolism; however, HA is unable to bind with adhesion 
receptors such as integrins and therefore offers poor adhesion properties. HA is slowly degraded by 
hyaluronidase and can be modified with various chemical groups and polymers to incorporate cell-
adhesion ligands, protease-sensitive sequences, and signalling molecules for protein retention, 
increasing the adhesion and altering the degradation properties of the biopolymer 61, 73. Hydrogels 
developed from this protein are an attractive option for tissue engineering applications owing to their 
non-immunogenicity, biocompatibility, biodegradability, ease of chemical modification, cost-
effectiveness, targeting properties and high availability.72-73 Moreover, HA is highly versatile and as 
such has been widely used in a diverse range of applications, from surgery to tissue engineering.61, 72 
15 
 
Fibrin/Fibrinogen 
 
Fibrinogen is a soluble plasma protein which is converted to insoluble polymeric fibrin in response to 
vascular system damage, initiating clotting at the wound site.74 The conversion of fibrinogen to fibrin 
is initiated by the serine protease thrombin (factor  IIa) which plays a crucial role in haemostasis, 
inflammation and wound healing.75 Fibrin is a significant component of the provisional ECM formed 
during tissue repair following injury, and enables cell infiltration and anchoring at the wound site.76 
Fibrin clots allow platelet, leukocyte and fibroblast infiltration and adherence in wound sites enabling 
natural wound repair; this, combined with the ease of fibrinogen purification from blood has resulted in 
fibrin development for a number of applications76 - including tissue engineering,77 drug delivery78 and 
clinically as a tissue sealant.79 The provisional fibrin matrix also provides a physically supportive 
network to the wound site before eventually being replaced by natural ECM proteins, including collagen 
and fibronectin to form new tissue.80 
Fibroin 
 
Fibroin is a natural fibrous protein existent in silk spun by silk-producing arthropods, including 
silkworms and spiders.81 Fibroin is one of two main proteins of silk. The other protein, sericin, is usually 
processed out of the natural material through alkali- or enzyme-based degumming processes. The 
composition of silk fibroin is dependent on its source. Silk fibroin sourced from B. mori is composed 
of a heavy (H) and a light (L) chain linked together by a disulphide bond, and another glycoprotein 
(P25) is also non-covalently linked to these chains;82 these fibroin proteins can form anti-parallel β-
sheets.81 Alternatively, silk produced by non-mulberry Saturniidae do not contain L chain or P25; 
instead, they contain H-chain homodimers;83 forming β-sheets due to the higher Ala/Gly ratio and poly-
alanine blocks.81, 83 Silk fibroin offers numerous advantages for use as a biomaterial including its 
excellent inherent mechanical properties, good biocompatibility, biodegradability, ease of processing 
and ease of modification.81 As such, these materials have been used for the regeneration of a variety of 
tissues, including bone,84-85 tendon,86-87 and cartilage.88-90  
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Chitosan 
 
Chitosan is a linear polysaccharide derived from natural chitin – an abundant protein found in the 
exoskeletons of many crustaceans.91 Chitosan is non-toxic, stable, biodegradable and sterilisable; 
making it exceedingly versatile for an extensive range of applications. The insolubility of unmodified 
chitosan at neutral pH necessitates further modification for use in hydrogel synthesis. Modification of 
chitosan involves the formation of carboxylate salts, such as formate, acetate, lactate, malate, citrate, 
glyoxylate, pyruvate, glycolate, and ascorbate.50, 92  The deployment of unique crosslinking mechanisms 
enables chitosan gels to have tailored porosities, mechanical strengths and dimensions; allowing for a 
highly engineered natural scaffold. Finally, chitosan elicits no immunogenic response; making it 
extremely desirable for tissue engineering applications. 92 
Plant-Sourced 
Agarose 
 
Agarose is a natural, seaweed-sourced polysaccharide polymer which demonstrates unique 
characteristics beneficial to tissue engineering applications. Hydrogels developed from this natural 
carbohydrate polymer have resemblances to the natural ECM, are highly hydrated, show excellent 
biocompatibility, and demonstrate unique thermo-reversible gelation properties.93 Furthermore, the 
controllable permeation of oxygen and nutrients through agarose scaffolds, combined with its inherently 
inert structure, has seen significant use in tissue engineering applications – as both an artificial scaffold 
and drug delivery vehicle.93-94 However, the lack of bioactivity in agarose hydrogels have also restricted 
its use in tissue engineering applications, resulting in poor cell-material interactions; therefore, agarose 
hydrogels are often combined with other natural or synthetic hydrogels to develop biomaterial blends.93  
Alginate 
 
Alginate is an abundant protein isolated primarily from brown seaweed. Alginate is a highly 
biocompatible, non-immunogenic, hydrophilic unbranched polysaccharide which gelates gently 
through ionic binding between divalent or trivalent cations and guluronic-acid rich blocks. 50  This mild 
gelation method makes gels highly suitable for encapsulation of cells, proteins and peptides, 
minimalizing trauma while allowing the controlled release of growth factors and signalling molecules. 
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Unfortunately, alginate is not naturally biodegradable in mammals; this leads to a poorly regulated 
degradation pathway.95-96 Moreover, cells have no specific receptors for binding to alginate, and as such 
unmodified alginate offers poor cellular adhesion properties.96   Mechanical properties of the hydrogel 
can be controlled through alteration of physical factors including crosslinking density, crosslinker type, 
molecular weight distribution, gelation temperature and chemical modification of the polymer. 
Degradation may be improved through gamma-irradiation of alginate, ‘mismatching’, and partial 
oxidation; all of which work through the weakening of bonds within the polymer yielding enhanced 
degradation. 96 To encourage cell adhesion to the scaffold, alginate can be functionalised through 
coupling of ECM proteins including laminin, collagen and fibronectin. However, the coupling of whole 
proteins to alginate is difficult to control and can lead to non-specific interactions.96-97 Therefore, as an 
alternative, the bioactive epitope, RGD, may be bound to alginate through carbodiimide chemistry to 
offer a specific means to control cell adhesion while maintaining high specificity.96 The addition of the 
RGD motif has been shown to encourage myoblasts adherence, proliferation, and diffusion through a 
modified RGD-alginate scaffold; while a further study by the same author demonstrates control over 
myoblast phenotype through alteration of RGD motif concentration. 97,98 Alginate hydrogels are soft 
and have been shown to have shear shielding effects on cells which they encompass during extrusion;99 
making them a highly sought after natural hydrogel material.  
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Figure 2-3 – Microstructure of tissue and common biomaterials as observed under SEM . A) Sectioned 
skeletal muscle (Scalebar = 500 µm), B) Porcine muscle-derived decellularised ECM (dECM) (Scalebar = 500 
µm), C) Collagen/Gelatin Blend (Scalebar = 600 µm), and D) Alginate (Scalebar = 100 µm). Reproduced with 
permission from100,101 and 102 
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2.3.1.2 Synthetic 
 
Compared to natural hydrogels, synthetic hydrogels demonstrate higher water absorption capabilities 
and have more controlled structures.51, 57 These materials are also consistent between batches and 
demonstrate high chemical and physical tuneability.4, 103 Conversely, synthetic hydrogels are less 
biocompatible and less bioactive compared to natural hydrogels.103 Commonly used synthetic 
biomaterials include poly(caprolactone), poly(ethylene glycol), poly(lactic acid), poly(propylene 
fumarate) and poly(vinyl alcohol). 
Poly(caprolactone) 
 
Poly(caprolactone) (PCL) is a synthetic polyester of semi-crystalline structure which has been granted 
FDA approval for use in medical devices and drug delivery applications.103 PCL demonstrates excellent 
biocompatibility and is extensively used in bone-tissue engineering applications;104-105 and may be 
degraded under physiological conditions through microorganism, hydrolytic, enzymatic, or intercellular 
mechanisms.51 However, use of PCL in tissue engineering applications has been limited owing to its 
considerably slow degradation time.103  
Poly(ethylene glycol) 
 
Modification and copolymerization of the widely used synthetic polyether compound, poly(ethylene 
glycol) (PEG), results in the development of a variety of different hydrogels. Through specific 
modifications, favourable mechanical properties may be introduced into the hydrogel; specifically, 
photo-crosslinked and temperature-responsive PEG hydrogels may be synthesised through the 
modification of PEG with known degradable polymers, such as acrylates or methacrylates and 
poly(lactic acid) (PLA) or poly(lactide-co-glycolide) (PLGA) respectively.50 PEG hydrogels have also 
been synthesised through the grafting of enzyme sensitive molecules such as tyramine, to enable 
enzyme-mediated crosslinking.50 Crosslinked PEG hydrogels have been used in tissue engineering 
scaffolds wherein cells or signalling molecules and factors are encapsulated; as such, PEG has 
successfully been used for the encapsulation of islet cells, chondrocytes, fibroblasts and stem cells. 106 
Recently, the use of a degradable PEG scaffold (PEG-PLA) has seen successful encapsulation of HA; 
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through degradation of the scaffold, HA is released to bovine chondrocyte cells, resulting in 
significantly higher cell numbers than the HA-free control following four weeks culture. 107 
Poly(lactic acid) and Poly(lactic-co-glycolic acid) 
 
PLA and PLGA are thermoplastic aliphatic polyesters which have been approved for certain human 
clinical applications by the FDA.103 These materials have been extensively studied and have shown 
significant promise in health and tissue engineering applications, owing to their suitable mechanical 
strength and favourable biodegradability.103 Furthermore, their extended release rates spanning from 
days to months provides substantial application for biotherapeutic delivery.108 Degradation rates and 
products can be tuned via alteration of composition, structure and molecular weight of polymers, with 
degradation usually a result of hydrolysis of ester groups in their backbones.51  These materials can 
form biocompatible scaffolds which are frequently used in cartilage and bone engineering 
applications.103 
Poly(vinyl alcohol)  
 
Similar to PEG, Poly(vinyl alcohol) (PVA) is a hydrophilic synthetic polymer which has been widely 
explored for various tissue engineering and regenerative medicine applications. The formation of 
hydrogels from PVA involves crosslinking through either physical, chemical or radiation methods.109 
Physical crosslinking employs a freeze-thaw process, where repeated freeze-thawing cycles of the 
aqueous polymer leads to crosslinking and subsequently hydrogel formation. Chemical crosslinking 
may be performed through the addition of organic aldehydes to produce a hydrogel structure; while 
crosslinking through radiation may be done via γ-ray and electron-beam irradiation.50 Due to the 
possible toxicity of hydrogels produced through chemical or radiation methods, many authors prefer 
physical and photo-polymerisation crosslinking.109-111 Effective crosslinking yields a biocompatible 
hydrogel which is mechanically tuneable, tough, and elastic, while maintaining a high water content.109, 
111-113 Furthermore, PVA hydrogels are easily fabricated and sterilized, have the ability to attach to a 
variety of molecules, and through correct tailoring of mechanical properties, may be able to mimic the 
physical architectures of a variety of soft tissues.109-110, 112 However, PVA demonstrates poor cell 
adhesion and resists protein absorption, and therefore cells seeded onto the unmodified hydrogel display 
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low proliferation rates.112, 114 Nevertheless, PVA has a high abundance of hydroxyl pendant groups on 
its backbone which, through modification, provides sites available for the attachment of bioactive 
molecules including growth factors, adhesion proteins, and other molecules of biological importance.52, 
113-114 The covalent linkage of biological factors or amino-acid motifs to create a functionalised scaffold 
adequately promotes cell attachment, proliferation and migration, and provides a method to mediate 
biospecific cell attachment.109, 111-112, 114   
Poly(propylene fumarate) 
 
Poly(propylene fumarate) (PPF) is a linear, unsaturated, hydrophobic polyester which undergoes 
degradation through hydrolysis of the ester linkage to form propylene glycol and fumaric acid by-
products.115 Fumaric acid is a naturally occurring product of the tricarboxylic acid (TCA) cycle, and as 
such is biocompatible; while propylene, also known as 1,2-Propanediol is metabolised by the body and 
is commonly used as a drug diluent in pharmaceutical applications.116 Hydrogel formation of PPF can 
occur when synthesised as a block copolymer with PEG and crosslinked either chemically117-118 or 
through photo-crosslinking.119-121 Alginate-PPF hydrogels have also been developed to create a hybrid 
biosynthetic tissue engineering scaffold material.122  
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Figure 2-4 – Structure of Synthetic Biomaterials.  (A-E) Chemical Structure of A)PCL-diol, B) PPF, C)PEG, 
D)PLA, and E) PVA in i) partially hydrolysed and ii) fully hydrolysed form. F) SEM observation of Poly(lactic-
acid) hydrogel microstructure with different triallyl isocyanurate (TAIC) and dicumyl peroxide (DCP) 
crosslinker concentrations. i) PLA alone, ii) PLA + 1.0% wt. TAIC and 1.0% wt. DCP, and iii) PLA + 3.0% wt. 
TAIC and 1.0% wt. DCP. Reproduced with permission from 123-126 127 
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2.3.1.3 Semi-synthetic 
 
Semi-synthetic materials include synthetically sourced natural peptide-based materials and synthetic 
protein analogues. The primary focus of this section will be on novel self-assembling peptides. 
Self-assembling Peptides 
 
In nature, biological molecules self-organise into larger hierarchical structures to fulfil and perform a 
specific purpose, similarly SAPs are a class of bioinspired materials capable of forming complex 
biomimetic structures through the spontaneous self-assembly of low-molecular-weight peptide 
sequences.26 The ability of SAPs to spontaneously form hydrogels containing intricate nanofibrous 
networks, combined with their ability to be synthesised through standard peptide synthesis approaches 
has resulted in success in tissue engineering applications.128 As these peptides are synthesised from 
amino acids, they are inherently biocompatible and demonstrate good biodegradability.7 Mechanically, 
SAPs offer high tuneability; while biological functionalisation may be incorporated through the addition 
of well-known bioactive motifs.128 One particular advantage of these materials is their ability to undergo 
reversible shear thinning, making them highly suited to minimally invasive tissue engineering and drug 
delivery applications, particularly when loaded with cells.24,129 Semi-synthetic SAPs include peptide 
amphiphiles (PAs), lipid-like peptides, and aromatically-capped peptide derivatives. 
Peptide Amphiphiles 
 
PAs are unique bioinspired molecules consisting of two distinct regions: 1) hydrophobic aliphatic tail 
of variable length (usually between 12-16 carbon alkyl subunits in length), and 2) a hydrophilic 
biofunctional head-group attached to the tail via an amide bond.7 Under aqueous conditions, aliphatic 
tales aggregate driving assembly and resulting in high-presentation of peptide portions displayed on the 
surface of the structure.130 Depending on the sequence employed, self-assembly can be triggered via 
manipulation of pH or ionic concentration enabling supramolecular ordering into a variety of 
architectures including nanotapes,131 ribbons,131-132 fibrils,131 fibres,131, 133 and helical ribbons.7, 134  
PAs tail organisation leads to the self-assembly of nanofibrous architectures similar to 
cylindrical micelles where the hydrophobic tails pack in the core of the fibre while hydrophilic peptide 
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portions are expressed in high affinity on the surface of the structure.130 These compounds presented on 
the surface can be cell targeting through extracellular targeting ligands, receptor-specific peptides, or 
antibodies; enabling control of cell fate.135 PAs can be further functionalised through electrostatic 
interactions with macromolecules or other oppositely charged PAs – yielding hierarchically ordered 
networks.136 The nature of PA systems allows for use in both tissue engineering and drug delivery, 
wherein a high concentration of peptide may be delivered to the target (60-90% introduced 
concentration).135  
Unfortunately, many PAs still lack control over thickness, composition, and structure, as well 
as the functional dynamic nature and structural complexity found in the biological systems which limit 
many biological applications.136 Furthermore, PAs are synthetically complex which yields high costs 
for synthesis – ultimately limiting the potential for large scale production.7 
Aromatically-capped Peptide Derivatives 
 
Aromatically-capped peptide derivatives are a class of SAPs containing short peptide sequences paired 
to aromatic side-chains. These materials take advantage of π-interactions to drive self-assembly, 
resulting in the formation of biomimetic structures.8 Research in recent years has focused on protecting 
peptides with N-fluorenylmethoxycarbonyl (Fmoc) groups. One system which has been illustrated is 
that of   Fmoc- di-phenylalanine (Fmoc-FF) which forms a hydrogel under physiological conditions.8, 
137 Di-phenylalanine (FF) without Fmoc-protection has been shown to form elongated tubular structures 
in the presence of an organic solvent,138 however FF is unable to form supramolecular structures under 
biological conditions without the addition of an inorganic solvent.7 The addition of a Fmoc-group to the 
N-terminal has been shown to enable spontaneous self-assembly using a pH switch method under 
physiological conditions.7-8, 137 This self-assembly is driven by a combination of π- π stacking between 
aromatic side-chains and β-sheet formation between short peptide sequences.139 The combination of 
several of these interactions results in the formation of elongated nanofibrils. These nanofibrils then 
interact with each other, forming larger, branched fibrous bundles through supramolecular ordering; 
which further entangle to highly hydrated networks.7 The true novelty of these hydrogels, however, is 
their ability to present amino acid sequences in high density, facilitating biochemical signalling and 
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enabling biofunctionality through interaction with cell-surface receptors.26, 140-141 Recently, the resultant 
self-assembled structure of this peptide is also found to be influence by charge, allowing for charge 
induced α-helix transition, potentially providing advance in the therapy of neurological diseases through 
the inhibition of β‐sheet aggregation.142 Research performed by Modepalli and coworkers focused on 
introducing the fibronectin-derived cell-attachment motif RGD to the extensively studied peptide 
Fmoc-FF, resulting in the development of Fmoc-FRGDF. The addition of the cell-attachment motif was 
found to promote fibroblast attachment and enhance cell viability when compared to a scrambled 
sequence Fmoc-FDGRF, highlighting the ability to functionalise these peptides with bioactive motifs.143 
 
Figure 2-5 – Peptide self-assembly mechanisms  of A) Peptide amphiphiles (c16-AHL3K3-CO2H) showing i) 
peptide monomer showing lysine (blue), leucine (green), histidine (red), alanine and c16 (yellow), ii) β-sheet 
organisation ((PPIX)Zn in purple, showing ability to incorporate functional molecules) iii) Schematic of formed 
fibril cross-section showing hierarchical organisation, iv) TEM showing resultant fibrillar network formation. 
(scalebar 1 µm) B) Fmoc-SAP (Fmoc-FF) showing i) anti-parallel β-sheet organisation, ii) π- π stacking of 
fmoc-groups, iii – iv) formation of nanofibrils and v) CryoSEM showing network formed (scalebar 10 µm). 
Reproduced with permission  8, 144 
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2.4 Techniques. 
 
Further to material design, material deposition technique is of crucial consideration, with various 
deposition techniques available each with their respective benefits and shortcomings. Through control 
of deposition techniques, the macro- and microstructure of tissue engineered scaffolds can be tuned. 
Common material deposition techniques including casting, microinjection, electrospinning, and 
bioprinting are discussed further below. 
2.4.1 Casting 
 
Hydrogel casting is the most straightforward material deposition technique which forms the basis for 
preliminary biomaterial testing. Here, the material is deposited within a mould or culture plate and cells 
are either seeded on top or are encapsulated within the material. Casting provides a simplistic way of 
culturing tissue in vitro and allows for material testing regarding bioactivity and cytotoxicity. Despite 
the simplicity of this approach, material properties including porosity, material stiffness, signalling 
availability, and nutrient diffusion profile need to be well understood. Using casting approaches, 
bioactive properties of a range of materials has been tested, including materials intended for muscle145 
and cartilage regeneration.146  
2.4.2 Microinjection 
 
Microinjection allows for minimally invasive material deposition in vivo. Microinjection is a simple 
technique where the material is passed through a needle and delivered to the site of interest. Materials 
intended for microinjection must be both biologically suitable (incorporating similar properties to cast 
materials), and must allow for adequate shear-thinning and recovery of structure post-injection.147 
Furthermore, these materials are required to protect encapsulated cells during the injection process. 
Microinjection techniques also need to consider needle diameter and flow-rate, as increased shear-stress 
is known to result in decreased cell-viability.148 Microinjection is a fundamental technique from which 
various other material deposition techniques build on – including various bioprinting and 
electrospinning approaches. 
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2.4.3 Electrospinning 
 
Electrospinning is a unique deposition technique which takes advantage of electrostatic forces to drive 
material extrusion. A typical electrospinning setup consists of several basic components, these being: a 
spinneret, a high-voltage power supply, a syringe pump, and a grounded collector.149 During 
electrospinning, a high voltage difference is placed between the spinneret and a collector plate. Next, 
the syringe pump pushes material to the outlet of the spinneret; here it forms a small droplet (Taylor 
cone) which is influenced by the electric field created as a result of the high voltage difference.149-150 
The electric field induces a charge on the spinning solution, resulting in a charge repulsion force which 
is directly opposite to the droplets surface tension force.150 Upon raising the electric fields’ intensity 
past a critical value, the repulsive force overcomes material surface tension forces, resulting in material 
expulsion from the spinneret toward the collector.150 This jet of material undergoes a change in material 
state (usually from solution to gel or solid) resulting in the formation of a fibrous network on the 
collector plate. Nanofibre morphology can be altered through modification of electrospinning process 
properties (electric potential, flow-rate, needle to collector distance and, collector shape and 
composition), materials parameters (viscosity, conductivity, surface tension, molecular weight , and 
concentration of material), and/or ambient parameters (humidity, temperature).151 Spinneret design also 
influences fibre morphology which has driven the development of various spinneret types, including 
single-nozzle, double-/multi-nozzle, co-/multi-axial, multi-channel, flat, cylinder, and disk 
spinnerets.149 Using these spinnerets, a range of fibres have been created, including core-shell, triaxial, 
multichannel, and Janus fibres.149 Collector selection allows for control over network architectures, with 
a variety of collector types available, including traditional grounding plate, 3D columnar, helical spring-
shaped, parallel electrodes, patterned, rotating drum, and rotating disk collector.149 Using these 
collectors, networks can be designed with random orientation or aligned nanofibers. Electrospun 
scaffolds have similar architectures to the native ECM, and can be modified to include bioactive 
signalling; and as such have found success in a range of tissue engineering applications, including 
bone,152 cartilage,153-154 muscle,155 cardiac156 and nerve regeneration.151, 157-158 Electrospun scaffolds 
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have also found use in drug-delivery applications – particularly as a means of controlling drug release 
profiles.159 
 
Figure 2-6 – Tubular Electrospun chitosan nanofibrous scaffolds for nerve regeneration.  Top: Tubular 
structures formed from A) Non-orientated chitosan fibres, B) orientated chitosan fibres, C) Bi -layer chitosan 
scaffold with orientated fibres on the inside and non-orientated on the circumference. Bottom: Magnified inner 
tubular surface showing D) non-orientated construct network morphology, E) orientated network morphology 
F) Bi-layer construct with orientated inner surface. Reproduced with permission from 158 
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2.4.4 Bioprinting 
 
The recent advancements of additive manufacturing technologies, material science, and cell biology 
have brought forth the ability to print complex artificial tissue-engineered scaffolds through 
bioprinting.160 This technology enables the precise placement of structural and biologically suitable 
materials containing living cells, biochemicals, and biologically relevant molecules within a well-
defined geometry.160 The ability of these printed tissue scaffolds to have spatially defined regions of 
different material enables previously unachievable fabrication of tissue constructs capable of providing 
the necessary behavioural cues to cells, while also facilitating vascular network generation.161 Currently 
several bioprinting techniques are being employed for the printing of tissue constructs based on 
commercially available or modified printers, including inkjet bioprinting, extrusion bioprinting, laser-
assisted bioprinting, and stereolithography-based bioprinting. Figure 2-7 (A) shows an idealised 
cartoon of the ability to present multiple cell types in a defined fashion with excellent fidelity.  
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Figure 2-7 – Schematic showing working principles, bioprinting systems, and outcomes.  A) Cartoon of 
multi-component tissue construct showing different cellular and structural regions; top neural cells, middle 
rigid component, bottom blood vessel. B) Basic bioprinter; C) Inkjet printhead workings showing actuator in 
dark blue, Mechanical printhead showing plunger configuration, Pneumatic -driven printhead showing 
compressed air input with valve, and solenoid printhead showing solenoid valve (left to right)e; D) AFA -LIFT 
laser-assisted bioprinter (left), MAPLE-DW laser-assisted printer (right); and E) Beam-scanning SLA (left), 
Mask-image projection SLA (right). Reproduced with permission from 11 
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Developments in nanotechnology and microfabrication have led to advances in additive 
manufacturing, enabling the ability to fabricate micrometre scale scaffolds and control the spatial 
distribution of cells more accurately than before.162 Among these developments lies the advanced 
biofabrication technique of bioprinting, which enables the printing of cell-laden inks, distinguishing 
this method from traditional additive manufacturing techniques in which the processing parameters 
were typically too harsh to support cell viability.160, 162 The ability to print 3D, cell-embedded artificial 
tissue construct allows for highly intricate scaffold development, opening the possibilities for successful 
and complex tissue engineering approaches that were previously unavailable. Ultimately, bioprinting 
has the potential to (1) Create fully functional replacements for damaged or missing tissues in patients, 
and (2) Rapidly fabricate small-sized tissue models or organoids, for diagnostics, pathology modelling, 
and drug delivery.163 
Figure 2-7(B-E) shows schematic versions of each of these approaches. In bioprinting, the 
spatially controlled, layer-by-layer deposition of biological materials, biochemicals, and living cells 
yields 3D tissue constructs.160 There are four necessary steps to this process: (1) a computerised 3D 
solid model is developed and converted to a suitable file format; (2) the file is then sent to the bioprinter 
for manipulation to control part orientation and scaling; (3) the structure is printed through layer-by-
layer deposition, and finally; (4) maturation, where the materials undergo tissue culture conditions 
either in vivo or in a bioreactor160, 164  Different printing techniques depend on vastly different material 
dispersion mechanisms.165 The four predominant bioprinting techniques currently being used for tissue 
engineering applications are inkjet bioprinting, extrusion bioprinting, laser-assisted bioprinting, and 
stereolithography-based bioprinting.163 Table 2-1 provides an overview of these techniques with 
references for further reading.  
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Table 2-1 - Bioprinting processes showing working principle, materials, advantages and disadvantages . 
Bioprinting Process Technique Working Principle Materials Advantages Disadvantages References 
Inkjet-based  Thermal-based Thermally-vaporised bubble-induced 
pressure. 
Low viscosity hydrogels 
and bioinks (relatively 
volatile) 
High-speed printing,  
Cost-effective,  
Widely available 
Require relatively volatile 
materials 
Thermal and mechanical 
stresses, 
Low droplet directionality,  
Nonuniform droplet size,  
Prone to clogging,  
Unreliable cell encapsulation 
166 160 
Acoustic-based Acoustically induced force  
(piezoelectric through actuator volume 
change, ultrasound through ultrasound 
field) 
Low viscosity hydrogels 
and bioinks 
Controlled droplet size and 
direction, 
No thermal stress 
High Frequency induced cell 
damage and possible lysis 
160 
Electrostatic-
based 
Actuator volume change through 
electrostatically induced pressure plate 
movement 
Low viscosity hydrogels 
and bioinks 
No thermal stress 
Stable over a variety of 
materials 
Difficulty controlling droplet 
size 
167-168 
Microextrusion-based Pneumatic-driven Air-pressure driven extrusion (valve-free 
and valve-based) 
Low viscosity hydrogels 
and bioinks 
Very high precision and 
accuracy  
Simple mechanisms 
Force limited only by pressure 
capabilities of the system 
Possible delay due to 
compressed gas movement 
Compressed gas/air must be 
sterile 
Increased system cost as 
accuracy increases 
160, 169 
Mechanical-
driven 
Mechanical-induced pressure-driven flow 
(screw and piston) 
High viscosity hydrogels 
and bioinks 
Direct control over bioink flow 
Able to facilitate high viscosity 
hydrogels 
Affordable, portable, easy to 
program, great special control 
Careful gear selection for 
screw-based approaches due to 
increased pressure and pressure 
drops along the nozzle 
Lower force capabilities 
160, 169 
Solenoid-based Pressure-driven flow controlled by a 
solenoid valve 
Low viscosity hydrogels 
and bioinks 
High accuracy (>1 µL drops) 
Advantageous for low viscosity 
inks particularly with ionic or 
UV-irradiation based 
crosslinking mechanisms 
Time delays between actuation 
and opening/sealing. 
Vulnerable to factors affecting 
accuracy and reproducibility. 
Particularly affected by change 
in material temperature yielding 
a change in viscosity. 
169-170 
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Requires high actuation 
pressure to force material 
through open valve 
Laser-based Laser-guided 
Direct flow 
Laser-controlled optical-trapping enabling 
biological molecule positioning 
Limited materials with 
low-reflective index.’ 
Simple mechanism Low cell viability 
Low throughput 
Low-range of fabrication 
potential 
Movement efficiency greatly 
affected by material refractive 
index 
171-174 
Matrix-assisted 
pulsed laser 
evaporation 
direct-writing 
(MAPLE-DW) 
Localised laser-induced pressure change 
resulting in hydrogel and cell deposition 
from ‘ribbon’ (hydrogel-coated) onto 
substrate  
Non-transparent 
bioinks/hydrogels with cell 
coating. 
Low-powered lasers 
 
Potential for UV induced cell 
damage. 
Ineffective with optically 
transparent inks 
160, 174-176 
Absorbing film-
assisted laser-
induced forward 
transfer (AFA-
LIFT) 
Localised laser-induced pressure change 
resulting in bioink deposition from 
‘ribbon’ (film-coated)  onto substrate 
Moderate range of bioinks. Offers UV protection to 
bioinks 
Can print transparent bioinks 
 
Potential film-derived 
contamination. 
 
160, 174-176 
Stereolithography-
based 
(SLA-based) 
Beam-scanning Photopolymerisation of bioinks through 
spatial control of scanning laser beam 
resulting in photosensitive ink irradiation 
and subsequent layer-by-layer deposition 
on build platform. 
Photosensitive bioinks Very High accuracy Defocusing issues 
Risk of damage to cells (UV 
and chemical from 
photoinitiator) 
High costs 
164, 166, 177 
Mask-image-
projection 
Photopolymerisation of bioinks through 
mask-controlled light irradiation, resulting 
in a layer-by-layer deposition on build 
platform. 
Photosensitive bioinks High accuracy prints 
Rapid printing (Whole layers at 
once) 
Mask-associated challenges 
(accuracy, costs) 
Risk of damage to cells (UV 
and chemical from 
photoinitiator) 
High costs 
164, 166, 177 
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2.5 Peptide-based Bioinks 
2.5.1 Biomaterials for Bioink Development 
 
Bioprinting allows the controlled deposition of biomaterial print-blends containing living cells in a 
liquid or hydrogel suspension, which are termed ‘bioinks’.178 Ideally, bioinks should form tuneable, 
biocompatible scaffolds with desired mechanical strength, rigidity, and shape fidelity; should resemble 
the native ECM; and should facilitate large scale synthesis with minimal batch-to-batch variation.179 
Furthermore, bioinks are required to protect cells from shear stresses while maintaining printability and 
nutrient transport post-printing.180 Understanding the biological, chemical, and mechanical 
requirements of cells is crucial for successful tissue growth while understanding the material properties 
of bioinks is essential for ensuring printability, biocompatibility, and suitable biodegradability.181  
The study of bioink material science is of particular interest for biological and engineering 
fields, including drug delivery, tissue engineering, and regenerative medicine.182 Peptide and protein-
based biomaterials, in particular, have been extensively researched for use in tissue engineering 
applications, due to their highly favourable inherent biological properties.5  
Natural hydrogels are used extensively in tissue engineering applications due to their inherent 
biological properties; however challenges exist relating to batch-to-batch variation, risk of immune 
response and pathogen transfer.51-52, 128 Synthetic hydrogels provide good mechanical properties, high 
tuneability, and present no immunological concerns;51, 183 however generally demonstrate poor 
biodegradation and limited bioactivity unless modified.184-185 Semi-synthetic SAPs are engineered from 
versatile molecular building blocks which under appropriate conditions, spontaneously organise to form 
an entangled nanoscale scaffold. These are easily synthesised through standard peptide synthesis 
approaches such as solid-phase peptide synthesis (SPPS).7 The inherent biocompatibility and 
biodegradability of these molecules, combined with their batch-to-batch consistency and ease of 
synthesis have resulted in this material showing promise for biomedical applications.7   
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2.5.2 Peptide and Protein-Based Hydrogels 
 
Peptide and protein hydrogels are formed through the entanglement of typically nanofibrous structures 
which immobilise their surrounding solvent to form highly hydrated networks. These biomaterials are 
promising candidates for bioink formulation, due to their highly hydrated state (99% w/w water of their 
dry weight), ability to mimic the native tissue ECM, and propensity to undergo shear thinning before 
returning to their original shape.6, 186-187 This combined with their ability to shield cells from stress 
during printing makes these materials highly sought after for tissue bioprinting applications.188 Peptide 
and protein-based biomaterials may be natural (collagen, gelatin, fibrin)61, semi-synthetic (SAPs),141, 
189-191 or may form part of a biosynthetic blend (Collagen-PEG, PEG-Fibrinogen).192-193  
Table 2-2 gives an overview of these classes of materials and their uses. 
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Table 2-2 - Peptide-based bioink classification, formulation, and application. 
 Base-Material Bioink Application References 
Natural Decellularised ECM 3% Cartilage dECM, hASCs and hTMSCs Cartilage regeneration 53 
3% Adipose dECM, hASCs and hTMSCs Fat (adipose) tissue regeneration 53 
3% Heart dECM, Rat myoblast cells (L6) Cardiac Muscle regeneration 53 
Collagen/gelatin 10% wt. GelMA, 0.6% wt. collagen type I, Ru/SPS (0.2 mM /2 mM), MCF-7  Various tissues, (successful tests using HACs 
and HSCs 
194 
2wt% collagen, 4% wt. alginate, MC3T3-E1  Osteogenic regeneration 195 
2wt% collagen, 4% wt. alginate, hASCs  Various tissues 195 
5% collagen, crosslinked with 1 mM genpin (1h), MG63s, hASCs Hard-tissue regeneration 196 
5% (w/v) gelatin, HEK-293s, 3U mL-1 mTgase Angiogenesis/vasculagenesis 197 
Fibrin and fibrinogen 50 unit mL-1 thrombin, 80 mM Ca2+, HMVEC, (Thrombin printed onto fibrinogen 
biopaper to form fibrin gel) 
Angiogenesis/microvascular fabrication 198 
Fibroin 8 wt% Silk Fibroin, 15wt% gelatin, hTMSCs, 500units tyrosine. Osteogenesis, chondrogenesis. 199 
Semi-Synthetic SAPs 10 mg mL-1 Ac-ILVAGK-NH2, H1ESCs, hMSCs. Gastrointestinal and skin regeneration 179 
 2.24% (w/v) Gelatin + 0.75% (w/v) PA (CH3(CH2)15VVAAEEIKVAV, or 
CH3(CH2)15VVAAEE) + SV40SM Cells 
Bile duct formation 200 
HA-Gel-PEG 4 parts 2% Heprasil, 4 parts 2% Gelin-S, 1 part 8% PEGDA, 1 part 8% 8-Arm PEG 
Alkyne 
Liver regeneration (toolkit shows various other 
tissues) 
201 
Gel-PEO 3% gelatin, 2% PEO, HUVECS, HEK-293s, 3U mL-1 mTgase angiogenesis/vasculagenesis/various tissue 197 
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2.5.2.1 Natural  
Decellularised Extracellular Matrix 
 
In bioprinting applications, dECM constructs are often lyophilised before being ground into a powder 
and subsequently used to form a hydrogel.53-54 Pati et al. have developed application-specific dECM 
bioinks from decellularised adipose, cartilage and heart tissues.53 Decellularisation of the ECM material 
is completed through a combination of physical, chemical and enzymatic processes to yield 
decellularised tissue with a ~98% reduction in cellular contents and only 39 ± 15, 11 ± 1 and 6.7 ± 1.2 
ng of deoxyribonucleic acid (DNA) mg-1 of fat, cartilage and heart dECM, respectively. The required 
amount of ground dECM powder was weighed and solubilised in a solution of 0.5 M acetic acid with 
10 mg of pepsin for 100 mg dECM – such that the final concentration of dECM was 3%. Dropwise 
addition of 10 M cold sodium hydroxide (NaOH) neutralised the pH of the solution to physiological 
level (7.4). Human adipose-derived stem cells (hASCs) and human turbinate mesenchymal stromal cells 
(hTMSCs) were used to assess the effectiveness of adipose and cartilage dECM bioinks on adipogenic 
and chondrogenic differentiation respectively. Rat myoblast cells (L6) were used to verify the functional 
enhancement of myoblasts in heart-derived decellularised matrix (hdECM) bioinks. Concentrated 
culture media (10 ×) was added to the cell-free bioink at 1/10th volume before cultured cells are mixed 
into the bioinks. Constructs were printed, and cell viability tested following 24h, 7 days, and 14 days 
of culture. All constructs demonstrated high cell viability (>95%) following 24h culture, and cell 
viability was maintained above 90% following 7 days and 14 days in culture, with active cell 
proliferation evident. Analysis of gene expression finds increased expression in chondrogenic (SOX9 
and COl2A1), cardiogenic (Myh6 and Actn1) and adipogenic (PPARγ and LPL) constructs when 
compared to that of a control collagen bioink. The authors further expand this work through the 
development of a photo-crosslinkable dECM hydrogel facilitated through addition of a vitamin B2 
photoinitiator; resulting in a hydrogel which was approximately 33 times stiffer than the aforementioned 
dECM bioink.54 
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Collagen and Gelatin 
 
A gelatin-based photo-crosslinkable bioink composing 10% wt. GelMA and 0.6% wt. collagen type I 
was described by Lim et al.194 wherein two bioinks are engineered with different photoinitiators; the 
first contains the photoinitiator Irgacure 2959 (0.05% wt.), while the second contains ruthenium/sodium 
persulfate (Ru/SPS, 0.2 mM /2 mM). The Irgacure 2959 containing bioink undergoes ultraviolet (UV) 
light (300-400 nm) enabled crosslinking while the second was crosslinked under visible light (400-450 
nm). Using these bioinks, complex, multilayered constructs (dome and human nose) were printed. 
Breast adenocarcinoma cells (MCF-7) encapsulated within the hydrogels show the visible light system 
to be superior for bioprinting applications. When light source intensity is held constant (3 mW cm-2), 
MCD-7 cells demonstrate >80% cell viability in the visual light system after day 1 at the highest 
photoinitiator concentration (2 mM/20 mM, 15-minute irradiation, 3 mW cm-2) compared to ~45% at 
day 1 for the highest concentration of Irgacure 2959 (0.5%, 15-minute irradiation, 3 mW cm-2). 
Similarly, when photoinitiator concentration was held constant at minimal concentration (0.05% for 
Irgacure 2959 and 0.2 mM/2 mM for Ru/SPS), the visual light maintained a high cell viability of ~90% 
even under the highest intensity (100 mW cm-2) compared to ~45% for cells placed in the high intensity 
(100 mW cm-2) UV environment. However, cell viability was sufficiently maintained when extremes 
were avoided in the UV crosslinked system. Recent research has extensively characterised GelMA - 
Irgacure 2959 UV crosslinking systems, enabling high cell viability (~91%) through careful control 
over UV intensity and photoinitiator concentration.202 
Two collagen-based bioinks are developed by Lee et al.195 The first bioink (CA-1) consists of 
collagen which has been cultured with preosteoblast cells for 1 day to allow for initial ECM deposition 
within the collagen bioink; while the second (CA-3) consists of collagen which has been cultured with 
preosteoblast cells for 3 days to allow for increased ECM deposition. Both inks were formulated as 
follows:  2% wt. collagen was gelled in an incubator for 30 minutes before preosteoblast cells were 
cultured on the gelled collagen for various periods (1 day and 3 days). Mixtures were then combined 
with 4% alginate and cells in equal volumes. Other culture periods were also investigated however 
culture periods of 1 day and 3 days were found to present the best balance between printability and 
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bioactivity. A pure alginate bioink was used as the control.  An ionic crosslinking method was employed 
through aerosol dispersion of calcium chloride (CaCl2) onto printed constructs, facilitating alginate 
crosslinking. The compressive moduli of the printed inks were found to be 68 ± 15 kPa, 67 ± 13 kPa, 
and 69 ± 8 kPa for CA-1, CA-3, and alginate respectively. Unfortunately, these moduli were considered 
too low and therefore had to be reinforced with PCL struts.  Initial cell viability was sufficiently high 
with ~88% viability at day 1. Cell proliferation rates were significantly higher on scaffolds fabricated 
from CA-3 compared to those fabricated from either CA-1 or alginate. From this study, the 
collagen/ECM/alginate bioink was found to be effective in simultaneously presenting physical and 
biological cues required for tissue regeneration. Mechanically, the CA-3 bioink was able to protect cells 
from processing conditions, while biologically the ECM components of the ink provide a highly active 
cell-platform when compared to the alginate bioink.  
Similarly, Kim et al. develop a collagen-based bioink which uses Genipin as a crosslinking 
agent.196 Type-I collagen was mixed at 3, 5, and 7% wt. with cells (MG63s and hASCs) to yield a bioink 
that was biocompatible and mechanically stable. Printed constructs were crosslinked through structure 
incubation in 0.1, 0.5, 1, 3 and 5 mM genipin solutions over different periods (1, 6, 24, 48 hours). Of 
these conditions, 5% collagen crosslinked with genipin at a concentration of 1 mM for 1 hour was found 
to produce the best results. Using this ink, a cellblock was printed with a cell viability of >95%. In 
vitro testing of the printed construct shows increased viability, cell proliferation, and osteogenic activity 
compared to constructs printed using a control alginate-based bioink.  
A gelatin-based bioink developed by Irvine et al. takes advantage of enzymatic crosslinking 
through microbial transglutaminase (mTgase).197 Three gelatin concentrations (3%, 5%, 7%) were 
investigated. Human umbilical vein endothelial cells (HUVECS) and human embryonic kidney cells 
(HEK293s) were encapsulated within the hydrogels. Lower concentrations of gelatin showed increased 
cellular spreading resulting in pseudopodia; while cells in the higher concentration (7%) gelatin bioinks 
maintained a round shape. Constructs fabricated from bioinks with lower gelatin concentrations lacked 
sufficient mechanical strength, resulting in the inability to retain the printed structure; subsequently, a 
5% gelatin concentration was used for all subsequent printing applications. Using this bioink, 
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substantial proliferation was achieved, however difficulty remained in controlling shear induced 
apoptosis immediately following printing. 
Finally, Liu et al. reduce GelMA concentration thresholds in bioinks by controlling hydrogel 
temperature prior to printing. Physical crosslinking was initiated through bioink cooling to 4° C for 20 
minutes, enabling the development of GelMA physical gels (GPGs). Using this technique, the authors 
print stable constructs using substantially lower (3-5% w/v) concentrations compared to previously 
reported concentration thresholds (7% (w/v)) (Figure 2-8 A-H). Following printing, GPGs were 
covalently crosslinked through subjection to UV light in the presence of a photoinitiator. Printing of 
GPG bioinks allowed for the formation of hydrogel networks with significantly larger average pore-
size as assessed through SEM (Figure 2-8 I-K). HUVECs printed within the scaffolds demonstrated 
enhanced cell spreading compared to high concentration hydrogels with a smaller average pore-size 
(Figure 2-8 L-N). 
Together, these studies suggest that gelatin and collagen hydrogels have substantial promise for 
bioprinting applications owing to their favourable bioactivity and inherent ECM nanoarchitecture, 
however, care needs to be taken to avoid cell damage during printing and subsequent crosslinking. 
Specifically, careful consideration needs to be placed into bioprinting conditions (temperature, pressure, 
shear stress) and crosslinking parameters (photoinitiator, wavelength, concentration, temperature and 
time). Furthermore, as these materials are animal derived, there is an inherent risk of batch-to-batch 
variation, and therefore, advanced material approaches should work toward developing synthetic 
analogues. 
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Figure 2-8 – Bioprinted Gelatin-based (GelMA Physical Gels, GPG) constructs showing printed 
macroscopic shape (4% GPG gels) (A-H), microscale organisation observed via SEM (I-K), and cell 
spreading (L-N). Printed construct macroscopic shape includes A) cube B) rhombus, C,D) diagonal square 
(scalebar 3 mm), E,F) a thin‐walled tube, and G,H) a cone‐shaped tube (scalebar 2 mm). SEM images show 
nanostructure organisation of I) 3% GPG, J) 4% GPG, and K) 5% GPG (scalebar 100 µm). Cell-spreading on 
3% GPG, 4% GPG, and 5% GPG hydrogels (scalebar 100 µm). Reproduced with permission from 203 
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Fibrin and Fibrinogen 
 
Fibrin-forming hydrogels have recently been investigated for use as bioinks in bioprinting applications, 
enabling highly effective tissue regeneration owing to fibrins inherent wound healing properties. Xu et 
al. investigate the effectiveness of fibrin in bioprinting applications through modification of a thermal-
based inject printer to allow the layer-by-layer printing of neural (NT2) cells and fibrin gels, enabling 
the development of 3D cellular structures for use in neural tissue engineering applications..204 Two inks 
were developed, firstly, a NT2-containing cell ink was formulated through the re-suspension of cultured 
NT2 neuronal precursor cell pellets in Dulbecco's phosphate-buffered saline solution (DPBS), before 
secondly, a fibrin gel was formulated by printing bovine thrombin (dissolved in CaCl2 to yield a final 
concentration of 20 IU mL-1) onto a thin fibrinogen substrate. Bioinks were deposited in an alternating 
fashion starting with the fibrin ink. Once printed, this fibrin gel was allowed 3-5 minutes to facilitate 
fibrin formation before a new cartridge containing NT2 neurons was loaded into the printer and neurons 
printed on top of the fibrin layer. Another thin layer of fibrinogen was then placed over the printed 
structure, and the process was repeated. Results showed that this printing method allowed the controlled 
deposition of patterns and structures of primary hippocampal and cortical neurons while maintaining 
neuronal phenotypes and basic electrophysiological function.   
The group further build on this work formulating a thrombin bioink containing human 
microvascular endothelial cells (HMVEC) which was printed onto a fibrinogen substrate to form cell-
laden fibrin channels suitable for microvascular formulation.198 Various concentrations of fibrinogen, 
thrombin and Ca2+ were investigated, and an optimal formulation was selected such that the final bioink 
contains: 1-8 million HMVEC mL-1, 50 unit mL-1 thrombin, and 80 mM Ca2+ in 1× DPBS. This bioink 
was able to be effectively printed onto a ‘biopaper’ containing 60 mg mL-1 fibrinogen solution, enabling 
the simultaneous deposition of cells within a fibrin support gel. The cells were found to align within the 
channel during gel formation and effectively proliferate to form confluent lining along with the fibrin 
scaffold after 21 days.  During proliferation, endothelial cells within the scaffold were shown to form 
tubular structures which show angiogenesis functionality. Furthermore, the fibrin-based bioinks 
demonstrate desirable biodegradability and mechanical properties highlighting their potential use in 
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microvascular regeneration. Fibrin provides a novel natural biomaterial for use in bioprinting 
applications owing to its propensity to form a stable hydrogel upon thrombin and fibrinogen interaction. 
This enables the gentle encapsulation of cells within the printed scaffold and subsequently has attracted 
the interest of recent studies. 
Fibroin 
 
Fibroin-based bioinks were developed by Das et al. in which hTMSCs were encapsulated in a silk-
fibroin-gelatin (SF-G) blend.199 The SF-G blend was prepared by adding 15% wt.  of sterilised gelatin 
powder to 8% (w/v) SF solution; next, hTMSCs were encapsulated within the SF-G solution to 
formulate the bioink. Two crosslinking mechanisms (enzymatic and physical) were investigated; the 
first incorporated tyrosinase (500 units) to enable enzymatic crosslinking; while the second was 
physically crosslinked through sonication at 50% amplitude for 10 seconds.  When compared to an 
alginate control, both SF-G bioinks demonstrate superior mechanical properties regarding stiffness and 
stability, with the enzymatic crosslinking mechanism resulting in the best stability over 21 days. 
However, cellular responses of hTMSCs show cell proliferation to be highest in the enzyme crosslinked 
bioink. The enzyme-crosslinked ink also facilitates better cellular differentiation down chondrogenic 
and adipogenic lineages, while osteogenic differentiation favoured the physically crosslinked hydrogel. 
Cellular viability of the enzymatically crosslinked bioink was maintained for over a month when 
cultured under in vitro conditions. From this study, it is clear that the SF-G bioinks support better cell 
proliferation, differentiation and viability than the control bioink, likely due to the increased bioactivity 
facilitated through gelatin combined with the favourable mechanical properties of the silk fibroin. 
2.5.2.2 Semi-Synthetic 
 
Semi-synthetic materials include natural materials synthesised through artificial means, including 
SAPs. SAPs are a unique class of biomaterials able capable of spontaneously self-organising into larger, 
more useful structures. This process is similar to those that drive self-assembly in nature, and therefore, 
the developed fibrous architectures are biomimetic and highly reminiscent of the native ECM.205 
Moreover, the high degree of control over biological sequence presentation offered by SAPs enables 
the development of novel ECM-inspired signalling, ultimately leading toward the development of novel 
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synthetic protein analogues.140 However, despite SAPs being ideal candidates for bioprinting 
applications, few bioprinting studies have taken advantage of these semi-synthetic hydrogels.  
Raphael and coworkers demonstrate the potential of SAPs to be used in bioprinting applications 
through the use of two SAP-based peptides: “PGD-Alpha1” and “PGD-AlphaProB”. The authors find 
both materials demonstrate enhanced printability and cell viability – with encapsulated mammary 
epithelial cells remaining viable over 7 days. Similarly, Loo et al. detail a novel SAP bioink formulated 
from lysine-containing hexapeptides which self-assemble into stable nanofibrous hydrogels.179 Two 
hexapeptides (Ac-ILVAGK-NH2 and Ac-LIVAGK-NH2) were investigated and found to outperform 
various other SAPs regarding gelation behaviour – requiring both lower peptide concentration and 
gelation time. Optimised formulations of the Ac-ILVAGK-NH2 and Ac-LIVAGK-NH2 hydrogels 
resulted in the development of bioink suitable formulation, capable of gelating within 5 and 30 seconds 
respectively. Furthermore, both gels were shown to possess highly desirable mechanical properties with 
a stiffness of 40 kPa being achieved in Ac-ILVAGK-NH2 gels. Human mesenchymal stem cells 
(hMSCs) encapsulated within Ac-ILVAGK-NH2 gels were able to be successfully cultured and 
demonstrate uniform suspension within dispensed droplets. Using this bioink approach, multicellular 
constructs were fabricated by sequential deposition of different cell types localised to specific domains 
as demonstrated through the deposition of a multi-domain construct which could serve as an in vitro 
model for skin. Furthermore, through the culturing of intestinal epithelial cells on the SAP hydrogel, 
the native phenotype of the cultured cells was maintained – even outperforming that of the gold standard 
Corning transwell membranes. Finally, the peptide scaffolds were also shown to be inherently 
biocompatible and stable, with subcutaneous implantations of hydrogel discs into healthy mice 
persisting for at least two months with minimal immune response and no capsule formation evident.  
This study highlights the potential for SAPs in bioprinting applications; however more significant 
developments are still required to improve the gelation speed and mechanical properties of these 
materials. 
Hedegaard et al. investigate the feasibility of PA-based bioinks for bioprinting applications.189 
Bioinks are developed from novel short peptide sequences which are coassembled with naturally 
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occurring biomacromolecules and proteins; including fibronectin, collagen, keratin, elastin-like 
proteins and HA. Through the coassembly of these materials, the authors can generate hierarchical 
constructs with tuneable molecular composition and structural control. Inkjet printing of these 
biomaterials allows for the formation of complex structures facilitating control of construct presentation 
in the micro-/macro-scale. The ability of these materials to encapsulate NIH-3T3 and adipose-derived 
stem cells enable printing in high cell density with high cell viability (>88%). Tuning of printing 
parameters allows for a high degree of control over print size, shape, surface topology and network 
orientation; with various print droplet shapes achievable – including hollow-toroid, open sac, and 
biconcave. Such systems provide significant promise for tissue engineering in vitro models and network 
orientation. 
2.5.2.3 Biosynthetic 
 
Although synthetic scaffolds offer the ability to precisely control the mechanical properties of a 
material, they often provide inadequate biological information for effective cell culture; alternatively, 
biologically derived scaffolds offer an array of biological signals to regulate cell activity which can 
make it difficult to precisely regulate specific cellular events.206 Thus, combining the two material types 
can yield a biosynthetic scaffold which simultaneously provides the structural characteristics of 
synthetic materials while presenting the inherent biofunctionality of natural materials.206 Despite this, 
few biosynthetic peptide-based bioinks have been developed to date.  
Skardal et al. have developed a comprehensive hyaluronic acid-gelatin (HA-Gel) bioink toolkit 
comprised of a two-stage polymerisation technique.201 A combination of PEG-based crosslinkers 
facilitates the development of a highly modular toolkit suitable for a variety of tissue types. Bioinks are 
formulated through the addition of tissue-derived dECM-based solutions containing combinations of 
growth factors, collagens, GAGs, and elastin, enabling the targeting of specific tissues for regeneration. 
Using this model, primary liver spheroids were encapsulated and printed within a liver-specific bioink 
to create in vitro liver-like constructs which demonstrate high cell viability and tissue functionality 
through measurable albumin and urea output. The biosynthetic bioink toolbox provides both 
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biochemical and physical properties required in tissue engineering applications and as such have a vast 
potential to make a significant impact in a variety of applications. 
A biosynthetic gelatin-poly(ethylene oxide) (Gel-PEO) bioink was developed by Irvine et al. 
for 2D printing applications.197 The bioink was formulated from 3% Type-A gelatin, 2% poly(ethylene 
oxide), 3 U mL-1 mTgase, HUVECs, and HEK-293s. 3 U mL-1 mTgase was chosen to enable rapid 
gelation (3 minutes for Gel-PEO bioink). The bioink showed consistent, even print lines with little ink 
bleeding, producing a well-defined grid pattern. Cellular fluorescence imaging showed increased cell 
proliferation and a high degree of spreading throughout the bioink.  
Biosynthetic peptide-based materials show potential in bioprinting applications due to their 
ability to demonstrate a versatile range of mechanical properties while maintaining bioactivity; 
however, more research is required to increase the ease of synthesis and application-specific 
modification of these materials. 
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2.6 In Vitro and In Vivo Applications of Peptide-Based Inks 
 
Bioprinting of artificial tissue constructs is set to revolutionise tissue engineering approaches allowing 
for rapid yet controlled deposition of cells, biomimetic structures and signals within a spatially-defined 
advanced tissue scaffold.207 The potential capability of these approaches to provide immediate 
perfuseable structures, facilitating a greater depth of nutrient transport, allows for fabrication of tissue 
with greater thickness.145 Furthermore, the use of cell-laden bioinks provides superior-distribution of 
biological components within a scaffold;208 while the spatial delivery of different bioinks using multi-
head bioprinting technologies allows for the printing of gradient transition tissue constructs.209 
Bioprinting using peptide-based bioinks has been extensively investigated and have found use in both 
organ-engineering and non-organ tissue engineering applications. Non-organ tissue engineering 
includes the printing of bone,210-212 osteochondral,208, 213 cartilage,209, 214-215, vascular,70, 198, 216-217 
muscular,218 and neural tissue constructs,219 while organ regeneration includes the printing of cardiac,53, 
220-221 cardiac valve,222-223 liver,224-225 and skin constructs,226 as well as organoid regeneration for use in 
drug screening applications.224-225 Table 2-3 highlights various applications where peptide-based 
bioinks have been used and details printing process and bioink selection. 
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Table 2-3 - Application specific peptide-based bioprinting examples classified into non-organ and organ tissue regeneration. 
Application Bioprinter Classification  Technique/configuration Ink formulation References 
Tissue Regeneration 
Bone Regeneration Extrusion Mechanical-based hMSC laden hydroxyapatite/alginate/gelatin bioinks 210 
Extrusion Mechanical-based  MSC laden PLA/collagen microcarriers within GelMA-Gellan Gum hydrogel. (microcarrier 
containing bioink) 
211 
Inkjet - hMSC laden agarose/collagen bioinks 212 
Osteochondral regeneration Extrusion Pneumatic and Mechanical  hTMSC laden Atelocollagen bioink, hTMSC laden CB[6]-HA bioink, DAH-HA, PCL 
support ink 
213 
Inkjet  Thermal hMSC laden PEG-GelMA bioink 208 
Inkjet Thermal hMSC laden Acrylated peptide (GRDS and GCRDGPQGIWGQDRCG) /PEG hydrogel 208 
Cartilage Regeneration Extrusion Mechanical-based  Chondrocytes  laden Collagen type II 209 
Extrusion Mechanical-based  BMSC laden Alginate, Agarose, PEGMA and GelMA bioinks, PCL support ink 214 
Extrusion Pneumatic  hMSC laden GelMA bioink 215 
    
Vascular Regeneration Extrusion Pneumatic-based PDMS support-ink, Pluronic F127 fugitive ink, GelMA (cell free) ink, 10T1/2 laden GelMA 
bioink, hNDF laden GelMA bioink 
70 
Extrusion Mechanical-based  HUVEC and MSC laden GelMA/Alginate/PEGTA 216 
Inkjet Thermal HMVEC laden thrombin bioink (forms fibrin bioink) 198 
Laser-assisted AFA-LIFT Eahy926 endothelial cell or B16 carcinoma cell-laden thrombin/CaCl2 bioink printed onto 
Fibrinogen substrate. 
217 
Muscle Regeneration Extrusion 
 
Pneumatic C2C12 Myoblast laden mdECM bioink 218 
Neural Regeneration Extrusion 
 
Pneumatic Schwann cell-laden fibrinogen/factor XIII/HA/PVA bioink 219 
Organ Regeneration 
Cardiac Regeneration Extrusion Pneumatic- and Mechanical-driven  L6 laden hdECM bioinks 53 
Extrusion Pneumatic- and Mechanical-driven CPC and/or MSC laden hdECM, 220 
Extrusion Mechanical-driven HUVEC laden Alginate/GelMA 221 
Cardiac Valve Regeneration Extrusion Mechanical-driven SMC laden Gelatin/Alginate, VIC laden Gelatin/Alginate, 222 
Extrusion Mechanical-driven HAVIC laden HAMA/GelMA 223 
Liver Regeneration Extrusion Mechanical-driven ADSC laden gelatin/alginate/fibrinogen and Hepatocyte laden gelatin/alginate/chitosan 224 
Extrusion Mechanical-driven  HepG2/C3A spheroid laden GelMA 225 
Skin Regeneration Extrusion Mechanical-driven  hFB laden Fibrin gel 226 
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2.6.1 Non-Organ Tissue Regeneration 
2.6.1.1 Bone-Tissue Regeneration 
 
Bone is a bioceramic composite which is made up of organic collagen, inorganic hydroxyapatite (HAp), 
and water.227 The hierarchical organisation of these materials results in the development of various bone 
types through formation of mineralised collagen fibrils. The organisation of these fibrils is responsible 
for the determination of mechanical properties of bones, and therefore enables the formation of different 
bone types.228 Bone tissue engineering is of particular interest when considering the regeneration of 
large orthopaedic defects or the requirement to develop orthopaedic implants that are mechanically 
more suitable to their biological environments.229 
Wüst et al. develop a bioink designed specifically for bone-tissue regeneration applications.210 
The bioink is composed of encapsulated hMSCs within an alginate and gelatin hydrogel prepared with 
differing amounts of HAp, and demonstrates good printability with an extrusion-based bioprinter. A 
two-step gelation method is employed which implements both reversible thermal- and irreversible 
chemical-crosslinking, enabling rapid gelation during printing and long-term stability post-printing. To 
facilitate thermal gelation, the bioink solution was liquefied through heating to 40°C before printing. 
After extrusion, the bioink was cooled through contact with a cold substrate (~10°C) leading to a 
temporary increase in ink rigidity. Scaffolds were soaked in a cold CaCl2 solution following printing to 
enable chemical crosslinking of alginate within the ink; resulting in irreversible crosslinking yielding a 
scaffold which demonstrates long-term stability. Three different bioink formulations were investigated: 
8%HAp/2%Alginate/10%Gelatin, 4%HAp/2%Alginate/10%Gelatin, and 2%Alginate/10%Gelatin. 
The bioinks all demonstrate good cell viability (84-85%) 3 days following printing; however, the 
inclusion of HAp was found to increase bioink viscosity that leads to more difficult handling during 
printing. Interestingly, the addition of HAp was not found to significantly alter the stiffness of 
crosslinked bioink constructs, and hydrogels were shown to be ineffective in resembling the mechanical 
properties of bone tissue. 
An alternative approach for the development of bioprinted bone regeneration was investigated 
by Levato et al. wherein mesenchymal stem cell (MSC) laden poly(lactic acid) microcarriers were 
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distributed within a GelMA-Gellan Gum (GelMA-GG) hydrogel.211 Using a ‘green solvent-based’ 
method, PLA microcarriers of average diameter 120 μm were fabricated and later functionalised with 
human recombinant collagen type-I to improve cell responsiveness. The hydrogel component of the 
bioink was formulated through GelMA incorporated with 0.1% (w/v) Irgacure 2959 to facilitate photo-
crosslinking; and 1% (w/v) GG to improve printability. Microcarriers were either preseeded with rat 
derived MSCs and then supplemented at 30 mg mL-1 into hydrogel solutions (GelMA-GG MC-MSCs) 
or were supplemented alongside MSCs into the hydrogels (GelMA-GG, MC’s, and MSCs); creating 
two separate bioinks. A cell viability of 60% was observed after 1 day of culture in GelMA-GG MC-
MSCs, and 90% after 3 days of culture. The addition of PLA microcarriers was also shown to increase 
the compressive modulus of GelMA-GG. Alizarin red staining intensely marked diffused areas around 
MC-MSCs complexes, indicating strongly mineralised areas; furthermore, on a molecular level MC-
MSCs gels showed the most osteocalcin secretion and demonstrated matrix calcification suggesting the 
ability to form mature bone-like tissues. Despite the bioink not reaching sufficient compressive 
strengths for initial load-bearing applications, clinically relevant sized constructs were able to be printed 
with large cell numbers and high shape fidelity; furthermore, the bioinks demonstrated good printability 
and showed homogeneous cell distribution throughout the printed scaffold.  
Duarte Campos et al. utilise inkjet bioprinting for the fabrication of bone-tissue engineering 
scaffolds.212 In combining agarose hydrogels with collagen type-I, a thermoresponsive bioink can be 
developed which demonstrates superior printability than pure collagen hydrogels. The agarose/collagen 
bioinks (containing MSCs) demonstrated high cell viability (>98%) 21 days post-printing. Softer 
hydrogels with lower agarose concentrations and higher collagen concentrations were shown to 
demonstrate the highest degree of spreading with the longest elongation, as seen in ITGB3 staining; 
furthermore, through quantitative polymerase chain reaction (qPCR) it was evident that genes COL1 
and RUNX2 were expressed significantly more in low stiffness hydrogels (AG0.5-COL0.21) compared 
to other hydrogels. The increased cell spreading in softer hydrogels also resulted in increased 
differentiation to osteoblast cells; leading the group to conclude osteogenic differentiation was 
improved in the softer agarose-collagen hydrogels due to less restricted cell spreading and branching. 
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The study shows the challenges between balancing printability (high agarose bioinks) and oestrogenic 
differentiation (high collagen gels).  
2.6.1.2 Osteochondral Regeneration 
 
Osteochondral defects affect both articular cartilage and underlying bone tissues; therefore, regenerative 
engineering approaches need to adequately address this interface transition while supporting both bone 
and cartilage regeneration within their respective regions. As such, several strategies have been 
employed for osteochondral repair, including single-phase, layered and graded approaches.230 In these 
approaches, both structure and signalling can be modified to enable cell differentiation and tissue 
regeneration. 
A comprehensive 3D bioprinting process was presented by Shim et al. in which a multilayered 
3D construct containing human mesenchymal stromal cells was developed for osteochondral-tissue 
regeneration (Figure 2-9).213 Shim et al. made use of several hydrogels to provide support and 
conducive cellular microenvironments for tissue regeneration. The developed bioinks were based on 
atelocollagen and supramolecular HA, both of which are types of native ECM proteins. Atelocollagen 
containing hTMSCs and bone morphogenic protein-2 was used as the bone-forming bioink, whilst 
cucurbit[6]uril-Hyaluronic acid (CB[6]-HA) containing hTMSCs and transforming growth factor-β 
(TGF-β) formed guest-host interactions with another hydrogel, 1,6-diaminohexane (DAH)-conjugated 
HA (DAH-HA), to form the chondral layer.  Pores are made available in the bone-forming portion of 
the 3D printed scaffold to allow for infiltration of vascularisation, while in the chondral section, the 
PCL framework was fully interconnected to inhibit vascular invasion. High cell viability is evident in 
both printed bioinks; demonstrating 93% and 86% for atelocollagen and CB[6]/DAH-HA bioinks 
respectively. In vitro tests showed hTMSCs in the atelocollagen hydrogel exhibited a stretched 
morphology typical of the osteogenic phenotype at day 10, while hTMSCs within the CB[6]/DAH-HA 
bioink demonstrate spherical morphologies, characteristic of the chondrogenic phenotype. 
Additionally, atelocollagen bioink layers demonstrated an increase in ALP, COL-I, and OSX genes 
compared to those in the CB[6]/DAH-HA bioink layer, while the CB[6]/DAH-HA layers showed 
increases in ACAN, COL-II, and SOX9 compared to the atelocollagen layer at day 14. Cells within 
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atelocollagen constructs showed high levels of RUNX2 (a master transcription factor in osteoblasts), 
whereas cells cultured within CB[6]/DAH-HA hydrogels demonstrated high levels of COL-II (the 
major collagen in cartilage); RUNX2 was not detected in CB[6]/DAH-HA gels, nor was COL-II 
detected in atelocollagen hydrogels. These results demonstrated that the materials used were 
cytocompatible and capable of directing desired cell differentiation. In vivo tests on rabbit knee, 
osteochondral defects reinforced these observations, with the printed scaffold yielding outstanding 
regenerative ability in both gross morphological and histological evaluations after eight-weeks 
implantation.  
 
Figure 2-9 – In vivo bioprinted osteochondral regeneration approach.  A) Schematic showing experimental 
groups including i) Group 1- the osteochondral defect without treatment as a negative control; ii) Group 2 - 
defect filled with 3D-printed PCL scaffold seeded with hTMSCs; iii) Group 3 – defect filled with bioprinted 
PCL scaffold with alginate hydrogel encapsulating hTMSCs, and iv) Group 4 – defect filled with bioprinted 
PCL scaffold with CB[6]/DAH-HA and collagen hydrogels encapsulating hTMSCs. B) Gross images showing 
repair following 8 weeks implantation for i) group 1, ii) group 2, iii) group 3, and iv) group 4 (scalebar 1 mm). 
C) Histological analysis of tissue regeneration in the four groups with Massons Trichome staining at 8 weeks 
showing i) group 1, ii) group 2, iii) group 3, and iv) group 4. Reproduced with permission 213 
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An alternative osteochondral bioprinting method was presented by Gao et al. in which thermal-
based inkjet printing was employed to print acrylated-peptide/PEG bioinks.208 The bioinks were 
prepared at formulation 10% (w/v) poly(ethylene glycol) dimethacrylate (PEGDMA), 1 mM acrylated 
GRGDS, 1 mM acrylated MMP-sensitive (GCRDGPQGIWGQDRCG) peptides, 0.05% (w/v) Irgacure, 
and 6 × 106 hMSCs mL-1. Using this bioink, cylindrical artificial bone and cartilage tissue constructs 
were printed with 4 mm internal diameter. Printed constructs were placed in a 24 well plate containing 
either 1 mL osteogenesis medium or 1 mL chondrogenesis medium with 10 ng mL-1 TGF- β and 
cultured for 21 days. Bioinks were compared to regular, PEG, PEG-GelMA and GelMA inks regarding 
printability with results showing the peptide-PEG bioinks demonstrate excellent printability with 
viscosities highly similar to that of regular ink. Alternatively, PEG inks with the addition of GelMA 
demonstrated poor printability due to the significant increase in viscosity resulting in frequent printhead 
clogging. The pure GelMA bioink was found to be unprintable using this inkjet bioprinting setup. 
PEG/peptide bioinks demonstrated improved cell viability after 24 hours when compared to pure PEG 
hydrogels, with a ~90% cell viability in PEG/peptide hydrogels compared to ~83% in PEG hydrogels. 
The PEG-peptide scaffold demonstrated a lower compressive modulus than the PEG scaffold 
immediately following printing, however after osteogenic and chondrogenic differentiation, 
PEG/peptide scaffolds demonstrated a significant increase in compressive moduli with an increase of 
100% and 82% respectively from day 7 to 21. Alternatively, PEG hydrogels only showed a 44% and 
38% increase from day 7 to 21 for osteogenesis and chondrogenesis samples respectively. A complex 
analysis of gene expression found the printed scaffolds placed in the osteogenic media expressed very 
high levels of COL10A1 and MMP13 genes, suggesting that the PEG-peptide scaffold strongly 
stimulates endochondral bone formation; alternatively, scaffolds placed within the chondrogenic media 
demonstrates high chondrogenic differentiation factors, highlighting the ability for use in cartilage 
regeneration applications. Ultimately, the PEG/peptide bioink combined with the thermal inkjet 
bioprinting technique was found to promote homogeneous bone and cartilage regeneration, and thus, 
shows potential use in osteochondral regeneration applications. 
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A subsequent study by the same group investigated the use of an inkjet printable PEG/GelMA 
bioink for bone and cartilage tissue applications.208 Briefly, 10% (w/v) PEGDMA and 1.5% GelMA 
were mixed together with Irgacure 2959 (0.05% w/v) and subsequently seeded with hMSCs. The 
concentration of GelMA used in the bioink was determined as the highest concentration which 
maintained effective printability. Once again, through comprehensive cell viability testing, mechanical 
testing, gene expression, and histological analysis, the PEG/GelMA bioink developed was found to 
encourage stem cell differentiation down desired lineages.  
2.6.1.3 Cartilage Regeneration 
 
Cartilage is a dense connective tissue with a highly ordered matrix consisting predominantly of 
collagens and proteoglycans.214 Depending on the composition of the matrix, cartilage is classified into 
three categories: elastic, hyaline, and fibrocartilage.231  Elastic cartilage is surrounded by perichondrium 
and characterized by the presence of chondrocytes immersed in an ECM;232 in humans this tissue is 
found in the external ear, auditory tube, and epiglottis.231 Hyaline cartilage also contains primarily 
collagen type II; but rather is found in many load-bearing applications – particularly covering synovial 
joints as articular cartilage.214 Fibrocartilage contains both type I and II collagens and is found 
extensively in tendons, vertebral disks and menisci.214, 231 Due to the limited regenerative capabilities 
of cartilage and potential for chondral defects to induce early arthritis, cartilage regeneration is of 
significant interest to current tissue engineering approaches.233 
Ren et al. developed a gradient bioprinting method for the printing of zonal tissue constructs 
for cartilage engineering.209 Three collagen type-II based bioink groups were formulated, each with 
different cell densities (2×107, 1×107, and 0.5×107 cells mL-1); for each bioink, two different types of 
constructs were prepared, one with a biomimetic gradient chondrocyte density and the other with a 
homogenous density. For gradient scaffolds, the gradient concentrations were designed such that the 
total cell concentration through the whole construct equalled that of the homogenous scaffold. The 
biomimetic approach aims to mimic the native cell densities in zonal articular cartilage tissues; 
therefore, a construct was fabricated with areas of 10% superficial layer (high cell density), 10% middle 
layer (medium cell density), and 80% deep layer (low cell density). Constructs were cultured over 3 
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weeks and investigated regarding cell viability, reverse-transcription quantitative polymerase chain 
reaction (RT-qPCR), biochemical assays, and histological analysis. Cell viability was found to be 
extremely high after 1 day, with an average live cell percentage of 93 ± 3% evident in all groups. A 
slight loss in cell numbers was evident over the 3 weeks; however, this was not statistically significant. 
Analysis of gene expression showed low expression of COL1A1 over the 3 weeks, while expression 
levels of COL2A1 and ACAN showed a significant increase over the same period. Average single-cell 
GAG production was found to be highest in group B (1×107 cells mL-1 total concentration) after 3 
weeks; while Alcian blue staining and immunohistochemical analysis of chondrocytes in different 
gradient constructs showed high positive staining for collagen type-II. This study demonstrates the 
potential for gradient-based bioprinting in zonal articular cartilage regenerations, with results 
highlighting desired ECM deposition. 
The use of bioprinting for fibrocartilage and hyaline cartilage regeneration was investigated by 
Daly et al. in which four commonly used hydrogel bioinks (agarose, alginate, GelMA and PEGMA) 
were compared regarding printing properties, and potential to support either hyaline cartilage or 
fibrocartilage development.214 Each hydrogel was seeded with porcine bone-marrow-derived 
mesenchymal stem cells (BMSC), before being used to print cylindrical artificial tissue constructs. 
Histological, immunohistological and biochemical analysis of constructs showed that over the 4-week 
culture period, alginate supported the highest GAG synthesis, while GelMA demonstrated the lowest 
GAG synthesis. Furthermore, alginate and agarose hydrogels showed strong staining for collagen type-
II; whilst GelMA and PEGMA stained weakly for collagen type-II and strongly for collagen type-I. 
These results suggest that the alginate and agarose bioinks support greater development of hyaline 
cartilage-like phenotypes, while fibrocartilage-like phenotypes were supported to a greater extent by 
GelMA and PEGMA-based bioinks. In printability investigations, GelMA (10% (w/v) combined with 
0.05% (w/v) Irgacure 2959) demonstrated the greatest printability, while the PEGMA-based bioinks 
demonstrated poor printability. Alginate and agarose hydrogels presented moderate printability with 
higher filament spreading and variability compared to GelMA. Post-printing cell-viability was 
demonstrated to be sufficiently high (>80%) for all bioinks. The addition of a PCL support was found 
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to reduce cell viability slightly; however, the viability of all groups remained sufficiently high (>70%). 
The addition of PCL microfiber reinforcement in printed constructs was shown to significantly increase 
compressive stiffness of the scaffolds, yielding a printed scaffold which was within the range of native 
hyaline tissue. Although this was higher than required for fibrocartilage tissue, modifications to fibre 
diameter and fibre spacing could result in a mechanically suitable construct. Ultimately, alginate and 
agarose-based bioinks were shown to support the development of hyaline-like cartilage tissues while 
demonstrating sufficient printability; alternatively, GelMA and PEGMA-based bioinks supported 
fibrocartilage development, with GelMA exhibiting good printability properties.  Through these studies, 
the use of peptide-based bioinks paired with suitable printing techniques is shown to be effective for 
cartilage engineering applications, enabling printing of anatomically mimetic tissue constructs which 
encourage healthy tissue regeneration. 
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2.6.1.4  Vasculature Repair 
 
Due to the relation between narrowing blood vessels and heart disease, there is a significant need to 
develop vascular-tissue engineering approaches.234 Vascular tissue is comprised of three histologically 
distinct layers. The innermost layer (tunica interna) consists of a single layer of endothelial cells 
mounted on a basil lamina; below this lies the sub-endothelial fibro-elastic connective tissue layer and 
an organised internal elastic lamina.235 The middle layer (tunica media) consists of predominantly 
smooth muscle cells and elastin fibres, and a layer of external elastic lamina; while the outermost layer 
(tunica adventitia) is composed of fibro-elastic connective tissue.235 Considering the multicomponent 
nature of these constructs, there is substantial difficulty in adequately recapitulating these vessels. 
A novel 3D bioprinting method for the fabrication of tissue-engineered structures is described 
by Kolesky et al. wherein cells, vasculature, and ECM mimic were all able to be printed to form a 
multicomponent artificial tissue construct.70 The study took advantage of a multi-head, extrusion-based 
bioprinting technique to print four different inks: the first ink a ‘fugitive’ pluronic ink was designed to 
be gently removed (at <4°C) post-printing. This fugitive-ink acts to provide a temporary structure, 
which upon removal creates an open channel facilitating later seeding with HUVECs to form the 
preliminary vascular network. The pluronic ink was made at a 40% (w/v) (Pluronic F127) concentration 
dissolved within deionised, ultrafiltrated water. A cell-free GelMA ink was prepared by dissolving 15% 
(w/v) GelMA powder in media. A photoinitiator (Irgacure 2959) was added to the solution at 0.3% 
(w/v); enabling photo-crosslinking under UV light. The second ink formulated was a GelMA based 
bioink; this ink was prepared with 15 % (w/v) GelMA dissolved in media and subsequently mixed with 
human neonatal dermal fibroblasts (hNDF). A third bioink was prepared with the same formulation as 
the GelMA-hNDFs bioink, except hDMFs were replaced with mouse embryo fibroblast (10T1/2) cells. 
Using these inks, a diverse range of biological structures were printed within a single tissue construct. 
A polydimethylsiloxane (PDMS) support-ink was also used to set a well-defined border for the whole 
tissue construct. Initially, ‘1D’, ‘2D’ and ‘3D’ structures were printed using the fugitive-ink surrounded 
and encapsulated by the GelMA cell-free bioink. Removal of the fugitive-ink was found to be effective 
and could be done quickly at high fidelity even in the 3D vascular constructs. Following removal, the 
58 
 
open channels of the 2D printed system were seeded with HUVECs through injection before being 
cultured in media 48 hours. After incubation, cells demonstrated good cell viability (>95%) as assessed 
through confocal analysis of live/dead stained structures. To further investigate the effectiveness of this 
printing technique, a 3D construct containing both vasculature (fugitive-ink) and cell-laden constructs 
(hNDF containing GelMA bioink) was printed surrounded by the cell-free GelMA bioink. The fugitive-
ink was again removed, and endothelial cells were seeded as before; the scaffold shows good cell 
viability for both inks in confocal live staining images, with each cell-type being clearly distinguishable 
within its designated printed zone. Finally, multiple cell-types were printed into a single tissue 
construct, and endothelial cells were seeded into the fugitive–ink removed channels. Confocal 
observations show good cell viability (81% for hNDFs and 82% for 10T1/2 cells) after 7 days. Again, 
distinct regions were evident, correlating to the sections of different printed bioinks (Figure 2-10). 
 
Figure 2-10 - Bioprinting approach for multicomponent tissue fabrication : A) Schematic view of printed 
3D construct, and B) composite fluorescent image showing 10T1/2 fibroblasts (blue), hNDFs (green) and 
HUVECs (red). Reproduced with permission 70. 
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An extrusion-based bioprinting method was employed by Jia et al. for the fabrication of 
perusable vascular constructs in tissue engineering applications.216 Briefly, a bioink was developed from 
alginate (2 or 3% w/v), GelMA (5 or 7% w/v) and poly(ethylene glycol)-tetra-acrylate  (PEGTA, 2 or 
3% w/v); additionally, a photoinitiator was included at 0.25% (w/v) to enable GelMA photo-
crosslinking. Using a coaxial nozzle, the bioink was printed from the outer sheath; and the inner sheath 
pumps a CaCl2 solution to enable alginate crosslinking (ionic) inside the hollow vessel, while a spray 
of CaCl2 solution was used to crosslink the external surface of the vessels. The alginate crosslinking 
provides immediate temporary structure stability to the hollow tubes.  Next, covalent crosslinking 
occurs through GelMA photo-crosslinking, facilitating the development of a mechanically stable vessel. 
The vessel was then washed in mixture medium 3 times to remove excess CaCl2 and photoinitiator, 
before being immersed in a CA2+- ethylenediaminetetraacetic acid (EDTA) chelating agent for 5 
minutes to dissolve alginate. The PEGTA acts to combat the reduced mechanical strength post alginate 
removal, stabilising the crosslinked matrix. Printability investigations of the bioinks found the optimal 
ink formulation as follows: 7% (w/v) GelMA, 3% (w/v) Alginate, 2% (w/v) PEGTA; this ink was used 
for subsequent experimental observations. Cell viability (HUVECs and hMSCs) was shown to be 
sufficiently high when UV exposure does not exceed 30 seconds, demonstrating viability percentages 
above 80% after 1, 3, and 7 days. Cell metabolic activity was also found to increase as a function of 
culture time, confirming the cytocompatibility of the approach. The vascular constructs also 
demonstrated high expression levels of alpha-smooth muscle actin (α-SMA) and platelet endothelial 
cell adhesion molecule (PECAM-1), both of which were crucial for vessel formation and stabilisation. 
The perfusability of vessels was proven through confocal microscopy; and further extension of this 
work resulted in the use of a tri-layered nozzle which enables variance in vessel diameter through the 
controlled alternation of bioink delivery from the middle sheath to the external sheath, providing a 
comprehensive approach to tissue engineered vascularisation.  
Using a laser-assisted bioprinting approach Guillotin et al. investigate the biofabrication of 
microvascular tissue constructs through various bioink formulations.217 In this study, bioinks were 
formulated from alginate (containing glycerol), Matrigel, or a solution of thrombin; however due to the 
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scope of this study, only the thrombin solution will be focused on. The thrombin solution was 
formulated containing cell-laden (Eahy926 or B16) thrombin (250 UI) and CaCl2 (40 mM) which was 
printed onto a fibrinogen substrate. Using this approach, a stable construct was printed with microscale 
resolution comparable to microvascular dimensions. Cell-viability testing of Eahy926 cells 
demonstrates the presence of viable cells and good cell distribution. These studies highlight the potential 
for peptide-based bioprinting applications in vasculature regeneration, providing a fundamental 
advance in addressing the requirement to develop healthy vasculature within constructs.  
2.6.1.5 Muscle Regeneration 
 
Skeletal muscle is the most abundant muscle type and is responsible for various mechanisms, including 
voluntary and controlled body movement, facial expression and viscera protection.236 Skeletal muscle 
is a hierarchical tissue composed of tightly bound muscular fascicles within an epimysium sheath. Each 
fascicle contains numerous tightly bound muscle fibres; each of which is a single, multinucleated cell.236 
Within these muscle cells lie myofibrils, formed from actin and myosin filaments.237 Skeletal-muscle 
regeneration offers promise to clinical treatments for tissue lost through trauma or altered through 
disease. 
Choi et al. employ pneumatic-driven extrusion for the bioprinting of functional skeletal muscle 
constructs.218 The bioink was formulated from decellularised skeletal muscle ECM seeded with C2C12 
myoblasts and compared to a collagen bioink regarding mechanical properties, cell viability, myotube 
formation, and myogenic differentiation. Characterisation of muscle-derived decellularised 
extracellular matrix (mdECM) verified that the cellular contents were removed while ECM 
components, including GAGs, collagen and laminin, were retained. The bioink was found to possess 
excellent printability due to its thermally controlled gelation properties (owing to collagen content) and 
ability to undergo shear thinning; from this ink, a number of 3D cell-encapsulated muscle constructs 
with varying shape, pores and architectures were able to be printed with uniform cell distribution and 
good cell viability (Figure 2-11A). High cell viability (>90%) was evident after 24 hours of printing 
and maintained over 14 days; furthermore, cells were found to begin longitudinally aligning over the 
culture period. Cell alignment was shown to be a function of line width and culture time; thinner printed 
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lines (500 µm diameter) demonstrated the highest degree of cell alignment after induced differentiation, 
with 76 ± 2% alignment evident at day 7 compared to an initial value of 64 ± 9% at day 1. Mechanical 
testing of the mdECM bioink shows improved stiffness, tensile strength, and storage moduli (G’) 
compared to the control collagen hydrogel both at day 7 and day 14 of culturing. Furthermore, the 
mechanical properties of both collagen and mdECM were found to improve greatly between days 7 and 
14. Cell proliferation assays of printed constructs showed significantly increased levels of cell 
proliferation in mdECM-bioink printed structures compared to collagen bioink printed structures; 
furthermore, both collagen and mdECM-bioinks demonstrate improved cell-proliferation following 7 
days in culture. Investigation of gene expression showed significantly higher myogenic gene expression 
of Myf5, MyoG, MyoD, and MHC in the mdECM bioink compared to the collagen control; indicating 
a higher degree of cell stimulation toward myogenic maturation. A high level of myotube formation 
was evident in the mdECM printed constructs compared to the collagen control; with myotubes of 
greater length, width, area, and fusion index being evident in the mdECM bioink printed constructs. 
Finally, agrin preservation in mdECM was evident, providing the potential for increased acetylcholine 
receptor cluster formation in 3D printed constructs. The bioprinting approach investigated in this study 
highlights the potential for mdECM bioink use in functional skeletal muscle regeneration, enabling the 
customised formation of muscle substrates for the treatment of muscular injuries. 
 
Figure 2-11 – Bioprinted non-organ tissue constructs A) Skeletal muscle constructs containing C2C12 
myoblasts, [top] Fluorescence imaging showing high control over architecture, and [bottom] live dead staining 
of constructs at days 1, 4, 7, and 14; B) Bioprinted fibrin nerve construct: showing [left] encap sulated Schwann 
cell alignment, [right] neurite elongation and alignment . Reproduced with permission from 218 and 219 
respectively. 
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2.6.1.6 Neural Regeneration 
 
A nerve consists of a cell body (soma) and its extensions (axons and dendrites), the soma receives 
signals through its dendrites, before sending the signal down onward through the axon.238 Nerves are 
groups of axons, and may form part of the central nervous system or peripheral nervous system.238 In 
the peripheral nervous system, small injuries can be regenerated naturally; while more substantial 
injuries require surgical treatments.239 The central nervous system is more complicated, however, in 
that the body inhibits regeneration, and as such, there has been little success in spinal cord repair.239  
Peptide-based bioprinting was investigated by England et al. in which a pneumatic-driven 
extrusion printer was employed to print a fibrin-forming bioink containing fibrinogen, factor XII and 
HA.219 To enable nerve regeneration, Schwann cells were encapsulated within the hydrogel. The bioink 
was printed into a sodium chloride (NaCl), CaCl2, PVA and thrombin ‘crosslinking’ solution enabling 
fibrin formation while supporting the fabrication of multilayered fibrin-HA scaffolds. PVA 
concentration was found to be a crucial factor which affects material spreading and regulates strand 
uniformity, furthermore, PVA inclusion was found to compensate strand buoyancy; allowing for the 
formation of complex shapes. However, high levels of PVA results in poor adjacent layer attachment, 
subsequently resulting in lateral displacement of layers relative to each other. Fibrin fibres were found 
to orientate parallel to strand direction, with 97% of fibres orientated within ± 10°, and 45% of fibres 
orientated within ± 1° relative to the strand. Cell viability of Schwann cells within bioinks assessed 
immediately post-printing showed high cell viability (~98%), which was maintained over 7 days; high 
cell proliferation was also evident during the same period. Cell alignment was evident within printed 
constructs, with strands adopting elongated morphologies (Figure 2-11B); alternatively, no significant 
cell alignment was evident on control (plated) cultures of Schwann cells. Culturing of dorsal root 
ganglia on printed strands showed directional neurite growth compared to the control laminin-coated 
surface; furthermore, the dorsal root ganglia cultured on the fibrin-based strands demonstrated a greater 
average length of the longest dorsal root ganglia neurite. The findings of this study demonstrate the 
ability of naturally derived peptide bioink use in neural regeneration applications, enabling for printing 
of highly ordered autologous scaffolds.   
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2.6.2 Organ Regeneration 
2.6.2.1 Cardiac Regeneration 
 
Heart-failure is the primary cause of death in industrialised countries; therefore, there is a significant 
need to develop successful and practical cardiac regeneration approaches.240 Cardiac tissue engineering 
approaches are sophisticated as they are required to facilitate heart function while promoting cardiac 
tissue regeneration; thus, constructs should be (1) contractile, (2) electrophysiologic stabile, (3) 
mechanically robust yet flexible, (4) vascularised, and (5) autologous.240  
Using a multi-head, extrusion deposition system, Pati et al. bioprint heart, cartilage and adipose 
tissue constructs for in vitro culture through formulation of a dECM bioink as previously discussed (see 
Section 2.5.2.1).53 In addition, a synthetic PCL hydrogel is used to provide structure and support to 
cartilage and adipose dECM constructs. A PCL framework was created, and the dECM bioink was 
printed in alternating gaps between PCL lines creating a porous structure. Alternatively, printed heart 
tissue constructs were printed containing no PCL supports. dECM bioinks were then used to encapsulate 
hASCs, hTMSCs, and L6 cells, and approach effectiveness was determined through observation of 
adipogenic, chondrogenic, and myogenic differentiation. Cell viability was found to be sufficiently 
maintained after printing, showing greater than 95% cell viability following 24h culture and remaining 
above 90% following day 7 and 14 analysis with active cell proliferation evident. Gene expression is 
also enhanced in chondrogenic (SOX9 and COl2A1), cardiogenic (Myh6 and Actn1) and adipogenic 
(PPARγ and LPL) constructs when compared to that of the collagen bioink control.  
Extending this work, the group develop a cardiac-specific approach wherein bioinks were 
formulated from  hdECM bioinks.220 Three bioinks were formulated as follows: I) 20 mg mL-1 hdECM 
and 0.02% (w/v) vitamin B2 laden with human cardiac progenitor cells (hCPCs); II) 20 mg mL-1 
hdECM, 0.02% (w/v) Vitamin B2, and 10 µg mL-1 vascular endothelial growth factor (VEGF) laden 
with hMSCs; and III) 20 mg mL-1 hdECM, 0.02% (w/v) Vitamin B2, and 10 µg mL-1 VEGF laden with 
hCPCs and hMSCs. Bioinks I and II were used to make prevascularised patches; here, two PCL layers 
were extruded as support followed by sequential deposition of bioink I and II allowing for muscular 
and vascular regeneration, respectively. Meanwhile, bioink III was used to print a homogenous patch. 
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After printing, bioinks were irradiated with UV for 30-60 seconds, allowing for vitamin B2 initiated 
crosslinking. Cell viability 24 hours after printing demonstrates high cell survival (~95%) for the printed 
patch containing both bioinks printed alternately; and shows enhanced structural maturation of cells. 
MSCs supplemented with VEGF were shown to promote vascularisation after 5 days in culture, and in 
vivo tests demonstrated an improvement of cardiac function and decreased negative left ventricle 
modelling when compared to the negative control, bioink I or bioink III separately. These results 
highlight the potential of multi-bioink, hdECM bioink approaches for cardiac regeneration applications. 
An alternative method for cardiac regeneration was investigated by Zhang et al.  in which 
vasculature was printed prior to seeding with cardiomyocytes, resulting in highly vascularised tissue.221 
Briefly, vasculature was printed through a HUVEC seeded alginate/GelMA bioink containing Irgacure 
2959. A two-step crosslinking method was employed wherein ionic crosslinking of alginate was first 
induced through CaCl2 interaction, before photoinduced crosslinking of GelMA. The constructs were 
then washed in a phosphate-buffered saline solution (PBS) to remove excess CaCl2. Constructs were 
cultured for up to 33 days with endothelium formation evident following 15 days. Neonatal rat 
chondrocytes were seeded onto the scaffolds with spontaneous beating of cardiac tissues observed 
following 48 hours in culture. The method described was found to produce cardiac organoids with 
cardiomyocyte maturation, alignment, and contraction, and provides potential for use in both cardiac-
tissue engineering applications and drug screening applications. 
2.6.2.2 Cardiac-Valve Regeneration 
 
Heart-valve disease is a substantial problem which can often result in valve dysfunction leading to 
further, potentially fatal cardiac or systemic complications.240 These structures ensure unidirectional 
flow enabled through a unique arrangement of leaflets within a circular root; however, as these valves 
do not self-repair, there is a significant need to develop tissue engineering approaches which adequately 
regenerate healthy living tissues for surgical valve replacement.222, 240 
An alginate/gelatin bioink was developed by Duan et al. for use in cardiac-valve regeneration 
applications (Figure 2-12).222 The ink was initially investigated using a grid-like structure to assess its 
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printability - with results showing prints of high accuracy (84.3 ± 10.9%), high viability (VICs, 84.6 ± 
3.1% after 7 days) and good shape fidelity. The grid-like scaffolds were found to maintain geometry 
and mechanical integrity post-printing, with an even distribution of cells existing through the structure. 
Mechanical properties of cell-free printed constructs were found to be comparable to that of non-
calcified human aortic heart valve cusps following printing; however, stiffness decreased with 
increasing culture time. Alternatively, aortic valve leaflet interstitial cell (VIC)-laden constructs 
demonstrated a lower initial stiffness at day 0; however, remained constant over 7 days, after which 
sample stiffness was statistically equivalent to cell-free samples. To print the aortic-valve constructs, 
two bioinks were developed: the first contains smooth muscle cells (SMCs) and was used to print the 
root region; while the second contains VIC and was used to fabricate the leaflet region of the valve. 
Cells were able to be printed at high density (1 × 107 cells/mL) and were homogenously distributed 
within the printed tissue constructs; furthermore, the printed scaffold exhibits geometry comparable to 
the original scanned valve, with key anatomical features visible in the print. Cell viability was found to 
be sufficiently high, with an ~81% cell viability evident within the printed root (SMCs) component and 
a ~83% cell viability in the leaflets (VICs). Finally, the encapsulated VIC and SMCs were shown to 
demonstrate good spreading and phenotype expression in culture. 
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Figure 2-12 – Bioprinted organ tissue constructs . A) Endothelialised myocardium: [top] Schematic process 
showing formation of endothelialised vascular bed (left) and cardiomyocyte seeding resulti ng in endothelialised 
myocardium formation (right), [bottom] Confocal fluorescence image showing cross -sectional area of three-
layer scaffold at day 14 (left), high-resolution fluorescence imaging showing HUVEC distribution within a 
single microfiber at day 14 and 3D rendering of tubular structure at microfiber cross -section through dotted 
line (right); B) Bioprinting of aortic valve conduit: [left] Aortic valve model reconstructed from micro‐CT 
images (Green indicates valve root and red indicates valve lea flets), [middle] Fluorescent image of initial two 
bioprinted layers showing SMCs (labelled green) and VICs (labelled red), [right] printed aortic valve construct; 
C) Bioprinting of heart valve conduit with encapsulation of HAVICs within leaflets: [left] So lidworks® 
designed heart valve model, [right] printed valve construct; Reproduced with permission from 221, 222 and 223 
respectively.  
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The group further extend this work using an alternate hydrogel formulation, laden with human 
aortic vascular interstitial cells (HAVICs).223 A variety of hydrogels were investigated, all based on 
formulations of methacrylated hyaluronic acid (HAMA) and GelMA with differing concentrations (2%, 
4%, or 6% and 6%, 10%, or 12% respectively). Irgacure 2959 (0.05% w/v) was also added to GelMA 
solutions enabling photo-crosslinking. Mechanical testing of acellular hydrogels found the compressive 
moduli decreased with increasing GelMA concentration; while an increased HAMA concentration 
resulted in a stiffer hydrogel. The viscosity of hydrogels was found to be dependent on HAMA 
concentration, with viscosity too low for extrusion printing applications in 2% HAMA with 6-10% 
GelMA hydrogels; while viscosity was too high in gels with 6% HAMA with 10-12% GelMA, resulting 
in poor printability. For this reason, only gels containing 4% HAMA and 6%, 10% and 12% GelMA 
were used for subsequent cell encapsulation investigations. Cell viability testing demonstrated >90% 
viability for all tested hydrogels (4% HAMA/6% GelMA, 4% HAMA/10% GelMA, 4% HAMA/12% 
GelMA) on day 3 and day 7. Cells encapsulated within the 4% HAMA/12% GelMA bioink 
demonstrated the greatest degree of cell spreading compared to the other two gels (which demonstrated 
a more spherical shape) at day 7, likely due to favourable mechanical properties. Furthermore, all cells 
demonstrated a significant increase in cell metabolic activity over the 7-day period, corresponding with 
an increase in cell proliferation; however, no significant increase was seen between hydrogel 
formulations. GAG content within the scaffolds was also found to increase between days 3 and 7 for all 
hydrogel formulations; once again there was no significant difference between each hydrogel 
formulation tested. Analysis of gene expression showed significant α-SMA up-regulation in 4% 
HAMA/6% GelMA hydrogels; while all hydrogels demonstrated a significant increase in periostin and 
collagen I expression between day 3 and 7. Printability tests found the 4%HAMA/10%GelMA hydrogel 
to demonstrate the best accuracy at 111.3  ± 7.2% (the printed construct slightly increased in area) while 
maintaining sufficiently high cell viability (>90%). For this reason, this ink was selected to print the 
aortic heart valves. A printed construct was successfully fabricated showing high similarity to the 
original computer aided design (CAD) model. The heart-valve was constituted of two inks; the first was 
an acellular ink used to print the root, while the leaflets were printed using a HAVIC-laden bioink; both 
inks were formulated from a 4%HAMA/10%GelMA hydrogel base. The printed heart valve was shown 
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to demonstrate good viability, GAG increase, collagen deposition, and expression of both α-SMA and 
VIM after 7 days in culture; indicating the potential for peptide-based bioinks in heart-valve 
regeneration applications.  
 
2.6.2.3 Liver Regeneration 
 
The liver is a complex organ which plays an essential role in metabolic activities. Primarily, the liver is 
composed of two branched vascular networks and numerous hepatic lobules.224 Blood supply plays a 
crucial role in transporting nutrients into the liver while removing waste;224 therefore, there is a critical 
need for liver constructs to present a high degree of vascularisation. 
Bioprinting for liver regeneration applications was investigated by Li et al. wherein an artificial 
liver-like construct was printed using two different inks.224 The first ink was designed for printing of 
vascular structures within the construct and therefore contains adipose-derived stromal cells (ADSCs) 
encapsulated within a gelatin/alginate/fibrinogen hydrogel (30%, 5%, and 10% w/w, respectively); 
while the second ink comprises the hepatic tissue and was formulated from hepatocytes encapsulated 
within a gelatin/alginate/chitosan (30%/5%/2% w/w) hydrogel. After assembly, the scaffold was 
crosslinked in a thrombin/CaCl2/Na5P3O10 solution. Using these bioinks, a preliminary analogue of a 
functional liver construct was printed. Scanning electron microscopy images of the printed acellular 
hydrogels show physical architectures unlike that of either alginate or gelatin. After two-weeks of 
culturing hepatocytes demonstrate an elliptical or round structure with ~23% containing double nuclei; 
suggesting hepatocytes were alive and proliferating. Immunofluorescence staining was positive for both 
nuclei and the mature hepatocyte biomarker ALB; confirming cell-life and secretion ability. ADSCs 
were stained positive for the mature endothelial cell biomarker PECAM-1; indicating endothelial cell 
differentiation in vascular printed constructs. However, few ADSCs demonstrated spindle 
morphologies - a key characteristic of endothelial cells; this may be due to insufficient culture time. To 
investigate functionality of the construct, the rate of increase in ALB, urea, and ALT secreta in media 
was analysed. ALB content was found to increase steadily over 14 culture days, while ALT secretion 
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was shown to increase during early stages before subsequently decreasing (after day 6).  The steady 
increase in ALB confirms metabolic function. Alternatively, ALT secretion indicates acute liver 
damage; therefore, it was suggested that the initial increase was due to hepatocyte isolation yielding an 
early inflammatory reaction, while the decrease may be a result the inflammatory reaction subsiding 
upon hepatocyte adaption to the new environment. The urea content was found to increase before a 
slight decrease at day 14. Using this method, a liver-like construct is developed which upon culturing 
demonstrates preliminary functionality. The approach has potential application in tissue regeneration, 
physiological simulation, and drug screening systems. 
A liver-on-a-chip platform containing bioprinted hepatic spheroids was presented by Bhise et 
al. wherein a GelMA bioink containing HepG2/C3A spheroids was bioprinted within a bioreactor 
platform.225 To ensure functional sustainability over long culture periods, the printed spheroids were 
cultured under continuous perfusion (200 µL h-1) for 30 days, with findings demonstrating sufficient 
biomarker (albumin, transferrin, A1AT, and ceruloplasmin) secretion over cultured days; indicating 
metabolic activity and function. Drug toxicity tests were facilitated through spheroid exposure to 
acetaminophen within the bioreactor. Analysis of cellular activity shows that the acute hepatotoxic dose 
results in apoptosis of HEPG2 cells within spheroids, resulting in decreased biomarker secretion levels 
over time. The liver-on-a-chip platformed detailed was shown to respond to acute toxic drug doses; and 
therefore, demonstrates the potential for bioprinting in organ engineering and drug-screening 
applications.  
2.6.2.4 Skin Regeneration 
 
Skin is the largest organ in the human body and serves as a protective barrier between the internal 
structures and the surrounding environment. This unique organ has three layers, the epidermis, dermis, 
and hypodermis. The epidermis is a thin layer attached to the basal membrane and primarily consists of 
keratinocytes and melanocytes.241 The dermis is a vascularised layer which is rich in collagen and other 
ECM proteins excreted by fibroblasts; within this layer there are various other functional structures, 
including hair shafts and sweat glands.241-242 Alternatively, the hypodermis consists of mainly fat tissue 
which acts to insulate the body and provides an energy source.241  
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Bioprinting-enabled skin regeneration was investigated by Cubo et al. wherein human bilayered 
skin constructs were printed using a fibrin-based bioink, containing fibroblasts and later seeded with 
keratinocytes.226 The bottom layer (dermal) of the construct was formed using a human fibroblast (hFB) 
laden fibrin bioink, whilst the upper layer (epidermal) was formed through seeding of human 
keratinocyte cells on top of the initial dermal equivalent. In vitro tests showed well-spread hFBs within 
the dermal layer after 17 days; with immunofluorescence analysis confirming proper growth and 
spreading of hFBs through human VIM expression. Keratin K10 expression was detected in suprabasal 
cells; indicating normal skin synthesis. In vivo tests completed through grafting skin substrates on 
immunodeficient athymic mice resulted in the development of grafted skin which was visually very 
similar to native human skin. Histological analysis found the regenerated skin presented a structure very 
similar to that of normal human skin, with all strata characteristic of normal skin easily identified. 
Immunofluorescence analysis of skin markers showed basal proliferation through K5 staining; while 
staining against human collagen VII shows high fluorescence at the dermo-epidermal junction 
demonstrating the presence of anchoring fibrils that bind together the epidermis and dermis. Analysis 
of K10 shows high expression which was characteristic of normal skin; while staining of filaggrin (a 
late differentiation marker) shows its presence in the granular layer. The presence of rete ridges suggests 
the developed skin was mature human skin rather than mouse skin, as mouse skin does not demonstrate 
the phenomenon. Immunostaining against human vimentin shows hFBs exclusively in the dermal 
region. This study highlights the potential of peptide-based bioprinting approaches in multicomponent 
tissue engineering applications. 
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2.7 Conclusion and Future Perspectives 
 
The development of advanced artificial tissue-engineered constructs capable of effectively mimicking 
the intricacies of the native ECM would be of significant advance to the fields of tissue engineering, 
drug delivery and regenerative medicine. Currently, the requirement for vascularised, spatially defined 
constructs capable of simultaneously presenting biological and physical signals to cells is yet to be fully 
attained. Additive manufacturing offers promising resolve due to the inherent ability to spatially 
distribute cells, structures, and signals within an artificial biomimetic construct, enabling the 
development of a variety of tissues types.  
Despite significant development of these systems, biomaterial selection remains a challenge; 
with few bioinks adequately recapitulating the complexities of the native ECM.  Novel application-
specific materials are required to truly mimic the properties of the native ECM. The materials must 
provide suitable biodegradability, biocompatibility and mechanical properties to the scaffold while 
enabling cell encapsulation and protection during printing processes. Furthermore, post-print 
crosslinking of these materials needs to be designed in such a way to minimise cell damage.  
Peptide-based biomaterials are extensively researched and possess excellent biological 
properties including high biocompatibility and biodegradability. The ability of these materials to form 
hydrogels capable of encapsulating cells and biological factors while shielding cells from stresses 
encountered during bioprinting makes them highly suitable for in bioink development. Natural-peptide 
based biomaterials have been widely researched for bioprinting applications owing to their high 
bioactivity and resemblance to the native ECM. However, due to batch-to-batch variance and animal 
source, frontier applications would benefit from the development of synthetic peptide-based analogues. 
Semi-synthetic peptides have seen very little use in bioprinting applications, despite these inks 
demonstrating highly desirable properties for bioprinting applications.  
The development of effective bioinks using functionalised SAPs would be a practical way to 
increase bioink bioactivity while maintaining desirable properties associated with synthetic materials. 
The propensity of these peptides to spontaneously self-assemble into nanoarchitectures which mimic 
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that of the ECM would not only provide a gentle cell-encapsulation mechanism but would also provide 
printed tissue constructs with favourable nanoarchitectures for tissue growth. However, to achieve 
advanced SAP-based bioinks, research needs to be placed into increasing SAP stability through 
triggered covalent crosslinking and improving the rate of material recovery post-printing.  
The ability to print structures of controlled porosity as enabled through bioprinting applications 
would circumvent the immediate need to introduce vascularisation, enabling custom-controlled 
perfusability to printed constructs and allowing later infiltration of host-vascular tissues. Further 
improvements in material selection, bioink design, and printing technologies are essential to enable 
successful and effective tissue regeneration. The complex nature of organs necessitates elevated control 
over the spatial distribution of cells, structures and biological factors, and as such these need to be 
precisely controlled if functional tissue regeneration is to occur. Successful organ regeneration would 
greatly alleviate the current demand for donor organs and subsequently enable faster and more effective 
treatment methods; however, as of yet, organ engineering has seen limited success, with most current 
progress arising in simple tissue regeneration. The development of peptide and protein bioinks along 
with current advancements in printing technology will help to unlock the promise of 3D bioprinting to 
transform the field of regenerative medicine, and potentially, lead to the eventual regeneration of 
functional and effective organ tissues. 
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Chapter Three: 
 
 
 
3.  
MATERIALS AND METHODS 
 
3.1 Preview 
 
This chapter gives a detailed account of all materials and experimental methods used throughout this 
research. All Fmoc-peptides were custom synthesised by Pepmic, Suzhou, Jiangsu, China. Peptides 
were tested for purity (>95%) using HPLC by Pepmic, Suzhou, Jiangsu, China upon purchase. Gelatin 
Methacryloyl (GelMA, 18% and 80% DoF) was purchased from the University of Wollongong, 
Wollongong, Australia. GelMA (46% and 61% DoF) was purchased from Sigma Aldrich, Australia. 
Transmission Electron Microscopy (TEM), Atomic Force Microscopy (AFM), and rheology shown in 
Chapters 4 and 6 were performed at the labs of Institute for Frontier Materials (IFM), Deakin 
University, Waurn Ponds, Australia. TEM and Cryo-Scanning Electron Microscopy (CryoSEM) used 
through Chapters 5, 8, and 9 were completed at RMIT Microscopy and Microanalysis Facility 
(RMMF), Melbourne, Australia. Small-angle X-ray scattering (SAXS) was completed at the Australian 
Synchrotron, Clayton, Australia. Small-angle neutron scattering (SANS) was completed at the ILL, 
Grenoble, France. Spectroscopic analysis performed as part of Chapter 4 and 6 was performed at the 
Centre of Chemistry and Biochemistry, Deakin University, Waurn Ponds, Australia. Circular Dichroism 
(CD) performed through Chapters 5, 8, and 9 were completed using the labs of the School of Science, 
RMIT, Bundoora, Australia. Fluorescence Spectroscopy and Fourier-Transform Infrared Spectroscopy 
(FT-IR) used in Chapters 5, 8, and 9 were performed through the School of Engineering and Health, 
RMIT, Melbourne. Rheology presented in Chapters 5, 7, 8, and 9; and all bioprinting and printability 
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testing was performed at the Biofabrication 3D Centre (BioFab3D), St Vincent’s Hospital, Melbourne, 
Australia.  
All in vitro cell culture work completed in Chapters 4 and 6 was performed in the labs of 
School of Medicine, Deakin University, Waurn Ponds, Australia. All in vitro cell culture detailed in 
Chapter 5 was completed at labs in the School of Health and Biomedical Science, RMIT, Bundoora, 
Australia. In vitro cell culture work completed through Chapters 8 and 9, were completed in the labs 
of Biofabrication 3D Centre (BioFab3D), St Vincent’s Hospital, Melbourne, Australia.  
3.2 Fmoc-SAP Characterisation 
3.2.1 Fmoc-SAP hydrogel Preparation 
 
All solutions used to make peptides for in vitro cell culture were sterilise filtered using 0.22 µm PES 
Express® syringe filters (Merck Millipore Ltd. Cork, Ireland). Peptides were dissolved, and assembly 
was triggered under aseptic conditions.  
3.2.1.1 Fmoc-SAP Hydrogels 
 
The required amount (5 mg/mL or 10 mg/mL) of Fmoc-SAP was suspended into 400 µL MilliQ water 
(Direct-Q® 8 UV, Merck Millipore Ltd. Pty., Australia). 0.5 M NaOH was added via dropwise addition 
to the suspended peptide solution under constant, gentle vortex (BR-2000 Vortexer, Bio-Rad 
Laboratories Inc., NSW, Australia) until fully dissolved. Once dissolved, the peptide solution was 
charge neutralised via dropwise addition of 0.1 M Hydrochloric acid (HCl), such that a final pH of 7.4 
was achieved. Finally, 0.1 M PBS (pH 7.4) solution, or Gibco® Dulbecco's Modified Eagle Medium 
(DMEM), (Life Technologies, Melbourne, Australia) containing 10% fetal bovine serum (FBS) was 
added such that the final, diluted concentration of peptide was either 5 mg/mL (for Chapters 8, 9) or 
10 mg/mL (for Chapters 4, 5 and 6). The pH of the peptide hydrogel was measured using a microprobe 
pH meter (Oakton™ pH 700, Thermo Fisher Scientific). Fmoc-FRGDF and Fmoc-DIKVAV hydrogels 
were allowed to gel overnight in 37°C, while Fmoc-FRGDF, Fmoc-PHSRN and Fmoc-FRGDFPHSRN 
used through Chapter 5 were allowed to gel over 10 days. 
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3.2.1.2 Coassembled Fmoc-SAP Hydrogels 
 
The coassembled Fmoc-SAP hydrogels for Chapters 4, 5 and 8 were prepared similarly to the Fmoc-
SAP hydrogels mentioned above (Section 3.2.1.1); however, the single peptide was substituted for a 
1:1 mix of peptide powder. Specifically, coassembled hydrogels used in Chapter 4 contained 10 
mg/mL of the peptide at a 1:1 mix (mass) of Fmoc-FRGDF and Fmoc-PHSRN. The coassembled 
hydrogel in Chapter 5 contained 10 mg/mL of a 1:1 mix of Fmoc-FRGDF and Fmoc-DIKVAV. 
Finally, the coassembled Fmoc-FRGDF/Fmoc-PHSRN hydrogel used as a control in Chapter 8 
contained 5 mg/mL of Fmoc-FRGDF and Fmoc-PHSRN at a 1:1 weight ratio. Hydrogel formation was 
achieved as detailed above (Section 3.2.1.2). 
Fmoc-FRGDF/Fmoc-DIKVAV hydrogels were allowed to form a gel over 24h, while PHSRN 
containing coassembly were allowed to gel over 72h. 
3.2.1.3 Fmoc-SAPs containing Fucoidan or Versican Macromolecules 
Fucoidan-Containing Hydrogel (Coassembled) 
Fmoc-FRGDF was prepared as above (section 3.2.1.1), however prior to assembly the required amount 
of fucoidan (0.5 mg mL-1, 2 mg mL-1, 5 mg mL-1, or 10 mg mL-1 ) was added as a powder.  
Fucoidan-Containing Hydrogel (Post-assembled) 
Fmoc-FRGDF was prepared as above (section 3.2.1.1), however following assembly the required 
amount of fucoidan was added in solution such that a final concentration of 10 mg mL-1 is acheived.  
Versican-Containing Hydrogel  
Fmoc-FRGDF was prepared as above (section 3.2.1.1), however PBS was substituted for versican-
transfected media mixed with growth media (25 mM glucose DMEM containing FBS) at a 1:4 ratio.  
Media was adjusted such that a final concentration of 10% FBS is achieved.  See Section 3.3.2 for 
versican conditioned media preparation. 
Empty Vector Control Hydrogel  
Fmoc-FRGDF was prepared as above (section 3.2.1.1), however PBS was substituted for empty vector-
transfected media mixed with growth media (25 mM glucose DMEM containing FBS) at a 1:4 ratio.  
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Media was adjusted such that a final concentration of 10% FBS is achieved. See Section 3.3.2 for 
Empty-vector conditioned media preparation. 
3.2.2 1% Agarose Preparation 
 
A 2% low-melting agarose (#200-0030, Progen Ind. Ltd., Australia) solution was dissolved in dH2O 
and heated using a microwave to melt sample. Repeated stirring and heating was performed until the 
solution comes to a boil. The solution was then autoclaved before the sterile 2% agarose was cooled to 
37°C prior to mixing with equal volume sterile complete DMEM medium (with 10% or 20% FBS) or 
0.1 M PBS to form a 1% agarose mixture. The mixture was set at room temperature before spheroid 
encapsulation (in media containing gel) or mechanical analysis (in PBS containing gel). 
3.2.3 Bioink Preparation 
3.2.3.1 Gelatin Methacryloyl Bioinks 
 
Gelatin Methacryloyl (GelMA) with 18% and 80% degree of functionalisation (DoF) was purchased 
from the University of Wollongong, Wollongong, NSW, Australia. Non-sterile GelMA was dissolved 
(at 37°C) in MilliQ water such that the final concentration is < 2% (w/v). Following being left for 24h 
to dissolve, solution (40 mL at a time) was passed through a syringe filter (0.22 µm PES Express® 
syringe filters, Merck Millipore Ltd. Cork, Ireland) into 50 mL, pre-weighed Mini Bioreactors (Corning, 
NY, USA) under aseptic conditions to sterilise solution.  Permeable caps were then fitted to tubes, and 
sterile aliquots were frozen at -80°C. Frozen aliquots were then removed and placed into a freeze drier 
(Alpha 1-2 LD Plus, Martin Christ Gefriertrocknungsanlagen GmbH, Germany) for 72h. Following 
72h, samples weight was recorded once an hour for 3 hours to ensure stable mass indicating samples 
are sufficiently dry. Sterile, dry aliquots were then sealed with fresh, sterile caps (under aseptic 
conditions) and stored in -80°C until use.  
46% and 61% DoF GelMA (Sold as Gelatin Methacryloyl 300 Bloom 40% DoF (900629-1G), 
and Gelatin Methacryloyl 300 Bloom 60% DoF (900622-1G), respectively) was purchased from Sigma 
Aldrich, Australia. 46% and 61% DoF GelMA was maintained under sterile and dry conditions until 
time of use. 
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Sterile GelMA stock solutions were formed through the dissolve of dry GelMA in 0.1 M PBS 
such that the final LM-GelMA concentration is 15% (w/v). GelMA bioinks were prepared by dilution 
of GelMA stock to a final concentration  of 6% (w/v) (Chapters 7, 8, 9) and 10% (w/v) (Chapter 7) in 
1 × PBS with 0.1% (Chapter 7) or  0.025%  (Chapter 8 and 9) Lithium phenyl-2,4,6-
trimethylbenzoylphosphinate (LAP) (Tokyo Chemical Industry Co. Ltd., Tokyo, Japan). Reduced LAP 
levels were desired when used for cell-seeding applications. Bioinks were stored at 37°C under UV-
protected conditions until time of use (within 3 days).  
GelMA bioinks prepared for in vitro cell culture experiments were made to 90% volume 
(through minimalization of PBS addition) to allow sufficient volume for cell inclusion. Before use, 15 
million mouse primary myoblasts (Chapter 8) or 15 million rat cortical neurospheres (Chapter 9) were 
incorporated into the bioink via short and gentle vortex. Bioinks were then placed in incubation for 10 
minutes to allow bubbles to settle. 
3.2.3.2 Hybrid Fmoc-FRGDF/Fmoc-PHSRN/GelMA Bioinks (FPG-Hybrids) 
 
Fmoc-FRGDF/Fmoc-PHSRN/GelMA (FPG-Hybrid) bioinks (Chapter 8) were prepared as 
coassembled Fmoc-SAP hydrogel (5 mg/mL Fmoc-SAP concentration), however before addition of 1 
× PBS, 400 µL mL-1 of 15% (w/v) Low-Methacryloyl Gelatin Methacrylate (LM-GelMA, 18% DoF), 
and 12.5 µL mL-1 LAP (2%) was added and briefly vortexed such that a final concentration of 6% (w/v) 
LM-GelMA, and 0.025% LAP exists. FPG-Hybrid bioinks were allowed to gel over 72h at 37°C under 
UV-protected conditions. 
FPG-Hybrids prepared for in vitro cell culture experiments were made to 90% volume (through 
minimalization of PBS addition) to allow sufficient volume for cell inclusion. Bioinks were prepared 
under aseptic conditions and assembled over 72h. Before use, 15 million mouse primary myoblasts 
were incorporated into the bioink via short and gentle vortex. Bioinks were then placed in incubation 
for 10 minutes to allow bubbles to settle. 
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3.2.3.3 Hybrid Fmoc-DIKVAV/GelMA Bioinks (DIKVAV-Hybrids) 
 
Fmoc-DIKVAV/GelMA bioinks (DIKVAV-Hybrids, Chapter 9) were formed similarly to FPG-
Hybrid bioinks; however, 5 mg/mL Fmoc-FRGDF/Fmoc-PHSRN (1:1 ratio) was substituted for 5 
mg/mL Fmoc-DIKVAV. Bioink formation was achieved as detailed above (Section 3.2.3.2). Fmoc-
DIKVAV/GelMA bioinks were allowed to gel over 24h at 37°C under UV-protected conditions. 
For DIKVAV-Hybrids prepared for casting and subsequent rat cortical neurosphere seeding, 
neurospheres were prepared under aseptic conditions and placed into 48-well plates (CELLSTAR®, 
Greiner Bio-one GmbH, Kremsmünster Austria). Hydrogels were then UV (365 nm) crosslinked at 4.5 
mW cm-2 (UVP crosslinker, analytikjena, Jena, Germany) for 8 minutes followed by a short wash with 
PBS. Rat cortical Neurospheres were then seeded onto the bioinks at 1 × 104 cells per well.  
For DIKVAV-Hybrids prepared for in vitro encapsulation and bioprinting experiments, 
bioinks were made to 90% volume (through minimalization of PBS addition) to allow sufficient volume 
for cell inclusion. Bioinks were prepared under aseptic conditions and assembled over 24h. Before use 
15 million rat cortical neurospheres were incorporated into the bioink via short and gentle vortex. 
Bioinks were then placed in incubation for 10 minutes to settle bioinks and remove any induced bubbles.  
3.2.4 Circular Dichroism 
 
Dilute samples ranging in concentration from 0.1% to 0.001% (w/v) (Diluted in MilliQ water) were 
scanned using a Jasco J-815 Circular Dichroism Spectropolarimeter (Jasco Inc., Maryland, USA) from 
330-180 nm. 5 accumulations were averaged for each sample with a 1 nm data interval, 2 s-1 integration 
time, and at 50 nm min-1 (Chapter 4) or 100 nm min-1  (Chapter 4, 5, 6, 8, 9). A 1 mm quartz cell 
(Starna Pty. Ltd., Australia) was used for all samples. A MilliQ (Chapters 4 and 6) or dilute PBS 
(Chapters 5, 8, 9) background was obtained and subtracted from each sample. Data was smoothed with 
inbuilt software (Jasco J-815 Circular Dichroism Spectropolarimeter). 
3.2.5 Fourier Transform Infrared Spectroscopy  
 
For Chapters 4 and 6, a Nicolet 6700 Fourier Transform Infrared Spectrometer (Watham, MA, USA) 
in attenuated total reflection (ATR) mode was used to collect sample spectra. 12 μL of sample was 
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placed directly on the ATR crystal and scanned between wavenumbers 4000 cm−1  and 400 cm−1 over 
64 scans. A background scan of PBS was acquired and subtracted from each sample. 
For Chapters 8 and 9, FT-IR spectrums were acquired from a Frontier FT-IR/FIR spectrometer, Bruker 
D8 XRD (Bruker Co. Massachusetts, USA) from wavenumbers 4000 cm-1 to 400 cm-1 at a resolution 
of 1cm-1. 16 accumulations were performed, and a background (1 × PBS) was acquired and subtracted 
from samples. Data was smoothed with inbuilt software (Frontier FT-IR/FIR spectrometer, Bruker D8 
XRD). 
3.2.6 Fluorescence Spectroscopy 
 
For Chapters 4 and 6, fluorescence emission spectra were collected using a Cary Eclipse fluorescence 
spectrophotometer (Agilent Technologies CA, USA). The emission bandwidth was set to 5 nm, and 
scanning speed was set to 600 nm/min with a 1.0 nm data pitch. An excitation wavelength of 248 nm 
was selected, and emission was monitored from 300 nm to 600 nm. A quartz cuvette (Starna Pty. Ltd., 
NSW, Australia) of 1 mm path length was used during tests. Samples were diluted in MilliQ water to a 
final peptide concentration of 0.5% wt. 
For Chapter 8, sample fluorescence emission spectra were measured on a LS55 PerkinElmer 
Spectrometer (PerkinElmer, Australia). An emission bandwidth was set at 2.5 nm, and a scanning speed 
of 50 nm/min was selected with data pitch of 0.5 nm. The excitation wavelength was set at 248 nm, and 
emission was monitored between 200 nm and 600 nm. A quartz cuvette (PerkinElmer, Australia) of 10 
mm path length was used for scanning. Samples were diluted 1:5 in MilliQ water. 
3.2.7 Atomic Force Microscopy  
 
AFM images of the samples were collected using a Multimode 8 atomic force microscope (Bruker 
BioSciences Co. Massachusetts, USA). For sample preparation, peptide hydrogels (10 mg/mL) were 
diluted to a ﬁnal peptide concentration of 0.5 mg/mL before 15 μL of each diluted solution was applied 
to highly ordered pyrolytic graphite (HOPG) substrates (SPI), with any excess sample being absorbed 
by pipet. The tips used were ScanAsyst-Air probes with silicon tip on nitride lever (Bruker BioSciences 
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Co. Massachusetts, USA). The scan was operated in PeakForce QNM imaging mode with a scan size 
of 10 μm2. 
3.2.8 Transmission Electron Microscopy 
 
For Chapters 4 and 6, A JEOL-2100 LaB6 transmission electron microscope (TEM) (JEOL Ltd., 
Japan) at an operation voltage of 100 kV was used for TEM imaging. Images were acquired through a 
Gatan Orius CCD camera (Cuddy, PA, USA). Lacey carbon coated films on 300 mesh copper grids 
(Emgrid Pty. Ltd., Australia) were used as sample holders. 12 µL of dilute sample (5:1 dilution in MilliQ 
water) was applied onto the grid and allowed to absorb for 5 minutes, following which Whatman filter 
paper (No.1) was used to wick off excess fluid. One drop of negative stain NanoVan (Bio-Scientific 
Pty. Ltd., USA) was put onto parafilm “M”, then the grid was placed on the stain with carbon side down 
for 5 minutes. Samples were then dried in air for 2 minutes with carbon side up before grids were placed 
into the grid box and left to dry overnight. 
For Chapters 5, 8 and 9, Strong carbon grids (GSCu200C-25, ProScitech, Australia) were placed on a 
15 µL droplet of sample at a 1 in 5 sample dilution (diluted in MilliQ water) for 30 s; excess was wicked 
away with Whatman filter paper. All droplets were deposited on parafilm. Grids were placed on a 15 
µL droplet of uranyl acetate 1% stain for 5 min; excess was wicked away with Whatman filter paper 
and left at room temperature to air dry overnight. Bright Field TEM was performed at an accelerating 
voltage of 80kV (JEOL 1010 Transmission Electron Microscope). Images were captured by a Gatan 
Orius SC600 CCD Camera (Cuddy, PA, USA) . Fibril diameter was determined through use of the 
measuring tool in ImageJ, n=5. The average diameter and standard deviation were calculated for each 
sample. 
3.2.9 Cryo-Scanning Electron Microscopy  
 
CryoSEM was used to determine hydrogel microstructure. Fmoc-SAPs were prepared as detailed in 
sections 3.2.1 and 3.2.3; however, PBS was replaced with MilliQ water to minimise salt bridging. 
Although this would have some effects on network presentation;243 MilliQ substitution allowed for 
visualisation of network fibrils otherwise masked by salt bridging, and therefore was selected as the 
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best approach for comparing sample network organisation. Samples were plunge frozen into liquid 
nitrogen slush for ~30 seconds before being immediately transferred to a Gatan cryo-chamber and 
fractured at -170 ˚C. Samples were then sublimated at -95 ˚C for 2 minutes to remove amorphous 
surface ice and reveal structure depth. Samples were then gold sputter coated for 140 s before being 
imaged at 15 kV, spot size 5 (FEI Quanta 200 ESEM, Thermo Fisher Scientific). Fibril bundle diameter 
was determined through use of the measuring tool in ImageJ (n=5, Chapter 5); and average diameter 
and standard deviation were calculated for each sample. 
3.2.10 Small-Angle X-ray Scattering 
 
SAXS was performed at the Australian Synchrotron (Melbourne, Australia) using the SAXS/WAXS 
beamtime. Measurements used in Chapter 4 were taken at a calibrated camera length of 1598 mm with 
X-ray energy of 11 KeV (1.12713 Å). Using this length, a scattering vector (q) could be measured 
across the range of 0.01 to 0.6 Å−1. Measurements used in Chapters 5, 7, 8 and 9 were acquired at a 
calibrated camera length of 967.667 mm with X-ray energy of 12KeV (1.03320 Å); allowing for 
scattering vector (q) to be measured across the range of 0.018 to 0.92 Å-1. The diffraction pattern was 
recorded on a Pilatus 1M detector (169 mm × 179 mm, effective pixel size (172 µm × 172 µm) and 
processed using the Australian Synchrotron ScatterBrain Software (Melbourne, Australia). Hydrogels 
were prepared as detailed above (Sections 3.2.1 and 3.2.3) and loaded into 1.5 mm glass capillaries 
with a wall thickness of 0.1 mm  (Hilgenberg, GmbH, Malsfeld, Germany). Where appropriate 
(Chapters 7, 8, 9), samples were crosslinked within capillaries for 8 minutes at 4.5 mW cm-2. PBS 
backgrounds with and without LAP were collected before samples were loaded. Each sample (and 
background) was subjected to ten, 1 s-1 exposures at multiple (n=3) points along the capillary to 
minimise sample burning (Chapters 5, 7, 8 and 9). Repeat measurements were summed using 
Scatterbrain and q calibrated using an AgBeh sample, and intensity was normalised and set on an 
absolute scale using water and air shots.  Due to poor scattering, backgrounds were scaled by 0.9 
(Chapter 5, 8 and 9) before subtraction from the sample scattering data. For Fmoc-SAP and 
coassembled Fmoc-SAP hydrogel fibril radius calculations, data was subject to indirect Fourier-
transform (IFT) analysis and P(r) inversion using SASView (SASView, Australia) to calculate the 
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average diameter of the fibrils in the sample. For GelMA, FPG-Hybrid, and DIKVAV-Hybrid samples, 
data was fit to shape independent models using SASView. Specifically, the mass fractal dimension was 
determined through fitting with a power law model between mid q range (0.05 – 0.2 Å-1, Chapters 7, 
8, 9); correlation length was determined through fitting with correlation length model at low-mid q 
range (0.018 – 0.2 Å-1, Chapters 5, 7, 8); and mesh size was determined through fitting with two-power 
law model at low-mid q range (0.018 – 0.2 Å-1, Chapters 5, 7, 8, 9). All acquired scatter curves, and 
subsequent fits were further graphed using GraphPad Prism 7 (GraphPad Prism Software Inc., San 
Diego, USA, Chapter 5, 8, 9) for ease of graphical visualisation. 
3.2.11 Small-Angle Neutron Scattering 
 
SANS data was attained using the D33 instrument at the Institut Laue-Langevin, Grenoble, France. 
Scattering was measured at two sample-detector distances of 2 m and 12 m, allowing for a q range of 
0.03 – 0.5 Å−1.  A fixed wavelength mode was used with a wavelength of 6 Å and a wavelength 
resolution of Δλ = 10%. Data from the two detector distances were reduced using the GRASP program 
and joined through use of the NIST SANS package for Igor Pro. Samples were prepared at 21.5% 
Deuterium oxide (D2O) to contrast match for fucoidan, leaving only scattering relating to the peptide 
assemblies. Fucoidan-only samples were prepared in D2O solution for maximum contrast and 
background reduction. Samples were measured in sealed 1 mm path-length Hellma® cells (Hellma, 
UK). Samples were injected into cells and heated in a water bath to 70°C to nullify shear effects 
encountered during sample loading. 
3.2.12 Oscillatory Rheology 
3.2.12.1 Rheological Frequency Sweep 
 
Chapter 4 and 6: Mechanical properties of the hydrogels at various frequencies were determined 
through rheological measurements taken on a Discovery Hybrid Rheometers (TA Instruments, New 
Castle, DE, USA) using a cone-plate geometry (40 mm, 2° 1’ 37’’) with a 51 µm truncation gap. Sample 
was placed onto the lower plate to cover the measured area completely and excess trimmed. To ensure 
the measurements were made in the linear viscoelastic regime, amplitude sweeps were performed at a 
constant frequency of 10 rad/s with shear strain 0.01–100%. Data on dynamic frequency sweeps were 
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collected over a range between 0.1 and 100 rad/s at a constant strain (0.4% in Chapter 4,  2.83% in 
Chapter 4, and 1% in Chapter 6). Temperature was maintained at 25˚C via the use of Peltier plate 
control. A water trap was used to minimise sample evaporation. All measurements were carried out in 
triplicate to ensure reproducibility with the show of the average data. 
For viscoelastic data acquired during Chapter 5, storage and loss moduli were acquired under 
oscillatory conditions using a calibrated rheometer (Anton Paar MCR 301, Austria) fitted with a 15 mm 
cone plate fixture with a cone angle of 1° (CP15-1, Anton Paar GmbH, Austria); a water trap was used 
to minimize sample evaporation and drying. Data on dynamic frequency sweeps were collected over a 
range between 0.1 and 20 Hz at a constant shear strain of 0.1%. The temperature was maintained at 
37˚C via the use of Peltier plate control. All measurements were carried out in triplicate to ensure 
reproducibility with the show of the average data. 
3.2.12.2 Rheological Temperature Sweep 
 
Storage and loss moduli were acquired under oscillatory conditions using a calibrated rheometer (Anton 
Paar MCR 301, Anton Paar Pty. Ltd. Australia) fitted with a 15 mm cone plate fixture with a cone angle 
of 1° (CP15-1, Anton Paar Pty. Ltd. Australia); Paraffin oil (Sigma Aldrich, Australia) was placed over 
the cone to avoid dehydration. Thermal dependent viscoelastic properties were acquired via temperature 
sweep from 37 ˚C to 4 ˚C (~0.97˚C min-1) and at a shear strain of 0.1% and angular frequency of 10 rad 
s-1.  
For Chapter 7, gradient of stiffness change in response to temperature decrease was determined as 
follows. Firstly, the temperature (T1) and storage modulus (G’1) where loss tan = 0.1 is determined; 
next, storage modulus (G’2) at a temperature 4 ˚C below T1 is determined. G’1 is then subtracted from 
G’2 before subsequent division by 4; as described by equation 
𝐺𝑟𝑎𝑑𝑖𝑒𝑛𝑡 𝑜𝑓 𝑠𝑡𝑜𝑟𝑎𝑔𝑒 𝑚𝑜𝑑𝑢𝑙𝑢𝑠 𝑖𝑛𝑐𝑟𝑒𝑎𝑠𝑒 =
G’1 − G’2
4˚C
 
Equation 3-1 – Calculation of stiffness gradient in response to temperature  
Where G’1 and G’2 are measured in kPa. 
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Here, gradient of stiffness change was monitored over the first 4 ˚C to ensure uniform sample analysis. 
3.2.12.3 Rheological In Situ Crosslinking and Shear Resistance 
 
Storage and loss moduli were acquired under oscillatory conditions using a calibrated rheometer (Anton 
Paar MCR 301, Anton Paar Pty. Ltd. Australia) fitted with a 15 mm cone plate fixture with a cone angle 
of 1° (CP15-1, Anton Paar Pty. Ltd. Australia); Paraffin oil (Sigma Aldrich, Australia) was placed over 
the cone to avoid dehydration. In situ UV crosslinking was performed at a wavelength of 365 nm and 
intensity of 4.5 mW cm-2 for 20 minutes (OmniCure Lx400+, Lumen Dynamics Group Inc., Canada). 
UV intensity was verified using an OmniCure LED Light Meter System (Lumen Dynamics Group Inc., 
Canada). Samples were allowed to stabilise for 1-minute before UV application.  Constant shear strain 
of 0.1%, angular frequency of 10 rad/s and temperature of 37 ˚C was used during UV crosslinking. 
Crosslinking was performed for 15 minutes (Chapter 7) or 20 minutes (Chapter 8, 9). An amplitude 
sweep was obtained following crosslinking via a shear strain logarithmic ramp from 0.1% - 1000% at 
an angular frequency of 10 rad/s and at 37 ˚C. For analysis of shear yield point in Chapter 7, the 
complex modulus was plotted against shear-strain, and point of peak stress calculated. 
Structure-function correlations obtained in Chapter 7 were calculated using GraphPad Prism 
7 (GraphPad Prism Software Inc., San Diego, USA,). Specifically, a Pearson correlation test was 
performed between each sample with a 95% confidence interval and Pearson r values were calculated 
and plotted as a heatmap for ease of visualisation. A Pearson value of 1 indicates a perfect correlation 
while -1 indicates a perfect inverse correlation. For this study, anything above 0.5 or below -0.5 was 
considered well-correlated. 
3.2.13 Printability Tests 
 
Bioinks were prepared as above (Section 3.2.3), and immediately placed into 3 mL Optimum® syringe 
barrels (Nordson EFD, Ohio, USA) after which bioinks were sealed and allowed to self-assemble over 
24h (Chapter 9) or 72 h (Chapter 8) in 37°C incubation. For temperature printability tests, bioinks 
were cooled to 10°C, 15°C, and 20°C using an ES SERIES laboratory refrigerator (Thermo Fisher 
Scientific). Cartridge temperatures were monitored using a FLIRone thermal camera (FLIR Systems 
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Australia Pty Ltd., Australia). After cooling, Cartridges were fitted with conical 22G (TT) Blue 
Precision Tips (Nordson EFD, Ohio, USA) and placed into an Inkredible® Bioprinter (CELLINK AB, 
Gothenburg, Sweden) where they were prepared for bioprinting as per manufacturers recommendations. 
Briefly, axis’ were homed, and z-position calibrated. Pneumatic pressure was facilitated through MC 
mini compressor (MC90, Biltema, Helsingborg, Sweden) and further regulated to maintain consistent 
pressure (AD300C dispenser, Iwashita Engineering, Inc., Japan). A  4 × 4 × 2 grid-like pattern (2.5 mm 
strut spacing) was designed via in-house G-code and verified through printing with CELLINK START 
(Supplementary Figure S - 11). Bioinks were printed and extrusion pressure was adjusted accordingly 
with changes in viscosity between bioinks and printing temperatures. Pressures ranged between 30 – 60 
kPa. Printed grid constructs were printed onto cooled (-20°C) dishes (Greiner Bio-one GmbH, 
Kremsmünster Austria) and crosslinked immediately after printing at 365 nm and 4.5 mW cm-2 for 8 
minutes (UVP crosslinker, analytikjena, Jena, Germany). Images were taken both before and after 
crosslinking. Following crosslinking, samples were fully submerged in PBS and shape fidelity (swelling 
and degradation) was monitored for 4 weeks under simulated culture conditions (PBS, 37°C). 
For Chapter 9, and additional two grids were designed with alternate strut-spacings. Specifically, one 
8 × 8 × 2 grid was designed with strut spacings of 1.5 mm, and a second 10 × 10 × 2 grid was designed 
with 1 mm strut spacings. Grids were printed and crosslinked as above. 
Additionally, in Chapter 9, a DIKVAV-Hybrid construct was printed in a 4 × 4 × 2 grid-like pattern 
(2.5 mm strut spacing) as above however, LM-GelMA was substituted for LM-GelMA containing 
0.03% Fluorescein Isothiocyanate-labelled (FITC) GelMA for a final FITC-labelled GelMA 
concentration of 0.012%. FITC-GelMA was kindly donated by Dr. Zhilian Yue (University of 
Wollongong, Australia). Fluorescently-labelled DIKVAV-Hybrid constructs were then printed and 
crosslinked as above, before observation via fluorescence microscopy (EVOS FL Fluorescence 
Microscope, Life Technologies) to confirm GelMA isolation to structural regions. 
  
86 
 
3.2.14 Bioprinting 
 
Bioinks were prepared as above (Section 3.2.3); however, measures to ensure sterility were observed. 
Specifically, all reagents were prepared sterile, and assembly was performed under aseptic conditions.  
For bioprinting conducted during Chapter 8, bioinks were prepared as detailed in section 3.2.3. 
Cell incorporated bioink was transferred to previously sterilised bioink cartridge via 1 mL pipette and 
allowed to settle for 10 minutes under incubation at 37 ˚C before subsequent cooling to optimal 
temperature as determined in printability tests (10 ˚C and 15 ˚C for LM-GelMA and FPG-Hybrid 
respectively). Cartridge temperature was monitored via FLIRone thermal camera to ensure accuracy. 
Bioinks were printed into a grid as above, and immediately UV crosslinked at 4.5 mW cm-2 for 8 minutes 
using an OmniCure LED Light Meter System (Lumen Dynamics Group Inc., Canada). Bioprinted grids 
were immersed in 2 mL proliferation media (Ham’s F10 (Thermo Fisher) supplemented with 20% Fetal 
Calf Serum (Gibco), 2.5 ng bFGF (Peprotech), 2 mM L-glutamine (Gibco) and 1 × 
penicillin/streptomycin (Gibco))  for 10 minutes before media was removed and fresh media added. 
Constructs were then placed in incubation (5% CO2) and maintained at 37 ˚C with 1 mL media change 
every 24 h. Triplicate grids were fabrication and analysed per time point. 
For bioprinting conducted in Chapter 9, bioinks were prepared as detailed in section 3.2.3. 
Cell incorporated gel was transferred to previously sterilised bioink cartridge via 1 mL pipette and 
allowed to settle for 10 minutes under incubation at 37 ˚C before subsequent cooling to optimal 
temperature as determined in printability tests (10 ˚C and 15 ˚C for LM-GelMA and Fmoc-
DIKVAV/GelMA Hybrid respectively). Cartridge temperature was monitored via FLIRone thermal 
camera to ensure accuracy. Bioinks were printed using a 25G red (TT) conical needle (Nordson EFD, 
Ohio, USA) into a grid as above, and immediately UV crosslinked at 4.5 mW cm-2 for 8 minutes using 
an OmniCure LED Light Meter System (Lumen Dynamics Group Inc., Canada). Bioprinted grids were 
immersed in DMEM/F12 for 10 minutes followed by media removal and immersion in fresh 
neuroproliferation media (Neurocult NS-A Proliferation Kit (STEMCELL technologies) supplemented 
with 20 ng/mL bFGF (Peprotech), 20 ng/mL EGF (Peprotech), 2 g/mL Heparin (STEMCELL 
technologies) and 1 × penicillin/streptomycin (Gibco)). Constructs were then placed in incubation (5% 
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CO2) and maintained at 37 ˚C with 1 mL media change every 24 h. Triplicate grids were fabrication 
and analysed per time point. 
3.3 In Vitro Cell Culture 
3.3.1 Cell Lines and Culture Conditions 
 
Chapter 4: Primary Human Mamillary Fibroblast Cells (HMFCs) were maintained and cultured in the 
ﬁbroblast media containing 10% FBS, ﬁbroblast growth supplement, 2% penicillin/streptomycin 
(ScienCellResearch Laboratories, Carlsbad, CA, USA) at 37 ◦C and 5% CO2. After reaching 80–90% 
confluence cells were detached using Trypsin/EDTA. 
Chapter 5: Murine Lewis Lung Carcinoma (LLC) cell line was provided by the Peter MacCallum 
Cancer Centre, Melbourne, Australia. LLC cells were cultured in complete 10 media (DMEM, 1× 
penicillin/streptomycin and 10% FBS). Murine skeletal muscle fibroblasts (NOR-10) were purchased 
from ATCC, USA, and maintained in a complete 20 media (DMEM, 2 mM Glutamine, 1× 
penicillin/streptomycin and 20% FBS). Cells were incubated at 37°C and 5% CO2. After reaching 80–
90% confluence LLC cells were detached using 0.05% Trypsin/EDTA and NOR-10 using 0.25% 
Trypsin/EDTA.  
LLC and NOR-10 cells were cultured in monolayer with media described above. Spheroids 
were formed through seeding of LLC, NOR-10 and co-culture cell populations (LLC and NOR-10 at 
1:1 ratio) at 1 × 104 cells/well using 96-well, ultra-low attachment, round-bottom plates (Corning Inc., 
NY, USA). After 24h culture, dense multicellular spheroids were observed. These spheroids were 
termed 3D. 3D+ECM spheroids were formed through spheroid encapsulation in a coassembled Fmoc-
SAP. For 2D cultures, cells were cultured in tissue culture 96-well flat-bottomed plates (Corning Inc., 
NY, USA) using the same culture media and at the same cell concentration.  
Chapter 6: HEK-293T cells were cultured in DMEM containing 10% (v/v) FBS and 0.4% (v/v) 
penicillin/streptomycin in atmospheric O2 plus 5% CO2 at 37°C. C2C12 myoblasts were cultured in 
growth media (25 mM glucose DMEM plus 10% FBS, (Thermo Fisher, Australia)) in atmospheric O2 
with 5% CO2 at 37°C and passaged when 70 − 80% conﬂuent. 
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Chapter 8: Primary myoblasts isolated from C57Bl/6 mice (ARC, Western Australia) were generously 
donated by Dr Anita Quigley (St. Vincent’s Hospital Melbourne, Australia). Myoblasts were cultured 
in growth media (HamsF10 (Gibco), 20% FCS (Gibco), 2.5ng/ml bFGF (Peprotec), 2mM L-glutamine 
(Thermo)), 100 units/mL penicillin and 100 µg/mL streptomycin (Thermo)) in atmospheric O2 with 5% 
CO2 at 37°C and passaged when 70 − 80% conﬂuent. Myoblasts were differentiated in DMEM (Lonza), 
2% Horse Serum (Gibco), 2mM L-glutamine and 100 units/mL penicillin and 100 µg/mL streptomycin 
(Thermo). 
Chapter 9:  Cortical neurosphere cultures isolated from E18 Sprauge Dawley rat pups were generously 
donated by Dr Anita Quigley (St. Vincent’s Hospital Melbourne, Australia). Neurospheres were 
propagated using a Neurocult NS-A Proliferation Kit (STEMCELL Technologies), supplemented with 
20 ng/ml EGF (Peprotec) and 20ng/ml bFGF (Peprotec), according to manufacturer instructions. 
Neurospheres were differentiated in DMEM/F12 (Lonza) supplemented with 1% Stempro (Thermo 
Fisher), 0.5% N2 (Thermo Fisher), 20 ng/mL BDNF (Peprotech), 100 units/mL penicillin and 100 
µg/mL streptomycin (Thermo). 
3.3.2 Preparation of Versican and Empty Vector Conditioned Media 
 
Lipofectamine 2000 (Life Technologies) was used to transfect cells with constructs encoding the V1 
versican construct (provided by Professor Dieter Zimmermann) or the empty vector control 
(pcDNA3.1MycHisA, Life Technologies). Conditioned medium was produced as previously 
described.244 The conditioned media was collected into 1.5 mL Eppendorf tubes at 48 h post-transfection 
and stored at −80°C. 10% FBS was added to the conditioned media before use. 
3.3.3 Western Blotting of Versican Enriched Conditioned Media 
 
Versican was deglycosylated through addition of Chondroitinase ABC to aliquots of conditioned media 
improving V1/V0 versican anti-GAG-β antibody (AB1033, Merck Millipore Ltd. Pty., Australia) 
binding affinity to V1 versican. To prepare conditioned media samples for immunoblotting, 
Chondroitinase ABC was added to versican or empty vector conditioned media at a 1:30 ratio and 
incubated at 37°C for 2 h. Samples were then diluted with a 4 × loading buﬀer (Bio-Rad Laboratories 
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Inc., NSW, Australia) containing β-mercaptoethanol and incubated for 5 minutes at 95°C. Samples were 
run at 120 V on mini-protean TGX stain-free gels (Bio-Rad Laboratories Inc., NSW, Australia). Gels 
were then activated, and proteins visualised using the ChemiDoc XRS+ system (Bio-Rad Laboratories 
Inc., NSW, Australia). Gels were then transferred to Polyvinylidene difluoride (PVDF) membranes 
using the Trans-Blot Turbo system (Bio-Rad Laboratories Inc., NSW, Australia) as per manufacturer’s 
recommendations. PVDF membranes were blocked in 5% (w/v) skim milk in tris-buffered saline with 
tween (TBST) for 1h at room temperature, then incubated overnight at 4°C with versican anti-GAG-β 
antibody (AB1033, Merck Millipore Ltd. Pty., Australia) (1:500 dilution in 1% skim milk). Samples 
were then incubated for 1h with a secondary goat anti-rabbit HRP antibody in 1% skim milk in TBST 
(1:5000). Bands were observed using an ECL substrate (Bio-Rad Laboratories Inc., NSW, Australia), 
and blots were imaged through the ChemiDoc XRS+ system. 
3.3.4 Immunofluorescence to Confirm Media Incorporation to Scaffolds 
 
Hydrogels were prepared with either versican or empty vector conditioned media as outlined in Section 
3.2.1.3. Aliquots of gel samples were air-dried on poly-L-lysine microscope slides before fixing with 
4% paraformaldehyde in PBS for 5 minutes at room temperature. Immunostaining  was performed using 
the V1/V0 versican anti-GAG-β antibody, as previously described.245 Stained gels were imaged on a 
benchtop confocal microscope (Fluoview FV10i, Olympus, Australia) at 600× magniﬁcation. 
3.3.5 Live/Dead Cell Staining 
 
Chapter 6: C2C12 cells were stained using calcein AM and propidium iodide (Sapphire Bioscience 
Pty. Ltd., NSW, Australia) as per manufacturer’s instructions to show the relative percentage of 
live/dead cells at 24 and 72h post seeding onto the four hydrogel groups. Following 60 minutes 
incubation in atmospheric O2 with 5% CO2 at 37°C, live and dead cells were imaged using a ZOE 
ﬂuorescence cell imager (Bio-Rad Laboratories Inc., NSW, Australia) at 200× magniﬁcation. Live cells 
stained green with calcein AM, and dead cells stained red with propidium iodide. Cell-size was 
monitored as an indicator of cell spreading and was measured using ImageJ. N = 3 biological replicates 
were performed in duplicate wells for each scaﬀold at each time point. Total cell area was determined 
for an average of 880 cells per scaﬀold. 
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Chapters 8 and 9: At 24 and 72 h in culture 1 mL media was gently removed and Ethidium bromide 
and Calcein AM stains were added to constructs as per manufacturers instruction. Cells were stained 
for 15 minutes (Chapter 8) and 30 minutes (Chapter 9) to ensure sufficient fluorescence. Stained cells 
were observed under a fluorescent microscope (EVOS FL Fluorescence Microscope, Life 
Technologies) and imaged at 100x (Chapter 8) or 200x (Chapter 9) magnification. A Live/Dead cell 
count was performed manually using ImageJ cell counter and the relative proportion of live cells 
determined.  
3.3.6 Cell Proliferation and Metabolic Activity 
 
Chapter 4: Hydrogels were seeded with HMFC cells (4000 per well in 100 µL of media) and cultured 
for 24, 48 and 72h on Fmoc-FRGDF, Fmoc-FRGDFPHSRN, and coassembled Fmoc-FRGDF/Fmoc-
PHSRN (1:1, w/w) samples. Live cell quantification was performed through a colourimetric method by 
adding MTS reagent (Promega, Madison, WI, USA) to cells at each timepoint. MTS (20 µL) was added 
to samples and gently mixed. Cells were then incubated for 4 h at 37 ◦C before reading absorbance 
values at 490 nm using spectrophotometer (Bio-Rad, Hercules, CA, USA). 
Chapter 5: LLC, NOR-10 and co-culture 3D+ECM spheroid metabolic activity was determined to 
investigate cell response to encapsulation within Fmoc-SAP hydrogels. A CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (Promega, Madison, WI, USA) was used and samples were compared 
to non-encapsulated 3D spheroids, according to manufacturer’s instructions. Briefly, after 3D+ECM 
and 3D spheroid formation and incubation, MTS solution was added to each well and incubated at 37°C 
for 4 hours. Supernatant (100 μL) was then transferred to a clean flat-bottom 96-well plate (Corning 
Inc., NY, USA) and cell metabolic activity was quantified through absorbance measurement at 490 nm 
using a plate reader (Clariostar plate reader, BMG LABTECH, Australia) 
Chapter 6: Following 72h seeding, cell number was determined using a commercially available 
cytotoxicity kit (Vybrant Cytotoxicity AssayKit (Glucose-6-phosphatedehydrogenase (G6PD) Release 
Assay, V231111, Thermo Fisher Scientific), as per manufacturer’s recommendation with the following 
modiﬁcations. Hydrogel samples were solubilised in 15 mL PBS and centrifuged for 5 minutes at 3202g 
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to pellet cells. 12 mL of PBS was then removed, and myoblasts were washed and recentrifuged in 15 
mL of fresh PBS. The resultant cell pellet was then resuspended in 1 mL of PBS and centrifuged for 5 
minutes at 11688g. The cell pellet was then lysed using 1% lysis buﬀer for 15 minutes on ice. Samples 
were then diluted at 1:10 to assay glucose-6phosphate activity (a marker of cell number) using a 
multimode microplate reader Flexstation II384 (Molecular Devices, San Jose, CA, USA) at an 
excitation wavelength of 544 nm emission wavelength of 590 nm. Remaining cell lysate was used to 
assess total protein content as an indicator of cell growth through use of a Pierce BCA Protein Assay 
Kit (Thermo Fisher Scientific), as per manufacturer’s instructions. N = 3 biological replicates were 
performed in triplicate wells for each experiment, and the results were normalised to the respective 
control scaﬀolds (Fmoc-FRGDF, or Fmoc-FRGDF coassembled with empty vector conditioned media). 
3.3.7 Flow Cytometry 
 
Chapter 5: After culturing samples for 72 hours, vinculin and α-SMA expression levels were quantified 
via flow cytometry. Harvested spheroids and cells in 2D cultures were trypsinised using 0.25% trypsin-
EDTA, and spheroids were dissociated through repeated pipetting. Dissociated cells were then fixed 
using 2.5% paraformaldehyde for 20 minutes followed by permeabilisation using 0.5% saponin in PBS 
and subsequent blocking with 0.5% Bovine Serum Albumin (BSA) in PBS. Immunostaining was 
completed through incubation of cells with either mouse monoclonal anti-vinculin primary antibody 
(1:100 dilution, ab18058,  Abcam, Cambridge, UK) followed by Alexa Fluor 594-conjugated secondary 
antibody (1:200 dilution, A11005, Goat Anti-Mouse IgG (H+L); Life Technologies Pty Ltd., Australia); 
or mouse monoclonal anti-α-Smooth Muscle Actin primary antibody (1:100 dilution, ab7817,  Abcam, 
Cambridge, UK) followed by Alexa Fluor 488-conjugated secondary antibody (1:200 dilution, A11059, 
Rabbit Anti-Mouse IgG (H+L); Invitrogen, USA ). Following incubation, cells were washed with PBS 
and resuspended in 500 μL fluorescence-activated cell sorting (FACs) fix buffer. Negative controls 
(incubation in secondary antibody only) were prepared for each experimental condition. Flow 
cytometry analysis was performed using a FACS Canto™ II Flow Cytometer (BD Biosciences, San 
Jose, CA, U.S.A.) and data was analysed through use of Flowing software 2 (V 2.5.1, University of 
Turku, Finland). Each experiment was performed three times in duplicate. 
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3.3.8 Nucleus (DAPI) and Actin (Phalloidin) Staining 
 
Chapter 4: Following 48 h culture, cells seeded on hydrogel samples were ﬁxed using 4% 
paraformaldehyde for 10 minutes at room temperature. Cells were then gently washed twice with 1 × 
PBS and subsequently permeabilised with 0.1% tritonX-100 for 15 minutes at room temperature. Cells 
were again gently washed twice with 1× PBS with care taken to avoid gel damage. Rhodamine-
phalloidin (Life Technologies, Mulgrave, Australia) was used to stain cell actin as per manufacturer’s 
recommendation, and stained cells were observed using ﬂuorescent microscopy (Nikon, Tokyo, Japan). 
ImageJ analysis (Bethedsa, MD, USA) was used to determine cell area and intensity as per the software 
instructions. GraphPad prism (version3.03, SanDiego, CA, USA) was used to calculate the signiﬁcant 
student t-test for the values obtained using ImageJ. 
Chapter 6: To visualise cell actin and nuclei, C2C12 myoblasts were stained with Rhodamine 
phalloidin (Life Technologies) and 4′,6-diamidino-2-phenylindole (DAPI, Life Technologies) 
respectively. Cells were stained following 72 h culture to assess hydrogel effect on cell morphology 
and formation of multinucleated syncytia as an indication of cell differentiation. Brieﬂy, samples were 
ﬁxed using 200 μL of 4% paraformaldehyde in PBS (ProSciTech Pty. Ltd.) for 20 minutes at room 
temperature. Next, samples were washed in PBS and solubilised in 200μL of 0.1% Triton×100 
(ProSciTechPty.Ltd.) for 15 min. Cells were then stained with DAPI (1:200 dilution in PBS) and 
phalloidin (1:150 dilution in PBS) for 60 minutes. Following staining, cells were imaged using a ZOE 
ﬂuorescence cell imager (BioRad) at 200× magniﬁcation, and the number of myonuclei in a cell or 
syncytium was counted using ImageJ. N = 3 biological replicates were performed in duplicate wells for 
each sample following 24 and 72 h culture. An average of 450 cells or syncytia were analysed to 
determine average number of nuclei per cell or syncytia per scaﬀold. Furthermore, to verify cell-size 
calculations acquired through calcein AM staining, cell-size was determined using ImageProPlus. A 
reverse mask was used to identify ﬂuorescently labelled red and blue cells through selection of the black 
background, allowing for automated cell counting and determination of cell area. Cells at the edge of 
the image were excluded, and a minimum area of 40 μm2 was set. 
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Chapter 8: Primary myoblasts were stained using Alexa Fluor 488® phalloidin (Life Technologies, 
Australia) and DAPI (Life Technologies, Australia) to observe cell actin and nuclei, respectively, at day 
0 and day 14 differentiation. Briefly, following 3 days differentiation, proliferation media (Ham’s F10 
(Thermo Fisher, Australia) supplemented with 20% Fetal Calf Serum (Gibco), 2.5 ng bFGF 
(Peprotech), 2 mM L-glutamine (Gibco) and 1× penicillin/streptomycin (Gibco))  was replaced with 
differentiation media (DMEM supplemented with 2% horse serum, 2 mM L-glutamine (Gibco), and 
1% penicillin/streptomycin (Gibco)). Cells were cultured in differentiation media for 14 days with a 
half media change every 2 days. Media was removed following 14 days differentiation, and cells were 
fixed with 4% formalin overnight. Formalin was then removed, and constructs washed twice with PBS 
followed by a 1h PBS soak. PBS was then removed, and phalloidin was added as per manufactures 
instructions. Phalloidin was left overnight to ensure good stain penetration through the depth of the 
print. Again, constructs were washed twice with PBS before a subsequent 1h PBS soak. PBS was then 
removed and DAPI was added as per manufactures recommendation. DAPI was stained for 1h to ensure 
good stain penetration through the depth of the scaffold. Finally, constructs were washed twice followed 
by two 1h PBS soaks. Constructs were then imaged via confocal analysis (Nikon A1R Confocal laser 
microscope) and morphology assessed as an indication of myogenic differentiation. 
Chapter 9: Dissociated rat cortical neurospheres were stained using Alexa Fluor 488® phalloidin (Life 
Technologies, Australia) and DAPI (Life Technologies, Australia) to visualise cell actin and nuclei, 
respectively, following 3 days proliferation and following 14 days differentiation. For proliferative 
studies, cells were cultured in proliferative media (Neurocult NS-A Proliferation Kit (STEMCELL 
technologies) supplemented with 20 ng/mL bGNF (Peprotech), 20 ng/mL EGF (Peprotech), 2 g/mL 
Heparin (STEMCELL technologies) and penicillin/streptomycin (Gibco)) for 3 days following printing; 
while for differentiation studies, cells were cultured in proliferation media for 7 days following which 
media was substituted for differentiation media (DMEM/F12 supplemented with 1% Stempro (Thermo 
Fisher), 0.5% N2 (Thermo Fisher), 20 ng/mL BDNF (Peprotech), and 1 × penicillin/Streptomycin 
(Gibco)) and cells were cultured for a further 14 days with a half media change every 48h. Following 
desired culture (3 days proliferation or 14 days differentiation), media was removed, and cells were 
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fixed with 4% formalin overnight. Formalin was then removed, and constructs washed twice with PBS 
followed by a 1h PBS soak. PBS was then removed, and phalloidin was added as per manufactures 
instructions. Phalloidin was left overnight to ensure good stain penetration through the depth of the 
print. Again, constructs were washed twice with PBS before a subsequent 1h PBS soak. PBS was then 
removed and DAPI was added as per manufactures recommendation. DAPI was stained for 1h to ensure 
good stain penetration through the depth of the scaffold. Finally, constructs were washed twice followed 
by two 1h PBS soaks. Constructs were then imaged via confocal analysis (Nikon A1R Confocal laser 
microscope) and morphology assessed. 
3.3.9 Immunofluorescence Staining for DAPI, Vinculin and F-actin 
 
Chapter 5: Vinculin and filamentous-actin (F-actin) co-localisation was observed in 2D, 3D and 
3D+ECM co-cultures through immunofluorescence staining. Following 72 h culture, cells were fixed 
in 4% paraformaldehyde and washed twice in 0.05% Tween-20 in PBS. Cells were then permeabilised 
using 0.5% Triton X-100 solution in PBS and blocked with 1% BSA in PBS. Cells were then immersed 
in mouse monoclonal anti-vinculin primary antibody (1:100 dilution, ab18058, Abcam, Cambridge, 
UK) at 4°C overnight.  Samples were then washed with 0.05% Tween-20 in PBS and spheroids were 
incubated with Alexa Fluor 488-conjugated secondary antibody (1:200 dilution, A11059, Rabbit Anti-
Mouse IgG (H+L); Invitrogen, USA) and tetramethylrhodamine isothiocyanate (TRITC)-conjugated 
phalloidin (1:200, R415; Life Technologies Pty Ltd., Australia). Finally, DAPI (R37606, Life 
Technologies, and Grand Island, NY) was used to stain cell nuclei for 5 minutes following which 
samples were washed using 0.05% Tween-20 in PBS. Samples were then immersed in PBS to avoid 
sample drying and imaged through confocal microscopy (A1R+ confocal microscope system; Nikon, 
Tokyo, Japan).  
3.3.10 Cell Migration Tracking 
 
Chapter 5: To investigate cell migration through agarose and Fmoc-SAP hydrogels, LLC cells were 
fluorescently labelled red (CellTracker™ Red CMTPX Dye, C34552, Invitrogen, USA), and NOR-10 
cells were fluorescently labelled green (MitoTracker Green FM, M7514, Invitrogen, USA) prior to co-
culture and spheroid formation. Briefly, cell concentrations were adjusted to 1 × 106 mL-1 in PBS and 
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CMPTX red (LLC cells) and MitoTracker Green (NOR-10 cells) were added at a final working 
concentration of 5μM and 10 μM, respectively. Cells were then incubated for 37°C under light protected 
conditions, followed by fluorescence quenching using two volumes of complete media and washed 
thrice. Fluorescently labelled cells were co-cultured into spheroids as described in section 3.3.1. 
Subsequently, spheroids were encapsulated within coassembled Fmoc-SAP hydrogel or 1% agarose 
(prepared as detailed in section 3.2.1 and 3.2.2). Finally, cell migration was observed as tracked by 
confocal microscopy after 72 hours of incubation. 
3.3.11 SEM Observation of Cell Interaction with Bioinks 
 
Chapter 8: Primary myoblast interaction with printed bioinks was assessed via SEM following 14 days 
differentiation. Briefly, cells were fixed in formalin overnight followed by washing thrice in PBS. 
Samples were then washed three times in 0.1 M cacodylate buffer to avoid salt precipitation. Next, 1% 
osmium tetroxide was added to samples and samples were soaked for 30 minutes. Osmium tetroxide 
was then removed, and samples were washed 3 times with MilliQ water. Samples then underwent 
various drying steps through sequential increase in ethanol content. Specifically, samples were 
immersed in 50% ethanol for 10 minutes, followed by soaking in 70% ethanol for 10 minutes. Samples 
were then soaked in 90% ethanol for 30 minutes followed by further soak in 100% ethanol for 30 
minutes. 100% ethanol was then removed, and samples were placed in fresh 100% ethanol overnight at 
4°C. Finally, samples were removed from ethanol and placed onto SEM stubs where they were allowed 
to dry for a minimum of 1 hour. Samples were then gold sputter coated and stored in a sealed 
environment prior to imaging. Samples were imaged using a FEI Scios Dualbeam FIBSEM and/or FEI 
Verios 460L FEGSEM at an operating voltage of  5 kV and 3 kV, respectively. 
Chapter 9: Rat cortical neurosphere interaction with printed bioink constructs was observed via SEM 
following 3-days culture to investigate cell protrusion and material interaction. Constructs were 
prepared as above. Briefly, cells were fixed in formalin overnight followed by washing thrice in PBS. 
Samples were then washed three times in 0.1 M cacodylate buffer to avoid salt precipitation. Next, 1% 
osmium tetroxide was added to samples and samples were soaked for 30 minutes. Osmium tetroxide 
was then removed, and samples were washed 3 times with MilliQ water. Samples then underwent 
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various drying steps through sequential increase in ethanol content. Specifically, samples were 
immersed in 50% ethanol for 10 minutes, followed by soaking in 70% ethanol for 10 minutes. Samples 
were then soaked in 90% ethanol for 30 minutes followed by further soak in 100% ethanol for 30 
minutes. 100% ethanol was then removed, and samples were placed in fresh 100% ethanol overnight at 
4°C. Finally, samples were removed from ethanol and placed onto SEM stubs where they were allowed 
to dry for a minimum of 1 hour. Samples were then gold sputter coated and stored in a sealed 
environment prior to imaging. Samples were imaged using a FEI Scios Dualbeam FIBSEM at an 
operating voltage of 5 kV. 
3.4 Statistical Analysis 
 
A student paired, two-tailed t test was performed between control and test groups for all cell culture 
experiments in Chapter 4 and 6. GraphPad Prism (Version 3.03 and 7 for Chapter 4 and 6, 
respectively) was used for statistical analysis and samples were prepared in triplicate with 3 biological 
repeats. For Chapter 5, 3 biological repeats were performed in duplicate for all samples and statistical 
analysis performed through Graphpad Prism (Version 7.0, GraphPad Software, San Diego, CA, USA). 
Student unpaired, two-tailed t test was used to determine statistical significance between two samples, 
whilst Two-Way Analysis of Variance (ANOVA) with Tukey post-hoc tests was used for multiple 
comparisons. For Chapter 7, all correlation analysis was performed using GraphPad Prism (Version 
7.0, GraphPad Software, San Diego, CA, USA). Specifically, a Pearson correlation test was performed 
between each sample with a 95% confidence interval and Pearson r values were calculated and plotted 
as a heatmap for ease of visualisation (Supplementary Figure S - 6). One-way ANOVAs with Tukey 
post-hoc tests were used to identify statistically significant changes between groups in Chapter 8 and 
9, all in vitro data was completed in triplicate. In all chapters, statistical significance was set at a value 
of P < 0.05. All data was presented with mean ± standard error of the mean (SEM), or data ± standard 
deviation (σ). In Chapters 5, 7, 8, and 9, SAXS data presented as calculated value ± uncertainty. For 
all correlations in Chapter 7, a Pearson value of 1 indicates a perfect correlation while -1 indicates a 
perfect inverse correlation; anything above 0.5 or below -0.5 was considered well-correlated.  
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Chapter Four: 
 
 
 
4.  
TUNING THE BIOMECHANICAL AND 
BIOCHEMICAL PROPERTIES OF SCAFFOLDS 
VIA COASSEMBLY 
 
4.1 Preview 
 
In this chapter we tune the biomimetic properties of SAP materials through the development of multi-
component scaffolds. Firstly, synergistic epitopes from fibronectin were incorporated into rationally 
designed SAPs (Fmoc-FRGDF, Fmoc-PHSRN). These were then assembled into nanofibrils, where 
they were synergistically presented to promote a more ECM-like environment that enhanced attachment 
during in vitro cell culture. A sulphonated polysaccharide, Fucoidan, was then investigated as a means 
of influencing nanofibrillar supramolecular organisation. Results show that these two distinct 
mechanisms of multicomponent assembly enable tuneable control over mechanical properties and 
network orientation, and enhance cell adhesion and spreading. This chapter forms foundations for 
subsequent studies including Chapter 5, and those investigating macromolecule functionalisation on 
cell-behaviour (Chapter 6), and bioink development (Chapter 8). 
Contribution of the candidate: 
• Involvement in analysis regarding material properties and assembly mechanisms.  
• Contributed in manuscript preparation.  
Publications relevant to this chapter 
Figures within this chapter reprinted (adapted) with permission from: 
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Abstract: 
The native ECM is a complex, protein-rich milieu which varies in mechanical and biological properties 
between tissue types. Current tissue engineering approaches aim to replicate these conditions; however, 
despite research efforts, few researchers have engineered suitable materials which present controlled 
biological and mechanical tunability under physiological conditions.  Here, we investigate two separate 
mechanisms for simultaneous mechanical and biological tunability. The first takes advantage of simple 
peptide synthesis techniques to selectively engineer biologically relevant epitopes within a stable SAP. 
Natively, fibronectin presents the attachment motif RGD synergistically with PHSRN; however, many 
functionalisation approaches focus solely RGD presentation. As such, we aim to address these 
shortcomings through combination of fibronectin-inspired Fmoc-FRGDF with PHSRN. This is 
achieved through two approaches: a) concatenated peptide Fmoc-FRGDFPHSRN, and b) coassembly 
of Fmoc-FRGDF with Fmoc-PHSRN. The second half of this chapter focuses on introducing 
mechanical tunability through macromolecule incorporation. Here, the anti-inflammatory 
polysaccharide fucoidan is coassembled with Fmoc-FRGDF.  
Assembly mechanisms and their influence on mechanical characteristics are investigated through 
spectroscopic analysis and electron microscopy. Fucoidan influence on network architecture is further 
observed through SANS; while underlying nanostructure of multisequence scaffolds is observed using 
SAXS. Preliminary in vitro cell response is also investigated for multisequence scaffolds through 
seeding of HMFCs. Results show maintenance of self-assembly in both cases. Fucoidan addition altered 
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fibril supramolecular ordering – resulting in increased bundling proportional to fucoidan concentration.  
Alternatively, Fmoc-PHSRN addition to Fmoc-FRGDF did not significantly alter network topology; 
and cells cultured on Fmoc-FRGDF/Fmoc-PHSRN coassembled scaffolds demonstrated enhanced 
adhesion and spreading compared to Fmoc-FRGDF alone. 
4.2 Introduction 
 
Recent advances in materials engineering has enabled tailored tissue regeneration previously 
unobtainable through conventional treatment protocols.246 The potential for these biomaterials to mimic 
aspects of the native ECM has inspired significant research through fields transcending tissue 
engineering, regenerative medicine, and drug delivery.247-248  However, despite some success, there is 
still substantial research to be undertaken if we are to truly mimic the complexities of natural tissue 
microenvironments. 
The native ECM is a complex cellular microenvironment which provides structure and 
signalling to tissue through the mediation of interactions between cells and various bioactive proteins, 
polysaccharides and other biological macromolecules.1 Fibronectin is a fibrous glycoprotein found in 
abundance within the native ECM which plays a crucial role in facilitating cell-ECM interactions.249 
Significant research into fibronectin’s cell-attachment region has revealed short sequences of amino-
acids responsible for promoting cell attachment through integrin binding.249 In particular, research has 
centred on the minimalistic peptide motif RGD, a key attachement site which numerous materials 
engineering approaches have incorporated to facilitate successful biomaterial functionalisation.250 
However, in native fibronectin, this amino acid sequence does not work in isolation, rather it works 
synergistically with another minimalistic cell attachment motif, PHSRN, to promote cell adhesion.249, 
251-252 Despite this, few approaches have investigated material functionalisation through PHSRN 
addition.  
ECM mechanical properties are also known to differ significantly between tissue types and as 
such advanced biomaterials are required to possess simplistic and tuneable ways of controlling material 
stiffness.253-255 One potential resolve is offered through structural macromolecule integration to 
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hydrogel systems. Previously, the oligosaccharide agarose has been combined with low-molecular-
weight gelators to increase hydrogel stiffness substantially.256 Similarly, to investigate macromolecule 
incorporation in this peptide system and its subsequent influence on mechanical properties, the 
polyanionic polysaccharide fucoidan was selected.257 Fucoidan is a highly sulphated, seaweed-derived 
biomacromolecule which demonstrates anti-inflammatory and anti-coagulant activity.258-259 
Furthermore, fucoidans have shown success in hemopoietic expansion cultures,260 as wound healing 
accelerators,261-262 and are known to bind heparin-binding growth factors.263-264 However, unlike 
agarose, fucoidan alone has not demonstrated the propensity to form hydrogels, and therefore, needs to 
incorporate gelling components for wound care applications.261 Consequently, fucoidan can be 
considered as a polyelectrolyte, which at low concentrations, interacts with supramolecular bundles and 
is subsequently presented on the surface of the fibrillar scaffold in a bioactive fashion.265 
Biomimetic artificial tissue microenvironments must adhere to stringent design rules. Here, 
biocompatible materials are required to provide cells with a 3D microenvironment, while providing the 
necessary structural and biochemical signals to cells directing cell fate.143, 266 These materials should be 
tuneable (both mechanically and biologically), should present optimised biodegradation profiles, and 
should control the local inflammatory environment.141, 267-268 SAPs are unique biomaterials capable of 
spontaneous self-organisation into larger hierarchical structures through mechanisms similar to those 
in nature.128, 141 The ability of these materials to be easily biofunctionalised through sequence selection, 
combined with their ease of synthesis and mechanical tunability, have made them promising candidates 
as artificial ECMs.26, 243, 265 
Previous work in our laboratory has developed the fibronectin inspired, RGD presenting SAP, 
Fmoc-FRGDF.143 Recently, the coassembly of this peptide with other SAPs or polysaccharides has 
resulted in optimised tissue engineering scaffolds.26, 265 Therefore, in this chapter, we investigate the 
ability of Fmoc-FRGDF enhancement through mechanical and biological manipulation. Biological 
optimisation is investigated through the incorporation of the synergistic sequence, PHSRN. Here, two 
assembly mechanisms are detailed – the first is enabled through the synthesis of the decapeptide, ‘Fmoc-
FRGDFPHSRN’, while the second approach focuses on coassembly of Fmoc-FRGDF with a second 
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SAP, ‘Fmoc-PHSRN’. Mechanical tunability is investigated through fucoidan coassembly with Fmoc-
FRGDF at three different fucoidan concentrations (2 mg/mL, 5 mg/mL, and 10 mg/mL), and compared 
to Fmoc-FRGDF alone.  
In all functionalisation approaches, material assembly mechanisms, network topology, and 
resultant mechanical properties are investigated. Additionally, material bioactivity is investigated for 
PHSRN-containing scaffolds.  
4.3 Results and Discussion 
4.3.1 Development of Multi-Sequence Self-Assembled Peptide Hydrogels 
4.3.1.1 Formation of Hydrogels 
 
To investigate the propensity of Fmoc-based SAPs to form advanced biomimetic, multisequence 
scaffolds, three fibronectin inspired peptide sequences were developed (Figure 4-1A-C). Fmoc-
FRGDF, Fmoc-PHSRN, and Fmoc-FRGDFPHSRN were synthesised via SPPS, resulting in the 
formation of a white crystalline powder in each case. A fourth peptide mixture was also developed 
through mixing of Fmoc-FRGDF and Fmoc-PHSRN powders at a 1:1 ratio. Peptides hydrogels (10 
mg/mL) were developed from each of the four samples via a well-characterised pH switch method 
(Figure 4-1D).8 Here, Fmoc-FRGDF formed a clear, stable hydrogel within 2 hours. Alternatively, 
Fmoc-PHSRN was unable to form a stable hydrogel under all tested conditions. This is likely due to 
the presence of proline residues, which literature shows is unable to form effective hydrogen bonds 
owing to its cyclic structure which lacks the normal NH2 backbone; subsequently limiting its ability to 
form α-helix or β-sheet conformations.269-270 The concatenated decapeptide sequence ‘Fmoc-
FRGDFPHSRN’ formed a hydrogel over 10 days; whilst the coassembled peptide mixture (Fmoc-
FRGDF + Fmoc-PHSRN, 1:1 ratio) required 3 days to form a stable hydrogel. The ability of these 
peptides, containing both ‘PHSRN’ and ‘FRGDF’ epitopes to form hydrogels is interesting, as it shows 
that interactions within the ‘FRGDF’ component are stable enough to maintain sufficient self-assembly, 
despite the presence of proline. The delay in hydrogel formation in these samples, however, may explain 
the relatively limited research into PHSRN-containing, SAP hydrogels.  
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Figure 4-1 – Structure of three Fmoc-based self-assembling peptides. A) Fmoc-FRGDF; B) Fmoc-PHSRN; 
C) Fmoc-FRGDFPHSRN and D) hydrogels formed of (i) Fmoc-FRGDF; (ii) Fmoc-PHSRN; (iii) Fmoc-
FRGDFPHSRN and (iv) peptide mixture of Fmoc-FRGDF/Fmoc-PHSRN (1:1, w/w).  E) Cartoon Schematic of 
peptide assembly mechanisms. Reproduced with permission 314 
  
  
103 
 
4.3.2 Investigation into Network Topology of Engineered SAP Hydrogels. 
 
All hydrogels were allowed to gel over 10 days; after which their resulting nano- and microarchitectures 
were analysed using microscopy techniques. TEM analysis was employed to analyse hydrogel nano-
structure (Figure 4-2A-D). Here, Fmoc-FRGDF, Fmoc-FRGDFPHSRN, and the coassembled 
hydrogel, Fmoc-FRGDF/Fmoc-PHSRN, all demonstrated nanofibers of width 5-10 nm and length 
several micrometres as analysed via ImageJ; while no fibrillar structures were evident in Fmoc-PHSRN 
samples. Fmoc-PHSRN’s lack of fibrous structure provides insight into the inability of this peptide to 
gel on its own – as there are no structures capable of effectively immobilising surrounding water 
(Figure 4-2B). Analysis of Fmoc-FRGDF alone showed the formation of a highly ordered network 
with a lateral association between many peptide fibrils resulting in the formation of ‘bundles’ (Figure 
4-2A).  Alternatively, TEM analysis of Fmoc-PHSRN showed no fibrils, rather, granules or clusters are 
present. The long peptide, Fmoc-FRGDFPHSRN, demonstrates short peptide fibrils with no noticeable 
bundling (Figure 4-2C); these short fibrils provide a potential explanation for the long hydrogelation 
time, as these truncated structures would be ineffective at trapping surrounding water, and as such would 
require more time to trap sufficient water. Further analysis of Fmoc-FRGDFPHSRN structures show 
the coexistence of globular structures which may be due to unassembled peptide particles. Finally, TEM 
analysis of the coassembled hydrogel, Fmoc-FRGDF/Fmoc-PHSRN shows the formation of a well-
ordered fibrillar network (Figure 4-2D).  
AFM provides insight into network orientation (Figure 4-2E-H). Fmoc-FRGDF shows a well-
ordered network which confirms the highly-structured nature of this hydrogel (Figure 4-2E).143 
Alternatively, Fmoc-PHSRN is once again shown to have no observable fibrils, rather aggregates in an 
array of sizes are visible (Figure 4-2F). Here, it is likely that the presence of the proline residue perturbs 
stable fibril formation. Fmoc-FRGDFPHSRN shows a highly dense network consisting of short 
truncated fibrils compared to Fmoc-FRGDF alone (Figure 4-2G). Observation of the mixed hydrogel 
formed through coassembly of Fmoc-FRGDF and Fmoc-PHSRN shows a highly branched network 
similar in topology to Fmoc-FRGDF alone (Figure 4-2H). 
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Figure 4-2 –Hydrogel Nano/Microtopology observations in response to assembly mechanism.  (top panel 
TEM images and bottom panel AFM images). A,E) Fmoc-FRGDF; B,F) Fmoc-PHSRN; C,G) Fmoc-
FRGDFPHSRN and D,H) peptide mixture of Fmoc-FRGDF/Fmoc-PHSRN (1:1, w/w). Reproduced with 
permission 314  
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Further analysis of material nanoarchitecture was performed using SAXS (Figure 4-3). As 
Fmoc-PHSRN failed to form a suitable hydrogel, it was excluded from SAXS analysis and subsequent 
in vitro investigation. AFM and TEM analysis revealed fibrillar structures, and therefore we anticipate 
that SAXS analysis will demonstrate similar findings. All remaining samples showed SAXS spectra 
characteristic of cylindrical structures, indicated by q-1 angle dependence in low q values (Figure 4-3A). 
Length of each fibril could not be established as the length lies outside the range tested (q range). As 
such, the length can be considered infinite during this analysis, and all calculated values can be 
attributed to the radius of structures within the hydrogel. To determine radius, an IFT method was 
employed. As we have previously determined the cylindrical nature of these structures, and, as the 
length is known to be outside the q range, analysis of the max P(r) of IFT functions indicates the average 
radius (Figure 4-3B). The resulting fibril diameter is found to be 8.4 nm (41.8 Å, σ = 0.7 Å), 6.3 nm 
(31.3 Å, σ = 1.2 Å), and 7.1 nm (35.3 Å, σ = 1.2 Å) for Fmoc-FRGDF, Fmoc-FRGDF/Fmoc-PHSRN 
(coassembled), and Fmoc-FRGDFPHSRN respectively. However, TEM analysis of Fmoc-
FRGDFPHSRN also indicated the presence of spherical structures which may convolute the determined 
fibril radius. Despite this, all results are consistent with previous TEM observations relating to fibril 
diameter. 
 
Figure 4-3 – Investigation of material nanostructure via SAXS A) Scattering curve of Fmoc-FRGDF, Fmoc-
FRGDFPHSRN, and Fmoc-FRGDF/Fmoc-PHSRN displaying q−1 relationship at low q angles. B) P(r) inversion 
of RGD-containing SAPS. Reproduced with permission 314 
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4.3.3 Investigation of Self-Assembly Mechanisms 
 
Spectroscopic analysis, including FT-IR, CD, and fluorescence spectroscopy was employed to analyse 
the driving mechanisms of assembly in each case. All samples showed similar self-assembly 
mechanisms driven through Fmoc-interactions and stabilised via various hydrogen bonds.271 FT-IR 
analysis indicates the dominant organisation of the peptide backbone. Here, Fmoc-FRGDF, Fmoc-
FRGDFPHSRN, and the coassembled hydrogel, Fmoc-FRGDF/Fmoc-PHSRN all demonstrated two-
distinct absorption peaks within the amide I region, occurring at approximately 1627cm-1 and 1690cm-
1 corresponding to the formation of stable β-sheet conformations (Figure 4-4A).272 These peaks were 
not evident in samples containing Fmoc-PHSRN alone, instead, a broad transition is evident which 
centres near 1667 cm-1 indicating the presence of randomly coiled conformations.273 Interestingly, the 
coassembled peptide sequence, Fmoc-FRGDF/Fmoc-PHSRN, demonstrated an additional peak at ~ 
1664 cm-1 indicative of random coils; this additional peak in conjunction with those centred around 
1627cm-1 and 1690cm-1 indicate that in addition to β-sheet formation, random coils are also evident. 
The presence of random coils is likely a result of non-ideal assembly, owing to the presence of proline 
residues which necessitate differing spatial requirements and therefore are unable to pack efficiently 
during self-assembly. The same peak, centred around 1664 cm-1, is not observed in samples constituting 
Fmoc-FRGDF alone, and therefore, it can be reasoned that any disruption in β-sheet formation is due 
to the presence of the PHSRN motif. Findings gained in FT-IR analysis support observations made in 
TEM and AFM analysis, where Fmoc-PHSRN addition was found to influence assembly mechanisms. 
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Figure 4-4 – Spectroscopic characterisation of the peptide hydrogels. A) Truncated FT-IR absorption spectra 
in amide I region, and B) CD spectra. Reproduced with permission 314 
 
CD allowed for further analysis of amino acid secondary structure. Investigation into Fmoc-
FRGDF assembly shows a strong, positive peak centred on 198 nm and a second, negative peak located 
at 220 nm (Figure 4-4B). These peaks indicate a negative cotton effect induced by n-π transitions.274-
275 The combination of these peaks indicates the presence of stable β-sheet conformations.274-275 Another 
positive peak is evident at ~263 nm in the Fmoc-FRGDF sample spectrum, signifying induced chirality 
of aromatic-stacking moieties and relating to the stacking of Fmoc-groups.276 Contrastingly, Fmoc-
PHSRN establishes a strong negative peak at 200 nm and a weak positive peak at 223 nm; as such, this 
peptide is likely to assume a non-hydrogen bonded polyproline type II helical structure and present as 
random coils in dilute solution (10 mg/mL).277-278 Interpretation of Fmoc-PHSRN CD spectra is in 
agreeance with findings gained in FT-IR analysis and provides further explanation for the fluidic state 
observed in this sample during hydrogel synthesis (Figure 4-1D). Fmoc-FRGDFPHSRN demonstrated 
a comparable trend to Fmoc-FRGDF alone, demonstrating a positive peak at 196 nm and a negative 
peak at 213 nm, once again indicating the formation of β-sheet structures.274 Finally, CD analysis of the 
Fmoc-FRGDF/Fmoc-PHSRN hydrogels demonstrated a strong negative peak at 212 nm yet lacked a 
prominent positive peak at 218 nm, indicating the presence of indistinct β-sheet structures which might 
be due to the incidence of random coils identified in FT-IR analysis. Another peak evident at 
approximately 260 nm indicates Fmoc-group stacking.276 The evidence of β-sheets in this sample shows 
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that despite prolines inability to form β-sheet conformations, the remaining moieties can maintain these 
structures. 
Analysis through fluorescence spectroscopy provides insight into emission of fluorenyl 
moieties and further enforces understandings gained in FT-IR and CD analysis.279 Peaks at ~330 nm 
indicate Fmoc-monomer interactions and consequently indicate the relative amount of Fmoc-monomers 
in solution.279 As expected, Fmoc-PHSRN showed the most significant peak at this wavelength 
indicating the highest amount of Fmoc-monomers present compared to the remaining samples (Figure 
4-5A). Alternatively, Fmoc-FRGDF and Fmoc-FRGDF/Fmoc-PHSRN samples showed decreased 
Fmoc-monomers, likely a result of stable hydrogel assembly. Fmoc-FRGDFPHSRN was shown to 
demonstrate the smallest peak around this wavelength and subsequently shows the least number of 
Fmoc-monomers present out of all four samples. Further analysis of the fluorescent spectra shows all 
samples demonstrate a broad peak centred around 450 nm, relating to extensive stacking between 
aromatic groups (J-aggregates) and owing to contributions from both phenylamine and fluorenyl 
groups.280 Specifically, this peak relates to π-π stacking between multiple fluorenyl rings during 
efficient hydrogel formation and subsequently, indicates fibre formation.280  Excimer peaks are more 
noticeable in Fmoc-FRGDFPHSRN and the coassembled, Fmoc-FRGDF/Fmoc-PHSRN sample, 
suggesting increased Fmoc-stacking despite evidence of random coil structures in CD and FT-IR 
analysis techniques. Contrastingly, this peak is hardly evident in Fmoc-PHSRN samples, signifying a 
lack of apparent J-aggregate formation in this sample possibly resulting from the steric effect of proline 
residues;270 subsequently, Fmoc-organisation in self-assembly is likely to be negatively influenced, and 
the resultant self-assembled structure is expected to be interrupted. The coassembled Fmoc-
FRGDF/Fmoc-PHSRN system demonstrates the greatest peak at this wavelength; therefore, it can be 
deduced that weak hydrogen bonds relating to the proline-containing PHSRN sequence are 
compensated by increase Fmoc-stacking to maintain stable fibril formation.  
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Figure 4-5 – Spectroscopic and rheological characterisation of the peptide hydrogels. A) fluorescence 
spectra, and B) rheological analysis of peptides showing viscoelastic characteristics . Reproduced with 
permission 314 
 
Oscillatory rheological analysis was employed to analyse the broad viscoelastic properties of 
the developed hydrogel systems. For all samples, the storage modulus was found to be greater than the 
loss modulus indicating the successful formation of a stable hydrogel (Figure 4-5B); however, despite 
this, Fmoc-PHSRN demonstrated an extremely low storage modulus of 0.5Pa (at 50 rad/s), and as such, 
exhibited a fluidic state in macroscopic analysis. The observations gained in spectroscopic and 
microscopic analysis show structures are formed during Fmoc-PHSRN self-assembly, and this may 
contribute to the perceived storage modulus being above that of the loss modulus in this sample, despite 
this, these structures are shown to be non-conducive to self-supporting gel formation. Contrastingly, 
Fmoc-FRGDF was shown to form a soft hydrogel with a storage modulus of approximately 50 Pa at 50 
rad/s. The long peptide Fmoc-FRGDFPHSRN, demonstrated a relatively low storage modulus of 
approximately 8.5 Pa at 50 rad/s. Interestingly, the coassembled Fmoc-FRGDF/Fmoc-PHSRN system 
demonstrated the most robust hydrogel, exhibiting a storage modulus of ~1600 Pa at 50 rad/s. 
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4.3.4 Biological Effect of Synergistic Scaffolds 
 
Finally, synergistic scaffold bioactivity is investigated via in vitro analysis of seeded cell viability, 
proliferation, and spreading. As Fmoc-PHSRN alone could not form an adequate hydrogel under all 
tested conditions, it was excluded from cell-culture investigation. All hydrogels were allowed to 
undergo sufficient gelation over 10 days, after which HMFCs were seeded onto the hydrogel surface. 
Cell viability and proliferation was analysed over 3 days through colourimetric MTS Assay. Fmoc-
FRGDF alone at day 1 was used as a control, and all samples were normalised to this result; Fmoc-
FRGDF was selected for use as a control as it has previously proved suitability for cell culture 
conditions.143, 281  Fmoc-FRGDF alone was found to proliferate steadily over 3 days (Figure 4-6A). 
Alternatively, the long peptide, Fmoc-FRGDFPHSRN, showed a decrease in cell viability resulting in 
a significant difference between Fmoc-FRGDFPHSRN and Fmoc-FRGDF alone after 3 days. This 
observation may be a result of weak assembly and/or insufficient cell attachment. Contrastingly, the 
coassembled peptide, Fmoc-FRGDF/Fmoc-PHSRN demonstrated a substantial increase in cell 
proliferation over three days; being significantly higher than that of Fmoc-FRGDF and Fmoc-
FRGDFPHSRN by day 3.  
Cell attachment and spreading was analysed through actin staining after 48h culture (Figure 
4-6B, C), this time point was selected as it allows cells to react and integrate within their respective 
environments. Fmoc-FRGDF alone shows viable cells with a typical fibroblast morphology 
demonstrating slight focal adhesions to the peptide. Fmoc-FRGDFPHSRN did not show such 
projections; alternatively, cells appeared more rounded in structure indicative of poor cell attachment. 
Finally, the mixed peptide coassembly, Fmoc-FRGDF/Fmoc-PHSRN demonstrated substantially more 
spreading when compared to Fmoc-FRGDF alone; indicating cell attachment is significantly increased 
in this sample by 48h. Such differences between Fmoc-FRGDFPHSRN and the coassembled system 
may be a result of epitope spacing, as research into fibronectin shows RGD and PHSRN are separated 
by approximately 30-40 Å and that this distance is important for correct synergistic signalling.282 
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Figure 4-6 – Cytocompatibility of HMFCs on Fmoc-SAP hydrogels A) Cell viability of HMFCs on peptide 
hydrogels over three days as assessed through MTS assay (absorbance wavelength of 490 nm). Absorbance 
value of cells grown on Fmoc-FRGDF was considered as control and a p-value of <0.05 was considered 
significant.  B) Analysis of spreading area: following 48h of HMFCs on peptide surface, cells were stained 
with actin, and images were obtained using through fluorescence microscopy (20x magnification). ImageJ 
analysis was performed, and values were plotted using GraphPad Prism, the p -value**** <0.05 was considered 
statistically significant. C) Typical morphologies of HMFCs following actin staining for samples measured in 
(b) scale bat 10 µm. Reproduced with permission 314 
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4.4 Enabling Mechanical Tunability Through Macromolecule Addition 
4.4.1 Formation of Hydrogels 
 
Fmoc-FRGDF based hydrogels were used to investigate network tuning through bioactive 
polysaccharide addition. Here, Fmoc-FRGDF (10 mg/mL) assembly was triggered in a solution 
containing the highly sulphated polysaccharide fucoidan to observe the mechanical effect of the process 
(Figure 4-7A-D). Here, we added varying amounts of fucoidan to form 4 distinct hydrogels: Fmoc-
FRGDF (+0 mg/mL fucoidan), +2 mg/mL, +5 mg/mL, and +10 mg/mL. In each case – fucoidan 
containing samples were combined before assembly via a pH switch method, resulting in a coassembled 
peptide network. We hypothesise that fucoidan integration during the assembly process allows for 
modification of the assembly process, while fucoidan addition post-assembly does not facilitate such 
tunability. Therefore, a fifth hydrogel was developed as a control; this hydrogel consisted of Fmoc-
FRGDF (10 mg/mL) which was allowed to assemble to completion before subsequent addition of 10 
mg/mL fucoidan – resulting in a post-assembled fucoidan-containing network. In coassembled 
hydrogels, gelation occurs within 2 hours of assembly. Interestingly, fucoidan containing samples are 
found to assemble more rapidly compared to Fmoc-FRGDF alone; therefore, we anticipate that fucoidan 
addition is effectively able to influence fibril interactions. Increase in rate of self-assembly has 
previously been observed as a function of the extent of stimulus during early self-assembly stages.279, 
283 Previously, studies using similar peptides have found that although pKa was unaffected by 
macromolecule addition, the rate of pH change was effected, and subsequently, hydrogels formed more 
rapidly.284 Likewise,  fucoidan addition influenced rate of gelation, however, was found to have no 
effect on hydrogel pKa, and subsequently, did not change the pH of hydrogelation.140 All gels formed 
optically transparent hydrogels, however, the hydrogel coassembled with 10 mg/mL fucoidan 
demonstrated slightly increased opacity (Figure 4-7E).  
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Figure 4-7 – Peptide self-organisation in the presence of fucoidan.  A) Chemical structure of Fmoc-FRGDF. 
B) schematic of peptide assembly showing fibril formation and subsequent entanglement to form a hydrogel 
network. C) repeating fucoidan subunit D) Schematic of proposed supramolecular ordering through interactions  
between fucoidan and individual fibrils to produce organised fibre bundles of thicker morphology.. E) Gel 
macromorphology as formed from i) Fmoc-FRGDF, ii) +2, iii) +5, iv) +10 mg/mL fucoidan.  Reproduced with 
permission 337 
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4.4.2 Investigation into Network Topology of Macromolecule Functionalised SAPs 
 
To analyse fucoidans influence on network topology, TEM and AFM techniques are employed (Figure 
4-8). TEM analysis of Fmoc-FRGDF once again shows the development of nanofibers with a diameter 
of ~10 nm and microns in length (Figure 4-8A). Fucoidan addition during assembly is found not to 
interrupt the formation of nanofibrils, with fibrils comparable to those seen in Fmoc-FRGDF alone 
present in all samples (Figure 4-8B-D). Despite this, TEM analysis of fucoidan-containing samples 
demonstrates greater fibre bundling compared to Fmoc-FRGDF alone. Alternatively, analysis of 
network microstructure through AFM shows a significant difference between samples. Fmoc-FRGDF 
demonstrates a highly interconnected network of individual fibrils (Figure 4-8E). Observation of 
coassembled Fmoc-FRGDF + 2 mg/mL fucoidan samples shows no significant increase in fibre 
bundling; however, there is a notable increase in fibril alignment (Figure 4-8F). As the concentration 
of fucoidan increases from 2 mg/mL to 5 mg/mL, fibre bundling is observed, with bundles ranging in 
diameter from 50 nm – 100 nm (Figure 4-8G). Further increase in fucoidan concentration to 10 mg/mL 
results in a further increase in fibril bundling, resulting in large bundles of approximately 150 nm in 
diameter (Figure 4-8H). Additional analysis of this sample shows a greater degree of fibre alignment, 
resulting in features up to 1 µm in width. Subsequently, fucoidan addition is found to influence the 
ordering of Fmoc-FRGDF in both nano- and micro-environments, with the degree of ordering 
proportional to fucoidan concentration. These observations are in agreeance with similar investigations 
which found that peptide assembly driven via biocatalytic induction or increased ionic concentration 
results in an increase in fibre bundling;243, 285 however, to our knowledge, this is the first time a 
polyanionic polysaccharide has been employed to increase supramolecular ordering in Fmoc-SAP 
systems using pH switch driven assembly under physiological gelation. 
Observation of the post-assembled hydrogel via TEM and AFM analysis reveals thinner, more 
flexible fibrils coexistent with globular artefacts (Supplementary Figure S - 1A. These artefacts are 
likely a result of free fucoidan precipitation upon drying, resulting in dried fucoidan aggregates. This 
effect is not visible in coassembled samples and therefore indicates that fucoidan addition post-
assembly does not allow for sufficient association with peptide fibrils).  
115 
 
 
Figure 4-8 –Hydrogel Nano/Microtopology changes upon macromolecule addition (top panel TEM and 
bottom panel AFM) A, E) 10 mg/mL Fmoc-FRGDF shows scaffold formation through random interaction of 
fibrils; B, F) +2 mg/mL shows a small increase in supramolecular organisation yielding thicker bundles where 
individual fibrils have aligned C, G) +5 mg/mL and D, H) +10 mg/mL fucoidan show a large number o f thick 
bundles and consequently fewer individual fibrils. TEM scale bar represents 50 nm, AFM 1 µm. Reproduced 
with permission 337 
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SANS was performed to verify hydrogel nanoarchitecture and observe fucoidans effect on 
hydrogel properties further (Figure 4-9). Fucoidan containing samples were analysed and compared to 
Fmoc-FRGDF alone (Figure 4-9A), while further analysis was performed on fucoidan solutions 
dissolved in D2O to determine if fucoidan alone contributes to structural observations or if such 
characteristics are resultant of fucoidan-driven supramolecular assembly (Figure 4-9B). Analysis of 
fucoidan only samples demonstrated weak scattering curves owing in part to a large number of 
exchangeable hydrogen atoms as well as the relatively low fucoidan concentration. Fucoidan dissolved 
free of peptide demonstrated a concentration-dependent behaviour similar to observations noted in other 
polyelectrolytes.286-287 Higher fucoidan concentrations (5 mg/mL and 10 mg/mL) demonstrated broad 
correlation peaks. q scattering results in I(q) ∝ q-2.7 and I(q) ∝ q-3 for 5 mg/mL and 10 mg/mL samples 
respectively, with correlation peaks centred at q*5 =0.028 and q*10 = 0.032. Interpretation of these 
results reveals mesh sizes of diameter 22.4 nm and 9.8 nm for 5 mg/mL fucoidan and 10 mg/mL 
fucoidan samples respectively.288 The presence of a mesh in solutions prior to peptide assembly 
potentially describes some morphological differences between samples coassembled in the presence of 
fucoidan and those assembled after (post-assembled). The Debye screening effect of the pH switch used 
to trigger assembly, and the subsequent neutralisation of solution to pH 7.4 means a final ionic 
concentration of 0.1 M is achieved; this concentration is sufficient for fucoidan in solution to form 
random coil conformations.289  Despite this, emerging SAP fibrils with high affinity for fucoidan would 
potentially influence this structure. 
 
Figure 4-9 – Characterisation of nanostructured changes as observed through SANS  A) Scatterplots from 
hydrogels formed with fucoidan under fucoidan contrast matching conditions, here, increases in low q scattering 
at higher fucoidan concentration result from an increased density of large objects within the sample. B) SANS 
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plots from pure fucoidan solutions in D2O shows polyelectrolyte scattering with a single broad peak Q*.  
Reproduced with permission 337 
 
Further analysis of the assembled peptide hydrogels shows trends in agreement with TEM and 
AFM findings. A low q scattering in samples of higher fucoidan concentration results from the presence 
of larger hierarchical structures with properties too large for the range of SANS analysis. SANS analysis 
of structures formed during hydrogelation in the presence and absence of fucoidan is analysed under 
two separate conditions. The first condition takes advantage of isotropic contrast monitoring to render 
fucoidan scattering invisible, here, hydrogels are dissolved in 21.5% D2O; the second technique 
dissolves hydrogels in ‘pure’ D2O enabling sufficient contrast for all components to display adequate 
scattering. Scattering in 21.5% D2O samples for fucoidan free, 2 mg/mL, and 5 mg/mL samples 
demonstrated rod-like structures with intermediate q scattering which is proportional to q-1 shifting to 
q-4; this shift is indicative of fibril radius. Alternatively, samples containing 10 mg/mL fucoidan 
demonstrate a similar trend; however, in this case, scattering is convoluted as additional structures are 
influencing sample spectrum. Shape independent analysis of samples gives insight into fibril diameter. 
Here, the fibril radius is found to decrease upon fucoidan introduction, from an initial 4.9 nm (±0.1 nm) 
to 3.6 nm (±0.1 nm). Investigation of the intermediate q region indicated the average structure of 
individual SAP fibrils is maintained over the tested fucoidan concentrations. Despite this, analysis of 
low q range in samples of higher fucoidan concentrations (5 mg/mL and 10 mg/mL) demonstrates more 
significant structural differences. Observations in this region can be attributed to the presence of larger 
structures which are likely a result of fibril bundling. These observations are in agreeance with those 
made during microscopic and spectroscopic analysis.  
Fitting using a power law model shows different contributions to scattering in each system. 
Fucoidan samples containing 5 mg/mL show increased intensity at low q values and a clear deviation 
from I ∝ q-1 to q-4.  We interpret this as the presence of dilute large aggregates. Alternatively, the 10 
mg/mL fucoidan coassembled sample shows a drastic trend following a q-4 decline which we believe is 
indicative of Porod scattering from the increased density of large bundles. However, the limited q range 
renders us unable of determining lateral bundle size. Despite this, the presence of a Braggs peak at q = 
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0.0376 Å-1 provides evidence of a characteristic length of approximately 16.7 nm; which is roughly 2x 
fibril diameter, and therefore we attribute this to the lateral association of two peptide fibrils in the 
presence of fucoidan. These observations agree with observations made during microscopy analysis.  
The altered bioactivity of fucoidan-containing samples was not investigated in this chapter as 
the focus of this chapter was to investigate the ability to enable mechanical tunability through peptide 
sequence engineering or macromolecule addition. Extensive analysis of macromolecule-modified 
Fmoc-FRGDF hydrogels is investigated in Chapter 6. 
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4.4.3 Investigation of Self-Assembly Mechanisms and Impact on Mechanical Properties 
 
Spectroscopic techniques are used to investigate fucoidans influence on molecular ordering, and 
specifically, if the addition of fucoidan to the self-assembled peptide network maintained stable fibril 
formation (Figure 4-10). CD analysis shows chiral spectrums relating to intra- and interfibrillar 
interactions involved in peptide assembly.140, 279, 290 Fmoc-peptides are chiral molecules which produce 
pronounced CD signals when hierarchically organised into self-assembled structures.291 In all samples, 
CD analysis demonstrates a maintenance of β-π hierarchical assemblies indicated by transitions over 
three distinct regions (Figure 4-10A). The amide region, (200-230 nm), provides insight into protein 
secondary structure, and specifically (in the context of Fmoc-self-assembly) relates to the formation of 
β-sheet structures.8, 279 Here,  there was a noticeable noise effect on scattering in high fucoidan samples  
(below 220 nm).8, 279 Next, the region between 300 – 310 nm is indicative of aromatic π-π stacking 
between Fmoc groups, here our results suggest this mechanism is maintained in accordance with 
findings of other assemblies.8, 140 Finally, the region between 230 nm and 270 nm indicates degree of 
supramolecular ordering and subsequently, provides insight into fibril bundling.279-280 Here, it is evident 
that fibril bundling increases at high fucoidan concentrations. Importantly, the spectra relating to the 
post-assembled control containing 10 mg/mL fucoidan demonstrated no significant difference 
compared to the Fmoc-FRGDF alone; therefore, it can be deduced that fucoidan induced 
supramolecular ordering only occurs during coassembly with Fmoc-FRGDF, not post-assembly 
(Supplementary Figure S - 1B). FT-IR is used to analyse vibrations within the amide I region (1600-
1700 cm-1) to observe secondary structure formation between peptides (Figure 4-10B).273 All samples 
demonstrate conserved self-assembly features demonstrated by a major peak at 1690 cm-1 and a second 
minor peak at 1630 cm-1, indicative of β-sheet formation and carbamate characteristic to this class of 
assembly. 273   
Fluorescence spectroscopy observes interactions between Fmoc-groups.279 Here, all samples 
showed trends characteristic of this class of assembly, once again indicating a broad maintenance of 
self-assembly despite the presence of fucoidan (Figure 4-10C). The peak centred at 310 nm represents 
the fluorenyl excimer, and is shown to increase proportionately to fucoidan concentration up until a 
120 
 
fucoidan concentration of 10 mg/mL, wherein it decreases; this is likely due to quenching effect 
(Supplementary Figure S - 1C) .280 Another peak at 495 nm is representative of excimer species and 
can provide insight into the formation of J-aggregates.8, 280 Once again, this peak increases 
proportionately to increase in fucoidan concentration within the coassembled peptides. A peak in this 
range is indicative of supramolecular ordering, and as such supramolecular ordering is found to increase 
alongside fucoidan concentration, reinforcing observations gained in CD and microscopic analysis.8, 279  
Once again, the post-assembled control showed a significantly smaller peak in this region, indicating 
supramolecular assembly via macromolecule addition is only effective when coassembled with the 
Fmoc-SAP (Supplementary Figure S - 1D). 
Finally, the mechanical properties of the developed systems were investigated via parallel-plate 
oscillatory rheology. All samples showed a conserved hydrogel structure indicated through a storage 
modulus of magnitude higher than that of the loss modulus for the tested frequencies (Figure 4-10). 
Furthermore, a slight increase in viscoelasticity was observed at high frequencies owing to water loss; 
this observation is characteristic of non-covalent networks.290, 292 Fmoc-FRGDF alone demonstrated a 
soft hydrogel with a storage modulus of approximately 1 kPa. In fucoidan containing samples, storage 
modulus was significantly increased (G’ ~1600Pa); with further fucoidan increase resulting in stiffness 
(relating to G’) stabilisation at approximately 2kPa. Here, it is thought that stiffness attributing to 
increased bundling is compromised by reduced entanglement and junctions, resulting in solitary fibrils 
existent within the hydrogel. Analysis of a separate fucoidan solution showed no significant 
contribution to stiffness (Supplementary Figure S - 1E); therefore, the increase in stiffness in fucoidan 
containing samples is likely due to increased supramolecular ordering facilitated through fibril/fucoidan 
interactions as observed through spectroscopic analysis. 
121 
 
 
Figure 4-10 – Spectroscopic and rheological analysis of peptide assembly with increasing  fucoidan 
concentration A) CD spectra showing increased magnitude in the region located at 260 –270 nm associated 
with increasing supramolecular organisation; B) FT-IR spectra showing consistent β-sheet formation in all 
samples, suggesting the maintenance of assembly despite an increase in fucoidan concentration C) Fluorescence 
spectra of the region 480–510 nm showing increasing fluorescence from Fmoc ordering  upon fucoidan increase. 
D) Rheological Characterisation of the hydrogels. Typical frequency sweeps showing storage (G’) and loss 
(G”) moduli, where the increase in fucoidan is associated with an increase in stiffness. Reproduced with 
permission 337 
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4.5 Conclusion 
 
Alteration of hydrogel biological and structural properties was successfully achieved through 
incorporation of selectively engineered peptide sequences, or through macromolecule addition. In both 
cases, the fibronectin-derived, short peptide sequence Fmoc-FRGDF was employed as a relative 
control.  
Control of biological properties through peptide sequence focused on the incorporation of a 
synergistic fibronectin attachment motif, PHSRN. Scaffolds were formed from this bioactive sequence 
in one of three ways: 1) synthesis of Fmoc-PHSRN alone, 2) synthesis of Fmoc-FRGDFPHSRN, and 
finally, 3) coassembly between Fmoc-FRGDF and Fmoc-PHSRN at a 1:1 ratio. Analysis of these 
hydrogels found Fmoc-PHSRN alone was unable to form a self-supporting hydrogel – likely due to the 
conformational constraints of proline residues when placed in the environment of self-assembly.  
Alternatively, the decapeptide, Fmoc-FRGDFPHSRN, formed a weak hydrogel with undesirable 
mechanical properties. Finally, the coassembled scaffold, containing fibrils constituting both Fmoc-
FRGDF and Fmoc-PHSRN, resulted in the formation of an enhanced hydrogel with robust mechanical 
and structural properties. Preliminary in vitro analysis of hydrogel bioactivity revealed enhanced results 
in the coassembled system, showing significantly greater cell spreading and proliferation compared to 
the Fmoc-FRGDF control.  
Integration of mechanical tunability was investigated through macromolecule incorporation 
during self-assembly. Here, Fmoc-FRGDF was coassembled with the highly sulphated polysaccharide, 
fucoidan, at various concentrations. Analysis of self-assembly mechanisms and subsequent 
microarchitecture demonstrated a correlation between fucoidan concentration and supramolecular fibril 
ordering; resulting in increased fibre bundling proportional to an increase in fucoidan concentration. 
Importantly, the presence of fucoidan during self-assembly was found to maintain fibril formation at 
these concentrations. Samples allowed to gelate in the absence of fucoidan did not demonstrate 
increased fibre bundling even when fucoidan is added after assembly (post-assembly); therefore, 
increased supramolecular ordering using this system requires fucoidan inclusion during the assembly 
process (coassembly). In all tested conditions, fucoidan addition was shown to increase material 
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viscoelastic properties; however, interestingly, high fucoidan concentrations did not result in a 
substantial increase in stiffness (as indicated by material storage modulus). We anticipate that although 
there is a substantial increase in fibre bundling, stiffness is compromised by a reduction in fibre 
intersections.  
In this chapter, we have successfully introduced and extensively characterised two novel 
methods for influencing mechanical and biological tunability in SAP systems. Overall, both approaches 
resulted in alterations in fibre presentation either in the micro- or nano-scale which lead to transient 
effects on material stiffness. Preliminary biological effects were investigated in PHSRN-functionalised 
scaffolds, while the effect of macromolecule addition on scaffold bioactivity will be comprehensively 
analysed in consequential chapters (Chapter 6).  
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Chapter Five: 
 
 
 
5.  
INVESTIGATION OF MULTISEQUENCE 
MATERIAL AS AN ADVANCED TUMOUR 
MICROENVIRONMENT  
 
5.1 Preview 
 
In this chapter, an advanced modular cancer model is developed through the culturing of heterogeneous 
cancer spheroids within a coassembled Fmoc-SAP hydrogel. Specifically, heterogenous spheroids were 
formed through the co-culturing of LLC cells and NOR-10 fibroblasts and subsequently encapsulated 
within a fibronectin/laminin-inspired Fmoc-FRGDF/Fmoc-DIKVAV hydrogel. Fmoc-SAP 
encapsulated spheroids were compared to 2D controls and 3D non-encapsulated spheroids. Results 
show spheroids encapsulated within the Fmoc-SAP hydrogel demonstrate enhanced metabolic activity 
and increased motility compared to non-encapsulated counterparts. Furthermore, Fmoc-SAP 
encapsulated spheroids demonstrated higher levels of cancer-associated fibroblast (CAF) differentiation 
and greater endothelial to mesenchymal transition compared to the 2D control and non-encapsulated 
spheroids. Finally, Fmoc-SAP encapsulated spheroids were compared to agarose encapsulated 
spheroids, with results showing enhanced migration in Fmoc-SAP hydrogels compared to the agarose 
control. 
Contribution of the candidate: 
• Material Analysis (CryoSEM, Rheology), and assembly mechanisms (SAXS, CD).  
• Manuscript preparation.  
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• Prepared proposal, successful Funding for Synchrotron Experiments (ANSTO, AUS) 
Publications relevant to this chapter 
Al Balushi, N., Boyd-Moss, M., Firipis, K., Darby, I., Nisbet, D., Pouniotis, D., Williams, R., (2019) 
‘Bioactive Peptide Microenvironments as functional lung tumour models.’ Manuscript in preparation. 
 
Abstract 
Effective modelling of tumours in vitro will provide rapid, cost-effective systems for the testing of anti-
cancer therapeutics. Currently, cancer modelling is routinely conducted in 2D cultures; although these 
systems are simple, they lack multidimensional cell-cell and cell-matrix interactions which govern 
cellular behaviour. Cancerous tumours exist within a supportive microenvironment which encourages 
development; thus, we hypothesise that spheroids placed within a 3D, functionalised artificial 
microenvironment would mimic in vivo tumours to a greater degree compared to those cultured in 2D 
or the absence of a functionalised microenvironment. Here, we develop a novel system, whereby we 
encapsulate heterogenous cancer spheroids within a functionalised, multi-epitope SAP scaffold. 
Specifically, we coassemble a fibronectin-inspired SAP, Fmoc-FRGDF; with a laminin-inspired SAP, 
Fmoc-DIKVAV to better mimic the cancer microenvironment. Encapsulated spheroids were compared 
to non-encapsulated spheroids and a 2D co-culture control. Environment functionalisation was further 
investigated through comparison with agarose-encapsulated spheroids. We selected agarose as a control 
owing to its comparable network orientation yet lack of cell-recognised sequences. The physical 
properties of the developed hydrogels were discussed concerning assembly mechanisms, network 
organisation, nanoscale morphology, and viscoelastic properties; whilst influence of functional matrix 
incorporation was investigated regarding cell metabolic activity, motility, migration, and CAF 
fibroblast differentiation. Results showed cancer cell, and co-cultured spheroid motility was enhanced 
in encapsulated spheroid samples compared to non-encapsulated counterparts. This part of the work 
demonstrated the potential of multi-sequence Fmoc-SAPs in cancer modelling applications and 
confirms the versatility of these materials. 
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5.2 Introduction 
 
Traditionally, cancer studies performed in vitro have been conducted in 2D environments. These 
conventional models are cheap, simple, and have substantially increased understanding of cancer 
behaviour; yet they fail to sufficiently capture the complexities of the in vivo tumour microenvironment 
(TME). Notably, these models are limited as they lack direct, multidimensional cell-cell contact and 
cell-matrix interactions required to drive major cellular processes, including tumour initiation, 
proliferation, migration, and invasion. 49, 293-294 
The natural TME is a complex system which consists of the ECM, blood vessels, tumour cells, 
soluble factors, and numerous other stromal cell types, including endothelial cells, fibroblasts, and 
immune cells.293 During tumour progression, the stroma surrounding epithelial tissue undergoes 
substantial changes. The stroma is contains predominantly collagen-I, which appear ‘curly’ and 
anisotropic, however in the early stages of cancer progression, the amount of collagen within the stroma 
increases and collagen fibres transform into straighter, more aligned morphologies.295-296  In invasive 
cancers, these collagen fibres become more bundled and orientate perpendicularly to the basement 
membrane; promoting the migration of cancer cells away from the primary tumour, and subsequently, 
decreasing patient survival rates.297 Stromal network reorganisation by CAFs also increases network 
stiffness through the secretion of ECM proteins and enzymes which crosslink collagen fibrils.295, 298 
This increase in stiffness, combined with the track-like organisation of collagen, significantly increase 
cancer cell migration, leading to later metastasis.295-296, 298 
The ECM is an essential component of the TME which supports cells while providing necessary 
biochemical and biomechanical cues essential for cell-cell communication and cell-matrix 
interactions.293 Therefore, 3D in vitro models for cancer progression have become increasingly popular 
with researchers, as they allow for the controlled presentation of biochemical and biomechanical signals 
in a biomimetic fashion.299 These systems effectively bridge the gap between 2D cancer models and in 
vivo studies, enabling effective investigation into cancer progression and allowing for better evaluation 
into drug therapies. 293 
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In cancer research, tumour spheroid models have been extensively used as a popular technique 
to model 3D cancer progression and behaviour in vitro; owing to their high similarities to solid tumours 
in vivo. In particular, tumour spheroids present similar structural characteristics to solid tumours, having 
proliferative zones and necrotic zones (Figure 5-1A).299 Furthermore, tumour spheroids allow 
biomimetic cell-cell communication, present similar oxygen and nutrient gradients and allow for the 
development of heterogeneous models. 299-300  However, unlike clinical tumours, tumour spheroid 
models often lack a suitable ECM, resulting in the spheroids existing in an attachment-free 
microenvironment, and therefore, experiencing very different mechanical and biochemical properties 
than that provided by the native ECM.299 
Mimicking the in vivo environment in vitro requires the use of advanced biomimetic scaffolds 
which are capable of supporting cell-cell and cell-matrix interactions. Recently, studies have placed 
patient-derived tumoroids within Matrigel environments, allowing for highly biomimetic behaviour 
analysis. 301 However, organoids are complex and difficult to reproduce accurately, and Matrigel is 
difficult to tune and suffers from batch-to-batch variability.302 Similarly, Lan et al. took the advantage 
of alginate hydrogels for liver cancer cell encapsulation to study cancer cell viability, morphology and 
drug metabolism. Despite alginate hydrogels allowing ease of encapsulation and cell recovery, these 
materials are highly soluble in solution and lack cell-adhesion sites essential for cell development.303 
One recent class of materials which have offered significant promise to tissue engineering 
applications are SAPs. Hydrogels developed from these materials allow for high biomimicry, boasting 
the ability to form highly similar structures to the native ECM while enabling for substantial control 
over biochemical signalling through amino-acid sequence selection.143, 304 Furthermore, these materials 
are inherently biocompatible owing to their formation from amino acid building-blocks.. Using these 
materials, researchers have seen success in a range of tissue-regeneration applications, including 
muscle, nerve, and bone regeneration;26, 305-307 as well as cancer modelling.308 
Fluorenylmethyloxycarbonyl self-assembling peptides (Fmoc-SAPs) are promising biomaterials which 
are easily functionalised through sequence selection. These short aromatic peptide sequences allow for 
triggered self-assembly through π- π stacking between Fmoc-groups and β-sheet formation between 
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short peptide sequences.8 Importantly, this class of SAP allows for the formation of biocompatible 
hydrogels from highly decorated, bioactive nanofibrous structures similar to the in vivo ECM.128 
In this chapter, a complex, multidimensional in vitro lung cancer model is developed through 
the formation of heterogenous spheroids placed within a highly biomimetic self-assembled 
microenvironment.  Specifically, tumour spheroids are developed through the co-culturing of LLC lung 
cancer cells and murine NOR-10 fibroblasts (NOR-10); while an artificial microenvironment is formed 
through the coassembly of Fmoc-DIKVAV and Fmoc-FRGDF. Previous investigations using Fmoc-
DIKVAV and Fmoc-FRGDF have shown good biocompatibility, suitable mechanical properties, and 
high bioactivity facilitated through the presentation of IKVAV and RGD motifs.26 
5.3 Results and Discussion 
5.3.1 Formation of Spheroids and Artificial Microenvironments 
5.3.1.1 Formation of Spheroids  
Cancer cells cultured in a 3D microenvironment illicit significant behavioural differences compared to 
those cultured in 2D models.294 Tumour spheroids are 3D spherical clusters of cells which better present 
in vivo tumours, allowing for cancer models of increased accuracy.309 The proximity of these cells in a 
3D configuration allows for biomimetic cell-cell communication, while the ability to culture spheroids 
from multiple cell types facilitates better replication of the heterogeneous tissue microenvironment.299-
300, 309  Heterogenous co-cultures of murine LLC cancer cells and murine NOR-10 fibroblasts (NOR-
10) were used for subsequent spheroid formation. 2D co-cultures were also developed through co-
culture of LLC and NOR-10 cells on tissue culture plastic (Figure 5-1B i) and compared to non-
encapsulated 3D spheroids (Figure 5-1B ii) and 3D spheroids encapsulated in hydrogels (Figure 5-1B 
iii). Within this chapter, hydrogel-encapsulated spheroids are termed 3D+ECM. 
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Figure 5-1 – Schematic of spheroid and hydrogel formation  A) Cartoon comparison of similarities between 
in vivo tumour and spheroids, B) schematic of spheroid preparation showing 2D co -culture, 3D spheroid, and 
3D+ECM spheroid, C) Cartoon showing Fmoc-SAP hydrogel assembly (i) Chemical structure of Fmoc-FRGDF 
and Fmoc-DIKVAV, (ii) individual subunit in schematical depiction, (iii) formation of fibril, (iv) 
supramolecular ordering of fibrils, (v) entanglement of fibrils into net work. D) Cartoon depiction of Agarose 
hydrogel formation. (i) chemical structure of agarose, (ii) artistic depiction of polymer, (iii) formation of helical 
structures, (iv) polymer association and formation of network.  
 
5.3.1.2 Formation of Hydrogels 
 
The development of an artificial TME is enabled through the coassembly of a fibronectin-inspired SAP, 
Fmoc-FRGDF with a laminin-inspired SAP, Fmoc-DIKVAV, to form the coassembled hydrogel – 
Fmoc-FRGDF/Fmoc-DIKVAV as previously reported (Figure 5-1C i).26 Previously, these systems 
have been shown to present both peptides within a single fibrils within a coassembled network (assessed 
through FT-IR, SAXS, CD) which drives enhanced cell spreading and morphology.26 Peptides were 
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combined at 1:1 ratio prior to self-assembly, allowing for the formation of fibrils that present both 
epitopes simultaneously. Previous investigation into Fmoc-based SAPs finds short peptide sequences 
capped with the Fmoc-group undergo spontaneous self-assembly triggered by a well-characterised pH 
switch method, resulting in the formation of larger hierarchical structures through π-β assembly.140 
Specifically, fibril formation is facilitated through π- π stacking of Fmoc-groups and anti-parallel β-
sheet formation between short peptide sequences, resulting in the controlled self-organisation of short 
sequences into long fibrillar structures (Figure 5-1C ii – iv).8 Further association and entanglement of 
fibrillar structures results in the formation of a hydrogel network (Figure 5-1C v). Coassembled Fmoc-
FRGDF/Fmoc-DIKVAV hydrogels were formulated at 10 mg/mL (1% (w/v)) and used to encapsulate 
spheroids in 3D+ECM samples.  
A control artificial TME was developed through the gelation of low-melt agarose (1% (w/v)). 
Agarose is a seaweed-derived polysaccharide comprised of repeating agarobiose units (Figure 5-1D 
i).93 Hydrogel formation from agarose is facilitated through hydrogen bonding and electrostatic 
interactions resulting in the formation of helical structures which associate with one another to form 
networks, specifically upon cooling from melted state (Figure 5-1D ii – iv). 93 Hydrogels developed 
from both agarose and coassembled SAPs were able to maintain stable gel formation under 
physiological conditions (pH 7.4, 37° C); with both hydrogels eliciting self-supporting properties as 
demonstrated through hydrogel inversion (Supplementary Figure S - 2). In both cases, the resultant 
hydrogel was slightly opaque (Supplementary Figure S - 2A), and spheroids were encapsulated within 
hydrogels as indicated (Figure 5-1B). 
Despite both artificial microenvironments being characterised in regard to mechanical 
properties in the following section, agarose is not used for comparison of 2D, 3D and 3D+ECM samples 
until the peripheral sections of this chapter (see Section 5.3.4).  
5.3.2 Mechanical Characterisation of Formulated Materials 
5.3.2.1 Observation of Network Topology of Engineered SAP Hydrogels. 
 
Investigation into hydrogel morphology was facilitated through TEM, allowing direct visualisation of 
underlying hydrogel nanostructures (Figure 5-2A i, ii). The coassembled system presented as long 
131 
 
fibrils as has been previously noted (Figure 5-2A i).26 Contrastingly, agarose samples presented as 
aggregates with no noticeable structural organisation as previously observed (Figure 5-2A ii).310 
Coassembled Fmoc-SAP fibrils were measured using ImageJ and an average fibril diameter of 14.72 
nm (σ = 2.10) was calculated. The lack of visible hierarchical order in the agarose hydrogel suggests 
agarose structures lies outside the range of TEM. 
Hydrated microscale network topology was investigated qualitatively through CryoSEM 
techniques allowing for observation of sample microscopic structure under hydrated conditions (Figure 
5-2A iii, iv). The coassembled hydrogel containing both Fmoc-FRGDF and Fmoc-DIKVAV sequences 
presented as a typical fibrous hydrogel with high porosity and morphological similarities to the native 
ECM (Figure 5-2A iii). A bundle width of 0.61 µm (σ = 14 µm) was observed in the coassembled 
sample as calculated using ImageJ. Alternatively, agarose samples presented as thicker bundles (1.77 
µm width, σ = 0.56 µm), yet retained the highly porous structure observed in the coassembled hydrogel 
(Figure 5-2 A iv). Despite agarose samples appearing as denser structures, both networks demonstrate 
comparable network organisations.  
5.3.2.2 Nanoscale Investigation of Local Polymer Organisation 
 
Sample structure was quantitatively investigated via SAXS (Figure 5-2B). Considering the SAXS 
curve follows a trend comparable to characteristic cylinders as is evident by a transition from q-4 at low 
q range to q-1 at mid q range, IFT scattering curves can be fitted with a P(r) model which provides 
insight into average fibril radius (Supplementary Figure S - 2B). TEM analysis of fibrils finds fibril 
length lies outside SAXS q range; as a result, the maximum intensity in the p(r) curve can be correlated 
to fibril radius, rather than length. Through P(r) fitting, an average fibril diameter of 14.2 nm (r = 71.04 
Å) was calculated, reinforcing results gained in TEM analysis. Agarose samples did not demonstrate a 
suitable trend for P(r) fitting. Consequently, agarose scattering curves were modelled with shape 
independent models and compared to coassembled hydrogels regarding correlation length, and mesh 
size (via two-power model fitting). 
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Analysis of scattering curves over mid-low q range allows for the determination of correlation 
length (Figure 5-2B i), as described by Equation 5-1.  
𝐼(𝑞) = (
𝐶
(1 + 𝑄𝜉)𝑚
) + 𝑏𝑘𝑔 
Equation 5-1 SAXS Fitting for correlation length   
Where the Porod scaling factor (C) is deduced from the scattering vector q = 0 and relates to 
scattering intensity. The Porod exponent (m) relates to the local polymer structure and provides 
information about polymer conformation. Correlation length (ξ) provides a reasonable estimate of the 
average length of entanglement in semi-dilute polymer solutions;311 and bkg takes into account 
background scattering. The agarose sample demonstrates a correlation length of 5.0 nm (± <1%) while 
the coassembled sample shows a correlation length of 4.7 nm (± <1%). These results suggest agarose 
has a slightly larger distance between entanglements compared to the coassembled hydrogel.  
Determination of mesh size provides insight into polymer spatial association within the 
network, and specifically, into nanoscale polymer mesh organisation. Mesh size can be determined 
through calculation of the crossover point (qc) when scattering profiles are modelled using a two-power 
law (Figure 5-2B ii). The point of crossover can also be described as the position of a shoulder formed 
at low-scattering vectors in self-similar structures of comparable dimensions and is indicated by the 
intercept of two-power laws, one in the low q range (before shoulder) and another in mid q range 
(following shoulder).312 Mesh size is related to crossover as indicated by arrows (Figure 5-2B ii) and 
as described by Equation 5-2.  
𝑀𝑒𝑠ℎ 𝑆𝑖𝑧𝑒 =
2𝜋
qc
 
Equation 5-2 – SAXS Fitting for Mesh Size    
Analysis of mesh size using a two-power law found agarose samples to have a mesh size of 
10.2 nm (± 0.047 nm), while the coassembled sample presented a mesh size of 19.4 nm (± 0.14 nm).  
The agarose sample presented two-power laws of 2.50 (± <1%)  and 3.27 (± <1%) for the low and mid-
q range respectively. A similar trend was evident in the coassembled sample, returning a power law of 
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2.46 (± 1.4%) for low q range and 3.85 (± <1%) for mid q range. Power law model fitting provides 
insight into the mass fractal dimension and correlates to polymer conformation. Mass fractal dimensions 
range from 1 to 3.312 A mass fractal dimension of 1 indicates a linear object - such as a mathematical 
line; while a mass fractal dimension near 1.67 indicates a swollen polymer in a good solvent.311 Mass 
fractal dimensions between 2 and 3 indicate the formation of branched polymer conformations and 
network formation. 311 Power laws which return values greater than 4 indicate a density change is finite 
but discontinuous at the boundary of scattering.313 Therefore, the similarity of power laws presented at 
low q range (2.50 and 2.46 for agarose and coassembled respectively) indicates a similarity of polymer 
conformation between the two samples, relating to the presence of highly branched polymer polymer 
conformations and indicating the similarity of network formation; while power laws at mid q indicate 
the presence of structures outside the range of scattering. 
Assembly mechanisms were verified using CD to provide insight into chiral interactions and 
subsequently, provide information of assembly mechanisms and polymer/protein backbone 
conformation (Figure 5-2C). Absorption peaks in the amide I region indicate peptide folding, and 
specifically, the formation of β-sheets, α-helix and random coil conformations. A strong negative peak 
is evident in the coassembled peptide hydrogel centred around 209 nm, indicating the presence of 
indistinct β-sheets as is characteristic of Fmoc-assemblies. A positive peak centred at 261 nm is 
representative of supramolecular ordering, while a positive peak between 300 nm and 310 nm is 
indicative of Fmoc-stacking through J-aggregate interactions. Contrastingly, the agarose hydrogel 
shows no dominant structural organisation. CD results confirm the highly ordered structure of the 
coassembled Fmoc-FRGDF/Fmoc-DIKVAV system. 
5.3.2.3 Determination of Material Viscoelastic Properties 
 
Following determination of assembly mechanisms, hydrogel viscoelastic properties were analysed via 
oscillatory rheology (Figure 5-2D). A frequency sweep was applied from 0.1 Hz to 20 Hz to investigate 
material stability in response to shear. In both hydrogels, the storage modulus was of greater magnitude 
than loss modulus, indicating the formation of a stable hydrogel. The agarose sample demonstrated a 
storage modulus of approximately 1 kPa. Contrastingly, the coassembled hydrogel demonstrates a 
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storage modulus of approximately 10 kPa, being approximately one order of magnitude stiffer than 
agarose. A slight thickening effect is evident in both samples with increasing frequency, as is 
characteristic of non-covalent hydrogel systems.292, 314 
 
Figure 5-2 – Material characterisation A) investigation of material architecture and network topology, i) 
TEM imaging of Fmoc-SAP fibrils, ii) TEM imaging of Agarose aggregates, (TEM Scalebar 1  µm)  iii) 
CryoSEM imaging of coassembled peptide network showing fibres, and iv) CryoSEM imaging of 1% agarose 
sample showing bundled network topology (SEM Scalebar 20 µm)   B) Fitting of scattering curves attained 
during SAXS investigation, i) fitting for correlation length, and ii) fitting to two -power model used for the 
determination of mesh size (arrows point to power intercept), C) CD spectra of agarose and Fmoc-
FRGDF/Fmoc-DIKVAV, D) Rheological analysis of material viscoelastic properties of agarose and Fmoc -
FRGDF/Fmoc-DIKVAV as indicated through storage (G’) and loss (G”) modulus. 
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5.3.3 Comparisons of 2D, 3D and Encapsulated 3D Cultured Conditions 
5.3.3.1 Analysis of Spheroid Metabolic Activity and Adhesion 
 
The preliminary aim of this study is to investigate the effect cell organisation has on cell metabolic 
activity, adhesion and migration. LLC and NOR-10 mono-spheroids and co-cultures (1:1 ratio) were 
placed within a Fmoc-FRGDF/Fmoc-DIKVAV coassembled microenvironment (3D+ECM) and 
compared to spheroids placed within media (3D) and monolayer cells cultured in 2D. Cell metabolic 
activity was investigated through MTS assay analysis over 72 hours (Figure 5-3A). Following 24h 
culture, mono-spheroids (LLC, and NOR-10) and co-cultured 3D+ECM spheroids (LLC/NOR-10, 1:1 
ratio) demonstrated significantly greater metabolic activity compared to their non-encapsulated 
spheroid counterparts (LLC p < 0.0001, NOR-10 p = 0.0125, co-culture p = 0.0004, Figure 5-3A). A 
similar trend is evident following 72-hours culture, with NOR-10 and co-cultured spheroids 
demonstrating a significant increase in metabolic activity compared to non-encapsulated spheroid 
counterparts (NOR-10 p < 0.0001, co-culture p < 0.0001, Figure 5-3A).  LLC monospheroids did not 
see a significant difference in metabolic activity at this time point. 
Investigation of general cell health was facilitated through the investigation of cell metabolic 
activity as determined through MTS assay analysis. 3D+ECM spheroids demonstrated enhanced 
metabolic activity compared to those cultured in media alone following 72-hour incubation, indicating 
that the artificial microenvironment is biocompatible and promotes healthy cell growth. This is in 
accordance with previous investigations which found Fmoc-FRGDF hydrogels support oral tongue 
squamous carcinoma cells (SCC25) and hMFCs viability over 3 and 5 days respectively.143, 265 
Collectively, these results demonstrate the inherent biocompatibility of functionalised Fmoc-SAPs and 
highlight their potential for use as artificial TMEs. Furthermore, our findings support the use of 
encapsulated spheroids to better monitor tumour progression, underlining the significance of cell-ECM 
interaction on cellular behaviour. 
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Figure 5-3 – Biological activity of spheroids in response to hydrogel microenvironment A) Metabolic 
activity of spheroids encapsulated within Fmoc-SAP hydrogels (3D+ECM) and non-encapsulated spheroids 
(3D) measured by MTS assay on i) day 1 and ii) day 3 post-cultivation. Statistics were obtained by two-way 
ANOVA and Tukey's post hoc test. Error bars represent the SEM; n = 3, *p<0.05, ***p<0.001, ****p<0.0001. 
B) i) Percentage of cell expressing vinculin in 3D LLC, NOR-10 and co-culture spheroids post encapsulation 
(3D+ECM) within hydrogel for 3 days compared to non-encapsulated 3D spheroids and 2D cell culture  and ii) 
representative histograms images of vinculin expression are shown . Statistics were obtained by two-way 
ANOVA and Tukey's post hoc test. Error bars represent the SEM; n = 3, **p<0.01, ***p<0.001.  
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The ECM plays an important role in cancer cell invasion to surrounding tissue. Vinculin is a 
116 kDa protein which is highly enriched in regions in which cells contact one another and the 
underlying substratum.315  Subsequently, vinculin plays crucial roles in governing cell-ECM adhesion 
(mediated through integrin receptors) and cell-cell adhesion (mediated through cadherin).315 A down-
regulation of vinculin expression is also observed in many invasive cancers, including colorectal cancer, 
melanoma, vaginal, and cervical carcinomas.316-318 Therefore, vinculin expression was also investigated 
as an indication of cell attachment and functional association between cancer cells and the ECM. 
Vinculin expression of 3D+ECM spheroids (mono- and co-cultured) was compared to that of non-
encapsulated spheroids (3D) and cells cultured on 2D tissue culture plastic via flow cytometry (Figure 
5-3B). Following 72h culture, a significant down-regulation of vinculin is observed in 3D+ECM NOR-
10 and co-cultured spheroids compared to the 2D control, demonstrating a vinculin surface expression 
of 0% for 3D+ECM encapsulated samples compared to 26.3% for 2D NOR-10 and 24.1% for 2D co-
cultured cells (NOR-10 p=0.0004, co-culture p=0.0019, Figure 5-3B). Non-encapsulated spheroids 
demonstrated no significant difference in vinculin expression levels (10.3% LLC, 9.8% NOR-10, and 
11.6% co-cultures) compared to 3D+ECM spheroids and the 2D control (p ≥ 0.05, Figure 5-3B).  
A reduction in vinculin expression has been shown to result in a decrease of cell adhesion and 
induction of motility, thus promoting cancer cell invasion and metastasis. Our results demonstrate a 
reduction in vinculin expression in 3D+ECM NOR-10 and co-cultured spheroids compared to the 2D 
control; indicating cancer cell culturing within this self-assembled, biomimetic microenvironment leads 
to increased motility as is characteristic of cancer cells in vivo. Furthermore, the elevated vinculin 
expression in 2D cultures and non-encapsulated spheroids indicates that the cells are more adherent to 
tissue culture plastic or themselves compared to those cultured within the coassembled 
microenvironment. Our results echo a study by Li et al. who observed a significant down-regulation of 
vinculin in patient-sourced metastatic colon cancer tissue samples and various invasive human colon 
cancer cell lines (HT116, Caco2, HT29, SW620, and SW480). 316 These results combined with 
observations in this study indicate that spheroid adhesion, motility, and invasiveness is significantly 
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impacted by a reduction in vinculin expression when cultured in a functionalised artificial 
microenvironment compared to 2D cell cultures.  
5.3.3.2 Vinculin and F-actin Co-localisation 
 
Cell migration and cytoskeleton organisational changes are further investigated through observation of 
vinculin and F-actin co-localisation as indicated through immunostaining and confocal analysis (Figure 
5-4). Following 72 hours in culture, cells cultured onto tissue culture plastic (2D) demonstrated highly 
flat morphologies with multidirectional stretched F-actin filaments (arrows showing filaments) (Figure 
5-4A, iii). Alternatively, non-encapsulated spheroids showed round F-actin filaments which were 
localised along the spheroid periphery (Figure 5-4B iii). Interestingly, 3D+ECM spheroids in the 
coassembled hydrogel presented more protrusive, round branched F-actin filaments compared to non-
encapsulated counterparts (Figure 5-4C iii). Despite an absence of observable focal adhesion points 
localised to the outer plasma membrane in co-cultured conditions, vinculin is clearly observed in all 
conditions. 
Integrin association with surrounding ECM proteins, including laminin and fibronectin, results 
in cytoskeleton changes through the formation of focal adhesion complexes comprising many 
cytoplasmic proteins, including vinculin and F-actin.319 Cell interaction with the ECM results in 
motility, allowing the migration of cells through the ECM. 319 These interactions are complex and 
require coordinated changes in actin cytoskeleton organisation, resulting in the development of focal 
adhesion points and alteration of cell morphology. 319 Our results find that culturing cells under different 
organisational conditions (2D culture, non-encapsulated spheroid, encapsulated spheroid) results in 
dramatic changes in F-actin distribution in co-cultured spheroids. 3D+ECM co-cultured spheroids 
demonstrated round, branched F-actin filaments which were substantially different in appearance to 
those observed in 2D cultures and non-encapsulated spheroids. These findings are supported by Zhou 
and colleagues who demonstrated that MSCs displayed stretched out F-actin filaments in 2D culture, 
yet presented along the periphery in spheroid samples.320 These results illustrate the importance of 
functional matrix incorporation and suggest that Fmoc-SAP hydrogels enhance the migratory 
phenotype of co-cultures in 3D spheroids. 
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Figure 5-4 – Cytoskeleton in A) 2D cultures, B) non-encapsulated spheroids and C) 3D+ECM spheroids.  
F-Actin and vinculin/focal adhesion organization in co-culture spheroids encapsulated within hydrogel 
(3D+ECM) for 3 days compared to non-encapsulated spheroids (3D) and 2D co-culture cells. Dashed line 
indicates the original spheroid border as internal margin for reference (scale bar, 50 µm). 
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5.3.3.3 Alpha-Smooth Muscle Actin  Expression 
 
Epithelial to mesenchymal transition (EMT) is a process during cancer development wherein epithelial-
like cancer cells switch toward a more motile mesenchymal phenotype.321 During EMT, epithelial 
markers are downregulated (such as E-cadherin) whereas mesenchymal markers (such as α-SMA) are 
upregulated; 321 therefore, α-SMA expression is commonly monitored to assess EMT transition. 321  α-
SMA expression is also used to assess differentiation of fibroblasts into CAFs, as α-SMA is normally 
expressed by differentiating CAFs in the TME.322 In this study, α-SMA expression was determined 
using flow cytometry following 72h cell culture as a measure of CAF differentiation and EMT induction 
(Figure 5-5). LLC, NOR-10 and co-culture spheroids were encapsulated within the coassembled Fmoc-
FRGDF/Fmoc-DIKVAV hydrogel and compared to non-encapsulated spheroids and 2D cells cultured 
on culture plastic. A noticeable reduction in α-SMA expression was observed in NOR-10 cells 
compared to LLC cells and co-culture in all conditions (Figure 5-5), signifying reduced fibroblast 
activation in the absence of cancer cells. Furthermore, there was a significantly greater percentage 
(36.3%) of α-SMA expression in 3D+ECM co-cultured spheroids following 72 hours in culture 
compared to non-encapsulated spheroids and 2D co-cultures (p < 0.0001 in both conditions, Figure 
5-5). Similarly, LLC spheroids in 3D+ECM and non-encapsulated environments expressed 
significantly higher percentages (21.2% and 22.9%, respectively) of α-SMA expression compared to 
the 2D control, indicating that the 3D+ECM spheroids may have undergone EMT (p = 0.0005 and 
0.0001, respectively, Figure 5-5). Analysis of α-SMA expression in this study indicate that 
encapsulating cancer cells within a bioactive, Fmoc-SAP hydrogel results in increased induction of 
mesenchymal phenotypes compared to 2D culture and non-encapsulated spheroids.  
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Figure 5-5 – Analysis of α-SMA expression. A) i) α-SMA expression of LLC, NOR-10, and co-cultured 
encapsulated spheroids (3D+ECM) compared to 3D non-encapsulated and 2D cultures following 72h culture; 
measured by flow cytometry ii) representative histograms images of α-SMA expression are shown. 
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5.3.4 Effect of Microenvironment  
5.3.4.1 Monitoring Migration in Encapsulated co-culture Spheroids  
 
Migration within artificial microenvironments was further analysed through comparison of spheroids 
encapsulated in Fmoc-FRGDF/Fmoc-DIKVAV hydrogels to spheroids encapsulated in a 1% agarose 
hydrogel (Figure 5-6). Agarose was selected as a control owing to its structural similarities yet lack of 
cell-recognisable, bioactive epitopes.93 Cells within co-cultured spheroids were tracked to monitor 
migration in RGD and IKVAV functionalised hydrogels and compared to the agarose control. 
Following 72-hour culture, confocal imaging was performed on LLC cells loaded with cell CMTPX 
dye (red) and NOR-10 cells loaded with MitoTracker™ Green FM.  Results show that both LLC and 
NOR-10 cells migrate into the coassembled hydrogel yet remain stationary within the 1% agarose 
hydrogel (Figure 5-6A). Expression of vinculin and α-SMA was investigated for co-cultured spheroids 
encapsulated within the coassembled hydrogel and compared to the agarose control (Figure 5-6B). 
Flow cytometry was employed to analyse expression levels following 3-days culture. A significant 
down-regulation in vinculin expression was measured for spheroids cultured in the coassembled Fmoc-
SAP hydrogel compared to spheroids cultured in the agarose control (0% compared to 23.6% 
respectively, p=0.0003, Figure 5-6B). Contrastingly, a significantly higher expression of α-SMA was 
evident in spheroids cultured in the coassembled hydrogel compared to those cultured in agarose (36.3% 
and 12.4% respectively, p = 0.00078, Figure 5-6B). 
Results show enhanced motility of CMTPX-labelled LLC cells and MitoTracker™ Green FM-
labelled NOR-10 cells when cultured in the coassembled hydrogel compared to a 1% agarose control. 
Furthermore, cancer cell motility in the coassembled hydrogel demonstrated a significant down-
regulation of vinculin expression compared to the agarose control, indicating a loss of cell adhesion. 
Ulrich et al. made similar observations. wherein U373-MG human glioma spheroid cell migration was 
inhibited when cultured in agarose compared to collagen or collagen-agarose blends. 323 Therefore, 
results from this study indicate that cellular response to the coassembled artificial microenvironment is 
likely due to integrin interactions with bioactive motifs, highlighting the potential of this model to 
replicate lung cancer cell adhesion and migration in vitro. 
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Figure 5-6 – Investigation of cell motility  A) LLC (labelled with CMPTX red) and NOR-10 (labelled with 
Mitotracker green) in 3D co-culture spheroids encapsulated within Fmoc-SAPs and 1% Agarose hydrogels for 
3 days; images were acquired by confocal microscopy (scale bar, 200 µm).  B) Vinculin expre ssion level in co-
culture spheroids encapsulated within Fmoc-SAPs hydrogels and 1% Agarose for 3 days; measured by flow 
cytometry. Results are shown as mean ± SEM (n=3, ***p<0.001, Student’s unpaired t -test). 
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5.4 Conclusion 
 
A biomimetic Fmoc-SAP hydrogel has been developed for use as part of an advanced TME for cancer 
modelling applications. Spheroids cultured in the hydrogel presenting fibronectin’s RGD, and laminin’s 
IKVAV sequences demonstrated high cell viability, supporting previous observations into material 
biocompatibility. Furthermore, spheroids containing Lewis lung cancer cells co-cultured with NOR-10 
fibroblasts demonstrated enhanced motility compared to non-encapsulated spheroids or those cultured 
on 2D tissue culture plastic. Co-cultured spheroids also demonstrated a greater degree of fibroblast 
differentiation into CAF when encapsulated in the Fmoc-SAP microenvironment compared to the 2D 
control as observed via assessment of α-SMA expression. Finally, the encapsulation of co-cultured 
spheroids within the Fmoc-SAP coassembled hydrogel was found to enhance metabolic activity of 
tumour spheroids and promoted the invasiveness of cancer cells via a reduction in vinculin expression 
compared to a control.  Our results demonstrated the effectiveness of this system as a lung cancer model 
in vitro. 
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Chapter Six: 
 
 
 
6.  
FUNCTIONALISING SCAFFOLDS VIA 
INCORPORATION OF MACROMOLECULES 
 
6.1 Preview 
 
This chapter aims to influence cellular behaviour through the functionalisation of the biomaterial 
scaffold via coassembly of biomacromolecules into the peptide networks. Here, a developmentally 
important proteoglycan, Versican and an anti-inflammatory polysaccharide, fucoidan were selected as 
macromolecule candidates. We hypothesise that macromolecules would be incorporated via a 
conserved mechanism owing to their similar molecular properties (charge, highly sulphated nature) and 
yet would provide distinct biological influences. The physical and mechanical properties of the 
functionalised Fmoc-FRGDF hydrogel networks are discussed with respect to macromolecule 
presentation, assembly mechanisms, viscoelastic properties, and fibre/network topology; whilst 
influence of macromolecule incorporation is investigated through analysis of cell number, protein 
content, cell morphology, cell viability, and finally, formation of multinucleated syncytia as an 
indication of myogenic differentiation. The results showed successful macromolecule decoration on 
Fmoc-FRGDF nanofibers, resulting in a homogenous presentation of each respective macromolecule 
in a 3D environment. Furthermore, macromolecule inclusion led to changes in structural and biological 
properties, ultimately altering the biological outcomes of a muscle cell progenitor line, C2C12. This 
part of the work is a prerequisite for understanding mechanisms of macromolecule association for later 
bioink development (Chapter 8). 
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Abstract: 
Advanced functionalised biomaterial scaffolds which better mimic the structural and biological 
complexities of the native ECM provide significant potential for tissue engineering and regenerative 
medicine applications. The complex nature of the ECM provides developing cells with a variety of 
signals simultaneously to effectively control cell-fate. Therefore, progressive biomaterial scaffolds 
must also provide an array of biomechanical and biochemical signals to cells in a dynamic yet 
synergistic nature. Fmoc-SAPs have emerged as promising candidates for tissue engineering 
applications owing to their ability to incorporate functional, bioinspired motifs within short, structurally 
relevant sequences. Despite this, further functionalisation is often desired to better mimic native cellular 
microenvironments. Macromolecule functionalisation offers an additional means of providing artificial 
scaffolds with complex, bioactive signals presented in high affinity throughout a 3D environment. In 
this chapter, a novel tissue engineering hydrogel is presented that takes advantage of a simultaneous 
‘large and small’ assembly to non-covalently incorporate functional macromolecules. ‘Small assembly’ 
is enabled through peptide self-assembly, wherein the fibronectin inspired SAP, Fmoc-FRGDF, is self-
organised via π-β organisation. Alternatively, in ‘large assembly’, structurally and developmentally 
important macromolecules are constrained on fibril surfaces via supramolecular interactions, including 
electrostatic forces, hydrophobic forces, and physical entrapment. Results show macromolecule 
inclusion - using fucoidan and versican – enables controlled structural and biological tunability. C2C12 
skeletal muscle progenitor cells seeded onto macromolecule scaffolds demonstrate altered cellular 
processes, yet cell viability and proliferation remain unaffected. 
6.2 Introduction 
 
Advanced tissue engineering applications require optimally functionalised biomaterials; providing the 
necessary physical and biochemical cues to cells in a biomimetic fashion. The native ECM presents 
numerous cell-signalling proteins and bioactive polysaccharides to developing tissues; providing an 
effective cocktail of biological cues which regulate cellular fate.1 These large molecules rarely work in 
isolation and the relative proportion of each macromolecule - including laminins, fibronectins, collagens 
and proteoglycans - differs significantly between tissue types.1, 324 
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Fibronectin is a highly expressed glycoprotein which regulates a variety of interactions 
between cells and the ECM.249 Extensive research into fibronectin’s structure has revealed distinct, short 
regions responsible for promoting cell attachment through integrin α5β1 binding.249 The most well-
understood of these attachment sites is the minimalistic attachment motif, arginine–glycine-aspartic 
acid (RGD); subsequently, through integration of this bioactive motif within an artificial cellular 
microenvironment, various materials have been successfully functionalised for drug delivery325-326 and 
tissue engineering applications.327-331 
Similarly, SAP biomaterials have seen improved cellular 3D outcomes from the incorporation 
of RGD sequences.332-334 These peptides may be categorised by the mechanism of assembly; including 
PAs and aromatically-capped peptide derivatives.7 One particular advantage of aromatically-capped 
peptide derivatives is their ability to form very short bioactive sequences via routine peptide synthesis 
techniques, including SPPS.7 Within this class of peptide lies Fmoc-SAPs, here, assembly is driven 
through π-β interactions, resulting in π- π stacking between Fmoc-groups and subsequent β-sheet 
formation between short peptide sequences.8 Using this approach, researchers in our lab have 
successfully presented a wide range of biochemical signals at high density, including biologically 
relevant peptide derivatives, RGD,141, 143, 243 IKVAV,141, 335 and YIGSR,141 as well as synergistic 
combinations, including RGD-PHSRN314, and RGD-IKVAV26. However, despite this unique ability, 
peptide functionalisation through sequence engineering forms only part of the solution; with complex 
material functionalisation in a truly biomimetic fashion remaining a significant challenge. 
One approach which offers substantial promise focuses on the incorporation of whole 
macromolecules within biocompatible SAP scaffolds.336 Unlike many current macromolecule 
functionalisation techniques which focus on 2D surface functionalisation; the resulting network can 
present complex large biological molecules in a constrained 3D manner. Using this approach, our 
laboratory has previously functionalised Fmoc-SAP networks with the anti-inflammatory 
polysaccharide ‘fucoidan’; resulting in a network of altered biological and structural characteristics.265, 
335, 337  
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Similarly, here we investigate the incorporation of structurally and developmentally important 
macromolecules within a SAP hydrogel network. Namely, we investigate the biological and structural 
effects of two highly sulphated biomacromolecules, fucoidan and versican, incorporating each 
macromolecule within a Fmoc-FRGDF hydrogel. These biomacromolecules were selected owing to 
their similar bulk macromolecular properties (charge, sulfonated nature) that control supramolecular 
assembly yet different biological functions.  Fucoidan is a seaweed-derived polysaccharide which has 
previously shown excellent anti-inflammatory properties and has demonstrated the propensity to induce 
apoptosis in epithelial cancer cells.265 Furthermore, fucoidan addition within a SAP hydrogel network 
grants the ability to tune network microtopology; resulting in increased fibril supramolecular ordering 
and subsequent increase in network stiffness.337 Contrastingly, versican is a developmentally important 
ECM proteoglycan involved in regulating various cell-behaviours.338 This large proteoglycan is broken-
down by cell-secreted ADAMTS versicanases, resulting in the production of versikine, a bioactive 
peptide fragment which has demonstrated importance in myoblast differentiation and proliferation.244  
In this investigation, supramolecular network functionalisation is achieved through 
biomacromolecule addition during peptide self-assembly. Macromolecule interactions with SAP fibrils 
take advantage of various intermolecular forces, including electrostatic interactions,339 hydrophobic 
interactions,290 and physical entrapment.129  The resultant network is robust, in that fibril nucleation and 
development is stable and conserved, while introduced macromolecules are tightly associated with the 
fibril surface.265 The ensuing bonds are non-covalent, and as such do not require commonly used 
cytotoxic crosslinking agents or crosslinking conditions. Additionally, the inclusion of large molecules 
to the assembly can be tuned as not to disrupt network ordering – retaining the nanofibrillar peptide 
structure.337 Macromolecule influence on self-assembling mechanism is investigated through 
spectroscopic practices including CD and FT-IR; while viscoelastic characterisation is completed 
through rheological analysis. TEM and AFM were employed to analyse macromolecule induced change 
in network nano-/microtopology. 
C2C12 cells were used to analyse the effects of macromolecule functionalised coassembled 
hydrogels on cell number, protein production, cell morphology, and formation of multinucleated 
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syncytia.  C2C12 cells were selected as they are a well characterised murine skeletal muscle progenitor 
cell line which are routinely used to investigate cellular processes relevant to myogenesis during skeletal 
muscle development and regeneration.340  Our results show that macromolecules may be incorporated 
within Fmoc-SAP networks, enabling controlled tunability of network biological and structural 
properties. Furthermore, we find ‘large and small’ assembly mechanisms can be used in conjunction to 
form more complex biomimetic scaffolds for use in advanced tissue engineering approaches.   
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6.3 Results and Discussion 
6.3.1 Formation of Hydrogels 
 
Fibronectin plays a key role in mediating a variety of interactions between cells and the ECM, providing 
chemical signals to cells in the form of recognised amino acid sequences, and contributing to the overall 
structural characteristics of the ECM through binding with other ECM proteins and proteoglycans.249 
This developmentally important ECM glycoprotein is secreted by a variety of cells and plays important 
roles controlling cell attachment, differentiation, growth and migration.249 Similarly, the fibronectin-
derived cell-attachment motif, RGD, is able to facilitate cell attachment.250 Despite RGD’s success in 
promoting cell attachment, RGD does not act alone in the native ECM, and therefore consideration 
needs to be placed into facilitating further functionalisation of these peptides.341 One approach which 
has been seen some success is the integration of biomacromolecules within hydrogel networks.342-343 
Therefore, in this study, the fibronectin-inspired SAP, Fmoc-FRGDF (Figure 6-1A, B), containing the 
cell attachment domain RGD was synthesised using SPPS as previously detailed.243, 265 Four hydrogel 
groups were developed from this Fmoc-SAP: 1) Fmoc-FRGDF, 2) Fmoc-FRGDF + 0.5 mg mL-1 
fucoidan, 3) Fmoc-FRGDF + empty vector conditioned media, and 4) Fmoc-FRGDF + versican 
conditioned media. Fmoc-FRGDF is self-assembled, while hydrogels 2, 3 and 4 are coassembled. All 
gels have a Fmoc-FRGDF concentration of 1% (w/v). and assembly is triggered via the well-
characterised pH switch method.243 In the coassembled hydrogel system 2, fucoidan powder (0.05% 
(w/v)) was mixed with Fmoc-FRGDF powder before assembly (Figure 6-1C, D). Fmoc-FRGDF was 
used as a control for fucoidan investigations, while a Fmoc-FRGDF hydrogel containing empty vector 
media was used as a control for versican investigations. Versican enriched media and versican free (or 
empty vector) media were obtained via culturing of HEK-293T cells transfected with V1 versican 
construct or an empty vector (pcDNA3.1MycHisA) respectively (Figure 6-1E, F). 245 
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Figure 6-1 – Schematic of peptide self-assembly, macromolecule co-assembly and resultant hydrogel 
formation. A) Fmoc-FRGDF chemical structure. B) Schematical representation of Fmoc-FRGDF self-assembly 
driven through π–π stacking between Fmoc-groups and β-sheet formation between short peptide sequences 
resulting in the formation of peptide nanofibrils which further entangle to form a hydrogel scaffold. C) 
Chemical structure of the fucoidan subunit. D) Schematic of Fmoc-FRGDF/fucoidan co-assembly. E) Schematic 
of V1 versican showing the G1 and G3 globular domains and the chondroitin sulphate side chains bound to the 
GAG-β subunit. F) Schematic of co-assembly between Fmoc-FRGDF and versican conditioned media or empty 
vector conditioned media, resulting in the presentation of molecules  on the surface of the peptide nanofibrils. 
G) Macroscopic observations of hydrogels showing self-supporting properties (i) Fmoc-FRGDF, (ii) + fucoidan, 
(iii) + empty vector conditioned media, and (iv) + versican conditioned media.  Reproduced with permission 381  
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6.3.2 Confirmation of Macromolecule Presentation 
 
The incorporation of fucoidan within a Fmoc-SAP hydrogel has been previously confirmed.265 To assess 
the incorporation of versican, the effectiveness of versican production by V1 versican transfected HEK-
293T cells were analysed via western blotting (Figure 6-2A). As expected, a prominent band was 
observed at a molecular weight greater than 250 kDa in the versican conditioned media; the same band 
was not evident in the empty vector conditioned media.344 A second band was also observed in the V1 
versican conditioned media at around 70 kDa. This band correspond to versikine – a product of versican 
proteolysis by ECM ADAMTS versicanases.345 The presence of other protein bands in the empty vector 
conditioned media indicates HEK-293T cells secrete other proteins and therefore justifies the need for 
an empty-vector control (Figure 6-2B). The inclusion of versican within the coassembled Fmoc-
FRGDF/versican hydrogels was assessed using immunofluorescent and confocal analysis. Gels were 
stained with Anti-GAG-β versican anti-body to enable the observation of versican. Versican was not 
detected in the empty-vector control (Figure 6-2B). Alternatively, the hydrogels assembled with 
versican-containing media showed versican localised to peptide nanofibers (red) throughout the 3D 
environment (Figure 6-2B), indicating the successful inclusion of versican in the coassembled versican 
network. 
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Figure 6-2 – Verification of versican production by HEK-293T cells and visualisation of versican 
incorporation in Fmoc-FRGDF scaffolds. A) Western blot analysis showing presence of versican in versican 
transfected media but not in empty vector transfected, conditioned media as indicated by a prominent band 
greater than 250 kDa. A smaller band located around 70 kDa is likely to indicate cleaved versikine.  B) Confocal 
observations of labelled V1 versican complex in the hydrogel as stained with the V1/V 0 versican anti-GAG-β 
antibody (red), i) Fmoc-FRGDF hydrogel containing untransfected media; (i ′) corresponding bright field image. 
ii) Fmoc-FRGDF hydrogel containing transfected V1 versican conditioned media; ( ii ′) corresponding bright 
field image. iii) Z-Stack of (ii) showing 3D fibres and network orientation. Reproduced with permission 381 
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6.3.3 Investigation of Hydrogel Architecture. 
 
The nano- and microstructure of the developed hydrogel scaffolds were analysed through TEM and 
AFM imaging to determine how macromolecule inclusion during the assembly process alters scaffold 
architecture. It should be noted that samples were dried prior to imaging; however care has been taken 
to use representative images free of artefacts which may be encountered during the drying process.346 
TEM images showed highly similar, nanofibril structures in all four hydrogels (Figure 6-3A-D). These 
nanofibrils are ~10 nm in diameter and micrometres in length. These findings are in agreeance with 
SANS data acquired in a previous study.337 AFM images show Fmoc-FRGDF has a highly interwoven 
homogeneous network (Figure 6-3E-H), reinforcing previous findings.243 The addition of fucoidan is 
shown to increase the degree of fibre bundling; once again, this is expected as a previous investigation 
into fucoidan incorporation showed increased bundling proportional to fucoidan concentration.337 
Samples coassembled with versican or the empty-vector conditioned media showed scaffold 
morphologies which were different to Fmoc-FRGDF and fucoidan-containing hydrogels. Here, the 
hydrogel network appears to be less linear with more flexibility and greater densification; this is likely 
due to the inclusion of proteins excreted by HEK-293T cells, or proteins found within FBS, which may 
interfere with scaffold morphology when included during hydrogel assembly. Our observations are 
consistent with previous studies concerning the inclusion of laminin290 or dextran within composite 
networks.284   
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Figure 6-3 – Hydrogel Nano/Micromorphological changes in response to macromolecule incorporation. 
TEM shows nanostructure of fibrils formed (top panel), AFM shows microstructure network formation ( bottom 
panel) of A, E) Fmoc-FRGDF, B, F) + fucoidan, C, G) + empty vector, and D, H) + versican hydrogels. TEM 
scale bar represents 50 nm, AFM 1 µm.  Reproduced with permission 381 
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6.3.4 Characterisation of Coassembled Structure, Mechanisms, and Mechanical 
Properties 
FT-IR and CD analysis techniques were employed to investigate the effect of macromolecule addition 
on the secondary structure of Fmoc-FRGDF hydrogels; while bulk mechanical properties of hydrogels 
were assessed through oscillatory rheology. Analysis of the FT-IR spectrum demonstrates a consistent 
large single peak at 1630 cm-1 in the amide I region and another smaller, shouldered peak at  1690 cm-
1 for all samples (Figure 6-4A); characteristic of β-sheet peptide organisation.347 The lack of spectrum 
shift between samples signifies that the presence of fucoidan, versican or empty vector condition media 
does not disturb the broad self-assembly of these hydrogels. Analysis of CD absorption below 240 nm 
provides insight into secondary protein structures; a large negative peak is observed at ~220 nm (Figure 
6-4B), indicating a cotton effect induced via the presence of n-π interactions.274-275 This indicates the 
formation of predominately β-sheet-like structures – reinforcing findings found in FT-IR analysis. A 
second, positive broad peak is evident at ~260 nm, indicating supramolecular ordering between 
nanofibrils in hydrogel samples; these results agree with CD spectra of similar SAP hydrogel 
structures.143, 290 
Rheological analysis was employed to test the viscoelastic properties of the developed 
hydrogels. A cone-plate rheometer configuration under oscillatory conditions was used to perform a 
frequency sweep to analyse shear stiffness and shear thinning of hydrogels. In each of the four samples, 
the storage modulus, is larger than the loss modulus, over the frequency range tested (Figure 6-4C, D); 
indicating the formation of a stable, self-supporting hydrogel. Fmoc-FRGDF co-assembly with 
fucoidan, versican, or the empty vector conditioned media results in an increase in stiffness by 
approximately one order of magnitude when compared to Fmoc-FRGDF alone. The increased stiffness 
in fucoidan containing hydrogels is due to increased fibre bundling; this is in accordance with previous 
studies in our laboratory which found macromolecule addition results in increased fibre alignment, 
bundling, and fibril densification.265, 337 Hydrogels containing versican conditioned media demonstrated 
comparable viscoelastic properties to hydrogels incorporating the empty vector conditioned media; 
therefore, it is likely that the increase in stiffness is due to proteins and macromolecules secreted by 
HEK-293T cells. There was no significant difference in stiffness between coassembled hydrogels 
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containing fucoidan, versican, and empty vector control; indicating a maintenance of assembly 
mechanism across these three samples, and therefore, differences in biological activity between samples 
are due to hydrogel bioactivity, rather than differences in material stiffness. 
 
Figure 6-4 – Hydrogel assembly and mechanical properties.  A) FT-IR spectroscopic analysis showing the 
amide I region with peaks characteristic of anti -parallel β-sheet structure present in all samples. B) CD analysis 
confirms the presence of β-sheet structures and indicates supramolecular ordering between nanofibrils in each 
sample. C) Rheological analysis showing storage and loss moduli over a range of frequencies for hydrogels 
formed by Fmoc-FRGDF and + fucoidan and D) Rheological analysis showing storage and loss moduli over a 
range of frequencies for hydrogels formed by Fmoc-FRGDF + versican conditioned media and + empty vector 
conditioned media. Reproduced with permission 381 
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6.3.5 Effect of Macromolecule Functionalisation on Cell Viability and Protein 
Production. 
 
Influence of scaffold functionalisation on bioactivity and biocompatibility is assessed through seeding 
of C2C12 cells on hydrogels. Following 72h culture, a similar cell number was observed between 
fucoidan-incorporated Fmoc-FRGDF hydrogels and the fucoidan-free Fmoc-FRGDF control (Figure 
6-5A); complimenting observations noted by Kim et al. wherein fucoidan addition (>0.1 mg/mL) had 
no effect on cell viability during C2C12 myogenic differentiation following 48h culture.348 The relative 
total protein content is also found to be similar between the two samples (Figure 6-5B), indicating a 
negligible effect of fucoidan on cell number and protein synthesis at this concentration .  
Versican was selected for matrix functionalisation owing to its native importance in skeletal 
muscle development; playing a vital role in myoblast proliferation and differentiation in developing 
tissue.349 Versican is remodelled by cell-secreted ADAMTS versicanases, resulting in the generation of 
versikine – a 70 kDa bioactive peptide fragment.345 Remodelling of versican is important for myoblast 
fusion and myofiber maturation;244, 349 however, the presence of versikine has also been shown to 
stimulate apoptosis in some cells, and subsequently may influence cell viability when cultured in a 
versican functionalised network.245 C2C12 cells secrete ADAMTS versicanases, potentially allowing 
for remodelling of scaffold-presented versican into versikine;244 however, versican functionalisation 
had no visible effect on cell viability, as cell lysate G6PD activity was observed to be similar between 
versican containing hydrogels and the empty vector control (Figure 6-5C). Similarly, total protein 
content was relatively indifferent between the two samples (Figure 6-5D). 
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Figure 6-5 – Analysis of material cytocompatibility A) Relative cell viability and B) relative total protein 
content (as an indicator of cell growth) of cells seeded in Fmoc-FRGDF and Fmoc-FRGDF + fucoidan 
hydrogels. Data was normalized to the Fmoc-FRGDF control group. C) Relative cell viability and D) relative 
total protein content of cells seeded in Fmoc-FRGDF + empty vector and Fmoc-FRGDF + versican hydrogels. 
Data was normalized to the empty vector control group. Reproduced with permission 381 
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6.3.6 Effect of Macromolecule Functionalisation on Cell-Size and Spreading 
 
Analysis of cell spreading and morphology can be used to indicate cell attachment in artificial 
scaffolds.350 Live/dead staining of cells was implemented using Calcein AM/Propidium iodine stain 
respectively, to determine cell viability and analyse morphology and integration at 24h and 72h post 
seeding (Figure 6-6A). In all four gels, cells were found to possess high viability (>85%); furthermore, 
cells were found to migrate into the hydrogel and spread evenly within the scaffold.  At 24h, viable 
cells in all four hydrogels demonstrated similar rounded morphologies; however, following 72h culture, 
cells in Fmoc-FRGDF, versican, and empty-vector containing hydrogels showed a significant change 
in morphology with large cells demonstrating numerous cytoplasmic extensions evident. Conversely, 
myoblasts within the fucoidan-containing hydrogel demonstrated consistent small, rounded or spindle 
morphologies with few cytoplasmic extensions. 
Image analysis techniques (Image J) were used to assess cell spreading objectively. Average 
cell-size was found to increase significantly between 24h and 72h, resulting in an overall increase in 
cell area of 225%, 465%, and 1227% in Fmoc-FRGDF, Empty-vector, and versican-containing 
hydrogels, respectively (Figure 6-6B-E).  
Further analysis of average cell-size found fucoidan incorporated hydrogels resulted in a more 
significant proportion of small cells (cell area <500 µm2) and a lower proportion of cells of area greater 
than 1000 µm2 following 24h culture (Figure 6-6B i). This effect was maintained after 72h culture, 
with fucoidan incorporated hydrogels showcasing more cells of area below 1000 µm2 and fewer cells 
of area above 3000 µm2 (Figure 6-6B ii). Contrastingly, versican-functionalised hydrogels 
demonstrated no significant difference in average categorised cell-size compared to the empty-vector 
control following 72h culture (Figure 6-6C). 
Seeded cells were also stained using phalloidin and DAPI following 72h culture. Phalloidin is 
an actin stain widely used for analysis of cell morphology, while DAPI is a nuclear stain often used to 
determine nuclei count and position; in combination, the two are commonly used to determine myotube 
formation.351 Cells-size was again determined through the use of ImageJ (Figure 6-6D); here, fucoidan 
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functionalised scaffolds demonstrated more small cells (<1000 µm2) and fewer larger cells (>3000 µm2) 
when compared to the Fmoc-FRGDF control (Figure 6-6D i). Alternatively, versican hydrogels did not 
show a significant difference in average cell area when compared to the empty-vector control (Figure 
6-6 ii); reinforcing live/dead cell staining observations. 
Myoblast attachment to fibronectin is heavily regulated by biological signalling of integrin 
α5β1.352-353 The addition of polysaccharides has been shown to influence cell attachment to fibronectin, 
therefore, it is unsurprising that fucoidan incorporation into fibronectin inspired SAP networks results 
in decreased cell attachment and spreading of C2C12 cells over 72h.354 Cell attachment findings in this 
work echo those of Kim et al. wherein the degree of cell attachment was inversely proportional to 
fucoidan concentration.348 
Versican addition demonstrated a far more elusive effect on cell attachment, with the only 
noticeable difference occurring in 24h samples – in which there was a greater proportion of small cells 
(>500 µm2) and a lower occurrence of large cells between 5000 and 8000 µm2. These results indicate 
that versican may attenuate C2C12 cell attachment in hydrogel networks; an observation which is 
comparable to findings by Evanko et al., wherein versican addition hindered spreading of human 
primary T cells seeded on a hyaluronan coated culture dish.355  C2C12 cells seeded on the versican 
functionalised scaffold demonstrated comparable cell spreading to the empty vector control after 72h, 
this is potentially due to the break-down of versican into versikine via ADAMTS versicanases, however 
this hypothesis needs to be further investigated. 
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Figure 6-6 –Determination of cell morphology and spreading  A) representative image of live/dead staining 
of C2C12 cells at 24 h and 72 h post seeding for each of the 4 hydrogel samples. Live cells stained using 
Calcein AM (green), and dead cells stained using propidium iodine (red).  B) Calculation of cell spreading area 
as determined through ImageJ analysis on Fmoc-FRGDF hydrogels as compared to the fucoidan containing 
systems i) on day 1 and ii) on day 3. C) Cell spreading on the empty vector and versican hydrogels i) on day 1 
and ii) on day 3. D) Cell spreading area on day 3 of C2C12 cells on i)  Fmoc-FRGDF and + fucoidan groups 
and ii) + versican and + empty vector groups as above. * p < 0.05, ** p < 0.01, *** p < 0.001. (B) and (C) areas 
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calculated using ImageJ based on the live/dead staining images , (D) area calculated using DAPI and Phalloidin 
stains. Reproduced with permission 381 
6.3.7 Effect of Macromolecule Functionalisation on Formation of Multinucleated 
Syncytia 
 
C2C12 cells were stained Phalloidin and DAPI to visually determine the degree of myogenic 
differentiation into multinucleated syncytia following 72h culture (Figure 6-7A, B). Fucoidan-
functionalised scaffolds are observed to possess significantly more mononuclear C2C12 myoblasts 
compared to Fmoc-FRGDF alone (Figure 6-7C). Furthermore, a significantly lower proportion of 
multinucleated syncytia containing greater than five nuclei were observed in fucoidan containing 
samples compared to the Fmoc-FRGDF control (Figure 6-7C).  Alternatively, versican-containing 
hydrogels demonstrated a similar degree of multinucleated syncytia formation compared to the empty-
vector control hydrogel (Figure 6-7D).  
The hindered development of multinucleated syncytia in fucoidan samples following 72h 
culture is potentially a result of reduced cell spreading; as disruption in cell morphological changes has 
previously been correlated with reduced myotube formation through myoblast fusion.348 Alternatively, 
versican addition did not increase the occurrence of multinuclear syncytia, despite previous studies 
highlighting the key role of versican in myotube formation; this may be attributed to versican 
degradation through ADAMTS versicanase.244 Notably, the total number of DAPI-stained nuclei 
remains consistent in all four samples – indicating that although macromolecule functionalisation 
influences C2C12 cellular processes, cell viability and proliferation remain unaffected. 
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Figure 6-7 – Observation of cell morphological characteristics as determined through  DAPI/actin staining 
and determination of multinucleation as an indication of cell maturity. A) DAPI/actin staining of C2C12 
muscle cells on 72 h post seeding. Scale bar 200 μm. B) Relative proportion of nuclei (blue) per cell or 
syncytium (red) for Fmoc-FRGDF and Fmoc-FRGDF + fucoidan groups C) and relative proportion of nuclei 
(blue) per cell or syncytium (red) for the + versican and + empty vector groups.  * p < 0.1, ** p < 0.01, *** p 
< 0.001. Number of nuclei and syncytium were calculated using ImageJ.  Reproduced with permission 381 
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6.4 Conclusion 
 
Macromolecule incorporation into SAP hydrogels through versican and fucoidan coassembly was 
successful and the underlying peptide self-organisation mechanisms were conserved. In this 
investigation, macromolecule coassembly is enabled through the addition of soluble large-molecules in 
the media during peptide assembly, making them available to interact with peptide nanofibers during 
the early stages of self-assembly. Using this technique, fucoidan, versican-transfected (V1) media, and 
empty-vector transfected media was coassembled with the fibronectin inspired SAP, Fmoc-FRGDF. 
For fucoidan samples, Fmoc-FRGDF alone was used as a control; while for versican-functionalised 
samples, an empty vector control was used. The use of an empty-vector control was important, as any 
candidate proteins excreted by HEK-293T cells may influence bulk network physical and biological 
characteristics.  Versican inclusion within the coassembled scaffold was confirmed through 
immunostaining with anti-GAG-β. Fucoidan incorporation within the SAP network has previously been 
established (Chapter 4).265 The characteristic SAP fibrillar nanostructure is conserved in all samples 
while microscopic network topology is found to be altered upon macromolecule addition. Fucoidan 
addition was shown to result in increased fibre bundling. Alternatively, versican addition resulted in 
network densification and the formation of less linear, more flexible fibrils; as this effect is maintained 
in the empty vector control, it is likely due to the presence of macromolecules secreted by HEK-293T 
cells. Secondary structure analysis through FT-IR and CD techniques revealed all samples formed stable 
anti-parallel β-sheet conformations. Further analysis of the resultant spectrums indicates that although 
macromolecule incorporation leads to alteration of fibril supramolecular ordering, it does not interrupt 
peptide self-assembly mechanisms. Rheological analysis of hydrogels found macromolecule addition 
led to an increase in material stiffness of approximately one order of magnitude for all samples – 
including the empty-vector control. The increase in fucoidan-containing samples is well documented 
and is likely a result of increased fibre bundling, whilst an increase in versican-containing and empty-
vector containing hydrogels is likely due to the presence of HEK239T secreted molecules.  
The biological influence of macromolecule functionalised hydrogels was investigated through 
seeding of C2C12 cells. In this study, macromolecule addition to SAP hydrogel scaffolds was found to 
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have no influence on cell number and total protein content. However, fucoidan containing samples 
demonstrated differences in cell morphology compared to the Fmoc-FRGDF control, with seeded cells 
demonstrating smaller, rounder morphologies after 72 hours in culture. The difference in cell spreading 
was subtler in versican-containing samples, with cells only demonstrating smaller morphologies at 24h 
culture. After 72h, cells seeded in the versican-containing scaffolds demonstrated morphologies similar 
to the empty-vector control. This attenuation of cell spreading is possibly due to surface presented 
versican inhibiting cell attachment to the scaffolds; we hypothesise that ADAMTS secreted from 
C2C12 cells degrade versican into versikine, after which cell adhesion continues uninterrupted, 
allowing the material to change in response to cellular activity over time. This feature is exceptionally 
novel and warrants further investigation.  Both versican and empty vector containing hydrogels 
facilitate myogenic differentiation, resulting in the formation of multinucleated syncytia.  
In this study, we have successfully incorporated advanced functionalisation using small and 
large assembly through epitope sequence selection and macromolecule functionalisation respectively. 
Finally, macromolecule addition is found to impact cell processes without altering cell viability or 
proliferation.   
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Chapter Seven: 
 
 
 
7.  
CHARACTERISATION OF GELATIN 
METHACRYLOYL MACROMOLECULES AS A 
HYDROGEL FOR BIOENGINEERING 
 
7.1 Preview 
 
This chapter aims to investigate the structure-function relationship of GelMA hydrogels, determining 
the correlations between nanostructured SAXS observations and the resultant mechanical properties as 
assessed through rheology. Here, commercially available GelMA nanostructure and viscoelastic 
properties were assessed at two commonly used concentrations (6% and 10%) and four different degrees 
of functionalisation (18%, 46%, 61% and 80%). Degree of functionalisation (DoF) refers to the relative 
percent of crosslinkable methacryloyl side-chains attached to the polymer backbone. It was 
hypothesised that control over DoF and concentration would highlight clear correlations between 
nanostructure and final mechanical properties. The physical and mechanical properties of crosslinked 
and non-crosslinked GelMA are discussed in respect to material nanostructure (Mass fractal dimension, 
correlation-length, and mesh-size) and material viscoelasticity. The results showed clear correlations 
between nanostructured morphologies and the resultant mechanical properties observed via rheological 
analysis.  This part of the work is a prerequisite for subsequent bioink development chapters and aids 
in GelMA selection.  
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investigation into Gelatin Methacryloyl Structure-function Relationships’. Manuscript in 
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Abstract 
GelMA is a functionalised, collagen-derived biomaterial which has seen substantial use in bioprinting 
applications. This gold-standard bioink possesses highly favourable mechanical and biological 
properties, boasting mechanical tuneability through control over DoF or polymer concentration. DoF 
refers to the proportion of crosslinkable methacryloyl groups introduced into the gelatin backbone. 
Mechanical properties of GelMA are well understood; however, biologically-important nanostructured 
properties are poorly characterised and the effect of DoF and polymer concentration on network 
topology have not yet been investigated. Here, for the first time, SAXS is used to investigate structural 
changes in GelMA. Specifically, we observe hydrogel nanostructure pre- and post-crosslinking, with 
emphasis on assessing structural changes in response to increased DoF and polymer concentration. 
Samples are modelled regarding local-polymer conformation (mass fractal dimension), distance 
between entanglements (correlation length), and mesh size. Effect on viscoelastic properties are 
observed and conclusions drawn based on shared correlations. Importantly, we show a clear increase in 
polymer conformation upon crosslinking, with high DoF samples demonstrating the greatest increase 
in mass fractal dimension. Similarly, increasing GelMA DoF is strongly inversely correlated with mesh-
size, with 80% DoF samples demonstrating the lowest mesh size. Clear correlations are also evident 
between polymer concentration and correlation length, likely a result of increased entanglement density. 
Finally, physical entanglements are also found to be influenced, with concentration and DoF altering 
the temperature required for stable gel formation; while chemical crosslinks are influenced by DoF with 
high DoF samples resulting in reduced strain tolerance. 
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7.2 Introduction 
Collagen-based biomaterials have seen substantial use in tissue engineering applications, owing to their 
inherent bioactivity and high abundance in the ECM; however, collagen is severely limited in many 
tissue engineering applications, owing to its relative instability under physiological conditions. 356 As a 
result, frontier materials scientists have focused on developing new ways of processing and handling 
this material. Consequently, gelatin-based biomaterials are increasingly popular, owing to their inherent 
biocompatibility, biodegradability, low-cost and ease of manipulation.65 Gelatin is a denatured 
collagen-derived protein with a sol-gel transition temperature below 37°C, above this transition 
temperature, gelatin elicits high solubility enabled through the collapse of single strands into random 
coils.312 When cooled below the sol-gel transition temperature, gelatin can partially recombine forming 
noncovalent triple-helix structures which are stabilised by hydrogen bonds, enabling the formation of a 
soft hydrogel.357 
However, considering the instability of gelatin under physiological conditions, substantial 
research has focused on introducing chemical crosslinks to gelatin, enabling the formation of collagen-
mimicking materials which are stable even under physiological conditions (37°C), and providing further 
mechanical control allowing for tuning of viscoelasticity and control over degradation profile.358-359 
Various Chemical crosslinkers, including formaldehyde, glutaraldehyde, carbodiimide, genipin and 
dextran dialdehyde have been used to crosslink gelatin-based biomaterials.360-361 Chemical crosslinkers 
are affordable and provide excellent crosslinking efficiency; however, these chemical crosslinkers are 
cytotoxic and require prolonged wash steps to remove residual crosslinker.312, 361 Therefore, more recent 
crosslinking attempts have focused on alternative approaches, including electron beam357, 362 and UV 
irradiation techniques.202 
Electron beam irradiation enables controlled, dose-dependent covalent crosslinking, allowing 
for a high degree of control over resultant material viscoelastic properties through the depth of the 
sample.357 However, electron beam irradiation is routinely used for sample sterilisation, resulting in 
substantial damage to DNA chains subsequently leading to cell death, and therefore is unsuitable for 
hydrogels containing encapsulated cells.363  
172 
 
Gelatin modification by methacrylic anhydride allows for the formation of GelMA;364 a 
biocompatible material which has seen extensive use in bioprinting applications.11, 365 In the presence 
of a photoinitiator, UV irradiated GelMA undergoes photoinitiated radical polymerisation; resulting in 
the formation of covalently crosslinked hydrogel networks. Specifically, upon exposure to UV 
irradiation, free radicals are generated from photoinitiators, initiating chain polymerisation of 
methacryloyl substitutions.366 Propagation ensues between methacryloyl groups on the same chain and 
methacryloyl groups on different chains; before finally, termination occurs between two propagating 
chains or between propagating chain and a second radical. 366 Through control over crosslinking 
conditions, including source parameters (intensity, wavelength, and crosslinking duration) as well as 
careful consideration over photo-crosslinker (type and concentration), authors have achieved high 
viability, even when crosslinked in the presence of cells.194, 202  
GelMA offers high mechanical tunability through control over the DoF; with typical GelMA 
hydrogels ranging between 20% and 80% DoF.65 Increasing DoF results in increased material stiffness, 
increases resistance to deformation, reduces material swelling, and reduces average material pore-
size.367-368 However, highly functionalised GelMA may also restrict cellular spreading due to extensive 
crosslinks in the system.65 GelMA mechanical properties are also heavily influenced by concentration, 
with higher concentrations yielding hydrogels of increased material stiffness and reduced swelling.368  
However, controlling concentration alone is not ideal, as networks formed at high GelMA concentration 
may constrain biological functionality and nutrient exchange;369 while a concentration threshold limits 
networks formed at low concentration.203 
While modulation of concentration and DoF has a clear influence on resultant mechanical 
properties, mechanisms of crosslinking are fundamentally different, and nanostructure organisational 
changes leading to macroscale mechanical differences are not well understood. Previously, SAXS has 
been used to observe nanostructured changes in electron-beam crosslinked gelatin hydrogels at various 
crosslinking doses and concentrations.312 However, to the best of our knowledge, this is the first time 
such analysis has been completed on GelMA hydrogels. Here, SAXS observations provide insight into 
local nanostructured differences between non-crosslinked and crosslinked hydrogels of differing 
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concentration and DoF. Nanostructured observations are further correlated to material viscoelastic 
properties as determined via rheology, and structure-function relationships are observed for a range of 
hydrogel parameters.   
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7.3 Results and Discussion 
 
Understanding the structure-function relationships of biomaterials is a key requirement allowing for 
objective determination of the influence of functionalisation on material mechanical and subsequent 
biological properties. In this study, we investigate the relationship between engineered material 
variables (concentration, DoF) and resultant changes in the nanostructure. Firstly, nanostructural 
material properties are assessed via SAXS, allowing for observation of polymer network orientation 
and conformation. Specifically, SAXS is used to assess polymer conformation and network formation 
(mass fractal dimension), length between entanglements (correlation-length), and average mesh-size 
(Figure 7-1A).  Secondly, we assess the effect concentration (Figure 7-1B i) or  DoF (Figure 7-1B ii) 
has on the nanostructured organisation of these systems, and subsequently, determine how these 
properties alter material viscoelastic characteristics before and after crosslinking (Figure 7-1B, C).  
Finally, the effect of crosslinking on material nanostructure is determined (Figure 7-1C i, ii) and the 
subsequent outcome on material mechanical properties are measured via rheology. 
 
Figure 7-1 – Schematic showing Nanostructured properties as determined by SAXS.  A) Polymer Network 
showing Frac. Dimension, Correlation Length, and Mesh size, B) Non -crosslinked nanostructure changes in 
relation to i) increased polymer concentration and ii) increased functionalisation, C) Nanostructural changes 
upon crosslinking and in relation to i) increased polymer concentration and ii) increased network 
functionalisation. 
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7.3.1 Non-crosslinked GelMA Trends 
 
Non-crosslinked GelMA nanostructure was investigated using SAXS; following which, non-
crosslinked viscoelastic properties were acquired via oscillatory rheology under temperature ramp 
conditions from 37°C to 4°C.  
7.3.1.1 Small-Angle X-ray Scattering 
 
SAXS analysis was employed to observe polymer conformational changes in response to concentration 
increase and alteration of peptide functionalisation. Scattering curves for 6% (w/v) (Supplementary 
Figure S - 3A i) and 10% (w/v) (Supplementary Figure S - 3A ii) samples were attained and analysed 
concerning polymer conformation, correlation length, and mesh-size. Fitting of models were performed 
over mid-low q ranges (Supplementary Figure S - 4). 
Non-crosslinked Mass Fractal Dimension 
The Porod region corresponds to a probed range smaller than the scattering objects, analysis of 
scattering in this region provides insight into polymer fractal dimension and subsequently, local 
polymer conformation.311, 313 A mass fractal dimension of 1 is indicative of a mathematical cylinder, 
while a mass fractal dimension of approximately 1.67 is associated with swollen polymer coils in a 
good solvent. Mass fractal dimensions between 2-3 are representative of branched polymers and are 
associated with network formation – particularly in chemically crosslinked systems. 311-312 Fitting for 
mass fractal dimension can be described by Equation 7-1 
𝐼(𝑞) =  
𝐴
𝑞𝑑𝑚
 
Equation 7-1 – Fitting for Mass Fractal Dimension  
Where A is a scaling factor, dm is the fractal dimension or power. 
A similar mass fractal dimension was observed for all non-crosslinked, 6% (w/v) GelMA 
samples, ranging between 1.78 (± <1%, 80% DoF) and 1.89 (± <1%, 61% DoF) as is expected of a 
polymer in a good solvent. (Figure 7-2A i) Alternatively, 10% (w/v) GelMA samples demonstrated 
lower mass fractal dimensions overall, ranging from 1.60 (± <1%, 18% DoF) to 1.75 (± <1%, 61% 
176 
 
DoF), indicating a reduction in polymer conformation complexity with increased concentration (Figure 
7-2A i). A similar trend was seen by Wisotski et al. wherein increasing gelatin concentration resulted 
in decreased mass fractal dimension.312 Importantly, mass fractal dimension in non-crosslinked samples 
does not appear to be a function of methacrylation percentage. These results are in accordance with 
correlation studies wherein a strong inverse correlation (-0.86) was observed between non-crosslinked 
mass fractal dimension and peptide concentration, while a negligible correlation (0.17) was observed 
between DoF and non-crosslinked mass fractal dimension. 
Non-crosslinked Correlation Length 
Analysis of correlation length provides insight into the distance between entanglements in semi-dilute 
systems and can be described by Equation 7-2.311-312 
𝐼(𝑞) = (
𝐶
(1 + 𝑄𝜉)𝑚
) + 𝑏𝑘𝑔 
Equation 7-2 - Fitting for Correlation Length 
Where C is the Porod scaling factor relating to the intensity extrapolated at scattering vector q=0. 
Bkg accounts for background scattering; (m) is the Porod exponent and provides information relating 
to the local polymer structure, and ξ is the correlation length and provides an estimate of average 
entanglement length for semi-dilute solutions. 311 
In non-crosslinked, 6% (w/v) GelMA samples correlation length ranged between 3.9 nm (39.2 Å 
± 1.2%, 80% DoF) and 5.1 nm (50.6 Å ± 1.6%, 46% DoF) (Figure 7-2A ii). Upon increase to 10% 
(w/v), samples demonstrated an overall decrease in correlation length as expected, ranging from 2.9 nm 
(29.1 Å ± <1%, 18% DoF) to 3.4 nm (34.4 Å ± <1%, 61% DoF) (Figure 7-2A ii). Once again, a strong 
inverse correlation (-0.90) was evident between non-crosslinked correlation length and peptide 
concentration, while negligible correlation (0.00) was observed between DoF and non-crosslinked 
correlation length. These results indicate an increase in GelMA concentration results in a decrease in 
distance between entanglements, as would be expected in a network of increased density; while increase 
in DoF does not appear to influence entanglement spacing. 
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Non-crosslinked Mesh Size 
The intercept of two-powers in a log-log plot can be used to calculate the point of crossover (qc), and 
subsequently, can be used to calculate the mesh characteristics of a polymer network, as described by 
Equation 7-3.311-312 
𝑀𝑒𝑠ℎ 𝑆𝑖𝑧𝑒 =
2𝜋
qc
 
Equation 7-3 - Fitting for Mesh Size 
Calculation of average mesh size in 6% (w/v) samples finds no substantial variance over DoF, 
ranging between 14.2 nm (142.0 Å ± <1%) in 80% DoF hydrogels and 14.3 nm (143.3 Å ± <1%)  in 
46% DoF hydrogel samples (Figure 7-2A iii). Following an increase in peptide concentration to 10% 
(w/v), a decrease in mesh size is evident, ranging from 13.0 nm (130.3 Å ± <1% ) , 18% DoF) to 13.6 
nm (136.1 Å ± <1%, 61% DoF) (Figure 7-2A iii). Non-crosslinked mesh size is found to be inversely 
correlated (-0.93) to peptide concentration, while alteration of DoF does not affect non-crosslinked 
mesh size (0.00 correlation score).  
178 
 
 
Figure 7-2 – Nanostructured and Viscoelastic properties of Non-crosslinked Gelma.  A) nanostructured 
properties as determined through SAXS regarding i) mass fractal dimension, ii) correlation length, and iii) 
mesh size; B) Thermodependent viscoelastic properties including i) effective temperature of gel formation, ii) 
final modulus at 4°C, and iii) gradient of storage modulus increase.  
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7.3.1.2 Material Viscoelastic Properties 
 
Rheological analysis was employed to investigate the effect of concentration and DoF on non-
crosslinked material viscoelastic properties (Supplementary Figure S - 7A). Non-crosslinked 
hydrogels were analysed in respect to temperature dependences; specifically, temperature wherein loss 
tangent falls below 0.1, storage modulus at 4°C, and gradient of storage modulus increase. 
Temperature of Stable Gel Formation 
The point where loss tangent falls below 0.1 was selected in place of traditional point of gelation (where 
loss tangent falls below 1) as many samples did not display typical solution characteristics (Loss tangent 
> 1) prior to temperature decrease (Supplementary Figure S - 5A). Despite the altered value of 
measurement, calculation of temperature where loss tangent < 0.1 is strongly correlated (>0.99) to tan 
> 1 and provides a good estimate of stable gel formation (Supplementary Table S - 1, 2). From here 
on in, this value will be called effective temperature of gel formation. 
6% (w/v) samples show a clear, inverse correlation to DoF, with effective temperature of gel 
formation ranging between 14.9°C (18% DoF) and 8.0°C (80% DoF) (Figure 7-2B i). Similarly, 10% 
(w/v) samples demonstrate a clear inverse correlation to DoF, with effective temperature of gel 
formation ranging from 17.7°C (18% DoF) to 12.1°C (80% DoF) (Figure 7-2B i). A good correlation 
(0.57) is evident between peptide concentration and effective temperature of gel formation, and DoF is 
found to be inversely correlated (-0.71) to effective temperature of gel formation. The inverse 
correlation between effective temperature of gel formation and DoF is likely a result of functional group 
interference in helix formation, as has previously been reported.364  
Storage Modulus at 4°C 
Storage modulus at 4°C was also assessed to further highlight correlations between material variables 
(DoF, and concentration) and functional properties. Here, storage modulus at 4°C was found to be 
dependent on both Gelma concentration and DoF. 6% (w/v) samples varied in storage modulus from 
2.3 kPa (18% DoF) to 0.4 kPa (80% DoF) (Figure 7-2B ii). While 10% (w/v) samples ranged between 
9.0kPa (18% DoF) and 3.0 kPa (80% DoF) (Figure 7-2B ii). A clear correlation (0.83) is evident 
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between storage modulus at 4°C and peptide concentration, while an inverse correlation (-0.5) is evident 
between storage modulus at 4°C and DoF.  An inverse correlation between modulus after cooling and 
DoF has previously been observed, with authors finding physical structuring to be less pronounced as 
DoF increases; owing to interference in triple helix formation.364 80% DoF samples had reduced 
molecular weights (62,688 Da) compared to 18% DoF samples (107,464 Da), (Supplementary Table 
S - 3) therefore, it is likely that DoF reduces molecular weight which would also affect GelMA viscosity. 
370 Unfortunately, molecular data for 46% and 61% DoF samples was unable to be acquired from 
supplier. 
Gradient of Storage Modulus Increase 
Finally, gradient of storage modulus increase as a function of temperature was used to further highlight 
correlations between material variables and outcome mechanical properties. Gradient of storage 
increase was assessed over 4°C following loss tangent < 0.1 to keep sample analysis consistent. The 
average gradient was determined as a means of demonstrating material kinetics, providing insight into 
the rate of storage modulus increase over a given temperature range, and subsequently, providing insight 
into the rate of entanglement formation. 6% (w/v) samples ranged in gradient of stiffness increase from 
0.136 kPa °C-1 (18% DoF) to 0.085 kPa °C-1 (61% DoF) (Figure 7-2B iii); while 10% (w/v) samples 
demonstrated substantially greater gradients ranging between 0.420 kPa °C-1 (18% DoF) and 0.257 kPa 
°C-1 (80% DoF) (Figure 7-2B iii). A clear correlation (0.90) between concentration and gradient of 
stiffness increase is observed with 6% (w/v) samples demonstrating substantially slower rates compared 
to 10% (w/v) counterparts. Alternatively, despite a general reduction in gradient as DoF increases past 
18%, no clear correlation (-0.34) is evident between DoF and gradient of stiffness increase. 
7.3.1.3 Structure-Function Correlations. 
 
Direct correlations between non-crosslinked nanostructured properties and observed viscoelastic trends 
are difficult to fully attain, as non-crosslinked SAXS data was collected at 37°C while viscoelastic 
trends generally only provided notable values below 18°C under these tested conditions. Nevertheless, 
37°C was selected such that accurate comparisons could be made between crosslinked and non-
crosslinked hydrogel nanostructure as observed via SAXS. 
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Despite the different temperature range, some strong correlations were observed. Moduli at 4°C 
demonstrated strong negative correlations with non-crosslinked mass fractal dimension (-0.79), 
correlation length (-0.75), and mesh-size (-0.77). Similarly, gradient of stiffness increase shared strong 
negative correlations with non-crosslinked mass fractal dimension (-0.89), correlation length (-0.86), 
and mesh size (-0.91). In both cases, concentration dependencies are likely the reason for strong 
correlations, as higher polymer concentrations yield networks of increased polymer densities, and 
subsequently, reduce mass fractal dimension, correlation length, and mesh size, yet increase modulus 
at 4°C and gradient of stiffness increase. The effect of temperature on these correlations, however, needs 
to be investigated further. 
A full comparison of correlations can be found in supplementary data (Supplementary Figure S - 6).  
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7.3.2 Crosslinked GelMA Trends 
 
To further investigate the effect of structural changes on functional properties, the structure-function 
relationship of Gelma is further assessed following photo-crosslinking. Again, GelMA nanostructure is 
investigated via SAXS; while viscoelastic properties are determined through oscillatory rheology. 
7.3.2.1 Small-Angle X-ray Scattering 
 
SAXS analysis is used to observe polymer conformation changes in response to photo-crosslinking. 
Scattering curves were acquired for GelMA samples at four DoF (18%, 46%, 61% and 80%) and at two 
concentrations (6% (w/v) and 10% (w/v)). SAXs trends were modelled with respect to polymer 
conformation (mass fractal dimension), distance between polymer entanglements (Correlation length), 
and average polymer mesh size. 
Crosslinked Mass Fractal Dimension 
Fitting SAXS curves to a mass fractal dimension model provides insight into polymer conformation.311, 
313 Following crosslinking, all samples dramatically increased in mass fractal dimension compared to 
non-crosslinked counterparts (Figure 7-2, Figure 7-3), indicating a substantial increase in polymer 
complexity towards branched networks as is expected in covalently crosslinked systems.311-312 6% (w/v) 
GelMA samples demonstrated a DoF-dependent increase in mass fractal dimension, ranging from 2.12 
(± <1%, 18% DoF) to 2.48 (± <1%, 80% DoF)(Figure 7-3A i); while 10% (w/v) samples demonstrate 
a similar trend, ranging in mass fractal dimension from 2.17 (± <1%,18% DoF) to 2.61 (± <1%, 61% 
DoF) (Figure 7-3A i). A clear correlation (0.89) is observed between DoF and crosslinked mass fractal 
dimension, indicating that GelMA samples of higher functionalisation result in the development of more 
complex polymer conformations following crosslinking. Alternatively, no significant correlation (0.2) 
is evident between concentration and crosslinked mass fractal dimension over the conditions tested. 
Results suggest that crosslinking of higher DoF samples results in greater polymer conformation 
complexity and branching, while concentration had a negligible effect on polymer complexity at these 
concentrations. 
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Crosslinked Correlation Length 
Calculation of average correlation length provides a good estimate of distance between entanglements 
and subsequently allows for observation into local polymer network morphology. 311 6% (w/v)GelMA 
samples demonstrated a correlation length, which is inversely proportional to DoF, ranging from 6.6 
nm (66.3 Å ± 2.0%) in 18% DoF samples to 4.0 nm (40.5 Å ± <1%) in 80% DoF samples (Figure 7-3A 
ii). Correlation lengths in 10% (w/v) samples followed a similar trend; however, correlation lengths 
presented shorter than 6% (w/v) counterparts (Figure 7-3A ii). 10% (w/v) GelMA samples ranged from 
5.0 nm (49.7 Å ± 1%) in 46% DoF samples to 3.4 nm (34.1 Å ± <1%) in 80% DoF hydrogels. Despite 
18% DoF, 10% (w/v) samples eliciting a lower correlation length than 46% DoF samples of the same 
concentration, a good inverse correlation (-0.65) was still observed between DoF and correlation length. 
As correlation length is reflective of all entanglements, it is likely that physical entanglements present 
during the crosslinking process remain post-crosslinking, resulting in 18% DoF samples demonstrating 
shorter correlation lengths compared to 46% DoF samples in higher concentration hydrogels;312 
however, further research covering a range of crosslinking temperatures is required. An inverse 
correlation (-0.59) was also observed between GelMA concentration and crosslinked correlation length, 
as is expected in networks of increased density.  
Crosslinked Mesh Size 
Calculation of average mesh size provides further insight into network nano-morphology. A clear 
inverse relationship is observed between DoF and mesh size, with 6% (w/v) samples demonstrating a 
mesh size of 11.1 nm (110.8 Å ± 1.2%) for 18% DoF samples and 8.7 nm (87.1 Å ± <1%) for 80% DoF 
samples (Figure 7-3A iii). This trend is further highlighted in 10% (w/v) samples, wherein mesh size 
ranges between 11.9 nm (119.5 Å ± <1%) for 18% DoF samples and 8.3 nm (82.6 Å ± <1%) in 80% 
DoF hydrogels (Figure 7-3A iii). A notable inverse correlation ( -0.93) is observed between DoF and 
crosslinked mesh size, as expected. These results indicate that as DoF increases, crosslinked mesh size 
decreases. As mesh size in similar covalently crosslinked systems largely reflect crosslinked mesh size 
and neglect physical entanglements,312 it is likely a result of reducing spacing between functional groups 
resulting in shorter spaces between polymer crosslinks and subsequently, reducing average polymer 
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mesh size. No significant correlation (0.05) is observed between peptide concentration and crosslinked 
mesh size at these tested concentrations. 
 
Figure 7-3 – Nanostructured and Viscoelastic properties of crosslinked GelMA. A) nanostructured 
properties as determined through SAXS regarding i) mass fractal dimension, ii) correlation length, and iii) 
mesh size; B) crosslinked viscoelastic properties including final modulus, yield strain, and strain at max loss 
modulus. 
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7.3.2.2 Material Viscoelastic Properties 
 
Changes in material viscoelastic properties during crosslinking were observed via oscillatory rheology. 
Samples were photo-crosslinked in situ (365 nm, 4.5 mW cm-2), and changes in storage and loss 
modulus were recorded for 15 minutes. UV irradiation was applied at 1-minute and allowed to run for 
a further 14 minutes. Following crosslinking, a logarithmic amplitude sweep was applied to samples to 
test sample response to shear strain between 0.1% and 1000%. Dynamic response to shear-strain 
increase was plotted, and values of interest were selected for further investigation (Supplementary 
Figure S - 7B, C).  
Crosslinked Storage Modulus 
Following crosslinking completion (15 minutes testing), the final storage modulus of each sample was 
calculated. 6% (w/v) samples demonstrate relatively low final storage modulus’, ranging between 1.2 
kPa in 18% DoF samples and 0.6 kPa in 61% DoF samples (Figure 7-3B i). Alternatively, 10% 
(w/v)samples demonstrate substantially higher storage modulus, ranging between 4.4 kPa in 46% DoF 
samples and 8.9 kPa in 80% DoF samples (Figure 7-3B i).  
Interestingly, observations made in 6% (w/v) samples challenge much of current literature, 
which finds increased DoF results in increased material stiffness following crosslinking.368 254 Here, we 
believe that these hydrogels at 6% are bordering on the concentration threshold for gel formation, 
limiting the number of crosslinks and subsequently, reducing the final storage modulus. Similarly, a 
discrepancy is evident in 10% (w/v) samples, wherein the 46% DoF hydrogel demonstrates a lower 
final modulus (4.4 kPa) than the 18% DoF sample (6.2 kPa). Here, it is possible that source variability 
and batch-batch differences is a leading cause for these inconsistencies. In both cases, however, further 
research is required over a greater range of concentration to adequately understand the underlying 
kinetics of these materials. Results may also benefit from analysis of material compressive moduli, 
allowing for more accurate comparison to literature. Despite no substantial correlation (0.13) between 
DoF and final modulus in this study, a clear correlation (0.93) was observed between GelMA 
concentration and final modulus. 
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Strain at Yield Point 
Stress was plotted against shear-strain for 6% (w/v) (Supplementary Figure S - 5B) and 10% (w/v) 
(Supplementary Figure S - 5C)  GelMA samples.  Strain at stress peak was recorded for each sample 
and used as an indication of strain at the yield point. 6% (w/v) samples ranged in yield strain, from 
269% in 46% DoF samples to 127% in 80% DoF samples (Figure 7-3B ii). Comparatively, 10% (w/v) 
samples were less tolerant to shear strain, with yield strains ranging between 140% in 18% DoF and 
46% DoF samples, to 30% in 80% DoF samples (Figure 7-3B ii). A strong inverse correlation (-0.72) 
was evident between yield strain and DoF; while no notable correlation (0.09) was observed between 
concentration and yield strain. The lack of correlation is surprising, as higher concentration samples 
demonstrated substantially lower strain-tolerance compared to their 6% (w/v) counterparts, however, 
source variability may be masking trends. These results agree with current literature, which finds 
increased crosslinking density results in decreased ability to tolerate strain.371 
Strain Macro-Crack Formation 
Strain at maximum loss modulus was used to measure material strain resistance. When an amplitude 
sweep is performed, the point of maximum loss modulus corresponds to the formation of a continuous 
macro-crack which runs the entire gap of the measuring system.372 The strain at this point was recorded 
for each sample and used as a measure of material resistance to crack-formation. 6% (w/v) samples 
demonstrated an enhanced ability to resist macro-crack formation, requiring between 403% and 171% 
strain to reach macro-crack formation in 18% DoF and 80% DoF samples, respectively (Figure 7-3B 
iii). (w/v) samples demonstrate substantially less strain conformity, forming cracks after 199% and 60% 
for 18% DoF and 80% DoF respectively (Figure 7-3B iii). A strong inverse correlation (-0.74) is 
observed between GelMA concentration and strain at maximum loss modulus; while a strong inverse 
correlation (-0.65) is observed between DoF and strain at maximum loss modulus. As strain at 
maximum loss modulus shares strong correlations with both DoF and concentration, we suggest 
considering strain at maximum loss modulus in conjunction with yield strain for future studies of similar 
nature. 
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7.3.2.3 Structure-Function Correlations. 
 
Various structure-function relationships are observed between crosslinked polymer network 
conformation and crosslinked hydrogel viscoelastic properties. Final storage modulus demonstrates a 
negative correlation (-0.66) with crosslinked correlation length; likely due to increased polymer density 
resulting in increased entanglement density. Strain at maximum loss modulus demonstrates a negative 
correlation (-0.75) with crosslinked mass fractal dimension, a strong positive correlation (0.93) with 
crosslinked correlation length, and a positive correlation (0.56) with crosslinked mesh size; here it is 
likely that high polymer complexity results in increased network rigidity and subsequently, less strain 
deformability prior to breaking. The direct correlation between correlation length and strain at 
maximum loss modulus is likely due to decreased entanglement density reducing network rigidity; 
likewise, an increase in mesh-size would reduce network rigidity, increasing strain tolerance. Similarly, 
yield strain demonstrated an inverse correlation (-0.64) with crosslinked mass fractal dimension, and a 
strong direct correlation (0.78) with crosslinked mesh size; these results strengthen observations made 
through analysis of strain at max loss modulus. 
Interestingly, all crosslinked viscoelastic properties investigated also share strong correlations 
with non-crosslinked nanostructured properties. Specifically, final storage modulus shares strong 
negative correlations with non-crosslinked mass fractal dimension (-0.78), correlation length (-0.84) 
and non-crosslinked mesh size (-0.94); while strain at maximum loss modulus shares positive 
correlations to non-crosslinked mass fractal dimension (0.53), correlation length (0.79) and non-
crosslinked mesh size (0.70). Again, this is likely an effect of concentration dependence, with increased 
concentration reducing non-crosslinked mass fractal dimension, correlation length, and mesh size yet 
once crosslinked, resulting in increased final modulus and decreased strain tolerance.   
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7.4 Conclusion 
 
SAXS was used to observe GelMA polymer organisations; allowing otherwise unavailable monitoring 
of nanoscale structural changes in response to alteration of polymer concentration or DoF. Trends were 
observed and correlated to bulk material viscoelastic properties acquired through rheology. Polymer 
organisation was modelled in regard to mass fractal dimension, correlation length, and mesh size. For 
non-crosslinked samples, an increase in polymer concentration resulted in a decrease in non-crosslinked 
mass fractal dimension, correlation length, and mesh size, indicating an inverse relationship; whilst no 
substantial correlations were evident in response to an increase in DoF. Upon crosslinking, polymer 
mass fractal dimension substantially increased for all samples, indicating increased polymer 
morphological complexity. This increase was positively correlated with material DoF.  Similarly, 
correlation length was found to increase upon crosslinking; however, magnitude of increase was 
inversely related to DoF. Mesh size decreased in response to crosslinking, with higher DoF samples 
experiencing the greatest decrease in mesh size. For crosslinked samples, an increase in polymer 
concentration only had a substantial effect on correlation length, resulting in an overall decrease in 
crosslinked correlation length. Alternatively, an increase in DoF was positively correlated with mass 
fractal dimension, and negatively correlated with correlation length and mesh size. Viscoelastic 
properties were determined via rheology. Clear positive correlations were evident between polymer 
concentration and resultant material stiffness, either in relation to cooling or photo-crosslinking. DoF 
was shown to be negatively correlated to temperature of stable gel formation, likely due to reduced 
molecular weights of these polymers. Despite an overall increase of final crosslinked modulus 
concerning DoF increase, no clear correlation was evident; here it is likely that source variability and 
concentration thresholds are masking trends.  Finally, both DoF and polymer concentration showed 
strong inverse correlations to strain tolerance as measured through strain at maximum loss modulus.  
Overall, these results highlight the structure-function relationships of GelMA and provide 
insight into nanostructured changes which result from control over GelMA concentration and DoF. 
Future investigations should focus on kinetics modelling of in situ structural changes during 
crosslinking, determining the dependence between threshold concentrations and DoF, and investigating 
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additional crosslinking temperatures. No substantial correlation was evident between source and trends, 
here it is likely that GelMA source variability was a contributing factor, as GelMA was sourced from 
two different suppliers (Sigma Aldrich and University of Wollongong) and methacrylation was 
performed on different gelatin batches. Subsequently, source variability may reduce clarity of 
observations; reiterating the need to move from natural proteins toward synthetic tissue analogues. 
Work outlined in this chapter will allow researchers to understand nanostructure organisations from 
rheological observations. From results in this chapter, 18% DOF at 6% (w/v) was selected for further 
bioink development in subsequent chapters, owing to its elevated gelation temperature and high strain 
tolerance. 
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Chapter Eight: 
 
 
 
8.  
MUSCLE BIOINK 
 
8.1 Preview 
 
This chapter intends to further investigate the ability of Fmoc-SAPs to integrate with mechanically 
advantageous biomacromolecules; specifically, for the development of a preliminary bioink toolkit. 
Here, the extensively used functionalised macromolecule GelMA is combined with SAP fibrils 
constructed through coassembly of Fmoc-FRGDF and Fmoc-PHSRN, as described in Chapter 4. We 
hypothesise that fibril formation will be maintained in the presence of GelMA, allowing for the 
presentation of tuneable and functional biochemical signals within a bioprintable hydrogel bioink. We 
anticipate that the charged GelMA molecules will associate with the peptide fibrils, allowing for a high 
degree of control over hydrogel morphology, from nanoscale (through fibril formation) through to 
macroscale (through bioprinting). Hybrid material physical and mechanical properties are extensively 
investigated in respect to assembly mechanisms, nano/microarchitecture, viscoelastic properties, and 
ability to form 3D constructs through spatial and temporal control as facilitated through bioprinting. 
Fmoc-SAP fibril integration and its resultant effect on primary myoblast viability and differentiation 
are also investigated.  Results show successful development of a hybrid bioink, resulting in a high 
degree of control over morphological properties, from nano- through to macroscale. Furthermore, the 
hybrid material demonstrates enhanced printability as assessed through thermoresponsive rheology and 
various printability tests. Here, printability is measured through calculation of loss tangent and ability 
to print a desired structure. Printed scaffolds remained stable over 4 weeks and supported high primary 
myoblast viability and early differentiation. This part of the work is a prerequisite for the development 
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of a modular bioink toolkit (Chapter 9), allowing for ease of customisation through Fmoc-SAP 
selection. 
Contribution of the candidate: 
• Concept development and experimental design 
• Key contributor to protocol development 
• Involved in the acquisition of all data, with substantial contributions in material analysis 
• Primary researcher for acquisition and analysis of SAXS Data 
• Prepared proposal, successful Funding for Synchrotron Experiments (ANSTO, AUS) 
• First author of the manuscript. 
Publications relevant to this chapter 
Boyd-Moss, M., Firipis, K., Quigley, A., Cichocki, A., Dekiwadia, C., Long, B., Ngan, C., Witty, S., 
Nisbet, D., Kapsa, RMI., Williams, R (2019) ‘Bioink Development using fmoc-SAP/Gelatin 
Methacrylate Blends’. Manuscript in preparation. 
  
192 
 
Abstract: 
The potential of bioprinting to deposit cells, structures and signals within a biomimetic, spatially 
defined, 3D construct provides substantial promise to current tissue engineering practices. The bottom-
up approach of bioprinting allows for extensive control over biochemical and biomechanical cues, 
allowing for multi-material printing of functional regions. However, despite immense potential, 
bioprinting is still critically limited in bioink development, with most bioinks unable to simultaneously 
provide suitable biological functionality and material printability. Therefore, the development of a 
simple bioink toolkit which allows independent control over biochemical stimulation and mechanical 
properties would be of substantial advance to current tissue engineering applications.  Fmoc-SAPs have 
shown considerable potential for use as artificial microenvironments, owing to their ease of biochemical 
modification and high structural similarity to the native ECM. Despite this, Fmoc-SAPs are limited in 
potential as they cannot form covalent bonds, and therefore are liable to dissociation in media. 
Alternatively, GelMA is a gelatin-derived biomaterial with extensive use in bioprinting applications 
owing to its favourable mechanical properties; however, GelMA is not without fault, as it is limited in 
biochemical functionalisation. Hence, this chapter focuses on the development of a novel bioink which 
has the potential for further development into a modular bioink toolkit through alteration of Fmoc-SAP 
sequence. Specifically, this chapter develops a hybrid bioink through the combination of Fmoc-
FRGDF/Fmoc-PHSRN fibrils with Low Methacryloyl GelMA (LM-GelMA, 18% DoF). Results show 
enhanced bioprintability compared to LM-GelMA alone; and further demonstrates the efficacy of this 
approach as demonstrated through primary myoblast viability and differentiation. 
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8.2 Introduction 
 
Tissue and organ engineering offers a substantial advance to current therapies for the replacement of 
damaged or diseased tissues; however, the regeneration of organs and higher order tissues is complex 
and requires control over spatial and temporal placement of cells and artificial tissue constructs.207, 373 
Advances in additive manufacturing, materials science, and cell biotechnology have led to the 
development of bioprinting technologies, allowing the placement of cells, signals and artificial 
microenvironments within confined, 3D geometries. 160 This rapidly advancing technique allows for 
intricate control over scaffold micro- to macro properties, and facilitates multi-material printing, 
enabling the development of complex structures from multiple materials.189, 374 The ability to fabricate 
multi-material structures allows for gradient presentations of cells, signals and materials within a single 
3D bioprinted construct. 375 However, despite significant advance, current bioprinting approaches are 
substantially limited by the availability of effective bioinks, with many bioinks unable to demonstrate 
suitable biological properties whilst maintaining adequate mechanical characteristics demanded in 
bioprinting applications. 11 
GelMA is a gelatin derived material which has been modified with methacryloyl groups, 
allowing for triggered covalent crosslinking upon exposure to UV irradiation.65, 366 GelMA 
demonstrates unique thermo-dependent viscoelastic properties allowing for precise control over 
material viscosity enabled through temperature control.369 These highly advantageous mechanical 
characteristics combined with GelMA’s high bioactivity and biocompatibility has resulted in substantial 
use in bioprinting applications.203  However, despite GelMA being a gold standard for many tissue 
bioprinting applications, it is inherently restricted in its cell-signalling capacity; presenting only one 
(RGD) of two synergistic cell adhesion (RGD, PHSRN) epitopes.314, 366 Furthermore, GelMA is limited 
in morphology; with recent research aiming to introduce fibril-like structures through 
electrospinning.376 Current interest in GelMA use for soft tissue engineering has focused on altering the 
degree of methacryloyl, allowing for the development of materials of altered stiffness ideal for 
mechanotransduction.377-378 However, attempts to translate LM-GelMA into a bioprintable material 
have been disappointing, with LM-GelMA bioinks unable to maintain suitable shape fidelity.368  
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SAPSs are a unique class of synthetic peptide which spontaneously form highly biomimetic, 
hierarchical, structures that immobilise the surrounding solvent to form biocompatible hydrogels.26   
These materials allow for high structural and biochemical tunability, facilitating the formation of 
various structures, including ribbons, tapes, nanotubes, and fibrils.379 Furthermore, SAPs allow for 
substantial control over biochemical signalling, enabling targeted cell signalling facilitated through 
sequence selection.7 Aromatic Fmoc-SAPs are a promising subclass of SAPs, allowing for charge 
neutralised assembly facilitated through pH manipulation; resulting in the formation of large, highly 
biomimetic structures through π-π stacking of Fmoc groups and β-sheet formation between short 
peptide sequences (π- β assembly).8 
Fmoc-FRGDF is a fibronectin-inspired SAP which has seen substantial success in tissue 
engineering applications both in vitro143 and in vivo. 141, 380 Recent research has combined this SAP with 
a similar, fibronectin-inspired sequence Fmoc-PHSRN, allowing for the formation of fibrillar structures 
decorated with synergistic fibronectin attachment motifs, RGD and PHSRN.314 Further 
functionalisation of Fmoc-FRGDF has also been enabled through coassembly with macromolecules, as 
confirmed through network incorporation of fucoidan and versican.265, 337, 381 The ability of Fmoc-
FRGDF to associate with charged molecules facilitates the development of novel hybrid artificial 
ECMs, increasing the versatility of this material. Despite the success of Fmoc-SAPs, hydrogels 
developed from this material demonstrate poor force endurance and some instability under 
physiological conditions; therefore, these materials would benefit from structural macromolecule 
incorporation.382 To our knowledge, no previous work has been completed using Fmoc-SAPs as bioink 
components. 
In this chapter, a hybrid material is developed through Fmoc-FRGDF/Fmoc-PHSRN 
coassembly in the presence of LM-GelMA; allowing for high mechanical tunability as offered through 
GelMA incorporation, and high biochemical tunability facilitated through Fmoc-SAP sequence 
selection. Specifically, we investigate the association between Fmoc-FRGDF/Fmoc-PHSRN fibrils and 
LM-GelMA, determining the mechanisms governing assembly. Hydrogel stiffness, printability, and 
network topology are also investigated, before subsequent investigations into material bioactivity and 
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ability to influence primary myoblast behaviour. The ultimate goal of this chapter is to investigate the 
potential of such hybrid systems as bioink toolkits, enabling ease of biochemical customisation through 
sequence engineering; and providing the foundation for further bioink development targeting alternate 
tissue types.  
8.3 Results and Discussion 
8.3.1 Formation of Bioinks 
 
We have previously demonstrated the synergistic behaviour of hydrogels formed from fibronectin-
inspired Fmoc-FRGDF and Fmoc-PHSRN (Chapter 4). In this study, we advance this hydrogel system 
into an effective bioink through the inclusion of LM-GelMA. Three peptide-based bioinks were 
developed. Firstly, a fibronectin-inspired Fmoc-SAP containing synergistic fibronectin attachment 
motifs, RGD and PHSRN, was self-assembled under physiological conditions (pH 7.4) using a well-
characterised pH switch method.8 Here, Fmoc-FRGDF and Fmoc-PHSRN were coassembled in 
accordance with our previous study (Figure 8-1A), from here on this bioink will be termed 
coassembled.314 A second bioink was developed through the low degree (18%) methacrylation of gelatin 
to form LM-GelMA which was dissolved in PBS such that the final concentration is 6% (w/v) (Figure 
8-1B). LM-GelMA can undergo photo-crosslinking when subjected to UV irradiation in the presence 
of a photoinitiator, allowing for controlled and rapid gelation. A third bioink was assembled through a 
combination of Fmoc-FRGDF/Fmoc-PHSRN hydrogel (0.5% w/v) with LM-GelMA hydrogel (6% 
w/v) for a final concentration hybrid of 6.5% w/v (Figure 8-1C). Hereafter, this gel is termed FPG-
Hybrid. Both the coassembled bioink and the FPG-Hybrid bioink were observed to present self-
supporting gel-like morphologies at 20°C, remaining stable even once inverted (Supplementary 
Figure S - 8). Contrastingly, LM-GelMA did not demonstrate noticeable gel-like properties at this 
temperature and subsequently was found to flow to the bottom upon tube inversion (Supplementary 
Figure S - 8). All bioinks were observed to be clear upon assembly. 
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Figure 8-1 – Schematic showing hydrogel assembly  (A) Chemical structure of Fmoc-FRGDF and Fmoc-
PHSRN, (B) Schematic detailing gelatin modification with methacryloyl groups to produce gelatin 
methacryloyl. (C) Schematic representation of assembly mechanisms showing self -assembly of Fmoc-SAPs into 
fibrils in the presence of gelatin methacryloyl before subsequent photo-crosslinking of the network.  
  
197 
 
8.3.2 Visualisation of Assembled Structures and Network Architecture 
 
Underlying structural and network morphologies of the developed bioinks were visualised using TEM, 
CryoSEM and SAXS.  
8.3.2.1 Transmission Electron Microscopy  
 
TEM provided insight into the nanoscale structures present in each bioinks (Figure 8-2A-C). The 
coassembled bioink was observed to possess fibrillar structures as is characteristic with this type of 
assembly.314 These fibrillar structures were not evident in LM-GelMA samples, instead aggregates were 
observed. The hybrid bioink containing both Fmoc-FRGDF/Fmoc-PHSRN and LM-GelMA 
demonstrated fibrillar structures comparable to those seen in the coassembled sample alone. Fibril 
diameter was quantified using Image-J analysis for coassembled and hybrid samples. An average fibril 
diameter of 15.06 nm (σ = 0.22 nm) was observed for coassembled samples while the hybrid sample 
was shown to have slightly smaller fibrils of 13.12 nm (σ = 1.00).  Despite a slight decrease in fibril 
diameter in hybrid samples, both were shown to maintain fibril formation.  
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Figure 8-2 – Network Morphology  (A-C) TEM analysis of material nanostructure Scale bar (200 nm), (D-F) 
CryoSEM Analysis of network microstructure before UV exposure, and (G-I) CryoSEM analysis of network 
microstructure following UV exposure. From left to right: Coassembled Fmoc -FRGDF/Fmoc-PHSRN, LM-
GelMA, and FPG-Hybrid samples. Scale bar (100 µm) 
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8.3.2.2 Cryo-Scanning Electron Microscopy 
 
The investigation into network microstructure was observed through CryoSEM, allowing for sample 
network topology to be investigated with minimal compromise to structures. As ice templating effects 
could corrupt results, care was taken to avoid crystallised ice formation. Specifically, samples were 
plunge frozen in liquid nitrogen before being fractured and sublimated; this technique is routinely used 
within the RMMF labs. In each sample, network morphology was analysed before and after subjection 
to UV irradiation (Figure 8-2D-I). The coassembled bioink demonstrated a chaotic fibrillar architecture 
both before and after UV subjection with no significant change in structure (Figure 8-2D, G). 
Contrastingly, LM-GelMA was observed to present as a jagged network before UV subjection (Figure 
8-2E) and transitions into a more ordered topology with a honeycomb-like structure following UV 
exposure (Figure 8-2H). Interestingly, the FPG-Hybrid sample appeared to contain both network 
morphologies before UV crosslinking, with nanofibrils and a jagged, LM-GelMA-like network both 
evident (Figure 8-2F). However, after UV exposure the network was found to become more ordered, 
following a similar trend to the crosslinked LM-GelMA sample (Figure 8-2I). These results suggest 
that the FPG-Hybrid sample possesses fibrillar structures owing to the presence of the SAP network 
and structural aspects relating to LM-GelMA addition. Importantly, the presence of LM-GelMA during 
self-assembly did not appear to influence fibril formation in the FPG-Hybrid. Furthermore, a significant 
structural change was evident in LM-GelMA containing samples upon subjection to UV irradiation, as 
generally observed in photo-crosslinkable samples. 
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8.3.3 Investigation of Assembled Structures and Mechanical Properties 
8.3.3.1 Small-Angle X-ray Scattering  
 
To verify structural observations made in TEM and CryoSEM analysis, SAXS was employed. 
Scattering curves were obtained for all samples and used to investigate nanostructural changes (Figure 
8-3A). Coassembled Fmoc-FRGDF/Fmoc-PHSRN has previously been shown to form cylindrical 
structures, such as fibres, as indicated through q-4 shifting to a q-1 dependence at low q range and a 
comparable trend was observed in this instance.314 Despite indications of fibrillar structures in FPG-
Hybrid TEM analysis, LM-GelMA containing samples did not sufficiently satisfy a cylindrical model 
and therefore were fitted using shape independent models.  
 
Figure 8-3 – Analysis of material nanostructure (A) SAXS curves of Fmoc-FRGDF/Fmoc-PHSRN, LM-
GelMA, and FPG-Hybrid Samples (B) Resultant probability of average fibril radius modelled using P(r) 
function (SASView) 
Calculation of Average Fibril Diameter 
 
IFT analysis was performed on the coassembled sample to calculate average fibril radius via application 
of the P(r) function (SASview) (Figure 8-3B). TEM analysis indicated fibril length lies outside of the 
q range, and therefore, the value resulting in the maximum P(r) intensity was attributed to fibril radius. 
Analysis of P(r) fitting indicated average fibril diameter of 15.0 nm (r = 75.2 Å) for the 5 mg/mL 
coassembled sample. Analysis of average fibril diameter was in agreeance with previous studies 314 and 
observations made during TEM analysis.  
Considering LM-GelMA containing samples did not sufficiently satisfy a cylinder model, shape 
independent analysis was performed on both crosslinked and non-crosslinked samples. Analysis of 
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scattering power or mass fractal dimension was calculated for each LM-GelMA containing sample 
before and after crosslinking (Supplementary Figure S - 9). 
Determination of Mass Fractal Dimension 
 
The linear region of scattering plots on a log-log scale was used to calculate mass fractal dimension, dm, 
which quantifies self-similar organizations over a range of length scales, and consequently offered 
insight into polymer structure and conformation.313 The mass fractal dimension can be described by 
Equation 7-1. (See Section 7.3.1 for more detail) 
Analysis of mass fractal dimension for each LM-GelMA containing sample across mid q range 
(0.05 – 0.2 nm-1, Supplementary Figure S - 9A) revealed a relatively low value for non-crosslinked 
LM-GelMA of 1.797 (± <1%). Upon subjection to UV irradiation, the mass fractal dimension is found 
to increase to 2.123 (± <1%), as is expected with covalently crosslinked systems. In comparison, the 
FPG-Hybrid sample demonstrated an initial mass fractal dimension of 2.089 (± <1%) before 
crosslinking, and this increased to 2.253 (± <1%) following UV exposure. These results indicated that 
all systems demonstrate an increase in polymer conformation complexity toward branched systems as 
is characteristic of similar gelatin-based crosslinking systems.312 Importantly, polymers in the FPG-
Hybrid system are initially branched to a greater degree, and upon UV subjection, retain their ability to 
crosslink further through the formation of covalent bonds, resulting in polymer conformations of greater 
complexity, likely due to the presence of nanostructured SAP fibrils. 
Determination of Correlation Length 
 
The correlation length of LM-GelMA and FPG-Hybrid samples was determined across the mid-low q 
range (Supplementary Figure S - 9B) using the correlation length model as described in Equation 
7-2. (See Section 7.3.1 for more detail) 
Correlation length provides a reasonable estimate of average entanglement length for semi-
dilute polymer solutions.311 Non-crosslinked LM-GelMA demonstrates the lowest correlation length of 
all samples, exhibiting a correlation length (ξ) of 4.07 nm (± <1%). Upon photo-crosslinking of LM-
GelMA, the correlation length was found to increase to 5.91 nm (± 1%). The FPG-Hybrid sample 
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demonstrated an initial correlation length of 8.31 nm (± 1.9%) before crosslinking, and shifted to 7.52 
nm (± 1.9%) in crosslinked samples; interestingly, this trend appears to be in agreeance with similar 
gelatin-based crosslinking investigations, wherein correlation length was found to decrease upon 
crosslinking. 312 This is likely due to increased network densification upon crosslinking, resulting in the 
formation of new junctions and subsequently, a decrease in correlation length. 383 A possible explanation 
for the alternate trend experienced by LM-GelMA alone can be provided by Lindemann et al. wherein 
it was reported that more reactive crosslinkers increased correlation length. 384 Despite both samples in 
this study using the same crosslinker and crosslinking concentration, LM-GelMA experienced a more 
considerable change in mass fractal dimension, and subsequently, demonstrated a greater structural 
change over the same crosslinking time.  
The Porod exponent, m, provides insight into polymer conformational changes in a similar way 
to the mass fractal dimension. Here, the Porod Exponent ranged from 2.04 to 2.28, comparable with 
similar assemblies.312 Once again, Porod exponent was found to increase with covalent crosslinking, 
reinforcing observations made through mass fractal dimension calculation (Supplementary Table S - 
4). 
Determination of Mesh Size 
 
Determination of mesh size provides insight into interpolymer relations (Supplementary Figure S - 
9C). The determination of mesh size can be described by Equation 7-3. (See Section 7.3.1 for more 
detail)  
Analysis of mesh size demonstrated a decrease upon crosslinking, from 13.64 nm (± 1.2%) to 
10.74 nm (± <1%) in LM-GelMA samples, and from 10.34 nm (± <1%) to 9.05 nm (± 1.2%) in FPG-
Hybrid samples (Figure S3C). These results are in agreeance with mass fractal dimension calculations 
and similar gelatin-based assemblies; wherein an increase in mass fractal dimension resulted in 
increased network formation and densification through the formation of covalent crosslinks. 
Consequently, this densification reduces the distance between polymers and results in reduced mesh 
size upon crosslinking. 312 
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Assembly mechanisms were further confirmed through CD, FT-IR, and fluorescence 
spectroscopy. Data demonstrated a maintenance of π-β assemblies in coassembled and FPG-Hybrid 
samples as are characteristic of Fmoc-systems, however spectra were heavily influenced by GelMA 
interactions (Supplementary Figure S - 10). 
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8.3.4 Mechanical Characteristics 
8.3.4.1 Rheology - In Situ Crosslinking 
 
Oscillatory rheology was used to determine mechanical changes during in situ photo-crosslinking 
(Figure 8-4Ai). The UV source (365 nm, 4.5 mW cm-1) was turned on 1 minute after test 
commencement. As expected, the coassembled hydrogel demonstrated no significant change in 
modulus throughout UV exposure, exhibiting a storage modulus of ~20kPa. Contrastingly, a notable 
change in storage modulus was observed in both the FPG-Hybrid sample and in LM-GelMA alone, 
increasing significantly upon UV subjection. LM- GelMA demonstrated an initial G’ of ~0.1Pa and this 
increased to 0.49 kPa. Similarly, the FPG-Hybrid sample increased substantially upon UV exposure, 
from G’ 220 Pa to 5 kPa.  Typical hydrogels demonstrate a storage modulus of greater magnitude than 
their corresponding loss modulus; as such, both SAP-containing samples were found to present as stable 
hydrogels before UV subjection in accordance with macroscopic observations. After UV subjection, all 
three samples were found to demonstrate typical hydrogel viscoelastic properties with storage modulus 
greater than loss modulus.  
Analysis of G’ rate of change can be used to indicate sufficient crosslinking (Supplementary 
Figure S - 11A). In this study, crosslinking completion was defined as the point where G’ rate of change 
fell below 0.1% s-1. LM-GelMA required the longest time to reach crosslinking completion, requiring 
~8.4 minutes of UV subjection (9.4 minutes of testing). Alternatively, the FPG-Hybrid material required 
only 7 minutes of UV exposure (8 minutes of the test) to reach a similar rate. A possible explanation 
for LM-GelMA hydrogels requiring more crosslinking time to reach a similar rate may be attributed to 
the requirement for more significant polymer conformation change, as indicated through SAXS mass 
fractal dimension calculations. A further contributing factor could be the magnitude of change each 
sample experiences, with LM-GelMA samples experiencing a change of approximately three orders of 
magnitude compared to the FPG-Hybrid hydrogel which only experienced a change of one order of 
magnitude. For all subsequent tests, both samples were subject to UV crosslinking for 500 seconds to 
maintain consistency. 
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Figure 8-4 – Analysis of material viscoelastic properties (A) Rheological Analysis of i) In situ Crosslinking 
and ii) post-crosslinking material resistance to shear strain.  
 
8.3.4.2 Rheology - Effect of Shear Strain 
 
Fmoc-SAPs’ propensity to swell coupled with their inability to undergo rapid gelation after shear 
thinning, resulting in poor shape fidelity, has rendered these peptides ineffective for bioink development 
to date (Supplementary Figure S - 11C). Therefore, SAP-incorporating bioinks which can withstand 
increased shear-strain post-printing would be of substantial benefit to bioprinting applications.  
Oscillatory rheology was employed to investigate hydrogel response to shear-strain following 
UV exposure for all samples. Samples were subjected to an amplitude sweep from 0.1% shear strain to 
1000% shear strain, and the point of modulus crossover (where G’ falls below G”) was recorded (Figure 
8-4A ii). As expected, the coassembled sample performed relatively poorly, undergoing a gel-sol 
transition at 1.15% shear strain. This relatively poor resistance to shear-strain is likely due to a lack of 
covalent bonds in this system. Alternatively, the LM-GelMA sample demonstrated significantly greater 
resistance to shear strain, with a crossover of modulus occurring around 450% shear-strain. Interesting, 
the FPG-Hybrid system demonstrated the greatest resistance to shear strain, as indicated by a crossover 
of modulus occurring at approximately 605% shear-strain. The enhanced ability to resist shear strain in 
the FPG-Hybrid system indicates the hydrogel is acting as a composite system wherein the nanofibrils 
aid in resisting shear forces when placed in the environment of the well-ordered LM-GelMA network. 
  
206 
 
8.3.5 Investigation of Bioink Printability 
 
Sample printability was investigated to determine the potential of formulated gels as bioink candidates. 
Initially, a temperature sweep was performed to determine temperatures which may provide suitable 
printability properties. Here, determination of suitable printability properties focused primarily on 
extrudability and shape integrity while maintaining relatively low-pressure printing conditions (> 69 
kPa) which is necessary for cellular viability.385 The thermal dependence of material viscoelastic 
properties were assessed, and material printability was determined through the printing of a dual-layer 
grid of length 1cm, strut spacing 2.5 mm and 22G needle size (Figure 8-5A). 
8.3.5.1 Viscoelastic Properties – Rheological Temperature Sweep 
 
Oscillatory rheology was selected to investigate material thermo-dependent viscoelastic properties 
(Figure 8-5B). A temperature ramp was selected starting at 37°C and cooling to 4°C. Storage and loss 
moduli was again monitored for each material, and loss tangent (tan δ) was calculated as G”/G’ (Figure 
8-5B, C). Despite some increase in stiffness upon cooling, the loss tangent of the coassembled system 
remained constant at approximately 0.3. The coassembled sample demonstrated the stiffest storage 
moduli of ~87kPa approaching 4°C. Contrastingly, LM-GelMA exhibited a significant decrease in loss 
tangent upon cooling, from < 1 to approximately 0.01, with an abrupt transition evident near 17°C. LM-
GelMA also exhibited the lowest storage modulus ranging from < 1 Pa to approximately 2 kPa upon 
cooling to 4°C, with no noticeable change evident between 37°C and 18°C. Interestingly, the FPG-
Hybrid was again found to be a compromise between LM-GelMA and the coassembled sample alone. 
A thermal dependence was evident with a notable sudden increase in material stiffness at approximately 
17°C. FPG-Hybrid material storage modulus was found to increase from 650 Pa (37°C) to 24kPa (4°C) 
following cooling. Interestingly, loss tangent was found to remain relatively constant (tan δ = 0.4) up 
until approximately 17°C, after which it decreases to 0.1 at 4°C. Recently, a study by Gao and 
colleagues found loss tangent to be a critical factor influencing material extrudability, extrusion 
uniformity, and structural integrity; ultimately finding loss-tangent as a suitable measure for indicating 
material printability.386 In their landmark study, the authors report a loss tangent between 0.25 and 0.45 
provides an optimal printing window, allowing for suitable extrusion while maintaining good 
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uniformity and structural integrity.386 Importantly, the FPG-Hybrid material was found to exist within 
this range over a substantially large temperature range, from 37.0°C to 14.6°C. Contrastingly, LM-
GelMA only exists in this window very briefly from 16.2°C to 16.0°C, during which the gradient was 
critically steep and as a result variance with temperature is significant. Therefore, we anticipated the 
FPG-Hybrid material would print best near 15°C, allowing for the most robust modulus while still 
existing within the range of desired loss tangent. 
 
Figure 8-5 – Investigation into material printability  (A) Images of LM-GelMA (left column) and Hybrid 
(right column) printability through printing of grid (1cm in length) at 10°C, 15°C and 20°C, (B) Thermoelastic 
properties of non-crosslinked materials acquired through oscillatory rheology, (C) Loss tangent as a function 
of temperature. 
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8.3.5.2 Optimising Printability Through Temperature Control 
 
Printability tests were performed following characterisation of material thermo-responsive viscoelastic 
properties. All materials were printed at 10°C, 15°C, and 20°C to determine bioink potential (Figure 
8-5A). Following printing, the coassembled material was unable to maintain shape fidelity under any 
of the tested conditions and therefore was excluded from all subsequent tests (Supplementary Figure 
S - 11C). Alternatively, LM-GelMA demonstrated relatively good prints at 10°C following which 
material printability reduced as temperature increased (Figure 8-5A).  The FPG-Hybrid material was 
found to produce the best prints out of all the materials, with optimal printing occurring at 15°C (42 
kPa) (Figure 8-5A). The FPG-Hybrid material-maintained printability at 10°C, however, prints were 
found to be less uniform and required greater pressure (66 kPa), while at 20°C the FPG-Hybrid was 
observed to be ineffective at maintaining printed geometry (Figure 8-5A). These results echo previous 
findings using similar gelatin inspired blends.386 Hydrogel network is likely to be disrupted during the 
printing process which may alter mechanical properties; however, care was taken to ensure sufficient 
recovery such that a self-supported network is maintained. Despite this possible mechanical disruption, 
hydrogels were found to remain stable past 4 weeks of simulated culture (PBS, 37°C, Supplementary 
Figure S - 12). Further investigation is required to comprehensively analyse the effect of printing on 
resultant mechanical characteristics. 
8.3.6 Investigation of Cytocompatibility 
 
Cytocompatibility of the developed bioink and associated bioprinting process was determined through 
bioprinting of Primary Myoblast-containing bioinks under predetermined optimal conditions (10°C, 
~30 kPa for LM-GelMA, and 15°C, ~ 40 kPa for FPG-Hybrid). Grid-like structures were printed onto 
cooled plates and immediately crosslinked under UV light followed by immersion in proliferative 
media. Interestingly, the addition of cells was found to influence shape fidelity, with some grids 
demonstrating early erosion (Supplementary Figure S - 13). However, following initial erosion over 
~1h, constructs remained stable and robust over the course of cell-culture experiments (2-weeks). This 
observation indicates that cells may be interfering with the crosslinking process and therefore warrants 
further investigation into cell seeding density and optimisation of printing processes, however this lies 
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outside the scope of this thesis. A 2D control was also prepared through seeding of primary myoblasts 
onto tissue culture plastic. 
8.3.6.1 Viability 
 
Following 24h and 72h culture, samples were stained with Calcein AM (green) and ethidium 
homodimer (red) to determine the proportion of live and dead cells respectively (Figure 8-6A). Cells 
were imaged using fluorescence microscopy, and the number of live and dead cells were determined 
through ImageJ analysis. Following 24h, the 2D control demonstrated the highest viability (97.3%) 
while printed LM-GelMA, and FPG-Hybrid samples demonstrated significantly lower viabilities of 
86.7% (p = 0.0056) and 85.9% (p = 0.0032), respectively (Figure 8-6B i). However, following 72h 
culture, all samples demonstrated comparable viabilities (>98% viability for all samples) (Figure 8-6B 
ii), indicating that although the printing process results in an initial decrease of cell viability, both 
bioinks support cell proliferation following crosslinking. These results demonstrate the cytocompatible 
nature of both materials for myoblast bioprinting applications. 
 
Figure 8-6 – Representative-images of Live/Dead stain (A) LM-GelMA 24 h (B) FPG-Hybrid 24 h (D) LM-
GelMA 72 h (E) FPG-Hybrid 72 h. Viabilities of primary skeletal myoblasts on 2D control, or 3D -printed LM-
GelMA and FPG-Hybrid at (C) 24h and (F) 72 h. 
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8.3.6.2 Differentiation 
 
Following 7 days of differentiation, cells were observed to form aligned fibres. Cellular fusion was also 
observed resulting in the formation of multinucleated bundles. After 14 days of differentiation, most of 
the cells had migrated to the surface of the bioink (Figure 8-7) as seen in similar studies within our 
laboratories (unpublished data). Evidence of multinucleated myotube formation, combined with high 
cell viability, highlights the potential for mature muscle tissue formation using these bioinks. 
 
Figure 8-7 – Representative confocal images of 3D printed samples after 14 days of differentiation , 
majority of primary myoblasts are shown to migrate to sample surface and fuse to form multinucleated bundles. 
(A) LM-GelMA 3D Projection, (B) LM-GelMA surface, (C) FPG-Hybrid 3D Projection, (D) FPG-Hybrid 
surface. 
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Following confocal analysis, SEM analysis was performed to observe cell-material interactions. 
Grids were fixed with formalin and stained with osmium tetroxide, before being dried and gold-coated 
prior to analysis. Extensive myotube formation is evident in both samples (Figure 8-8A, B), moreover 
both samples support formation of myotube bundles (indicated by arrows) (Figure 8-8C, D), 
confirming the development of mature myotubes. 
 
Figure 8-8 – SEM analysis of myotube formation on A) LM-GelMA bioink, B)FPG-Hybrid bioink, 
C)myotube bundle formation on LM-GelMA bioink, and D) Myotube bundle formation on FPG-Hybrid bioink. 
Arrows showing cell myotube formation. Scalebar: Top:50 µm Bottom: 10  µm 
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8.4 Conclusion 
 
Advanced tissue development demands precise control over the deposition of cells and signals within a 
spatially defined 3D construct. However, currently, there is immense difficulty between recapitulating 
the biological complexities of the native ECM whilst simultaneously providing materials with 
mechanical properties required for cytocompatible printing (low temperature, physiological pH, low 
pressure). Precise control over the cell microenvironment is key for successful regulation of cell 
proliferation, differentiation, and migration, while high mechanical tunability allows for enhanced 
control over material printability and allows for control over mechanical cues experienced by cells. The 
design of specific cell attachment sites into SAPs and further incorporation into effective bioinks via 
melding with LM-GelMA is the focus of this chapter. Synergistic SAPs, Fmoc-FRGDF and Fmoc-
PHSRN, were coassembled and combined with LM-GelMA. The coexistence of peptide and 
macromolecule provides nano- through macroscale features and proves to be of benefit through the 
enhancement of bioprintability. Encapsulated primary myoblast proliferation and differentiation were 
supported with high cell viability throughout printing and culture. Materials were extensively 
characterised to determine mechanisms of assembly, resultant structures, and effect on printability, with 
resultant hybrid bioinks demonstrating fibrous morphology (fibril diameter 15 nm), photo-curing (8 
minutes), shape fidelity and longevity under culture conditions (over 4 weeks). GelMA-SAP hybrid 
bioinks demonstrate efficacy as a bioinks, future studies into the modularisation of GelMA-SAP hybrids 
to include alternative cell attachment motifs will be explored, as well as gene expression in differing 
materials.  
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Chapter Nine: 
 
 
 
9.  
NEURAL BIOINK 
 
9.1 Preview 
 
This final experimental chapter intends to demonstrate the versatility and efficacy of the developed 
bioink toolkit. Explicitly, this chapter incorporates an alternate SAP sequence, Fmoc-DIKVAV, 
containing the laminin cell attachment motif IKVAV. Once again, this Fmoc-SAP sequence is 
incorporated within a LM-GelMA blend to develop an advanced hybrid bioink blend. We investigate 
the ability of this toolkit to support neural-cell growth and differentiation through seeding of rat cortical 
neurospheres. We hypothesise that the hybrid bioink containing the IKVAV-sequence will demonstrate 
unique mechanical properties, with trends similar to those observed in the previous chapter. We 
anticipate that the hybrid bioink will enhance neural cell viability and morphology, supporting early 
cell maturation.  Material physical properties are extensively investigated through rheology, electron 
microscopy, small-angle X-ray scattering, and printability, while material bioactivity is assessed 
through analysis of cell viability and morphology. Results show highly similar mechanical properties 
to those observed in Chapter 8, while biologically, the material is found to promote rat cortical 
neurosphere viability, with noticeable differences in cell morphology between the hybrid material and 
the LM-GelMA control. 
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Abstract 
The intrinsic limitation of the central nervous system to self-repair presents substantial difficulty in the 
field of tissue engineering. Bioprinting offers a potential avenue for enhanced tissue regeneration; 
however, the intricate balance between material printability and biological functionality has yielded few 
suitable bioinks. This balance is particularly precarious in neural tissue bioprinting applications, where 
cells necessitate soft biomaterials, yet extrusion printing processes generally benefit from materials of 
higher viscosity. Therefore, the development of a bioink which presents high mechanical tunability and 
is highly decorated with bioactive cell-specific motifs would be of substantial advance to the field. 
Fmoc-SAPs have been widely used in tissue engineering applications, with particular success in neural 
tissue engineering. However, these materials lack permanent bonds resulting in swelling and eventual 
dissociation in media. Alternatively, a gold-standard material in bioprinting applications, GelMA, is 
highly mechanically tuneable, yet lacks ease of biological tunability. Here, we combine these two 
materials to develop a hybrid bioink which draws on favourable properties from both materials, 
enabling high mechanical and biological tunability. Mechanical properties of bioinks are assessed 
regarding nano through to macromorphology, viscoelastic properties, and printability (as assessed 
through ability to print grid-like constructs); while biological properties are investigated through 
analysis of seeded and encapsulated rat cortical neurosphere viability and morphology. Results show 
enhanced printability and ability to support rat cortical neurospheres. Importantly, this chapter confirms 
the efficacy of the developed bioink toolkit and highlights its promise for bioprinting applications. 
  
216 
 
9.2 Introduction 
 
Central Nervous System  (CNS) repair presents a substantial challenge to tissue engineering 
applications owing to the inherently limited ability of self-repair in these tissues.387 Currently, disorders 
of the nervous system are estimated to affect over a billion people worldwide, with the prevalence only 
increasing owing in part to the increasing aging population.388-389 There are limited treatment options 
for many of these conditions, with some treatments only providing systematic relief.390 Cell therapy 
through the introduction of stem cells to damaged tissue has been proposed as a potential avenue for 
neural tissue regeneration,390 however cells alone do not provide an adequate environment conduce to 
functional tissue regeneration, with recent neural tissue engineering approaches focusing on the 
inclusion of biomimetic scaffolds to encapsulate cells and provide biochemical and mechanical cues 
required for controlling cell fate and driving tissue regeneration.391 Despite this, the difficulty remains 
in controlling material architecture and developing printed constructs with a high degree of control over 
3D shape. 392 
Bioprinting offers unique advantages to tissue engineering applications, allowing for the 
deposition of cells, structure and signals within a highly controlled 3D organisation.160 Furthermore, 
effective bioinks used in bioprinting applications help shield cells from shear stress encountered in 
printing processes, and allow for cell migration, proliferation, differentiation and eventual tissue 
regeneration.11, 188 Despite the potential offered by bioprinting in neural tissue engineering applications, 
the field is still critically limited in ability to form soft, biocompatible bioinks which maintain good 
printability while providing signals to cells spatially and temporally.11 Therefore, the development of 
new bioinks using novel materials would be of substantial benefit to neural tissue engineering 
applications.  
GelMA-based bioinks have been extensively used in bioprinting applications and have seen 
substantial success in vasculature, muscular and cartilage engineering applications.68, 216, 393-396 
Developed through the modification of gelatin with functional methacryloyl groups, GelMA presents 
unique advantageous over conventional gelatin for bioprinting applications.356 Particularly, GelMA 
allows control over DoF enabling a high degree of mechanical tunability both pre and post-crosslinking, 
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enabling enhanced mechanotransduction.377-378 Furthermore, GelMA retains collagens RGD attachment 
motif, allowing for cell attachment through integrin binding, and subsequently allowing for targeted 
cell adhesion.366 However, GelMA is restricted in its ability to target other cell domains; with recent 
bioprinting approaches incorporating additional biological functionalisation to drive neural cell 
differentiation with limited success.397 GelMA is also limited in ability to engineer specific nano-
/microarchitectures, with recent efforts to engineer nanofibrous morphologies relying on the use of 
external deposition techniques such as electrospinning.376 Therefore, combining GelMA with a highly 
nanostructured and biologically tuneable material may promote the development of a truly advanced 
bioink. 
Self-Assembled peptides have recently found substantial success in bioprinting applications.189-
191, 200, 398-400  These materials are characteristic in their ability to form useful hierarchical structures from 
small building blocks and boast high water content (~99%), ease of sequence customisation, and high 
similarity to biological structures.7, 128 Fmoc-SAPs are a subclass of SAPs which take advantage of π-π 
stacking between aromatic Fmoc groups, allowing for the development of short, SAP building blocks 
of smaller length than conventional SAPs. 8-9  This enables more straightforward modification of peptide 
sequence and ultimately facilitates easier mechanical and biological tuning. 9 Fmoc-DIKVAV is an 
ECM inspired peptide which self-assembles through π- β assembly to form long biomimetic nanofibrils 
decorated with the laminin epitope IKVAV.140  Despite Fmoc-DIKVAV’s success in neural tissue 
engineering applications,141, 380 similar achievements have not yet been attained in neural bioprinting 
applications, owing in part to the poor shear resistance of Fmoc-SAPs (See Section 8.3.4.2). Therefore, 
the combination of this material with a covalently crosslinkable material may alleviate the associated 
shortcomings of this material; increasing SAP versatility in bioprinting applications. 
In this chapter, a hybrid bioink is developed through the furthering of understandings gained in 
Chapter 8. Specifically, LM-GelMA is combined with Fmoc-DIKVAV during the assembly process 
to yield a hybrid material which draws from aspects of both bioinks. The hybrid material demonstrates 
enhanced printability as observed via rheology and printability tests with unique thermal dependent 
characteristics. Nanofibrils are present in the hybrid as observed via TEM and CryoSEM analysis. 
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Material conformational changes are also monitored via SAXS before cytocompatibility is investigated 
through seeding and bioprinting of rat cortical neurospheres. Our results show the efficacy of this bioink 
toolkit for neural tissue engineering applications and highlight the potential of this bioink system as a 
modular, tissue-specific toolkit. 
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9.3 Results and Discussion 
9.3.1 Formation of Bioinks 
 
Three peptide-based bioinks were developed. Firstly, a laminin-inspired Fmoc-SAP (Fmoc-DIKVAV), 
replete with a neurologically important attachment motif, IKVAV, was self-assembled under 
physiological conditions (pH 7.4) via a pH switch method.140 A second bioink was developed through 
low-degree (18%) methacrylation of gelatin to LM-GelMA. LM-GelMA can undergo photo-
crosslinking once subjected to UV irradiation in the presence of a photoinitiator, which allows for 
controlled and triggered gelation post-printing. A third bioink was developed through the incorporation 
of LM-GelMA during Fmoc-DIKVAV self-assembly. This hybrid material demonstrates properties 
owing to both materials, namely, the ability to present tuneable and biologically recognisable sequences 
(through peptide self-assembly); and the potential for photo-crosslinking via UV exposure. Here forth, 
we term this bioink DIKVAV-Hybrid. 
Hydrogelation of Fmoc-DIKVAV resulted in the rapid (<2h) formation of an opaque gel which 
was stable following inversion (Supplementary Figure S - 14). Contrastingly, LM-GelMA resulted 
in the formation of a clear solution which presented as a gel at 4°C and as a fluidic solution at room 
temperature (23°C, Supplementary Figure S - 14). Finally, gelation of DIKVAV-Hybrid containing 
both Fmoc-DIKVAV and LM-GelMA resulted in the formation of an opaque gel at room temperature 
(Supplementary Figure S - 14).  
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Figure 9-1 – Schematic of hydrogel assembly (A) Chemical structure of i) Fmoc-DIKVAV and ii) GelMA (B) 
Schematic representation of assembly mechanisms showing self -assembly of Fmoc-SAPs into fibrils in the 
presence of gelatin methacryloyl before subsequent photo-crosslinking of the network.  
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9.3.2 Investigation of bioink Micro-/nano-architecture 
9.3.2.1 Fibril Topology Observed via TEM 
 
To verify the structural morphology of the underlying assemblies and networks, a series of material 
characterisation techniques were performed. TEM showed the nanoscale structures formed for each 
material before photo-crosslinking (Figure 9-2A-C). The self-assembly of Fmoc-SAPs into nanofibers 
is found to be maintained in the Fmoc-DIKVAV sample (Figure 9-2A) with nanofiber morphology 
similar to previous investigations.140Alternatively, no fibrous morphology was evident in LM-GelMA 
samples (Figure 9-2B), rather material aggregates are observed throughout the sample. DIKVAV-
Hybrid bioinks formed fibrous structures similar to those evident in Fmoc-DIKVAV samples alone. As 
these fibrils are not evident in LM-GelMA samples, they can be attributed to the self-assembly of Fmoc-
DIKVAV within the LM-GelMA environment, demonstrating maintenance of self-organisation in the 
DIKVAV-Hybrid bioink (Figure 9-2C). Unfortunately, the requirement for TEM samples to be diluted 
before imaging limited their ability to image photo-crosslinked samples.  ImageJ analysis of fibril 
diameter found 11.1 nm (σ = 0.209) and 11.0 nm (σ = 0.213) for Fmoc-DIKVAV alone and DIKVAV-
Hybrid samples respectively. 
9.3.2.2 Network Morphology Assessed via CryoSEM 
 
CryoSEM shows the hydrated microscale structure of materials before and after subjection to UV 
irradiation (Figure 9-2D-I). Here, both photo-crosslinked and non-crosslinked samples are investigated 
in a hydrated state without dilution. CryoSEM analysis of Fmoc-DIKVAV bioinks shows a highly 
fibrous network both before and after subjection to UV irradiation (Figure 9-2D, G). LM-GelMA is 
found to have a highly porous structure before UV exposure (Figure 9-2E); this structure is generally 
maintained after photo-crosslinking, with some slight observable differences in perceived pore size and 
network order (Figure 9-2H). DIKVAV-Hybrid demonstrates a network morphology which is highly 
similar to that of LM-GelMA both before and after UV exposure (Figure 9-2F, I). Fibre-like structures 
are observed within pores in both LM-GelMA and DIKVAV-Hybrid samples, however, despite a 
perceived increase in fibre number within the DIKVAV-Hybrid bioink; this cannot be solely attributed 
to the presence of Fmoc-DIKVAV without further quantification. Interestingly in respect to the 
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DIKVAV-Hybrid, the overarching nanoscale structure as observed in TEM analysis can be attributed 
to the presence of Fmoc-DIKVAV, while through CryoSEM analysis, the predominant 
microarchitecture and network orientation are reminiscent of that seen in LM-GelMA. 
 
Figure 9-2 – Observation of hydrogel network morphology  (A-C) TEM analysis of material nanostructure 
Scale bar (100 nm), (D-F) CryoSEM Analysis of network microstructure before UV exposure, and (G-I) 
CryoSEM analysis of network microstructure following UV exposure. From left to right: Coassembled Fmoc -
FRGDF/Fmoc-PHSRN, LM-GelMA, and FPG-Hybrid samples. Scale bar (10 µm) 
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SAXS curves were obtained for all samples and used to assess nanostructural differences between 
bioink samples. Fmoc-DIKVAV curves supported the cylindrical nature of the nanofibrils as scattering 
curves provided a q-1 dependence at low q indicating elongated cylindrical structures (Figure 9-3A). 
Alternatively, crosslinked and non-crosslinked LM-GelMA and LM-GelMA/DIKVAV bioinks did not 
sufficiently satisfy the cylindrical model; therefore, these samples were fitted to shape independent 
models.  
IFT analysis was performed on Fmoc-DIKVAV scattering curves to determine probable radius 
through the implementation of the P(r) function (SASview) (Figure 9-3B). TEM observations showed 
fibril length was outside the q range of SAXS analysis and therefore our focus was attuned to the 
determination of average fibril radius. As the fibrillar nature of Fmoc-DIKVAV bioinks has been 
confirmed via TEM and CryoSEM analysis, the maximum P(r) value acquired during IFT calculations 
was attributed to an average fibril radius. These calculations indicate average fibril diameters of 11.1 
nm (r = 55.7 Å) for 5 mg/mL Fmoc-DIKAV, supporting observations gained through similar assemblies 
of higher concentration.140 SAXS analysis of nanofibrous Fmoc-DIKAV radius is in accordance with 
TEM observations.  
Crosslinked and non-crosslinked conditions were investigated for LM-GelMA and DIKVAV-
hybrid bioinks. As scattering curves did not adequately fit a cylindrical model, curves were fitted to 
shape independent models. Bioinks were analysed with respect to mass fractal dimension (Figure 
9-3C); providing insight into local polymer configuration313. The mass fractal dimension was 
determined for LM-GelMA and DIKVAV-Hybrid bioinks over a mid q range (Figure 9-3C) and is 
described by Equation 7-1. (See Section 7.3.1 for more detail) 
Calculation of mass fractal dimension for LM-GelMA and DIKVAV-Hybrid samples revealed 
a low value of 1.74 (± <1%) for LM-GelMA prior to crosslinking, increasing to 2.01 (± <1%) for 
crosslinked LM-GelMA. Similarly, DIKVAV-Hybrid demonstrated a comparable trend, demonstrating 
a dm of 2.02 (± <1%) and 2.21 (± <1%) for non-crosslinked and crosslinked conditions respectively.  
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Assembly mechanisms were also investigated via CD and FT-IR spectroscopy, however, in 
both cases, material proprieties were dominated by GelMA related peaks (Supplementary Figure S - 
15). 
 
Figure 9-3 – Investigation of hydrogel nanostructure and viscoelastic properties  (A) SAXS curves of Fmoc-
DIKVAV, LM-GelMA, and DIKVAV-Hybrid Samples (B) Resultant probability of average fibril radius 
modelled using P(r) function (SASView), (C) Fitting through power law model (SASVIEW) (D) Rheological 
Analysis of i) In situ Crosslinking and ii) post-crosslinking material resistance to shear strain.  
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Rheological analysis provides insight into material viscoelastic properties. (Figure 9-3D) 
Parallel-plate oscillatory rheology was employed to analyse change in material viscoelastic properties 
during in situ crosslinking. Briefly, materials were loaded into the rheometer (37°C) and analysed for 1 
minute at a constant shear rate (0.1%) before UV activation; this allowed materials to reach stable 
viscoelastic characteristics before subjection to crosslinking. After 1 minute, UV radiation was activated 
at 4.5 mW/cm-2 and remained activated until completion of analysis (10 minutes). As expected, Fmoc-
DIKVAV demonstrated a storage modulus of ~20kPA and did not demonstrate any significant increase 
in stiffness after UV exposure. Alternatively, LM-GelMA bioinks demonstrated a significant increase 
upon UV exposure, with storage modulus increasing from ~0.04 kPA to ~1 kPA. DIKVAV-Hybrid 
samples increased in storage modulus by an order of magnitude upon UV exposure, from an initial 
storage modulus of ~0.8 kPA before UV exposure to ~10 kPA post-crosslinking. This increase in 
stiffness confirms maintenance of photo-crosslinking in the DIKVAV-Hybrid sample. 
Analysis of G’ rate of change was once again used to determine the point of crosslinking 
completion and was defined as the point where G’ rate of change dropped below 0.1% s-1. Similar to 
observations made in FPG-Hybrid analysis, LM-GelMA required the longest time to reach crosslinking 
completion, requiring approximately 8.2 minutes of crosslinking (9.2 minutes into testing). 
Alternatively, DIKVAV-Hybrid required approximately 6.7 minutes of crosslinking to reach 
completion (7.7 minutes into testing). To maintain consistency between bioink toolkits, 500 seconds 
(8.33 minutes) at 4.5 mW cm-2 was once again selected for all samples in subsequent crosslinked 
experiments (Supplementary Figure S - 16A). 
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9.3.3 Material Printability and Thermoresponsive Viscoelasticity 
 
Thermoresponsive viscoelastic properties were tested for each bioink using parallel-plate rheology 
(Figure 9-4A). Here, a temperature sweep was performed on samples starting at an initial temperature 
of 37°C and sweeping at a constant rate to 4°C. Fmoc-DIKVAV did not demonstrate a significant 
increase in viscosity upon temperature change. Alternatively, LM-GelMA demonstrated a significant 
increase in viscosity as temperature decreased. DIKVAV-Hybrid samples presented as a hydrogel at all 
tested temperatures, as indicated by a storage modulus of greater magnitude than loss modulus; and 
demonstrated a more gradual and controlled increase in stiffness as temperature decreased. The stiffness 
of DIKVAV-Hybrid samples (5.7 kPa at 4°C) was also observed to be greater than that of LM-GelMA 
alone (~1.9 kPa at 4°C), here it is likely that the peptide fibrils act as a composite system, exaggerating 
entanglements and resulting in enhanced stiffness increase.  
The loss tangent can be calculated as G”/G’ and provides insight into material state. Recently, 
a landmark study by Gao et al. found that a loss tangent within the window of 0.25 and 0.45 provides 
optimal printability.386  The loss tangent was determined for each material between 4°C and 37°C 
(Figure 9-4B). Despite Fmoc-DIKVAV eliciting a loss tangent bordering this window (δ ≈ 0.25) for 
all tested temperatures, printability is likely to be reduced as demonstrated in the previous chapter 
(Chapter 8), as Fmoc-DIKVAV alone provides very little resistance to shear stress (Figure 9-3D). 
Contrastingly, LM-GelMA bioinks elicit a very steep change in loss tangent at the point of sol/gel 
transition; as a result, this bioink would be difficult to maintain within this window, with slight 
temperature fluctuations greatly effecting material printability and required printing pressures. 
DIKVAV-Hybrid bioinks provide a compromise between both bioink samples, and as a result, provide 
a flatter slope compared to LM-GelMA alone. This DIKVAV-Hybrid bioink remains in this window 
from approximately 17°C to 20°C, and therefore, provides a larger temperature range to maintain good 
printability. This coupled with the bioinks ability to form covalent crosslinks and resist strain forces 
highlights its efficacy in bioprinting applications. 
To further investigate material printability, all three bioinks (Fmoc-DIKVAV, LM-GelMA, and 
DIKVAV-Hybrid) were placed into 3 mL cartridges for printability tests. Three temperatures were 
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investigated for bioprinting as determined most suitable from analysis of thermodependent viscoelastic 
trends. Specifically, 10°C, 15°C and 23°C (room temp) were selected as printing temperatures and 
cartridge temperature was verified using a thermal imaging infrared camera (FLIR, Extech*). Fmoc-
DIKVAV alone was unable to hold its shape after printing, even at the lowest temperature, resulting in 
the formation of large ‘pools’ of solution (Figure 9-4C i), and therefore, was excluded from further 
printability tests. Alternatively, LM-GelMA demonstrated good printability at 10°C (Figure 9-4C ii) 
in accordance to findings in the previous chapter (Chapter 8), Material printability was substantially 
worse in the 15°C LM-GelMA and 23°C LM-GelMA samples (Supplementary Figure S - 16C). This 
observation is in agreeance with rheological data, which indicates a steep and rapid increase in loss 
tangent coupled with decreasing viscosity at these temperatures (Figure 9-3D). The DIKVAV-Hybrid 
bioink maintained the potential to print at 10°C; however, the print demonstrated relatively poor shape 
fidelity (Supplementary Figure S - 16D). Upon increasing the temperature to 15°C, the material 
demonstrated optimal printing conditions, resulting in the greatest maintenance of shape fidelity out of 
all the samples (Figure 9-4C iii). Further increasing the temperature to 20°C drastically reduced the 
materials ability to maintain suitable shape fidelity, likely due to diminishing storage moduli at this 
temperature (Supplementary Figure S - 16C). Constructs printed at optimal temperatures for each 
bioink are displayed in (Figure 9-4C). DIKVAV-Hybrid at 15°C demonstrated enhanced printability 
compared to both LM-GelMA and Fmoc-DIKVAV, however, required slightly increased pressure 
(~50kPA). Both LM-GelMA and DIKVAV-Hybrid demonstrated the ability to form 3D grids 
consisting of multiple layers with both bioinks capable of holding consistent shape fidelity during 
printing and following crosslinking. Our results echo the findings of Gao et al.,386 and further reinforce 
observations gained in the previous chapter (Chapter 8) where similar hybrid assemblies containing 
LM-GelMA demonstrated optimal printability at 15°C, while LM-GelMA alone printed best at 10°C. 
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Figure 9-4 – Investigation into material printability  (A) Thermoelastic properties of non-crosslinked 
materials acquired through oscillatory rheology, (B) Loss tangent as a function of temperature, (C) Images of 
Optimal material printability through printing of i) Fmoc -DIKVAV (10°C), ii) LM-GelMA (10°C), and iii) 
DIKVAV Hybrid (15°C). 
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Print geometries of differing strut spacings were designed to test the ability of the developed 
bioink further. Here, three grids are designed; the first incorporates 2.5 mm strut spacing, the second 
reduces this to 1.5 mm, and finally, the third reduces this distance further to 1 mm. (Figure 9-5) The 
reduction in gap allows for analysis of material regularity as a further test of material printability. Here 
a 25G (260 µm) nozzle was used. To investigate the effectiveness of geometry alteration, grid types are 
printed and crosslinked for 500 seconds before being cultured under simulated conditions (PBS, 37°C 
incubation) for 4 weeks. In all cases, the DIKVAV-Hybrid material printed well, producing complete 
multi-layer grids with consistent strut spacing and thickness (Figure 9-5). Furthermore, all geometries 
were found to swell following 10 minutes of simulated culture, resulting in a core region and a feathered 
fibrous outer region.  
Despite some loss of the feathered region following 9h culture, DIKVAV-Hybrid bioinks 
were found to remain stable over 4 weeks (Supplementary Figure S - 17), with the majority of swelling 
occurring in the first 10 minutes and no significant swelling evident at later time points. 
 
Figure 9-5 – Images of Print Geometries (i) before PBS addition, (ii) immediately following PBS addition, 
(iii) 10 minutes following PBS addition, and (iv) 1 hour following PBS addition for prints of (A) 2.5  mm strut 
spacings, (B) 1.5 mm Strut Spacings, and (C) 1 mm strut spacings. Scalebar 2000 µm (ii) and 400 µm (iii, iv) 
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Further analysis was completed to determine the nature of the feathered and core region. FITC 
fluorescently-labelled GelMA was added during bioink synthesis to distinguish GelMA regions. Gels 
were once again printed as before, and strut morphology analysed under fluorescence microscopy. Here, 
a clear localisation of GelMA to printed strut-cores was observed. Therefore, the feathered region is 
likely to be SAP fibrils presented on the surface, as is confirmed through GelMA isolation in strut core. 
(Figure 9-6) 
 
Figure 9-6 – Analysis of GelMA regions within DIKVAV-Hybrid bioink A) Image centred on printed strut 
i) Brightfield image, ii) Fluorescence overlayed on brightfield; B) Image centred on printed gap showing bioink 
feathered region i) Brightfield image, ii) Fluorescence overlayed on brightfield.  
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9.3.4 In Vitro Analysis of Developed Bioinks using Rat Cortical Neurospheres 
 
Material cytocompatibility was investigated in vitro using rat cortical neurospheres (Figure 9-7).  
Initially, cytocompatibility was investigated through seeding of dissociated rat cortical neurospheres on 
cast DIKVAV-Hybrid samples and viability was compared to cells seeded on laminin, Fmoc-DIKVAV, 
and LM-GelMA samples (Figure 9-7A). Following 24h culture, all samples demonstrated similar cell 
viability, with no significant difference evident between samples (Figure 9-7C i). However, following 
48h culture, significantly lower cell viability (40.4%, p = 0.0022) is evident in Fmoc-DIKVAV 
compared to the laminin control (Figure 9-7C ii). This is likely a result of material dissociation due in 
part to the low peptide concentration.  Following 72h culture, the SAP Fmoc-DIKVAV shows 
significantly lower cell viability compared to the laminin control (51.5%, p = 0.0076) (Figure 9-7C iii). 
No significant difference is evident between laminin, GelMA, and DIKVAV-Hybrid samples. Cells 
seeded onto the laminin control demonstrated a significant increase in viability over 3 day’s in culture 
(Figure 9-7B). Despite there being no significant difference in cell viability between GelMA and 
DIKVAV-Hybrid samples, there is a difference in morphology; dissociated neurospheres formed 
clusters when placed onto the GelMA bioink (Figure 9-7A i), whilst dissociated neurospheres cultured 
on DIKVAV-Hybrid scaffolds produced cell extensions (indicated by arrows) and generally avoided 
clustering (Figure 9-7A ii).  
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Figure 9-7 – Preliminary hydrogel cytotoxicity tests  (a) Neurosphere morphology following 48h culture on 
(i) LM-GelMA, and (ii) DIKVAV-Hybrid (arrows show cell extensions) , (B) Viability of cells seeded onto 
laminin control, (C) Cell viability of seeded neurospheres at (i) 24h, (ii) 48h, (iii) 72h culture, and (D) viability 
of encapsulated neurospheres following (i) 24h, (ii) 48h, and (iii) 72h culture.  
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9.3.5 In Vitro Analysis of Printed Constructs. 
 
Cytocompatibility is the most imperative factor to consider for neural bioprinting applications, 
especially considering neural cells tend to be less tolerant to environmental stresses than many other 
cells types.401 Therefore, bioprinting approaches which promote high cell viability are of particular 
promise to neural regeneration applications. Cytocompatibility of the DIKVAV-Hybrid bioink and 
associated bioprinting process was determined via bioprinting of rat cortical neurosphere-containing 
bioinks under predetermined optimal conditions (10°C, ~30 kPa for LM-GelMA, and 15°C, ~ 40 kPa 
for DIKVAV-Hybrid). Grid-like structures were printed onto cooled plates and immediately crosslinked 
under UV light. A 2D control was also prepared through seeding of rat cortical neurospheres onto 
laminin-coated tissue culture plastic. 
9.3.5.1 Cell Viability 
 
Following 24h and 72h culture, cell viability of printed rat cortical neurospheres was assessed for each 
material and compared to the laminin control (Figure 9-8A). Cell viability was quantified through 
staining with Calcein AM (green) and ethidium homodimer (red) to determine the relative proportion 
of live and dead cell respectively. Cells were imaged using fluorescence microscopy, and the number 
of live and dead cells were determined through ImageJ analysis. Following 24h, no significant viability 
was observed between the 2D control (83.4%) and either of the printed bioinks; however, a significant 
difference (p = 0.0201) was evident between GelMA and the DIKVAV Hybrid bioink, demonstrating 
viabilities of 70.6% and 87.3%, respectively. Following 72h culture, significant viability differences 
were observed between the control (91.8%) and printed samples. Specifically, GelMA demonstrated a 
significantly lower viability (p = 0.0001) of 60.6% compared to the 2D control, while DIKVAV-hybrid 
samples demonstrated significantly lower viabilities (p = 0.0156) of 74.5% compared to the control. 
Despite DIKVAV-hybrid bioink samples demonstrating superior viability to GelMA bioink samples, 
the difference was not significant. This is likely due to increased variance from refracted fluorescent 
light in these 3D bioprinted samples; however, despite lack of a significant difference in 72h viability, 
both printed constructs were shown to support sufficient cell viability.  
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Figure 9-8 – Biological response to scaffolds  A) Cell viability following i) 24h and ii) 72H proliferative 
culture. B) Morphology of cells printed within DIKVAV-Hybrid bioinks (arrows show cellular extensions), C) 
Depth coding of cells within DIKVAV-Hybrid bioinks, and D) cell morphology within DIKVAV-Hybrid bioinks 
showing increased density within feathered region. Scalebar: 100  µm 
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Cell Morphology following 72h proliferative culture was also assessed for DIKVAV-Hybrid 
samples (Figure 9-8B-D). Samples were stained with phalloidin and DAPI to observe actin filaments 
and cell nuclei, respectively. Confocal analysis was completed to verify cell morphology. Clear cell 
extensions are visible in DIKVAV-Hybrid samples with extensive networking evident (indicated by 
arrows) (Figure 9-8B). Furthermore, through depth coding, cells are shown to exist through the sample 
to a depth of 180 µm (Figure 9-8C). Interestingly, confocal staining also showed a greater density of 
cells within the feathered region previously observed (indicated by dashed region) (Figure 9-8D). The 
increase of cell density in this region may be a result of heterogeneity in the printing process; however, 
the altered morphology of these cells warrants future investigation, and potentially allows for the 
development of advanced scaffolds with regions of altered biological response.  
Interactions between cell extensions and bioinks were observed via SEM (Figure 9-9) 
following 3 days in proliferative culture. Despite cell-shrinking during the drying processes, cell 
extensions were clearly evident in both cases, indicating good cell-material integration. 
 
Figure 9-9 – SEM analysis of cells in A) GelMA and B) DIKVAV-Hybrid, Arrows showing cell extensions, 
Scale bar = 100 µm 
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Following 7-days of culture, proliferative media was removed and replaced with differentiation 
media. Confocal analysis was employed to observe morphological response as an indication of 
differentiation following 14 days in differentiation culture (21 days total culture) (Figure 9-10). Depth-
coding of LM-GelMA constructs revealed cell migration to the surface of the construct, with extensive 
cell spreading (Figure 9-10A). Depth-coding of DIKVAV-Hybrid samples demonstrate some 
migration to the surface, with more cells distributed through the construct, however encapsulated cells 
demonstrated poor cell spreading (Figure 9-10C) . Cells in LM-GelMA demonstrate extensive actin 
spreading (green) along the surface of the sample, while cells on the surfaces of DIKVAV-Hybrid 
printed structures show limited spreading (Figure 9-10B, D).  
Despite the poor differentiation of dissociated rat cortical neurospheres in the DIKVAV-Hybrid 
constructs, this material is still found to maintain high viability at high cell density, thus meeting the 
design requirements highlighted in section 2.2. Furthermore, we have verified the efficacy of this 
modular bioink approach for tissue engineering applications, with high cell viability evident following 
printing in the neural-specific DIKVAV-Hybrid bioink, despite the increased sensitivity of neural cells 
to external stresses.401 In this study, we have successfully developed a bioink approach for the printing 
of dissociated rat-cortical neurosphere cells, however further optimisation in bioprinting techniques and 
cell culturing would likely lead to improved cell response. In particular, the culturing of constructs 
within a bioreactor may lead to improved cell response, however this lies outside the scope of this thesis 
and should be a future research focus.49  
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Figure 9-10 – Analysis of cell morphology, migration and spreading following 14 days differentiation in 
LM-GelMA (Top) and DIKVAV-Hybrid (Bottom). A) Depth-coding of cells within LM-GelMA constructs, 
B) Flattened confocal stack showing cell morphology through actin (green) and nuclei (blue) staining in LM -
GelMA samples. C) Depth-coding of cells within DIKVAV-Hybrid constructs,  D) Flattened confocal stack 
showing cell morphology through actin (green) and nuclei (blue) staining in DIKVAV -Hybrid samples. 
(scalebars: 400 µm) 
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9.4 Conclusion 
 
Central nervous system repair is particularly complex owing to the bodies innate inability for self-repair. 
Bioprinting offers a potential resolve, allowing for the controlled spatial deposition of cells, signals, 
and factors within a highly engineered artificial tissue construct. However, currently, few bioinks can 
provide mechanical properties necessitated by cytocompatible bioprinting processes while maintaining 
suitable biological properties to support desired cell behaviour. The design of advanced bioinks 
allowing for high mechanical and biological tunability is investigated in this chapter. Here, LM-GelMA 
is combined with Fmoc-DIKVAV to form an advanced bioink for neural tissue repair. The DIKVAV-
hybrid bioink demonstrates high mechanical tunability owing to LM-GelMA’s unique 
thermodependent viscosity, while biological tunability is facilitated through Fmoc-DIKVAV 
incorporation. Furthermore, the hybrid bioink is shown to maintain the propensity to form covalent 
crosslinks when subject to UV irradiation, allowing for greater resistance to shear strain and a 
maintenance of shape fidelity even after 4 weeks in simulated culture (1× PBS, 37°C). Conservation of 
nanofibril formation is also observed in DIKVAV-Hybrid samples, confirming successful engineering 
of nano through to macro architectures.  DIKVAV-hybrid bioinks show comparable viability of seeded 
and printed rat cortical neurospheres to the gold-standard LM-GelMA control, with seeded rat cortical 
neurospheres also demonstrating enhanced cell morphology in DIKVAV-Hybrid samples compared to 
the LM-GelMA control. Results from this study emphasis the need for future optimisation of cell culture 
practices for 3D applications and provide fundamentals for further material optimisation. Importantly, 
this chapter highlights the versatility of this modular bioink toolkit and provides foundations for further 
comprehensive biological analysis. 
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Chapter Ten: 
 
 
 
10.  
CONCLUSIONS 
 
 
The research performed in this thesis has detailed the design, development, and use of advanced self-
assembling peptide-based scaffolds for tissue engineering applications. In each chapter, materials have 
been rigorously characterised and investigated regarding mechanical properties and/or biological 
influence on cells. Our results demonstrate a systematic approach for the development of advanced 
biomaterials containing Fmoc-based SAPs, with focus on achieving a modular bioink toolkit. In this 
thesis, we engineered hydrogels containing ECM-inspired motifs, including fibronectin’s RGD and 
PHSRN synergistic attachment motifs, and laminin’s IKVAV motif. In all cases, Fmoc-SAP assembly 
was triggered via charge neutralisation as enabled through a pH switch method, resulting in the 
formation of long nanofibrils through π-β assembly as facilitated through hierarchical self-organisation 
of short, Fmoc-based peptides. 
The ultimate aim of this project was to develop advanced fmoc-SAP based hydrogel systems 
for tissue engineering applications, with a focus on the formation of fmoc-SAP containing bioinks for 
soft-tissue engineering applications. These aims were achieved through sequential development of 
Fmoc-based self-assembling peptide systems. The research detailed in this thesis progressed from 
material functionalisation through sequence alteration, to structural and biological modification through 
macromolecule incorporation. Key understandings acquired during material functionalisation chapters 
were then applied for the development of Fmoc-based SAP-containing bioinks.  
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Specifically, early material development focused on the potential of multisequence 
functionalisation through control over the assembly mechanism. The incorporation of two fibronectin 
derived synergistic epitopes, RGD and PHSRN were investigated in ability to enhance HMFCs 
viability, proliferation, and spreading. Here, the effect of assembly mechanism was also investigated 
with peptide coassembly compared to sequence concatenation, or either sequence alone. Coassembly 
resulted in improved adhesion, proliferation, and spreading compared to the concatenated version or 
either sequence alone. The ability of these peptides to form coassembled, multisequence hydrogels was 
further observed through coassembly of a Fmoc-SAP containing fibronectin’s RGD motif, and a second 
Fmoc-SAP containing laminin’s IKVAV sequence. The utility of this material was investigated for use 
as an advanced cancer model, with comprehensive analysis comparing the effect of the cell environment 
regarding both cell-cell and cell-ECM communication. Results found that co-cultured spheroids 
containing both NOR-10 fibroblasts and Lewis lung cancer cells demonstrated greater cancer-like 
properties when encapsulated within the coassembled microenvironment containing RGD and IKVAV 
compared to an agarose control. Specifically, NOR-10 and LLC cells co-cultures encapsulated in Fmoc-
DIKVAV/Fmoc-FRGDF hydrogels demonstrated enhanced motility, and metabolic activity, with a 
higher degree of NOR-10 differentiation into CAF.  
We further investigated hydrogel functionalisation through the incorporation of 
developmentally and structurally important macromolecules. Here, fucoidan and versican were 
incorporated during Fmoc-SAP assembly, resulting in the formation of a multicomponent hydrogel. 
Influence of macromolecule incorporation on resultant assembly, structure, and mechanical properties 
were extensively evaluated. The coassembly of fucoidan and Fmoc-FRGDF resulted in increased fibre 
bundling proportional to fucoidan concentration. Subsequently, Fmoc-FRGDF/fucoidan coassembly 
demonstrated enhanced stiffness as assessed through rheology. Biologically, fucoidan addition did not 
affect myoblast (C2C12) proliferation and viability, but strongly influenced cell morphology, resulting 
in reduced cell surface area and an overall reduction of multinucleated syncytia. Similarly, versican 
addition had no significant effect on C2C12 proliferation and viability; however, morphology was 
greatly affected, with smaller cells evident at 24h compared to the empty vector control. After 72h 
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however, cells demonstrated similar morphologies to the empty vector control, and number of 
multinucleated syncytia was unaffected. 
Next, we demonstrated the ability Fmoc-SAPs to form hybrid bioinks through the incorporation 
of charged photo-crosslinkable materials. Specifically, GelMA was incorporated with Fmoc-FRGDF 
and Fmoc-PHSRN during assembly to form a hybrid material which elicits desirable mechanical and 
biological properties. Initially, the DoF of GelMA hydrogels was investigated regarding nanostructure 
and viscoelastic properties through SAXS and rheology respectively. Here, unique trends were observed 
tying nanostructure organisation to their associated effect on material viscoelasticity. Low-
Methacryloyl GelMA (18% DoF) was selected for hybrid bioink development owing to its heightened 
gel/sol transition temperature and excellent resistance to shear strain. We further extended this research 
into the development of a hybrid LM-GelMA/Fmoc-FRGDF/Fmoc-PHSRN bioink (FPG-Hybrid). 
Analysis of FPG-Hybrid bioink nanostructure found the preservation of nanofibrils, indicating a 
maintenance of nanofiber formation despite the presence of GelMA. Conformational changes of the 
bioinks were investigated through SAXS, wherein mass fractal dimension (power) increased upon 
crosslinking for both LM-GelMA and FPG-Hybrid, indicating the formation of chemically crosslinked, 
branched networks. Importantly, the FPG-Hybrid demonstrated enhanced printability, with optimal 
printing conditions existing at ~15°C compared to ~10°C in LM-GelMA samples. FPG-Hybrid bioinks 
maintained high cell viability following 72h culture (>98% viability) and facilitated early differentiation 
as assessed by multinucleated myotube formation. 
Finally, the utility of the hybrid bioink model for use as a bioink toolkit was investigated 
through substitution of Fmoc-FRGDF/Fmoc-PHSRN nanofibers for Fmoc-DIKVAV nanofibers, 
allowing for the targeting of neuronal tissue types. DIKVAV-Hybrid bioinks were assembled as FPG-
Hybrids; however, prior to assembly Fmoc-FRGDF/Fmoc-PHSRN was substituted with Fmoc-
DIKVAV.  DIKVAV-Hybrids demonstrated highly similar mechanical properties to FPG-Hybrid 
bioinks, highlighting the ease of biological tunability in these systems. DIKVAV-Hybrid bioinks, 
however, elicit unique swelling characteristics, with the formation of a feathered border following 10 
minutes culture. DIKVAV-Hybrids supported enhanced seeded rat cortical neurosphere viability and 
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facilitated neuronal extensions, while cells seeded on LM-GelMA constructs presented with more 
clustered morphologies; furthermore, printed rat cortical neurospheres within DIKVAV-Hybrid bioinks 
demonstrated high viability (87.3%) following 72h culture. These results highlight the potential of 
Fmoc-SAPs/GelMA systems as modular bioink toolkits for advanced tissue engineering applications 
and warrant further biological investigation and optimisation. 
In conclusion, we successfully achieved the aims set out within this project, resulting in the 
development of a modular Fmoc-SAP-based bioink toolkit for cytocompatible bioprinting allowing for 
the controlled deposition of cells, structures, and signals within predefined geometries. Bioinks 
developed through this approach boast ease of mechanical and biological tunability, allowing for tissue-
specific signalling and nano- through to macro control over bioink architecture.  
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Chapter Eleven: 
 
 
 
11.  
FUTURE DIRECTIONS 
 
 
In this thesis, we described the development of advanced Fmoc-SAP-based strategies to improve current 
tissue engineering applications and allow for the development of a functionalised, modular bioink 
toolkit. The results of this thesis demonstrate the versatility of Fmoc-SAPs for tissue engineering 
applications and establish the potential for biological functionalisation and mechanical tunability. 
Ultimately, this thesis establishes Fmoc-SAPs as a platform for the modification and development of 
advanced bioink toolkits through assembly with favourable macromolecules for use with a range of 
tissues. The potential use of Fmoc-SAP-based bioinks, however, can be further explored through 
extension in several directions. 
Firstly, as a furthering of work in Chapter 5, the utility of the cancer model containing 
spheroids encapsulated in Fmoc-FRGDF/Fmoc-DIKVAV could be further investigated through testing 
of anti-cancer drugs on encapsulated hydrogels, comparing their response to drug-free samples. Here, 
the anti-inflammatory polysaccharide fucoidan could be investigated, as previous use has indicated anti-
cancer properties and its integration within Fmoc-SAP hydrogels is well known. Similarly, as a 
furthering of Chapter 6, further research could be placed into assessing the mechanisms of surface 
versican degradation, resulting in attenuation of cell spreading. 
Secondly, as a continuation of work performed in Chapter 7, future works should focus on 
kinetics modelling of GelMA’s structure-function relationships through the pairing of in situ SAXS and 
rheological data to gain a deeper understanding of structure-function dependencies. Threshold 
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concentrations should also be investigated further, particularly in relation to DoF, as there are 
preliminary indications of DoF-related concentration dependencies within our data. Effect of increased 
DoF on molecular weight should also be investigated, as preliminary results indicate an inverse 
relationship. Crosslinking temperature and subsequent effect on nanostructured properties should also 
be investigated to gain a more robust understanding of mechanical synergies resulting from the interplay 
between physical and chemical crosslinks.  
 Thirdly, as a furthering of work performed in Chapter 7 and Chapter 8, the potential for 
mechanical tunability of Fmoc-SAP Hybrid bioinks could be further investigated through control of 
DoF. Specifically, hybrid bioinks could be developed using differing degrees of methacrylation to alter 
final modulus, shear resistance, thermodependent viscoelasticity, and nano-/microarchitectures.  
Fourthly, as an extension of Chapter 9, other peptide nanofibers or macromolecules could be 
incorporated into the hybrid bioink system, allowing for tailored and targeted cell signalling, resulting 
in tissue-specific bioink development while maintaining the modular nature of the developed bioink 
toolkit. The developed DIKVAV-Hybrid bioink could potentially be expanded for the development of 
neuromuscular junctions, with neural cells existing within the feathered, Fmoc-DIKVAV, region of the 
hydrogel, and muscle fibres forming on the surface of the GelMA core. However, research first needs 
to be placed into increasing and enhancing the longevity of this feathered region.  
Fifthly, as a continuation of work in Chapter 8 and Chapter 9, further cell analysis through 
molecular biology could be completed to comprehensively and systematically assess any differences 
between cells cultured on the hybrid materials compared to the control. In particular, further cell 
analysis should quantify differentiation and cell maturity. Investigation into optimal cell seeding density 
within these materials would also be of substantial benefit, as cell seeding density influences cell 
behaviour and material longevity. 
Further research in this area will require a multidisciplinary approach that encompasses the 
knowledge and understandings acquired in materials science, advanced manufacturing, and biology. 
Building on the foundations presented in this thesis, future research and development could 
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substantially advance current bioink and 3D scaffold technologies, yielding new treatment prospects 
for the regeneration and repair of once damaged, diseased, or lost tissue.  
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APPENDIX 
 
 
Supplementary Figure S - 1 – Structure of post-assembled Fmoc-FRGDF + fucoidan hydrogels.  A) AFM 
of post-assembled Fmoc-FRGDF + fucoidan network showing lack of bundle formation and presence of 
aggregates. B) CD spectra for the control gel (fucoidan added post assembly) vs. Fmoc -FRGDF C) full 
fluorescence emission spectra for the samples D) Control vs Fmoc-FRGDF of the feature centred on 495 nm E) 
Frequency sweep analysis of a solution of 10 mg/mL fucoidan showing no significant elastic contribution to 
the system. 
 
Supplementary Figure S - 2 – Structural properties of agarose and Fmoc-FRGDF/Fmoc-DIKVAV 
coassembled hydrogels. A) Inverted hydrogels showing structural stability, B) Resultant P(r) curve from IFT 
P(r) analysis of Fmoc-FRGDF/Fmoc-DIKVAV coassembled hydrogel SAXs Data. 
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Supplementary Figure S - 3 – Small-angle X-ray scattering curves. A) 6% GelMA Hydrogels, and B) 10% 
GelMA Hydrogels.  
 
Supplementary Figure S - 4 – Fitting of small-angle X-ray scattering curves. A) Fitting for power-law 
model (mass fractal dimension) in i) 6% GelMA Hydrogels, and ii) 10% GelMA Hydrogels.  B) Fitting for 
correlation length model in i) 6% GelMA Hydrogels, and ii) 10% GelMA Hydrogels. C) Fitting for two -power 
model (mesh size) in i) 6% GelMA Hydrogels, and ii) 10% GelMA Hydrogels.  
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Supplementary Figure S - 5 – Viscoelastic properties of GelMA with differing DoFs A) G’ and G” response 
to temperature change showing lack of traditional fluidic state of some DoF samples. B) Complex Stress 
response to strain in 6% GelMA samples showing effective yield point (arrows). C) Complex Stress response 
to strain in 10% GelMA samples showing effective yield point (arrows).  
 
Supplementary Table S - 1 – Comparison of Loss tangent < 1 and Loss tangent <  0.1 in 6% GelMA 
hydrogels. 
 
Supplementary Table S - 2 - Comparison of Loss tangent < 1 and Loss tangent <  0.1 in 10% GelMA 
hydrogels. 
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Supplementary Table S - 3 – Molecular Weight and Number of 18% DoF and 80% DoF GelMA.  
 
 
 
 
Supplementary Figure S - 6 – Heatmap showing Pearson r values as an indication of correlations between 
investigated variables as calculated through Pearson correlation test.  
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Supplementary Figure S - 7 – Viscoelastic Properties of GelMA hydrogels at different DoF and 
concentration. A) G’ and G” response to cooling in i) 6% GelMA and ii) 10% GelMA samples. B) G’ and G” 
response to i) crosslinking in 6% GelMA samples and ii) shear -strain in 6% GelMA samples. C) G’ and G” 
response to i) crosslinking in 10% GelMA samples and ii) shear -strain in 10% GelMA samples.  
 
Supplementary Figure S - 8 – Inversion test showing stable gel formation in Fmoc-SAP containing 
hydrogels (Coassembled and Hybrid) at room temperature (23 °C) 
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Supplementary Figure S - 9 - Fitting of small-angle X-ray scattering curves. A) Fitting for power-law model 
(mass fractal dimension) in coassembled (Fmoc-FRGDF/Fmoc-PHSRN), LM-GelMA. And FPG-Hybrid 
samples. B) Fitting for correlation length model in coassembled  (Fmoc-FRGDF/Fmoc-PHSRN), LM-GelMA. 
And FPG-Hybrid samples. C) Fitting for two-power model (mesh size) in coassembled (Fmoc-FRGDF/Fmoc-
PHSRN), LM-GelMA. And FPG-Hybrid samples. D) Fitting for P(r) for coassembled (Fmoc-FRGDF/Fmoc-
PHSRN) hydrogels 
 
Supplementary Table S - 4 – Porod values for LM-GelMA and FPG-Hybrid samples as determined 
through fitting to the correlation length model . 
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Supplementary Figure S - 10 – Spectroscopic analysis of coassembled (Fmoc-FRGDF/Fmoc-PHSRN), 
LM-GelMA, and FPG-Hybrid hydrogels showing GelMA dominance. A) Circular Dichroism analysis, B) 
Fluorescence spectroscopy, C) FT-IR Spectroscopy. 
 
Supplementary Figure S - 11 - Bioink Properties A) Rate of change of LM-GelMA and FPG-Hybrid in 
response to crosslinking as calculated through analysis of in -situ crosslinking rheological data. Red line 
indicates defined level of effective crosslinking (0.1% s -1) B) Demonstration of G-code print as printed using 
commercial, non-cytocompatible CELLINK® START. C) Coassembled (Fmoc-FRGDF/Fmoc-PHSRN) printed 
construct showing poor printability.  
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Supplementary Figure S - 12 – microscopic images showing material longevity past 4 weeks simulated 
culture (1 × PBS, 37°C). A) LM-GelMA following i) 1 hour and ii) 4 weeks simulated culture. B) FPG-Hybrid 
following i) 1 hour and ii) 4 weeks simulated culture.  
 
Supplementary Figure S - 13 – representative microscopic images showing material stability with and 
without primary myoblasts after 3h culture . A) LM-GelMA i) without cells and ii) with cells. B) FPG-Hybrid i) 
without cells and ii) with cells. FPG-Hybrid stability is substantially compromised following cell addition.  
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Supplementary Figure S - 14 – Inversion test showing stable gel formation in Fmoc-SAP containing 
hydrogels (Fmoc-DIKVAV and DIKVAV-Hybrid) at room temperature (23°C) 
 
Supplementary Figure S - 15 - Spectroscopic analysis of Fmoc-DIKVAV, LM-GelMA, and DIKVAV-
Hybrid hydrogels showing GelMA dominance. A, B) Circular Dichroism, C) FT-IR Spectroscopy 
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Supplementary Figure S - 16 – Bioink Printability and crosslinking properties. A) Rate of change of LM-
GelMA and DIKVAV-Hybrid in response to crosslinking as calculated through analysis of in -situ crosslinking 
rheological data. Red line indicates defined level of effective crosslink ing (0.1% s-1). B) Fmoc-DIKVAV 
printed construct showing very poor printability. C) Printability of LM -GelMA at i) 10°C, ii) 15°C, and iii) 
room temperature (23°C). D) Printability of LM-GelMA at i) 10°C, ii) 15°C, and iii) room temperature (23°C). 
Printability assessed visually through ability to form grid structure.  
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Supplementary Figure S - 17 – Microscopic images showing longevity of material and feathered region 
over 4 weeks simulated culture (1 × PBS, 37°C). A) LM-GelMA following i) 9 hours, ii) 24 hours, iii)2 weeks, 
and iv) 4 weeks simulated culture. B) FPG-Hybrid following i) 9 hours, ii) 24 hours, iii)2 weeks, and iv) 4 weeks 
simulated culture. C) Feathered region following i) 9 hours and ii) 24 hours  simulated culture. 
 
Supplementary Figure S - 18 – Viability of 2D laminin control over 3-day culture. 
